Professional Documents
Culture Documents
Addendums
If addendums are published during the lifespan of this edition replace pages with amended
pages. Please document addition and removal of pages
Page removed
Page
No.
ii
Date
Name
Page added
Signature
Page
no.
Uncontrolled
Controlled copy
copy
V1.0
Date
Name
Signature
Table of contents
Table of contents
Table
of contents
Foreword
xii
xii
xvi
xvi
xx
xx
xxiv
xxiv
Foreword
Acknowledgements
Acknowledgements
Abbreviations
Abbreviations
Terminology
Terminology
Introduction
Introduction
Section
2.
Section
2. Emergency
Emergency
Resuscitation
Resuscitation
DRS ABCD resuscitation / the collapsed patient - adult / child / infant
DRS ABCD resuscitation / the collapsed patient - adult / child / infant
Basic life support flowchart - adult / child / infant
Basic life support flowchart - adult / child / infant
Cardiorespiratory arrest - adult / child
Cardiorespiratory arrest - adult / child
Advanced life support - adult
Advanced life support - adult
Advanced life support - child / infant
Advanced life support - child / infant
Oxygen delivery systems - adult / child
Oxygen delivery systems - adult / child
Insertion of laryngeal mask airway (LMA)
Insertion of laryngeal mask airway (LMA)
Intraosseous infusion - adult / child
Intraosseous infusion - adult / child
Unconscious / altered level of consciousness (LOC) - adult / child / infant
Unconscious / altered level of consciousness (LOC) - adult / child / infant
Shock - adult / child
Shock - adult / child
Acute upper airway obstruction and choking - adult / child
Acute upper airway obstruction and choking - adult / child
Anaphylaxis and severe allergic reaction - adult / child
Anaphylaxis and severe allergic reaction - adult / child
Anaphylaxis flowchart
Anaphylaxis flowchart
Fits / convulsions / seizures - adult / child
Fits / convulsions / seizures - adult / child
Diabetic ketoacidosis (DKA) - adult / child
Diabetic ketoacidosis (DKA) - adult / child
Hypoglycaemia - adult / child
Hypoglycaemia - adult / child
Acute asthma - adult / child
Acute asthma - adult / child
Drowning - adult / child
Drowning - adult / child
Breathlessness - adult / child
Breathlessness - adult / child
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
33
33
34
34
35
35
39
39
40
40
41
41
44
44
46
46
49
49
52
52
55
55
58
58
60
60
62
62
66
66
68
68
70
70
75
75
76
76
iii
Table of contents
Cardiovascular emergencies
Chest pain - adult
Acute pulmonary oedema - adult
Cardiac arrhythmias - adult / child
Electrocution / electric shock - adult / child
4 Acute hypertensive crisis - adult
Acute arterial occlusion - adult
Neurological emergencies
Subarachnoid haemorrhage (SAH) - adult / child
Transient ischaemic attack (TIA) and stroke - adult / child
Trauma and injuries
Trauma and injuries - adult / child
Criteria for Early Notification of Trauma for Interfacility Transfer
Chest injuries - adult / child
Head injuries - adult / child
Decision making for escalation and CT scanning - adult / child
Spinal injuries - adult / child
Abdominal injuries - adult / child
Fractures, dislocations and sprains
Fractures, dislocations and sprains - adult / child
Simple fracture of limbs - adult / child
Compound fractures - adult / child
Fractured pelvis - adult / child
Fractured mandible / jaw - adult / child
Dislocations - adult / child
Sprains - adult / child
Compartment syndrome - adult / child
Acute wounds
Acute wounds - adult / child
Marine lacerations - adult / child
Human (tooth-knuckle) and animal bites - adult / child
Bat bite / scratch - adult / child
Subungual (under the fingernail or toenail) haematoma - adult / child
Burns
Burns - adult / child
Major burns - adult / child
Minor burns - adult / child
Chemical burns - adult / child
Environmental emergencies
Decompression illness (DCI / bends) - adult / child
Hypothermia - adult / child
Heat exhaustion / heat stroke / hyperthermia - adult / child
Ear nose and throat emergencies
Nose bleed / epistaxis - adult / child
79
87
91
92
93
95
98
99
102
106
110
114
118
120
122
125
125
130
131
132
134
135
136
139
149
152
155
155
156
159
163
165
168
170
172
175
iv
Uncontrolled
Controlled copy
copy
V1.0
Table of contents
Gastrointestinal emergencies
Acute abdominal pain - adult / child
178
A
lcohol related epigastric pain - adult
182
Upper gastrointestinal bleeding - adult / child
185
Rectal bleeding - adult / child
186
Bowel obstruction - adult / child
188
Genitourinary emergencies
R
enal colic - adult
189
Acute retention of urine - adult / child
192
Testicular / scrotal pain - adult / child
193
Poisoning and drug emergencies
Poisoning / overdose general approach - adult / child
196
Specific poisons
200
Anticholinergic agents - adult / child
200
Anticonvulsants - adult / child
201
Sodium valproate - adult / child
201
Carbamazepine - adult / child
202
Phenytoin - adult / child
202
Other anticonvulsants - adult / child
203
Antidepressants - adult / child
203
Selective serotonin reuptake inhibitors (SSRIs) - adult / child
203
Tricyclic antidepressants (TCAs) - adult / child
204
Antihistamines - adult / child
205
Antipsychotics - adult / child
205
Typical 205
Atypical
206
Aspirin / salicylates - adult / child
207
Carbon monoxide - adult / child
208
Caustic substances - adult / child
209
Cyanide - adult / child
209
Eucalyptus oil - adult / child
210
Hydrocarbons (including many oils) - adult / child
211
Iron - adult / child
212
Lithium - adult / child
213
Non-steroidal anti-inflammatory drugs (NSAID) - adult / child
214
O
pioids - adult
215
Organophosphates - adult / child
216
Paracetamol - adult / child
218
Paraquat - adult / child
219
Recreational drugs - adult / child
220
Amphetamines and cocaine - adult / child
220
Cannabis (marijuana) - adult / child
221
Gamma-hydroxybutrate (GHB) - adult / child
222
Petrol / glue / aerosol sniffing - adult / child
222
Sedative / hypnotics - adult / child
224
4
4
Uncontrolled
Controlled copy
copy
V 1.0
Table of contents
4
4
4
4
238
238
238
241
243
244
245
246
248
250
250
251
Section 3. General
253
255
Respiratory problems
Upper respiratory tract infection (URTI) - adult
Acute bacterial sinusitis - adult / child
Pneumonia - adult
Tuberculosis - adult / child
258
261
262
265
267
269
273
274
275
276
279
280
281
283
Eye problems
Assessment of the eye - adult / child
Red or painful eye - adult / child
Foreign body / corneal abrasion - adult / child
Flash burn to eye - adult / child
Chemical burn to eye - adult / child
Blunt eye injury - adult / child
Penetrating eye injury - adult / child
Sudden loss of vision - adult / child
Orbital cellulitis / periorbital cellulitis - adult / child
Conjunctivitis - adult / child
Bacterial conjunctivitis - adult / child
Viral conjunctivitis - adult / child
Allergic conjunctivitis - adult / child
Acute gonococcal and chlamydial conjunctivitis - newborn
Trachoma - adult / child
Corneal ulceration - adult / child
286
289
290
292
293
295
297
299
300
301
301
302
304
304
305
306
vi
Uncontrolled
Controlled copy
copy
V1.0
Table of contents
Episcleritis and scleritis - adult / child
307
Acute iritis - adult / child
308
Acute glaucoma - adult / child
309
Urinary tract problems
Urinary tract infection (UTI) - adult
311
Skin problems
Assessment and examination of skin, hair and nails - adult / child
314
Bacterial skin infections - adult / child
315
Impetigo - adult / child
315
4
Folliculitis / furunculosis (boils) / carbuncles - adult / child 320
Cellulitis / erysipelas - adult / child
322
Fungal skin infections
326
Tinea / ringworm - adult / child
326
Candidiasis - adult / child
328
Tinea versicolor / pityriasis versicolor - adult / child
330
Leprosy - adult / child
331
Skin parasites
333
Scabies - adult / child
333
Head lice / nits - adult / child
336
Nappy rash - child
338
Foot infection with diabetes
Infection in foot of patient with diabetes
340
Osteomyelitis in the foot of patient with diabetes
342
Chronic wounds
Chronic wounds - adult / child
343
Essential guidelines for assessment of lower limb ulcers
345
Description of wound dressings
346
Epithelialising superficial wounds
348
Clinically infected wounds
348
How to collect a wound swab / culture
348
Granulating wounds
349
Sloughy or necrotic wounds
349
Fungating wounds
350
Malodorous wounds
350
Communicable diseases
Acute hepatitis A - adult / child
351
Acute hepatitis B - adult / child 352
Acute hepatitis C - adult / child
354
Ross River Fever and Barmah Forest Virus - adult / child
355
Dengue - adult / child
356
Chronic diseases
358
Secondary prophylaxis for acute rheumatic fever (ARF) - adult / child
Chronic asthma - adult / child
360
4 Chronic obstructive pulmonary disease (COPD) - adult
361
Hypertension - adult
362
Chronic kidney disease (CKD) - adult
363
Chronic heart disease (CHD) - adult
364
Diabetes - adult / child
365
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
vii
Table of contents
367
369
376
379
386
388
390
392
392
395
396
Eating disorders
Eating disorders - adult / adolescent
399
Sleep problems
Sleep problems - insomnia - adult / child
401
Alcohol misuse
Alcohol misuse - adult / child
Acute alcohol intoxication - adult / child
Alcohol withdrawal - adult
403
408
411
Smoking
Tobacco smoking - adult / child
414
417
419
421
425
433
435
436
437
viii
Uncontrolled
Controlled copy
copy
V1.0
Table of contents
Labour, birth and postnatal care
Normal labour and birth
1st stage of labour
Transition
2nd stage of labour
Birth
Care of the newborn
3rd stage of labour
Rh D immunoglobulin
Postpartum haemorrhage (PPH)
Primary postpartum haemorrhage
Secondary postpartum haemorrhage
Episiotomy and repair of perineum
Neonatal resuscitation
Newborn life support
Mastitis / breast abscess
Postnatal check up
Contraception
Contraception - adult
Combined hormonal contraception - adult
Missed pill flowchart
Progestogen only pill - adult
Long-acting hormonal contraception - adult
Sub-dermal progestogen implant - adult
Emergency contraception - adult
Barrier methods of contraception - adult
Condoms
Diaphragm - adult
Intrauterine contraceptive device (IUCD) - adult
Sterilisation - adult
Natural methods - adult
Uncontrolled
Controlled copy
copy
V 1.0
439
440
441
442
445
445
446
447
449
451
453
455
457
460
461
463
463
467
467
468
470
470
472
475
475
479
480
482
485
486
488
490
492
496
498
500
503
503
505
505
505
506
507
507
ix
Table of contents
Section 6. Paediatrics
555
Paediatric presentation
History and physical examination - child
557
Diagnostic and pathology services
564
Consulting the Medical Officer (MO)
564
Child with fever
565
Child with cough
566
Child with stridor
567
Child with vomiting
568
Child with abdominal pain
569
Child with chronic diarrhoea 570
Meningitis
Meningitis - child
571
573
576
578
579
580
Respiratory problems
Upper respiratory tract infection (URTI) - child
Pertussis (whooping cough) - adult / child
Croup / epiglottitis - child
Bronchiolitis - child
Pneumonia - child
Immune complications
Acute post streptococcal glomerulonephritis (APSGN) - child
Acute rheumatic fever (ARF) - adult / child
583
587
Ear problems
Assessment of the ear - adult / child
Ear infections - adult / child
Uncontrolled
Controlled copy
copy
V1.0
591
593
Primary Clinical Care Manual 2013
Table of contents
595
598
601
603
606
607
607
608
609
610
611
613
613
615
618
622
623
625
628
630
631
632
635
641
643
645
Section 7. Immunisation
651
Immunisation
Immunisation program - adult / child
Sexual health immunisation program - adult
Tetanus immunisation - adult / child
Appendices
661
Index
653
656
658
663
664
665
667
668
Controlled
Uncontrolled
copy
copy
V 1.0
xi
Foreword
Anita Hansen
General Manager, Health Services
Queensland Health
The Primary Clinical Care Manual (PCCM) 8th edition provides Clinical Care Guidelines
and Health Management Protocols, especially for Scheduled Medicines Rural and Isolated
Practice Registered Nurses and authorised Aboriginal and Torres Strait Islander Health
Workers to administer and supply medications. The interventions recommended in the
PCCM 8th edition are evidence based and are in accordance with the Health (Drugs and
Poisons) Regulation 1996.
The PCCM 8th edition is the result of a successful partnership between Queensland Health
staff and the staff of the Royal Flying Doctor Service (Queensland Section).
The PCCM 8th edition is the principal clinical reference and policy document for health
professionals working in rural and remote Queensland. It contains Health Management
Protocols that support the advanced practice of authorised Aboriginal and Torres Strait
Islander Health Workers, Scheduled Medicines Rural and Isolated Practice Registered
Nurses, Authorised Sexual and Reproductive Health Registered Nurses and Immunisation
Program Authorised Registered Nurses. These Health Management Protocols set out the
circumstances, conditions and restrictions under which medicines listed in the Drug Therapy
Protocols can be used.
Queensland Health staff working in rural and remote ambulatory care settings use the Clinical
Care Guidelines and Health Management Protocols contained in the PCCM 8th edition as
their guide to practice. I commend the PCCM 8th edition as the principal clinical reference
and policy document to Queensland Healths rural and remote practitioners.
Dr Tony OConnell
Director-General, Queensland Health
xii
Uncontrolled
Controlled copy
copy
V1.0
Foreword
Robyn Walker AM
Rear Admiral, RAN
Surgeon General, Australian Defence Force
Uncontrolled
Controlled copy
copy
V 1.0
xiii
Foreword
Susan Pearce
Chief Nursing and Midwifery Officer, NSW Health
Adjunct Associate Professor, University of Sydney
xiv
Uncontrolled
Controlled copy
copy
V1.0
Foreword
Michael DiRienzo
Michael DiRienzo
Chief Executive
Uncontrolled
Controlled copy
copy
V 1.0
xv
Acknowledgements
Acknowledgements
Primary Clinical Care Manual 8th edition, editorial committee
Dr Anna Morgan, Chair, Executive Director of Medical Services, Cape York Hospital
and Health Service
Kathryn Dougherty, Clinical Nurse Consultant, Clinical Manuals (Rural and Remote
Research), Rural and Remote Clinical Support Unit, Cape York Hospital and Health Service
Dr Dean Taylor, Principal Medical Officer, Royal Flying Doctor Service (Queensland
Section), Cairns
Commander Darren Delaney, Duty Fleet Medical Officer, Royal Australian Navy Reserves
Dr Aaron Hollins, Public Health Registrar, James Cook University, Queensland
Aboriginal and Islander Health Council (QAIHC), Atherton
David Graff, Clinical Nurse, Esk Hospital, West Moreton Hospital and Health Service
Fiona Bittlestone, Outreach Pharmacist, Cape York Hospital and Health Service
Jo Mahony, Nurse Manager, Royal Flying Doctor Service (Queensland Section), Charleville
Josslyn Tully, Manager Health Worker Services, Cape York Hospital and Health Service
Maree Cummins, Nurse Manager - Aeromedical Training and Clinical Resources,
Royal Flying Doctor Service (Queensland Section)
Michael Maw, Nurse Practitioner (Emergency), Executive Director: The MORDUN Group
Peter McCormack, Manager Clinical Quality and Safety, Rural and Remote Clinical
Support Unit, Cape York Hospital and Health Service
Rosemary Schmidt, Contract Manager, Acting Research Governance Officer, Cape
York Hospital and Health Service
Susan Muirhead, Nurse Educator, Rural and Isolated Practice, Cunningham Centre,
Cairns, Darling Downs Hospital and Health Service
Sue Crocker, Nursing Director, Rural and Remote Education and Research, Cunningham
Centre, Cairns, Darling Downs Hospital and Health Service
Specialist input reproductive health
Professor Michael Humphrey, Clinical Advisor, Rural and Remote Clinical Support Unit,
Cape York Hospital and Health Service. Chair, Queensland Maternal and Perinatal
Quality Council
The Primary Clinical Care Manual editorial committee gratefully acknowledges the
contribution of clinicians and other stakeholders who participated in the development
and endorsement of the 8th edition
Section 1. Patient assessment and transport
Dr Mark Elcock, State Medical Director, Retrieval Services Queensland
Maree Cummins, Nurse Manager - Aeromedical Training and Clinical Resources,
Royal Flying Doctor Service (Queensland Section)
Susan Muirhead, Nurse Educator, Rural and Isolated Practice, Cunningham Centre,
Cairns, Darling Downs Hospital and Health Service
Section 2. Emergency
Dr Richard Mulcahy, Emergency Physician, Cairns Hospital
Dr Richard Stone, Emergency Physician, Cairns Hospital
Carol Wylie, Manager, Queensland Poisons Information Centre
Dr Colin Page, Toxicologist, Staff Specialist, Princess Alexandra Hospital. Queensland
Poisons Information Centre
Associate Professor Michael Muller, Staff Surgeon Burns, Trauma Service, Royal
Brisbane Women's Hospital
Siobhan Connolly, Burn Prevention / Education Officer, NSW Statewide Burn Injury
Service Agency for Clinical Innovation
xvi
Uncontrolled
Controlled copy
copy
V1.0
Acknowledgements
Section 3. General
Royal Flying Doctor Service (Queensland Section), Medical Officers
-- Dr Walter Dietz
-- Dr Adam Pritchard
-- Dr Dean Murray
-- Dr Liza Robertson
Statewide Respiratory Clinical Network
-- Dr Rick Sapsford, General Practitioner Brisbane, Representative General Practice,
Queensland
-- Dr Stephen Vincent, Physician, Cairns Hospital
-- Dr Graham Simpson, Physician, Cairns Hospital
-- Carmel Cochrane, Nursing Director, Queensland Tuberculosis Control Centre
Statewide Stroke Clinical Network
Office of the Chief Dental Officer
-- Dr Ben Stute, Director, Oral Health Outcomes, Office of the Chief Dental Officer,
Queensland Department of Health
-- Linda Bertram, Principal Advisor, Oral Health Programs, Manager, Oral Health
Programs
Statewide Diabetes Clinical Network - Statewide Diabetic Foot Working Group
Dr Trent Yarwood, Public Health Registrar, Communicable Disease Control, Cairns
Public Health Service
Dr Enzo Binotto, Staff Specialist, Infectious Diseases and Clinical Microbiology
Section 4. Mental health and substance misuse
Statewide Dementia Clinical Network
Statewide Mental Health Alcohol and Other Drugs Clinical Network
Anthony Weller, Mental Health Nurse Educator, Rural and Remote Mental Health
Service, Cairns and Hinterland Mental Health Alcohol and Other Drugs Service
Dr Geraldine M Dyer, Psychiatrist, Remote Area Child and Youth Mental Health Service,
Cairns and Hinterland Mental Health Alcohol and Other Drugs Service
Professor Ernst Hunter, Regional Psychiatrist, Remote Area Mental Health Service,
Cairns and Hinterland Mental Health Alcohol and Other Drugs Service
Samuel Schefe, Manager, Mental Health Alcohol and Other Drugs Service, Cape York
Hospital and Health Services
Isobel Moase, Program Developer - Standardisation and Clinical Practice, Royal Flying
Doctor Service (Queensland Section), Cairns
Dr Mark Daglish, Director of Addiction Psychiatry, Alcohol and Drug Service, Royal
Brisbane and Women's Hospital Brisbane
Section 5. Sexual and reproductive health
Dr Caroline Harvey, Medical Director, Family Planning Queensland
Rachel Slinger, Clinical Midwifery Consultant, Midwife Practitioner Candidate, Outreach
Midwife to Coen and Lockhart River, Cape York Hospital and Health Service
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
xvii
Acknowledgements
Margot Kingston, Nurse Practitioner, Sexual Health and HIV Services, Primary and
Community Health Services, Metro North Hospital and Health Service
Dr Patricia Fagan, Public Health Physician-Sexual Health, Public Health Unit, Cairns
Joanne Leamy, Clinical Nurse Consultant, Contact Tracing, Sexual Health Service
Cairns and Hinterland Hospital and Health Service
Professor Michael Humphrey, Clinical Advisor, Rural and Remote Clinical Support Unit,
Cape York Hospital and Health Service. Chair, Queensland Maternal and Perinatal
Quality Council
Susan Muirhead, Nurse Educator, Rural and Isolated Practice, Cunningham Centre,
Cairns, Darling Downs Hospital and Health Service
Jacki Doolan, Program Officer, Queensland Maternity and Neonatal Clinical Guidelines
Program, Queensland Department of Health
Statewide Diabetes Clinical Network - Diabetes in Pregnancy Working Group
Charlene Vogler, Sexual Health Worker, Sexual Health Service Cairns and Hinterland
Hospital and Health Service
Dr Anna Morgan, Executive Director of Medical Services, Cape York Hospital and
Health Service
Section 6. Paediatrics
Statewide Child and Youth Clinical Network
-- Associate Professor Andrew White, James Cook University and Staff Paediatrician,
The Townsville Hospital
-- Dr Anne Kynaston, Staff Paediatrician, Royal Children's Hospital
-- Dr David Levitt, Director of General Paediatrics, Mater Health Services, Brisbane
-- Dr Elena Mantz, Staff Paediatrician, Cairns Hospital
Jenny Costello, Child Protection Coordinator (North Queensland), Townsville Hospital
and Health Service
Matthew Brown, Director, Deadly Ears Program, Trachoma Program, Community
Youth and Family Health Services (Central) Childrens Hospital and Health Services
Annette Smith, Nurse Unit Manager, ENT Outreach, Deadly Ears Program, Community
Youth and Family Health Services (Central) Childrens Hospital and Health Services
Associate Professor Malcolm McDonald, Physician, James Cook University
Laurette Lubbers, Project Officer, Rheumatic Heart Disease Australia, Queensland
Dr Alan Ruben, Community Paediatrician, Apunipima Cape York Health Council
Section 7. Immunisation
Donna Palmer, Nurse Educator, Immunisation Authorisation Program, Cunningham
Centre, Cairns, Darling Downs Hospital and Health Service
Terrianne Messina, Public Health Nurse, Mackay Public Health Unit, Mackay Hospital
and Health Service
Susan Muirhead, Nurse Educator, Rural and Isolated Practice, Cunningham Centre,
Cairns, Darling Downs Hospital and Health Service
Medication Services Queensland
Nina Muscillo, Medication Safety Officer, Safe Medication Management Unit, Medication
Services Queensland
Robyn Arkinstall, Medication Safety Officer, Safe Medication Management Unit,
Medication Services Queensland
Management of patient death
Erin Finn, Assistant Director, Patient Safety Support, Patient Safety Unit, Health
Systems Innovation Branch, Queensland Department of Health
xviii
Uncontrolled
Controlled copy
copy
V1.0
Acknowledgements
Pathology
Russell Enbom, Supervising Scientist of Microbiology Pathology Queensland, Cairns
Health Services Support Agency, Department of Health
Deborah Moffat, Serology / Molecular Supervisor and AUSLAB Corrections Officer
Pathology Queensland, Cairns Health Services Support Agency, Department of Health
Endorsement by
Statewide Child and Youth Clinical Network Dr Julie McEniery, Deputy Director,
Paediatric Intensive Care Unit Royal Children's Hospital Brisbane, Clinical Chair
Statewide Child and Youth Clinical Network
Statewide Stroke Clinical Network Dr Rohan Grimley, Senior Medical Officer
Sunshine Coast Hospital and Health Service, Conjoint Senior Lecturer, University of
Queensland, Clinical Chair, Statewide Stroke Clinical Network
Chief Dental Officer, Department of Health Dr Rhys Thomas
Statewide Mental Health Alcohol and Other Drugs Clinical Network Dr Darren
Neillie, Clinical Director, The Park Centre for Mental Health, Chair, Statewide Mental
Health Alcohol and Other Drugs Clinical Network
Statewide Dementia Clinical Network Dr Edward Strivens, Co-chair Statewide
Dementia Clinical Network, Older Persons Health Services, Cairns Hospital and
Dr Kana Appaduri, Co-chair Statewide Dementia Clinical Network, Clinical Director,
Geriatric and Rehabilitation Services, Royal Brisbane and Women's Hospital
Statewide Maternity and Neonatal Clinical Network Dr Rebecca Kimble, Clinical
Director, Obstetric Services, Royal Brisbane and Women's Hospital, Chair Statewide
Maternity and Neonatal Clinical Network
Statewide Respiratory Clinical Network Dr Stephen Morrison, Director of Thoracic
Medicine, Royal Brisbane and Women's Hospital, Chair Statewide Respiratory Clinical
Network
Statewide Diabetes Clinical Network Dr Trisha O'Moore-Sullivan, Director of
Endocinology, Mater Health Services, Brisbane, Co-chair of the Type 1 Diabetes
Working Group, and Dr Anthony Russell, Director of Diabetes and Endocrinology,
Princess Alexandra Hospital Brisbane, Co-chair of the Statewide Diabetes Clinical
Network
-- Type 1 Diabetes Mellitus Working Group Dr Louise Conwell, Staff Endocrinologist
Royal Children's Hospital, Brisbane, Co-chair of the Type 1 Diabetes Working
Group
-- Statewide Diabetic Foot Working Group Ewan M Kinnear, Director of Podiatry,
Metro North Hospital and Health Service, Chair, Statewide Diabetic Foot Working
Group
-- Diabetes in Pregnancy Working Group Professor David McIntyre, Director
of Obstetric Medicine (Mater Health Services) Brisbane, Head of University of
Queensland Mater Clinical School, Head of Mater Mothers Research Institute
Mothers and Babies Theme, Chair, Statewide Diabetes in Pregnancy Working Group
Statewide Cardiac Clinical Network Dr Paul Garrahy, Director of Cardiology, Princess
Alexandra Hospital, Brisbane, Clinical Chair, Statewide Cardiac Clinical Network
Sexual Health, Dr Darren Russell, Sexual Health Physician, Cairns
Cover images
Ru Kwedza
Kathryn Dougherty
Bernadette Curnuck
The State of Queensland. Photographers Michael Marson, Don Stephens
lllustrations by
John Wright, Cairns
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
xix
Abbreviations
Abbreviations
ACEI
ACR
ADDS
ADR
ADL
ADT
AED
AFB
ALS
AMHS
AOM
APH
APSGN
ARF
ASOT
ATOD
AVPU
BBV
BCG
BGL
hCG
BLS
BMI
BP
BPMH
BSE
BVM
CALD
CBT
CCG
CCT
CDC
CEWT
CHD
CKD
CNS
COC
COPD
CPR
CRP
CSOM
CSA
CT
CVA
CVS
DCI
DKA
DTP
xx
Abbreviations
DT
DVT
EAR
ECC
ECG
EEG
EIA
ENT
ETT
FBC
FAST
FEV1
fFN
FHR
FiO2
FNE
FMH
FTA
FTT
G
GAS
GCS
GDM
GFR
GIT
GTN
GTT
GUD
Hb
hCG
HHS
HIV
HMP
HPV
HR
HRT
HVS
IADLs
IBD
IDC
IDU
IHD
IHW
IGT
IM
IO
IPAP
IPN
ITO
IUCD
delirium tremens
deep vein thrombosis
expired air resuscitation
external cardiac compression
electrocardiogram
electroencephalogram
enzyme immuno assay
ear, nose and throat
endotracheal tube
full blood count
focussed assessment with sonography for trauma
forced expiratory volume in 1 second
fetal fibronectin
fetal heart rate
fraction of inspired oxygen concentration (%)
forensic nurse examiner
feto-maternal haemorrhage
fluorescent treponemal antibodies
failure to thrive
guage e.g. 14 gauge
group A Streptococcus
glasgow coma scale
gestational diabetes mellitus
glomerular filtration rate
gastrointestinal tract
glyceryl trinitrate
glucose tolerance test
genital ulcer disease
haemoglobin
human chorionic gonadotrophin
Hospital and Health Service
human immunodeficiency virus
health management protocols
human papilloma virus
heart rate
hormone replacement therapy
high vaginal swab
instrumental activities of daily living
irritable bowel disease
indwelling catheter
injecting drug user
ischaemic heart disease
Authorised Indigenous Health Worker
impaired glucose tolerance
intramuscular
intraosseous
Isolated Practice Area Paramedic
Immunisation Program Authorised Nurse
involuntary treatment order
intrauterine contraceptive device
Uncontrolled
Controlled copy
copy
V 1.0
xxi
Abbreviations
IUGR
IV
IVP
J
LDH
LFT
LIF
LMA
LNMP
LOC
LVS
MAD
MAOI
MC/S
MCU
MDI
MDT
MgSO4
Mid
MO
MRSA
MSE
MSM
MSU
NAA
NGT
NIPs
NMDA
Non-STEMI
NP
NSAID
O2
OCCP
OCP
OGT
OGTT
OM
OME
ORS
OTC
PaPP
PCI
PCR
PEA
PEFR
PEP
PIC
PID
PIH
xxii
Abbreviations
PoCT
PPH
PPE
PPI
PPROM
PROM
PT
PV
QAS
QCC
QEMS
QH
rAOM
RFDS
RHD
RIF
RN
RPM
RPR
RSQ
S
S2
S3
S4
S8
SAH
SC
SCUBA
SM R&IP
SpO2
SRH
STEMI
STI
SVDK
TB
TCAs
TGA
TIA
TIG
TPPA
UEC
UKMEC
URTI
USS
UTI
VA
VDRL
VE
VF
VT
Uncontrolled
Controlled copy
copy
V 1.0
xxiii
Abbreviations
VTE
<
>
+
++
+++
++++
venous thromboembolism
less than
greater than
less than or equal to
greater than or equal to
slight trace or reaction
trace or notable reaction
moderate amount or reaction
large amount or pronounced reaction
xxiv
Uncontrolled
Controlled copy
copy
V1.0
Introduction
Introduction
The Primary Clinical Care Manual 8th edition (PCCM) has been developed and reviewed
according to the principles set out by the National Health and Medical Research Council [1].
The Clinical Care Guidelines (CCG) and Health Management Protocols (HMP) contained in
the PCCM are based on the current evidence as applied to rural and isolated practice settings.
The PCCM promotes and supports compliance with the Queensland Health (Drugs and
Poisons) Regulation 1996 for Registered Nurses, Indigenous Health Workers, Midwives and
Paramedics who have the authority to practise under a Drug Therapy Protocol (DTP), whilst
working in rural hospitals, isolated practice areas, Sexual Health or Immunisation Programs
as defined in Appendices 5, 8a and 9 of the Health (Drugs and Poisons) Regulation 1996.
The PCCM incorporates Health Management Protocols (HMP) for responding to patients
health needs, which are an essential requirement of each DTP.
Uncontrolled
Controlled copy
copy
V 1.0
Introduction
Nurse Practitioner (NP), may prescribe, give a written or oral instruction, supply
and administer the S8 and S4 medicines or S2 and S3 poisons that are necessary
to practise nursing, within the approved practice scope of the position in which
the Nurse Practitioner is engaged
Midwife (Mid), may as part of their midwifery duties, administer or supply the
S4 or S8 medicines listed in Appendix 1 of DTP Midwives under the conditions
of the DTP
Uncontrolled
Controlled copy
copy
V1.0
Introduction
Uncontrolled
Controlled copy
copy
V 1.0
Introduction
HMP contains a drug box that indicate the schedule of the medicine or poison and who is
authorised under which DTP to administer or supply the medicine or poison. The following
is an example of a drug box:
The top right hand corner of the drug box alerts authorised / endorsed health professionals
as to who can practise under the authorisation of their DTP. In this example the following
have authority. IHW (Authorised Indigenous Health Worker), SM R&IP (Scheduled
Medicines Rural and Isolated Practice Registered Nurse), IPAP (Isolated Practice Area
Paramedic), SRH (Sexual and Reproductive Health Program Registered Nurse)
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg
Azithromycin
a
x
E
le
p
m
Oral
ly
n
o
1g
Stat
[1]
Process for approval of HMP at the Hospital and Health Service level
Distribution of a controlled copy of the A4 PCCM to designated rural hospitals and isolated
practice areas as set out in Health (Drugs and Poisons) Regulation 1996
The use of the HMP must be supported at the Hospital and Health Service (HHS) level by
an interdisciplinary health team e.g. District Executive team, consisting of at least an MO,
RN and Pharmacist who must recommend use of the PCCM in the HHS
The HHS Executive Officer must endorse the use of all HMP in the HHS
Once endorsed the PCCM applies to all rural hospitals and isolated practice areas within
the HHS
Uncontrolled
Controlled copy
copy
V1.0
Introduction
Emergency
Anaphylaxis and severe
allergic reaction
Trauma and injuries
Fractures, dislocations
and sprains
Poisoning / overdose general
approach
Snakebite*
Redback spider
Scorpion stings and
centipede bites
Stingray injuries
Human (tooth-knuckle) and
animal bites
General
Upper respiratory tract
infection (URTI) - adult*
Skin problems*
Chronic wounds
New title
New Risk screening tool and Suicide risk assessment guide
Introduction
Sexually transmitted
infections (STIs)
Paediatric
Ear problems
Anaemia
Immunisation
New schedule in line with Immunisation Handbook 10th edition 2013
Appendices
Simple analgesia
Use of interim standing orders in areas designated as rural and isolated practice
settings per the Health (Drugs and Poisons) Regulation 1996 should not conflict with
the HMP / CCG contained in the Primary Clinical Care Manual 8th edition [2]
Referencing occurs throughout the text and is designated by numbers in brackets [ ]
References
1.
National Health and Medical Research Council, A guide to the development, implementation and
evaluation of clinical practice guidelines. 1999, Commonwealth of Australia: Canberra.
2.
Queensland Government (2010). "Circular 1/2010 Use of Standing Orders under the Health (Drugs and
Poisons) Regulation 1996." from http://qheps.health.qld.gov.au/hssa/medicines/docs/safety/circular.pdf
3.
Australian Commission on Safety and Quality in Healthcare (2013). "Recommendations for Terminology,
Abbreviations and Symbols used in the Prescribing and Administration of Medicines." Retrieved
September, 2013, from http://www.safetyandquality.gov.au/wp-content/uploads/2012/01/32060v2.pdf
6
Uncontrolled
Controlled copy
copy
V1.0
Section 1
Patient
assessment
and
transport
Section 1
Patient assessment and transport
Contents
Uncontrolled
Controlled copy
copy
V1.0
Rapid assessment
Does the patient look well or sick?
Airway - compromised?
Breathing - not breathing, significant respiratory distress?
Circulation - pulse absent, slow, rapid or profuse bleeding?
Level of consciousness - impaired? See Glasgow coma scale / AVPU
Rapid history
Observations - temperature, HR, BP, respiratory rate and often O2 saturation
Is the patient immediately compromised?
No
Yes
Perform immediate stabilising or
life saving measures
See DRS ABCD resuscitation / the
collapsed patient
Consult MO as soon as
circumstances allow
Uncontrolled
Controlled copy
copy
V 1.0
No
Contact MO
These tools have been developed to address human factor elements associated with
failures in recognising and managing deteriorating patients and comply with both the
National Safety and Quality Health Service Standard, Standard 9 available at:
www.safetyandquality.gov.au/wp-content/uploads/2011/09/NSQHS-Standards-Sept-2012.pdf
and the National Concensus Statement available at:
www.safetyandquality.gov.au/our-work/recognition-and-response-to-clinical-deterioration/
the-national-consensus-statement/
The ED CEWT and ED Q-ADDS are early warning and response system tools that:
Enable observations to be recorded graphically and separately
Provide visual cues when observations are abnormal and
Provide an overall score that corresponds with an action for clinicians to escalate
care, increase observations and facilitate early notification to Medical Officer
Royal Flying Doctor Service or Retrieval Services Queensland
Note:
The tools require all vital signs to be recorded and graphed (plotted) to be accurate.
Where the patient observations trigger an action or the patient requires ongoing monitoring,
the full ED CEWT and ED Q-ADDS form is required to be completed.
Children under 16 years must have observations documented on the age specific ED CEWT.
10
Uncontrolled
Controlled copy
copy
V1.0
Standard clinical
observations
Normal range
Temperature (oral)
35.5C - 37.5C
HR
Respiration rate
O2 saturation (%)
Level of consciousness
[1] [4]
See Standard clinical observations and other vital signs - child
Uncontrolled
Controlled copy
copy
V 1.0
11
Presentation
History taking
The purpose of a full history is to ascertain the cause of the patients illness. A careful
history will make the cause clear in the vast majority of cases
The first priority is to assess whether the patient is:
-- seriously ill and needs immediate management or
-- is a non urgent presentation and there is time for a complete patient history and
health education
Obtaining a full history is done in conjunction with examining the patient
-- in a sick patient this entails a full assessment of all systems
-- in a patient who has a localised problem it is reasonable to examine the relevant
system only. However, always be guided by the history and be prepared to examine
other systems as necessary. This is particularly important for children who often
present with generalised symptoms and signs
See History and physical examination - child
-- ask open ended questions
Presenting concern
Ask the patient what the problem is
Ask about length of illness and exact details of symptoms and signs. For each symptom
the following details are important [3]:
Site - where is the pain / symptom? does it go anywhere else?
Onset - when did it start? gradual or sudden onset?
Character - e.g. sharp, dull or burning
Radiation - does the pain radiate anywhere else?
Alleviating factors - what makes it better? e.g. sitting up, medicine
Timing - how long did it last? have they had it before?
Exacerbating factors - what makes it worse?
Severity - mild, moderate or severe: pain score 0 - no discomfort to 10 - unbearable
12
Uncontrolled
Controlled copy
copy
V1.0
Past history
Past medical and
surgical history
Family history
Social history
Medicines
Allergies
and adverse
medication
reactions
Immunisations
Significant illnesses in the past? Always ask about diabetes, hypertension, angina
and heart attacks, epilepsy, asthma, mental health problems
Previous hospital admissions, operations or injuries (where, when and why?)
Health problems in the family, especially siblings and parents e.g. diabetes,
hypertension, ischaemic heart disease, epilepsy, asthma, malignancies,
mental health
Job, marital status, housing, who else lives at home and what responsibilities do
they have in the family
Smoking - ever smoked? How many a day? Ever tried giving up?
Alcohol - how much and how often? Express in standard drinks per day or week
Ask about the use of other recreational drugs
Recent overseas travel?
Diet / exercise
Regular medicines (prescribed, herbal, bush medicines, over the counter) generic
name(s) dose, frequency? Are they taken correctly?
Specifically ask females if they are on the oral contraceptive pill
See Medication reconciliation and Medication history checklist for more details
Allergens e.g. bee stings, sticking plaster, nuts
Specific reaction e.g. skin reaction, bronchospasm
Is an EpiPen / medicine used to treat the allergy?
Adverse reactions / allergies to medicines?
-- if adverse medication reactions / allergies attach adverse medication reaction
sticker to medication chart
Check if up to date. Documented evidence of immunisation status should be
obtained, follow up with opportunistic immunisation
See Section 7 Immunisation
HR
Blood pressure
Respiratory rate
Temperature
If indicated:
-- O2 saturation
-- blood glucose level
-- conscious level
-- capillary refill time
See Standard clinical obervations and other vital signs
See Glasgow coma scale / AVPU
Uncontrolled
Controlled copy
copy
V 1.0
13
Physical examination
14
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
15
Ears
-- look at the pinna - redness, swelling, nodules?
-- any obvious swelling or redness of the ear canal? If there is, looking with an
otoscope will be painful
-- look inside with an otoscope and inspect ear canal - any redness, swelling,
discharge?
-- inspect eardrum - normal? or redness, dullness, bulging / retraction, fluid or
air bubbles, perforations or discharge?
-- See Assessment of the ear for detailed assessment
Nose
-- feel for facial swelling (sinuses) inflammation, pain
-- any discharge or obvious foreign body?
Throat
-- look at the lips, buccal mucosa, gums, palate, tongue, throat for redness /
swelling
-- teeth - condition?
-- inspect tonsils - redness, enlargement or pus?
Eyes
Always test the visual acuity of each eye, use a Snellen chart at 6 metres in
good light
Look at the eyes and surrounding structures - any redness, discharge or
swelling?
Look at the pupils - are they equal in size and regular in shape? Check pupillary
reflex to light
Check eye movements
See Assessment of the eye for detailed assessment
Urinalysis
Examine the urine of all sick patients, all patients with abdominal pain or
urinary symptoms and all patients with a history of diabetes
Look at the colour - is it normal, dark or blood stained?
Does it smell normal?
Perform urinalysis
Perform hCG in all females of childbearing age with abdominal pain
[3]
16
Point of care testing is available in some facilities e.g. iSTAT blood gases. However,
these should not be used as a substitute for formal laboratory testing for snakebites
Pathology request forms:
-- all pathology requests made by SM R&IP or RN must be compliant with the specific
Health Management Protocol
-- if other pathology is required this must be ordered by MO
Pathology results / follow up:
-- if an SM R&IP or RN has initiated pathology testing according to the Health
Management Protocol they are responsible for the follow up of pathology results
-- MO should be consulted if results are abnormal
Refer to the Pathology Queensland Specimen Collection Manual available at:
qheps.health.qld.gov.au/pathology/home.htm
Uncontrolled
Controlled copy
copy
V1.0
References
1.
McGrath B.P. and on behalf of the National Blood Pressure Advisory Committee of the National Heart
Foundation of Australia (2002). " Ambulatory blood pressure monitoring: position statement ". Retrieved
November 2012, from www.heartfoundation.org.au/SiteCollectionDocuments/Hypertension-guidelinesambulartory-blood-pressure-monitoring-Position-statement.pdf
2.
Estes M. and Schaefer K.P. (2002). Health assessment and physical examination. Albany, NY Delmar.
3.
Talley N. and OConnor S. (2010). A systematic guide to physical diagnosis: clinical examination.
Australia, Churchill Livingstone: Elsevier.
4.
Steen C. (2010). "Prevention of deterioration in acutely ill patients in hospital " Nursing Standard 24(49): 49-57.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
17
Routine and emergency medical advice can be obtained 24 hours a day from the
nearest RFDS Base with RFDS MO by telephoning one of the contact numbers
18
07 4654 1443
07 4743 2802
07 4040 0500
Scheduled Medicine Rural & Isolated Practice Registered Nurses and Authorised
Aboriginal and Torres Strait Islander Health Workers should consult with the appropriate
local MO or nearest RFDS MO as stipulated by Health Management Protocol (HMP)
and Clinical Care Guidelines (CCG) detailed in the Primary Clinical Care Manual
(PCCM)
Registered Nurses are encouraged to use the PCCM as a guide to their practise and
consult as required and in accordance with the Health (Drugs and Poisons) Regulation 1996
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
19
Consulting the MO
If it is necessary to consult with an MO, try to present your findings in a clear and methodical way. The
ISOBAR handover tool provides a framework for presenting clinical information in a clear, concise manner
utilising a recognised framework
It is often easier if you write your findings down first (time permitting)
It is helpful to advise the MO early that you have a patient about whom you want some advice or who
you think may need evacuation
Utilise the ISOBAR tool to convey the information to the MO. Say what you think is wrong - your
assessment is important, after all, you are actually with the patient
Always consult with the MO if you are not sure. Take the opportunity to discuss general or specific
cases or issues with the MO at the next clinic visit
ISOBAR
I
Identification of caller and identify name and spelling of receiving MO
I am ...... (your name and role)
I am calling from ...... (location)
I am calling because .....
S
O
B
A
R
20
Uncontrolled
Controlled copy
copy
V1.0
General considerations
All patients must be adequately prepared and stabilised prior to transport. In
many cases this can be done prior to arrival of the RFDS team
Please discuss with the RFDS MO or RSQ Medical Coordinator as required
Complete the RFDS Aeromedical Retrieval Checklist. This is to be completed for
all patients requiring transport with the RFDS and is useful when the patient is
being transported by other means
2. Specific clinical conditions
Many patients require preparation specific to transport and the aeromedical
environment. The following table illustrates some clinical conditions of particular
importance
Please discuss with the RFDS MO or RSQ Nursing or Medical Coordinator as
required
Patient transport
General considerations Rationale
Documentation
Analgesia
Antiemetic
Requirements
Documentation is
All patients must be accompanied by
required by the flight
appropriate documentation including:
-- prehospital documentation
crew and by the
-- referral letter
receiving facility in order
-- copy of medical / nursing records
to provide appropriate
-- pathology results
ongoing care
-- ECG print out
-- x-rays
Where digital radiology is available, if possible,
ensure the electronic transfer of x-rays to the
receiving facility has occurred
Any transfer involves
The patient should receive analgesia prior to
movement of the
transfer
patient, which may
See Pain management for interfacility transfer
exacerbate pain
- adult or consult MO
Vomiting will potentially Routine use of antiemetics is not indicated
exacerbate certain
Antiemetics should be considered if there is a
clinical conditions by
history of motion sickness
raising intracranial and Promethazine or prochlorperazine is preferred
intraocular pressure
for motion sickness and should be given 30
and placing the airway
minutes prior to transfer
at risk
Parenteral administration of an antiemetic is
Motion sickness
essential for patients with head, spinal injury
is common in
or penetrating eye injury
the aeromedical
For general nausea consider
environment
metoclopramide or ondansetron
Consult MO
Uncontrolled
Controlled copy
copy
V 1.0
21
Urinary
catheter
Venous
cannula
Infectious
conditions
Patient
escort
Baggage
22
Requirements
Reliable IV access
Night flights are to be avoided except in
exceptional circumstances due to
-- the disorientating effect of night flying
-- limited available landing sites should a
problem occur
Please prepare infusions prior to transfer
using RFDS or other retrieval service
compatible equipment if possible
Spinal injury
Bowel
obstruction
Pneumothorax
Requirements
Patients who have been appropriately
stabilised and prepared may be handed
over to the RFDS crew at the airport
Critical and unstable patients will be retrieved
from the health facility. Handover location will
be discussed during the coordination process
All ventilated spinal injured patients require
a nasogastric tube
A nasogastric tube should be considered
for all spinal injured patients who are
uncooperative or have an altered level of
consciousness
Consult MO
All patients with bowel obstruction should
have a nasogastric tube inserted. Leave
nasogastric tube on free drainage or attach
anti-reflux valve. Do not spigot nasogastric
tube
Administer parenteral antiemetic as indicated
and adequate analgesia prior to transfer
All patients with proven pneumothorax
should have an intercostal catheter inserted
and connected to a Heimlich valve or Portex
ambulatory chest drainage system
Suspected pneumothorax should be
excluded by appropriate imaging
All patients with proven or suspected
penetrating eye injury must receive a
parenteral antiemetic
Patients will be transported at reduced cabin
altitude
Uncontrolled
Controlled copy
copy
V 1.0
23
ETA
(Will be confirmed in flight)
Patient Weight
(kg)
Date of
Birth
Sex
M
Valuables - specify
Small bag <5 kg
Any other luggage must be approved by RFDS flight crew
Address
Approval
Weight (kg)
Diagnosis
Escort Name
Next of Kin
Contact Number
Infectious
condition
Y N
Specify
e.g. MRSA
Mobility
Requires stretcher
PLEASE NOTE
Please advise RFDS MO or Clinical Coordinator immediately if clinical status deteriorates
Any patient with a fear of flying; who is claustrophobic; who is confused, agitated or aggressive must be discussed in full with the
RFDS MO or RSQ Clinical Coordinator
REFERRAL DETAILS
Referring Facility
Referring Clinician
Receiving Facility
Receiving MO
Site
Date inserted
Infusion
IV Cannula (1)
IV Cannula (2)
Toilet prior to flight
Urinary Catheter
ICC
Heimlich valve
Other (Specify)
Fracture Immobilisation
Medicines given prior to transfer must be documented on a medication sheet and copy sent with the patient
Ensure adequate analgesia and antiemetic is given if necessary
Medication given prior to flight
Time given
Analgesia
Antiemetic
Sedative
Other
DOCUMENTATION
All patients must be accompanied with appropriate documentation
Copies / originals of all the following must accompany
LETTER
Medical
Nursing
OBSERVATION FORMS
Vital Signs
Neurological Observations
Blood Sugar Levels
Inpatient Notes
Emergency Dept flowsheet
QAS Report Form
Theatre Notes
Immunisation Status
PTSS Form
HANDOVER
Handover location and road transport details will be discussed during the coordination of the retrieval
Hospital handover
OR
Airport handover
Additional comments
Name
Signature
24
Uncontrolled
Controlled copy
copy
V1.0
Controlled
Uncontrolled
copy
copy
V 1.0
25
2. Immediate management
Identify the patients self reported level of pain 0 - 10 and pre-existing medical
condition / complaint
No
pain
0
Mild
1
Moderate
3
Severe
6
Worst
pain
10
3.
Clinical assessment
4.
Management
26
Monitor vital signs, pain score and sedation scores at intervals appropriate to
analgesia given
Pain score 1 - 3
and / or clinical assessment indicates mild pain. If not allergic can use
paracetamol. Paracetamol is rapidly absorbed after oral administration, with a
peak concentration in 10 to 60 minutes
Schedule
Paracetamol
DTP
IHW
Pain score 4 - 6
and / or clinical assessment indicates moderate pain. If not allergic can use
paracetamol 500 mg / codeine phosphate 30 mgs. Codeine is well absorbed from
the gastrointestinal track, peak onset of action is 1 - 2 hours [4] and / or
Can use ibuprofen if not allergic and does not have - asthma, renal disease, heart
disease, GI bleeding conditions, significant liver disease, coagulation disorder;
is not dehydrated, pregnant, lactating; is not taking ACE-inhibitors, angiotensin
receptor blockers (ARB), diuretics, warfarin or lithium
Paracetamol 500 mg /
DTP
Codeine phosphate 30 mg
IHW / SM R&IP
Authorised Indigenous Health Worker must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
1 - 2 tablets
Stat
Tablet
500 mg / 30 mg
Oral
every 4 - 6 hours up to a
can be repeated in
max. of
4 hours if required
8 tablets / day
Provide Consumer Medicine Information: warning - the paracetamol content of all medicines the patient
may have taken must be considered. Avoid repeated doses if at all possible particularly if breastfeeding
and infant is less than 1 month old. May cause drowsiness, GI upset, nausea / vomiting, constipation,
dizziness, bronchospasm [4]
Management of associated emergency: consult MO See Poisoning / overdose - opioids
[4]
Schedule
Controlled
Uncontrolled
copy
copy
V 1.0
27
Schedule
DTP
IHW
Ibuprofen
Schedule
Pain score 7 - 10
and / or clinical assessment indicates severe pain and patient has no allergies,
has a systolic blood pressure over 90 mmHg, a respiratory rate over 10 breaths
per minute and has a sedation score of 1 or less then give IV or IM morphine
If sedation score of 2 or more do not give morphine
Use with caution in elderly and those with significant renal / liver disease. Fentanyl
is more appropriate
Insert IV cannula if required
8
DTP
IHW / SM R&IP
Morphine
Strength
Route of
administration
Recommended dosage
Duration
Adult only
IM / SC
0.1 mg - 0.2 mg / kg
to a max. of 10 mg
Adult only
Stat
Initial dose of 2 mg
Ampoule
10 mg / mL
IV
then 0.5 mg - 1 mg
Further doses on
increments slowly,
(IHW may not
MO / NP order
repeated every 3 - 5
administer IV)
minutes if required to a
max. of 10 mg
Use the lower end of the dose range in patients > 70 years
Provide Consumer Medicine Information: advise can cause nausea and vomiting, drowsiness
Management of associated emergency: caution - in the elderly and those with significant renal / liver
disease. A reduced dose should be considered for these patients. Respiratory depression is rare - if it
should occur give naloxone See Poisoning / overdose - opioids
Note: as naloxone counteracts the opioid, it may cause the return of severe pain
[3] [6]
28
Uncontrolled
Controlled copy
copy
V1.0
Schedule
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
8
Fentanyl
DTP
IHW / SM R&IP
Metoclopramide
DTP
IHW / SM R&IP
Controlled
Uncontrolled
copy
copy
V 1.0
29
5. Follow up
Monitor patients response to analgesia
Document vital signs including GCS, BP, pulse and respirations, O2 saturation,
6. Referral / consultation
been administered
References
1.
2.
3.
4.
5.
6.
7.
30
Macintyre P.E. and Scott D.A. (2010). "Acute Pain Management: Scientific Evidence third edition."
Retrieved November, 2012, from www.anzca.edu.au/resources/books-and-publications/acutepain.pdf
International Association for the Study of Pain Subcommittee on Taxonomy (1986). "Classification of
chronic pain syndromes and definitions of pain terms." Pain 3(Suppl. 3): S1-S226.
Therapeutic Guidelines (2012). "Stepwise approach to acute pain management." Retrieved December,
2012.
MIMS (2012). "Codeine phosphate." Retrieved November, 2012.
Australian Medicine Handbook (2012). "Metoclopramide." Retrieved June, 2012.
MiMS (2013). "Morphine sulfate injection." Retrieved July, 2013.
Editorial Committee Primary Clinical Care Manual 8th edition 2013.
Uncontrolled
Controlled copy
copy
V1.0
Section 2
Emergency
Section 2
Emergency
Contents
32
Resuscitation
Cardiovascular emergencies
Neurological emergencies
Trauma and injuries
Fractures, dislocations and sprains
Acute wounds
Burns
Environmental emergencies
Ear nose and throat emergencies
Gastrointestinal emergencies
Genitourinary emergencies
Poisoning / overdose general approach
Toxinology (bites and stings)
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Sudden collapse
As part of clinical picture seen in conditions that can be regarded as emergencies
3. Clinical assessment
4. Management
5. Follow up
According to patients condition / presentation
6. Referral / consultation
References
1.
Australian Resuscitation Council (2010). "Managing an emergency Guideline 2." Retrieved December, 2012.
2.
Australian Resuscitation Council (2010). "Cardiopulmonary resuscitation Guideline 8." Retrieved November, 2012.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
33
Resuscitation
Responsive?
R
Normal breathing?
Start CPR
C
30 compressions : 2 breaths
Attach defibrillator
34
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Chest pain
Sudden collapse
A complication of heart attack
As part of the clinical picture seen in conditions that can be regarded as emergencies
2. Immediate management
Uncontrolled
Controlled copy
copy
V 1.0
35
Resuscitation
Non-shockable rhythm
Asystole
(example trace only)
Sinus rhythm
3. Clinical assessment
4. Management
36
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Medicines: [5]
-- adrenaline
child - adrenaline 10 microgram / kg, IV / IO after 2nd shock, then every
2nd cycle
adult - adrenaline 1 mg, IV / IO after 2nd shock, then every 2nd cycle
-- amiodarone (on MO / NP order only)
child - amiodarone 5 mg / kg / dose, IV / IO after 3rd shock, to a maximum
of 300 mgs
adult - amiodarone 300 mg, IV / IO bolus after 3rd shock. Additional
dose of 150 mg could be considered, followed by an infusion 15mg / kg
over 24 hours
-- magnesium, potassium may be ordered by MO / NP
Identify and correct reversible causes for all rhythms [1]
Non-shockable rhythms
Asystole
Do not defibrillate
Airway and breathing
-- bag and mask with high flow O2 See Basic life support
-- or laryngeal mask airway (LMA)
Cardiac compressions
Vascular access
-- insert IV / IO cannula
Medicine:
-- adrenaline
child - adrenaline 10 microgram / kg, IV / IO immediately, then every
2nd cycle
adult - adrenaline 1 mg, IV / IO immediately, then every 2nd cycle
Identify and correct reversible causes for all rhythms [1]
Pulseless Electrical Activity (PEA)
The presence of a cardiac rhythm on the monitor, with no palpable pulse is also
known as electromechanical dissociation (EMD) [6]
PEA can either occur:
In a heart with little functional viable myocardium e.g. dying heart
Secondary to reversible medical conditions including the 4Hs and 4Ts
The patient history will often guide to the possible causes:
If trauma e.g. motor vehicle accident (MVA), hypovolaemia, tension pneumothorax
or pericardial tamponade should be considered early
If known to be on a calcium antagonist or beta blocker medication, appropriate
management needs to be considered early
-- do not defibrillate
-- airway and breathing:
bag and mask with high flow O2 See Basic life support
or laryngeal mask airway (LMA)
-- cardiac compressions
-- vascular access:
insert IV / IO cannula
give IV / IO fluid bolus of sodium chloride 0.9% up to 20 mL / kg (adult
and child)
-- medicines:
child - adrenaline 10 microgram / kg, IV / IO
adult - adrenaline 1 mg, IV / IO
adrenaline can be repeated every 2nd cycle
-- consult MO and discuss what further intervention is required
Identify and correct reversible causes for all abnormal rhythms [1]
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
37
Resuscitation
Medicines:
-- child - atropine 20 microgram / kg, IV / IO (MO / NP must order)
-- adult - atropine 0.5 mg - 0.6 mg, IV / IO (MO / NP must order)
can be repeated every 3 - 5 minutes on MO / NP order to a maximum of
3 mg (adult) [7]
If still no response to treatment may require external cardiac pacing
Identify and correct reversible causes [1]
Cessation of resuscitation may not always follow a definite timeframe but will obviously
be determined by response to treatment. Usually asystole will intervene and generally
20 minutes of asystole after resuscitative efforts would be sufficient for an MO to advise
stopping CPR
5. Follow up
Post resuscitation care - if return of spontaneous circulation occurs it is essential
6. Referral / consultation
Always contact MO as soon as circumstances allow during a cardiac arrest
References
1.
Australian Resuscitation Council (2010). "Protocols for adult advanced life support Guideline 11.2."
Retrieved November, 2012.
2.
Australian Resuscitation Council (2010). "Introduction to advanced adult life support." Retrieved November,
2012.
3.
Australian Resuscitation Council (2010). "Electrical therapy for adult advanced life support Guideline
11.4." Retrieved November, 2012
4.
Australian Resuscitation Council (2010). "Techniques in paediatric advanced life support Guideline
12.6." Retrieved November, 2012.
5.
Australian Resuscitation Council (2010). "Flowchart for the sequential management of life threatening
dysrythmias in infants and children Guideline 12.3." Retrieved November, 2012.
6.
Australian Resuscitation Council (2010). "Management of specific dysrhythmias in paediatric advanced
life support." Retrieved November, 2012.
7.
Australian Resuscitation Council (2009). "Managing acute dysrhythmias Guideline 11.9." Retrieved
November, 2012.
8.
Australian Resuscitation Council (2010). "Post-resuscitation therapy in adult advanced life support."
Retrieved November, 2010.
38
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Start CPR
30 compressions : 2 breaths
minimise interruptions
During CPR
Airway adjuncts (LMA / ETT)
O2
Waveform capnography
IV / IO access
Plan actions before interrupting
compressions e.g. charge
manual defibrillator
Medicines for shockable rhythms
Adrenaline 1 mg after 2nd shock
(then every 2nd cycle)
Amiodarone 300 mg after 3rd
shock
Attach
defibrillator / monitor
Assess rhythm
Nonshockable
Shockable
Shock
CPR
for 2 minutes
CPR
for 2 minutes
Return of
spontaneous
circulation?
Post resuscitation
care
Uncontrolled
Controlled copy
copy
V 1.0
39
Resuscitation
Start CPR
15 compressions : 2 breaths
minimise interruptions
Attach
defibrillator / monitor
Assess rhythm
Non
shockable
Shockable
Shock
(4 J / kg)
Adrenaline
10 microgram
/ kg
immediately
then every
2nd cycle
CPR
for 2 minutes
CPR
for 2 minutes
Return of
spontaneous
circulation?
Post
resuscitation
care
40
During CPR
Airway adjuncts (LMA / ETT)
O2
Waveform capnography
IV / IO access
Plan actions before interrupting
compressions e.g. charge manual
defibrillator to 4 J / kg
Medicines for shockable rhythms
Adrenaline 10 microgram / kg
after 2nd shock then every 2nd
cycle
Amiodarone 5 mg / kg after 3rd
shock
Medicines for non-shockable
rhythms
Adrenaline 10 microgram / kg
immediately then every 2nd cycle
Consider and correct
Hypoxia
Hypovolaemia
Hyper / hypokalaemia / metabolic
disorders
Hypo / hyperthermia
Tension pneumothorax
Tamponade
Toxins
Thrombosis
(pulmonary / coronary)
Post resuscitation care
Re-evaluate ABCDE
12 lead ECG
Treat precipitating causes
Re-evaluate oxygenation and
ventilation
Temperature control (cool)
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Frequent clinical assessment is required in all patients receiving O2 therapy [1]. In the
primary clinical care setting arterial O2 saturation is measured via a non-invasive technique
- pulse oximetry documented as SpO2
Delivery methods
Delivery methods include nasal prongs, simple face masks and non-rebreathing masks
which deliver O2 concentrations (%) that may vary considerably [2]
In selecting the proper delivery method, consideration should be given to the clinical condition
of the patient and the amount of O2 needed [1] See O2 delivery systems
Target range:
SpO2 > 93% for most acutely ill adult / > 95% child [3]
SpO2 88 - 92% for patients with chronic hypoxaemia [4]
Utilise O2 delivery system to optimise patients clinical outcome
Definitions
SpO2
O2 saturation measured via pulse oximetry [5]
Low O2 tension in the blood [5]
Hypoxaemia
SaO2
O2 saturation obtained from arterial blood. SaO2 and SpO2 are often
used interchangeably. Equipment provided at primary health centre
only measure SpO2 levels
FiO2
Fraction of inspired O2 concentration (%)
High flow O2
O2 delivered at > 10 L / min via a partial or full non-rebreather mask [6]
Patients with COPD
Controlled O2 delivery is indicated for hypoxaemia (SpO2 < 88%). Target O2 saturation is
88 - 92% [4]. Careful monitoring is required
Principles
In the emergency setting:
O2 therapy should never be withheld from a hypoxaemic patient for fear of
complications or clinical deterioration [1]
In a patient with acute coronary syndrome, supplemental O2 should be initiated
for breathlessness, hypoxaemia (O2 saturation < 93%), or signs of heart failure
or shock [7, 8]
Shock states resulting from haemorrhage, vasodilatory states and / or obstructive
lesions can all lead to tissue hypoxia and should benefit from supplemental O2 [1]
It is reasonable to administer O2 to hypotensive patients and those with severe
trauma until hypoxia can definitely be excluded
Administer O2 to patients with carbon monoxide poisoning [1]
Administer 100% O2 at > 10 L / min to patients with decompression illness [9]
Uncontrolled
Controlled copy
copy
V 1.0
41
Resuscitation
User guide
% O2
1
2
3
4
25
29
33
37
6 L / min - 10 L / min
50 - 65%
[5]
5 L / min to 10 L / min
5 L / min - 6 L / min
35 - 50%
Flow
rate
42
Uncontrolled
Controlled copy
copy
V1.0
4 L / min to 10 L / min
Resuscitation
User guide
Partial non-rebreathing
face mask with reservoir
bag
Flow
rate
8 to 15 L / min
References
1.
Roberts J.R. and Hedges J.R., Clinical Procedures in Emergency Medicine. 5th ed. 2010, Philadelphia:
Saunders Elsevier.
2.
Therapeutic Guidelines (2012). "Principles of oxygen administration." Retrieved November, 2012.
3.
Beckett G., Walker S., and Rae P., Lecture notes. Clinical Biochemistry. 8th ed. 2010, Edinburgh: WileyBlackwell.
4.
McKenzie D.K., on behalf of the Australian Lung Foundation, et al. (2011). "The COPD-X Plan: Australian
and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease V2.3."
Retrieved November, 2012, from www.copdx.org.au/the-copd-x-plan-pdf
5.
The Royal Children's Hospital Melbourne (2010). "Oxygen delivery." Retrieved November, 2012.
6.
Editorial Committee Primary Clinical Care Manual 8th edition 2013.
7.
Australian Resuscitation Council (2011). "Acute coronary syndromes Guideline 14." Retrieved November,
2012.
8.
Chew D.P., Aroney C.N., et al. (2011). "Addendum to the National Health Foundation of Australia /
Cardiac Society of Australia and New Zealand Guidelines for the Management of Acute Coronary
Syndromes (ACS) 2006." Heart, Lung and Circulation 20: 487-502.
9.
Australian Resuscitation Council (2008). "The use of oxygen in emergencies Guideline 10.4." Retrieved
November, 2012.
10. Mayo Healthcare Australia, Mayo Healthcare Product Catalogue. 2010 -2012.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
43
Resuscitation
44
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
cuff
Photos demonstate Supreme LMA. Technique Cairns Skills Centre, 2011 Cairns Base Hospital
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
45
Resuscitation
46
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Uncontrolled
Controlled copy
copy
V 1.0
47
Resuscitation
DTP
IHW / SM R&IP
Lignocaine
Duration
Stat
Do not repeat the
total max. dose at
intervals of
< 1.5 hours
[3] [4]
References
1.
EZ-IO by Vidacare (2009). "Needle sets. Directions for use." Retrieved November, 2012, from
www.vidacare.com/EZ-IO/Index.aspx
2.
Bailey P. (2012). "Intraosseous infusion UptoDate." Retrieved November, 2012, from
www.uptodate.com/contents/intraosseous-infusion?source=search_result&search=intraosseous+can
nulation&selectedTitle=1%7E17
3.
Therapeutic Guidelines (2013). "Acute postoperative pain: regional and local administration of local
anaesthetics and opioids." Retrieved March 2013
4.
Therapeutic Guidelines (2013). "Pharmacological management of pain in children: local anaesthetics."
Retrieved March, 2013.
48
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Uncontrolled
Controlled copy
copy
V 1.0
49
Resuscitation
2. Immediate management
D
R
S
B
C
D
3. Clinical assessment
50
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
4. Management
5. Follow up
According to possible cause for unconsciousness
Patient will need evacuation / hospitalisation in suitably equipped facility
6. Referral / consultation
Always contact MO as soon as possible if patient presents with altered level of
References
1.
Australian Resuscitation Council (2010). "Unconsciousness Guideline 3." Retrieved November, 2012.
2.
Australian Resuscitation Council (2010). "Airway Guideline 4." Retrieved November, 2012.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
51
Resuscitation
Related topics
Cardiorespiratory arrest
DRS ABCD resuscitation /
the collapsed patient
Acute upper airway obstruction and
choking
Upper gastrointestinal bleeding
Rectal bleeding
Tubal / ectopic pregnancy
52
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
Obtain patient history including circumstances that may suggest the cause of
shock including medicines
Perform standard clinical observations +
-- O2 saturation
-- capillary refill
-- conscious state See Glasgow coma scale / AVPU
-- pay particular attention to the trends in vital signs
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
53
Resuscitation
5. Follow up
According to possible cause for shock
Patient will need evacuation / hospitalisation in suitably equipped facility
6. Referral / consultation
Consult MO on all occasions of shock
Reference
1.
Australian Resuscitation Council (2009). "Shock Guideline 9.2.3." Retrieved November, 2012.
54
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
2. Immediate management
Ineffective cough
Severe airway obstruction
Unconscious
See Unconscious /
altered LOC
Commence CPR
Effective cough
Mild airway obstruction
Conscious
Encourage coughing
Stay with patient until recovered
55
Resuscitation
3. Clinical assessment
4.
Management
5. Follow up
If the choking episode is minor and cause is a foreign body, which has been
dislodged and removed, the patient is asymptomatic and chest findings are
normal then patient can be allowed home after a period of observation
Review after one day and consult MO if the patient has any symptoms, an
increased HR, increased temperature or any chest findings
-- evacuation / hospitalisation will be required
6. Referral / consultation
56
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Effective cough
(Mild airway obstruction)
Patient positions themselves
Keep coughing until foreign body is expelled
Ineffective cough
(Severe airway obstruction)
Perform 5 sharp back blows
-- this is done with the heel of the hand in the middle of the back between the
shoulder blades
Check to see if each back blow has relieved the obstruction
The aim is to relieve the obstruction with each blow rather than to give all five blows
If back blows are unsuccessful perform up to 5 chest thrusts
-- identify the same compression point as for CPR to perform chest thrust.
Thrusts are similar to chest compressions but sharper and delivered at a
slower rate
Continue alternating five back blows with five chest thrusts if the obstruction is
still not relieved
Reference
1.
Australian Resuscitation Council (2010). "Airway Guideline 4." Retrieved November, 2012
Images reproduced with permission of the Australian Resuscitation Council
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
57
Resuscitation
2. Immediate management
58
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Schedule
Adrenaline
DTP
IHW
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
59
Resuscitation
Anaphylaxis flowchart
Anaphylactic reaction?
Airway, Breathing, Circulation, Disability, Exposure
Diagnosis
Look for
Acute onset of illness
Life-threatening Airway and / or Breathing and / or Circulation problems1
And usually skin changes
Call for help
Adrenaline2
Life-threatening problems:
Airway: swelling, hoarseness, stridor
Breathing: rapid breathing, wheeze, fatigue, cyanosis, SpO2 < 92%, confusion
Circulation: pale, clammy, low blood pressure, faintness, drowsy, coma
Adrenaline [4]: (give IM)
IM doses of 1:1,000 adrenaline (repeat after 5 minutes if no better)
10 kg - 100 microgram (0.1 mL)
15 kg - 150 microgram (0.15 mL)
20 kg - 200 microgram (0.2 mL)
25 kg - 250 microgram (0.25 mL)
30 kg - 300 microgram (0.3 mL)
40 kg - 400 microgram (0.4 mL)
Adult and child 50 kg
500 microgram (0.5 mL)
2
Hydrocortisone:
(IM or slow IV)
200 mg
100 mg
50 mg
25 mg
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Schedule
BP and respiratory rate and conscious state should be checked every 15 minutes
for 2 hours then hourly for a minimum of 4 hours
After the resolution of all symptoms and signs, observe for a minimum of 4 hours
after the last dose of adrenaline or until daylight hours
Those with severe reactions (hypoxia, hypotension, and / or neurological
compromise), delayed or inadequate response to initial therapy, poorly controlled
asthma or a history of life-threatening reactions and those who present late in the
evening, require longer observation [3]
Those with severe reactions who have had a 12-hour period of being symptom
free and have required no further adrenaline, may be discharged in consultation
with MO / NP
4
Promethazine injection
DTP
IHW / SM R&IP
Duration
Stat
[5]
5. Follow up
It is important to find out exactly what happened before the episode - food or
medicine ingestion, bites and stings etc. Make sure this is documented in the
notes, as well as what treatment was required
Patient must be advised to avoid re-exposure
Advise patient to carry an alert e.g. Medic Alert
Document in medical record Allergic to..
Promptly report any significant adverse event following immunisation (AEFI)
directly to Queensland Health by completing an AEFI form available at
www.health.qld.gov.au/immunisation/documents/adverse_event_immun.pdf
and fax to number on form. Queensland Health will forward on to the TGA.
There is no need to complete a TGA form.
For adverse reactions caused by medicines, report directly to the TGA Australian
Adverse Reaction Reporting System available at www.tga.gov.au/hp/problem.htm
If practicing outside Queensland report adverse reactions caused by immunisations
and medicines directly to the TGA Australian Adverse Reaction Reporting System
available at www.tga.gov.au/hp/problem.htm
Review the next day and if no symptoms or findings, review at next MO clinic
All patients are to be referred to MO for prescriptions for EpiPen
6. Referral / consultation
Consult MO on all occasions
Uncontrolled
Controlled copy
copy
V 1.0
61
Resuscitation
Hypoglycaemia
Alcohol withdrawal
62
Resuscitation
Focal seizures
-- localised area of jerking (may reflect a TIA or brain tumour)
Partial - complex partial seizures
The patient has impaired consciousness, but may remain standing / sitting,
although behaving oddly. Usually lasts a minute or two. Signs include:
-- may lick lips repetitively, or fidget with hands
-- may have focal jerking of one limb
-- head and eyes may turn to one side. May stare blankly
-- patient will usually have no memory and may deny episodes are occurring
Special syndromes - febrile convulsions
-- common in young children (3 months to 6 years). Mostly benign temperature
over 38C
-- most commonly associated with viral URTI, otitis media
-- prolonged febrile convulsions (greater than five minutes) need to be
stopped urgently
-- fits in older children and adults can not be put down to febrile convulsions,
even if the patient has a temperature. Another cause should be considered
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
Take emergency patient history from witnesses. Once patient has recovered
obtain more detailed history regarding presenting and previous fits
Check patient is taking their regular anticonvulsant medicine
Consider possibility of alcohol or drug related seizure caused by withdrawal
Perform standard clinical observations +
-- BGL
-- O2 saturation
-- conscious state See Glasgow coma scale / AVPU
Perform physical examination checking for any injury which may have occurred if
patient fell or hit themselves during the seizure
Check for skin rashes
4. Management
Consult MO
Insert IV cannula
If BGL less than 4 mmol / L
-- adult - give 50% glucose or glucagon See Hypoglycaemia
-- child - give 10% glucose or glucagon See Hypoglycaemia
Uncontrolled
Controlled copy
copy
V 1.0
63
Resuscitation
diazepam [9]
For people with known alcohol use or who are malnourished - give thiamine
100 mgs IV (made up to 10 mL with sodium chloride 0.9%, give slowly over 10
If seizure continues in a child despite 2nd dose (on MO orders) of midazolam /
diazepam, MO may advise to give IV phenobarbitone 15 - 20 mg / kg
Paracetamol has not been shown to reduce the risk of further febrile convulsions
oral (if fully conscious) or rectal paracetamol [7]
SeeSimple
Simple
back
analgesia
cover
See
analgesia
Schedule
DTP
IHW / SM R&IP
Midazolam
IV up to 10 mg in 2.5 mg increments
Give over 2 - 5 minutes
Child
IM 0.2 mg / kg to a
max. of 5 mg
IV 0.15 mg / kg to a max. of 10 mg
5 mg / 1 mL
Ampoule
5 mg / 5 mL
Buccal
Insert syringe
between the inside
of the lower cheek
and teeth and
gently squeeze
the contents until
contents given
Intranasal
via mucosal
atomisation device
(MAD)
or gently squeeze
contents into nostril
Duration
Adult
5 mg with second 5 mg dose
if required to a max. of 10 mg
Stat
Further doses on
MO / NP order
Child
0.2 mg / kg to a
max. of 10 mg
Adult
5 mg with second 5 mg dose
if required to a max. of 10 mg
Child
0.2 mg / kg to a
max. of 10 mg
Provide Consumer Medicine Information: midazolam response is highly variable. Caution should be
observed with the elderly, in the presence of hypotension or opioids and in children less than 8 years.
Patients should be regularly monitored for at least 4 hours after last administration in case of excessive
sedation, respiratory depression or hypotension
Management of associated emergency: See Poisoning / overdose - opioids
[6] [8]
64
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
or
Schedule
Diazepam
DTP
IHW / SM R&IP
5. Follow up
Any patient who presents with their first fit / convulsion / seizure usually needs full
6. Referral / consultation
Consult MO on all occasions
Any patient with recurrent seizures despite anticonvulsant medications needs
Controlled
Uncontrolled
copy
copy
V 1.0
65
Resuscitation
Chest pain
Fits / convulsions / seizures
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
66
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
3. Clinical assessment
Take comprehensive patient history when able with particular attention to current
diabetes status, insulin, food intake, exercise, recent alcohol intake, chest pain,
infections or possible injury, urine output, fluid intake, possible dehydration
Perform and monitor standard clinical observations +
-- capillary BGL
-- O2 saturations
-- conscious state See Glasgow coma scale / AVPU
-- ECG - look for large T waves
-- urinalysis for blood and ketones [12]
record blood ketone level as a number (normal value < 0.6) e.g. 0.6
or 1.4
record urine result as negative, +, ++,
Collect urine for MC/S
Collect blood for gases and electrolytes. In children, venous gas recommended
4. Management
5. Follow up
Minimum 3 monthly review by a Diabetes Specialist / Endocrinologist /
6. Referral / consultation
Consult MO as soon as possible on all occasions of DKA
Uncontrolled
Controlled copy
copy
V 1.0
67
Resuscitation
2. Immediate management
See Fits / convulsions / seizures
If confused or drowsy
-- check capillary BGL
-- do not give any oral fluid or food
-- give glucagon IM or SC
Schedule
Glucagon
DTP
IHW
Authorised Indigenous Health Worker may administer one dose then consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Pre-filled
IM
Adult and child 14 years Further doses on
1 mg
syringe
(can also be given SC)
1 mg
MO / NP order
Provide Consumer Medicine Information: unconscious patients should wake within 6 minutes following
glucagon administration. Recovery should occur in 5 - 15 minutes
Management of associated emergency: consult MO
[13]
68
Resuscitation
3. Clinical assessment
Obtain comprehensive patient history when able with particular attention to current
diabetes status, insulin, food intake, exercise, recent alcohol intake, illness or injury
Perform standard clinical observations +
-- capillary BGL
-- urinalysis
-- conscious state See Glasgow coma scale / AVPU
4. Management
If conscious and able to swallow - give rapidly absorbed form of oral sugar
(carbohydrate)
-- 3 teaspoons or sachets of sugar either straight or added to a non-sweetened
drink or
-- cup ordinary soft drink or cordial or sweetened juice or
-- 5 - 6 jelly beans or other chewable sweets or
-- 2 - 3 sweet biscuits
Follow with a sandwich, a piece of fresh or dried fruit or a meal
Check BGL in 15 minutes
-- if greater than 4.0 mmol / L, check again in another 15 minutes and if still
greater than 4.0 mmol / L, patient can go home, depending on cause, and in
consultation with MO
-- if less than 4.0 mmol / L, repeat above treatment, check in 15 minutes and 15
minutes later and if greater than 4.0 mmol / L at these 2 checks, patient can
go home, depending on cause, and in consultation with MO
Review next dose of insulin / diabetes medication
Review events with patient which may have lead to hypoglycaemic episode
-- was too much diabetes medication or insulin taken?
-- unplanned exercise?
-- not enough carbohydrate food / forgot to eat meal?
-- had too much alcohol? People consuming alcohol are advised to limit their
consumption and ensure that they eat carbohydrate to reduce the risk of
hypoglycaemia
-- patient has end stage kidney failure?
5. Follow up
Review signs and symptoms of hypoglycaemia with the patient
Review treatment of hypoglycaemia with the patient. Patients should know how
6. Referral / consultation
Consult MO on all occasions and prior to discharge
Refer to Diabetes Educator
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
69
Resuscitation
Breathlessness
O2 delivery systems
Glasgow coma scale / AVPU
Breathlessness
Wheeze / cough
Speaking in short sentences
In distress
Tiredness / exhaustion
Cyanosis
O2 saturation < 93% adult / < 95% child
Symptoms continue despite reliever medicine
2. Immediate management
3. Clinical assessment
70
Obtain complete patient history of this episode and previous episodes of asthma.
Of particular importance is severity of previous episodes including need for
hospitalisation and / or steroids
Perform standard clinical observations +
-- O2 saturation
-- conscious state See Glasgow coma scale / AVPU
Inspect for the use of accessory muscles chest and neck, nasal flaring, intercostal
recession and sternal retraction
Listen to the chest for air entry and wheezes. Air entry can often be unequal in
asthma due to mucous plugging and does not always mean pneumothorax or
pneumonia
Check spirometry (FEV1). If spirometry not available and patient is not distressed,
use peak expiratory flow rate (PEFR) before and after salbutamol administered
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
4. Management
Consult MO if this is the first attack, is a mild attack or the patient has fever, or
doesnt settle with initial dose of salbutamol
Management is based on the severity of the acute asthma presentation - mild,
moderate or severe. If moderate / severe asthma consult MO on all occasions.
Patients with severe asthma will require evacuation / hospitalisation
IM adrenaline for anaphylaxis or imminent cardiorespiratory arrest [16]
See Anaphylaxis and severe allergic reaction
Antibiotics are rarely needed
Chest x-ray (if available) to exclude pneumothorax
Moderate
Severe
Able to speak in single
Able to speak in phrases only
words only
Pulse rate 100 - 120 bpm
Pulse rate > 120 bpm
Central cyanosis may be
Central cyanosis likely
present
Wheeze often quiet
Wheeze moderate to loud
Physically exhausted
No physical exhaustion
O2 saturation < 93%
Management
Mild
Moderate
Supplementary O2 to achieve O2 to achieve > 93%
> 93% saturation
saturation
Monitor SpO2
Monitor SpO2
Salbutamol (MDI / spacer)
8 - 12 puffs 3 - 4 hourly
or
Salbutamol nebule
(2.5 mg / 2.5 mL or 5 mg /
2.5 mL) nebulised with O2
3 - 4 hourly
or
Salbutamol solution 1 mL
5 mg / mL mixed with sodium
chloride 0.9% to a volume of
3 - 4 mL nebulised with O2
3 - 4 hourly
Nebulised ipratropium
bromide not required
Corticosteroids e.g.
prednisolone
Consider oral corticosteroids
Prednisolone 0.5 to 1 mg / kg
orally
Uncontrolled
Controlled copy
copy
V 1.0
IV hydrocortisone 100 mg
6 hourly for 24 hrs then review
only on MO order
Oral prednisolone 0.5 mg / kg
71
Resuscitation
Corticosteroids e.g.
prednisolone
Consider oral corticosteroids
72
Severe
Respiratory distress, using
accessory muscles
Speaking in single words or
not at all
Wheezing not heard
Cyanosed O2 saturation < 90%
Increased HR (> 200 bpm)
Moderate
Supplementary O2 to achieve
> 95% saturation
Monitor SpO2
Moderate
Respiratory distress, using
accessory muscles
Some sentences interrupted
Wheezes in chest
O2 saturation 90 - 94%
Increased HR
(100 - 200 bpm)
Oral prednisolone
1 mg / kg up to 50 mg daily
for 3 days then cease abruptly
without tapering
Uncontrolled
Controlled copy
copy
V1.0
Hydrocortisone 4 mg / kg to a
max. of 100 mg IV 6 hourly on
day 1 only on MO order
Oral prednisolone 1 mg / kg /
dose daily for up to 5 days
Resuscitation
Schedule
Salbutamol
DTP
IHW
Authorised Indigenous Health Worker may administer one dose, then must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Stat
Adult and child 6 years
Metered
8 - 12 puffs
Inhalation
If initial response is
100 microgram
dose
with spacing
inadequate repeat
inhaler
per dose
device
Child < 6 years
15 to 30 minutes
(MDI)
6 puffs
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[14]
DTP
IHW / SM R&IP
Authorised Indigenous Health Worker may administer one dose, then must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Stat
Adult and child 6 years
Repeat if no response.
2.5 mg - 5 mg mixed with
Then every 15 to 30
sodium chloride 0.9% to a
minutes or continously
volume of
if severe
3 - 4 mL
on MO / NP orders
Nebulised with O2
2.5 mg / 2.5 mL
Stat. If no response,
Nebule
(at least 8 L / min)
5 mg / 2.5 mL
consult MO / NP
Child < 6 years
Note: in infants <
2.5 mg mixed with sodium
1 yr response to
chloride 0.9% to a volume of
bronchodilators may
3 - 4 mL
be minimal and if
so should not be
repeated
Stat. Repeat if no
Adult and child 6 years
response. Then every
5 mg mixed with sodium
15 to 30 minutes or
chloride 0.9% to volume of
continously if severe
3 - 4 mL
on MO / NP orders
Stat
5 mg / mL
Nebulised with O2
If no response consult
(at least 8 L / min)
Solution
in 30 mL
MO / NP
Child < 6 years
Note: in infants
2.5 mg mixed with sodium
< 1 yr response to
chloride 0.9% to a volume of
bronchodilators may
3 - 4 mL
be minimal and if
so should not be
repeated
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[14] [15]
Schedule
Salbutamol
Uncontrolled
Controlled copy
copy
V 1.0
73
Resuscitation
DTP
IHW / SM R&IP
Authorised Indigenous Health Worker may administer one dose then must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult or child 6
years
Adult and child 6 years
500 microgram mixed with
250 microgram
2 - 4 hourly
2
mL sodium chloride 0.9%
Nebule
Nebulised
with
O
/ mL
2
Child < 6 years
and
(at least
Child < 6 years
500 microgram
20 minute intervals
solution
8 L / min)
250 microgram
/ mL
for 3 doses if
mixed with 2 mL sodium
required.
chloride 0.9%
Further doses on
MO / NP orders
Schedule
metered
dose
inhaler
(MDI)
21 microgram /
dose
Ipratropium bromide
Inhalation
with spacing device
Stat
Further doses on
MO / NP order
5. Follow up
Can go home after 1 hour with advice to continue usual asthma medicines,
including salbutamol every 4 hours as needed, if mild attack, no fever and wheeze
settles with initial salbutamol
Review the next day and if still no wheeze present needs to see MO at next clinic
on next visit within 4 weeks
If returns earlier because requiring salbutamol more than every 4 hours or if
wheeze on review, consult MO
All asthmatics should have an Asthma Action Plan so that everyone knows
what to do to optimise management See Chronic asthma for additional advice,
information and ongoing care
Beware of labelling infants as asthmatic. Viral chest infections in infants may also
cause wheeze that may not respond to bronchodilators
Patients, relatives and friends of people with asthma should know asthma
4 X 4 first aid. See Chronic Disease Guidelines at www.health.qld.gov.au/cdg or
www.nationalasthma.org.au
6. Referral / consultation
If mild and first attack, or has fever, or doesnt settle with initial dose of salbutamol,
consult MO
If moderate / severe asthma consult MO on all occasions (as above) and see at
next MO clinic
74
Uncontrolled
Controlled copy
copy
V1.0
Resuscitation
Cardiorespiratory arrest
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
Cardiorespiratory arrest - adult / child
Give high flow O2 via non-rebreathing mask. A Hudson mask is not sufficient
See O2 delivery systems
Hypothermia makes assessment of the circulation difficult therefore if CPR
commenced do not stop, unless in consultation with MO and there is no response
to resuscitation efforts despite the patient's body temperature being above 32C
or cannot be raised despite every measure taken
Consult MO as soon as possible
Remove all wet clothing and dry patient
Keep patient warm with blankets and space blankets
3. Clinical assessment
4. Management
Consult MO
Uncontrolled
Controlled copy
copy
V 1.0
75
Resuscitation
5. Follow up
The patient may be allowed home in consultation with the MO and in the company
6. Referral / consultation
Consult MO on all occasions
Any patient who has lost consciousness or has chest symptoms or signs or had
2. Immediate management
76
Resuscitation
3. Clinical assessment
Obtain a complete patient history including this and any previous episodes of
acute or chronic breathlessness
Perform standard clinical observations +
-- O2 saturation
Assess quality of respirations and note signs of accessory muscle use e.g. nasal
flaring, sternal retraction, intercostal recession
Inspect chest for expansion
Auscultate the chest for air entry and added sound (crackles or wheezes)
4. Management
Probable cause
Pulmonary oedema
(fluid in the lungs)
/ heart failure
Uncontrolled
Controlled copy
copy
V 1.0
What to do
See
Acute pulmonary oedema
Consult MO urgently
Evacuating / attending
MO may consider
heparinisation
77
Resuscitation
5. Follow up
See Acute pulmonary oedema
6. Referral / consultation
Consult MO
References
1.
Australian Resuscitation Council (2012). "Anaphylaxis - first aid management Guideline 9.2.7." Retrieved
October, 2012.
2.
Simons F.E. and Camargo C.A. (2012). "Anaphylaxis: rapid recognition and treatment. UpToDate."
Retrieved November, 2012.
3.
Australian Prescriber (2012). "Anaphylaxis: emergency management for health professionals." Retrieved
November, 2012
4.
Australian Medicine Handbook (2012). "Management of anaphylaxis." Retrieved November, 2012.
5.
Australian Medicine Handbook (2012). "Promethazine." Retrieved November, 2012.
6.
Therapeutic Guidelines (2012). "Other paediatric seizures." Retrieved October, 2012.
7.
The Royal Children's Hospital Melbourne (2012). "Febrile convulsions." Retrieved January, 2013.
8.
Therapeutic Guidelines (2012). "Status epilepticus." Retrieved October, 2012.
9.
PEMSoft (2012). "Febrile seizures." Retrieved October, 2012.
10. Australian Medicine Handbook (2012). "Diazepam." Retrieved October, 2012.
11. Therapeutic Guidelines (2012). "Diabetic ketoacidosis." Retrieved October, 2012
12. Queensland Government (2012). "Insulin intravenous infusion order and blood glucose record - adult.
Guidelines for use in Queensland Health hospitals." Retrieved October, 2012, from
qheps.health.qld.gov.au/medicines/projects_initiatives/inpatient_insulin.htm
13. Therapeutic Guidelines (2012). "Diabetes complications: hypoglycaemia." Retrieved October, 2012.
14. National Asthma Council Australia, Asthma Management Handbook. 2006, South Melbourne: National
Asthma Council.
15. Therapeutic Guidelines (2012). "Summary of treatment of acute attacks of asthma in children (Table
9.15)." Retrieved October, 2012.
16. Therapeutic Guidelines (2012). "Summary of treatment of acute attacks of asthma in adults (Table
9.14)." Retrieved October, 2012
17. Therapeutic Guidelines (2012). "Near drowning." Retrieved October, 2012.
18. Australian Resuscitation Council (2005). "Resuscitation of the drowning victim. Guideline 9.3.2."
Retrieved October, 2012.
19. Roberts J.R. and Hedges J.R. (2010). Clinical Procedures in Emergency Medicine. Philadelphia,
Saunders Elsevier.
20. The Royal Children's Hospital Melbourne (2012). "Hypoglycaemia Guideline." Retrieved October, 2012.
21. AMH Children's dosing companion (2013). "Ipratropium." Retrieved July, 2013.
22. Australian Resuscitation Council (2011). "Resuscitation in special circumstances Guideline 11.10."
Retrieved July, 2013.
78
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
Stable angina
NSTEACS
STEMI
NSTEMI
Related topics
Cardiorespiratory arrest
Cardiac arrhythmias
Acute pulmonary oedema
Trauma and injuries
Alcohol related epigastric pain
Acute abdominal pain
Unstable angina
Uncontrolled
Controlled copy
copy
V 1.0
79
Cardiovascular emergencies
Chest pain
Nausea
Dizziness
Diaphoresis
Hypotension
Collapse / cardiac arrest
Irregular heart beat
Breathlessness
Confusion (especially if elderly)
Beware unusual presentation in older patients, people with diabetes and women
Acute coronary syndrome
(unstable angina, myocardial
infarction)
Chest infection with pleurisy
Pericarditis
80
What to do
O2 if patient has
-- O2 saturation < 93%
-- is breathless
-- has signs of heart failure or
Central chest pain or discomfort
shock [2]
may also be described as
Perform 12 lead ECG as soon
'heaviness' or 'pressure'
as possible and fax / scan /
Pain may radiate to the arm or
email to MO
neck or jaw or shoulder and
may have associated nausea, Aspirin
vomiting, pallor, sweating and / Glyceryl trinitrate (GTN)
Morphine
or breathlessness
Thrombolysis / PCI may be
necessary
See under Management
Sharp chest pain, worse on
deep breath
See Pneumonia - adult
May have reduced air entry or
wheezes / crackles in the lungs
A history of fever and malaise,
sharp retrosternal or left sided
chest pain
Pain is often eased by leaning Perform 12 lead ECG then fax
forward and is worse in the
/ scan / email to MO
supine position
Consult MO urgently
Friction rub on examination,
MO will recommend:
often transient
-- bloods
Tachycardia (often)
-- chest x-ray
Evidence of underlying cause
-- NSAID and
e.g. viraemia, uraemia,
-- admission to hospital
autoimmune connective tissue
disorders or recent myocardial
infarction [5]
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
What to do
Consult MO urgently
Perform 12 lead ECG then fax
/ scan / email to MO
Evacuating / attending MO
may consider heparinisation
Consult MO immediately
Perform 12 lead ECG then fax
/ scan / email to MO
No thrombolysis,
anticoagulant or antiplatelet
medication
Uncontrolled
Controlled copy
copy
V 1.0
81
Cardiovascular emergencies
3. Clinical assessment
4. Management
Acute coronary syndrome
82
Continue O2 if patient has O2 saturation < 93%, is breathless, has signs of heart
failure or shock [2]
Continuous cardiac monitoring
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
Uncontrolled
Controlled copy
copy
V 1.0
83
Cardiovascular emergencies
Schedule
DTP
IHW
Aspirin soluble
Schedule
[1]
DTP
IHW
Tablet
600 microgram
Adult only
300 - 600 microgram
provided the systolic BP is
greater than 100 mmHg
Stat
If pain persists can
repeat after 5 minutes
to a max. of 3 doses
provided not hypotensive
Adult only
1 - 2 sprays
provided the systolic
BP is greater than 100
mmHg
Stat
If pain persists can
repeat after 5 minutes
to a max. of 3 doses
provided not hypotensive
Sublingual
Spray
400 microgram
84
Uncontrolled
Controlled copy
copy
V1.0
[1]
Cardiovascular emergencies
Schedule
DTP
IHW / SM R&IP
Morphine
Schedule
Metoclopramide
DTP
IHW / SM R&IP
Duration
Stat
Ampoule
10 mg / 2 mL
IV
Further doses on
MO / NP order
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or children and
use with caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[10]
Adult only
10 mg
Uncontrolled
Controlled copy
copy
V 1.0
85
Cardiovascular emergencies
NON DTP
Must be ordered by MO / NP
Tenecteplase must be ordered by an MO / NP. The efficacy is greatest given in the first 3 hours of the onset
of symptoms [11]
Route of
Form
Strength
Recommended dosage
Duration
administration
30 - 50 mg
(over 10 seconds)
(up to 50 mg on basis
50 mg
of body weight)
Vial
IV
< 60 kg 30 mg
Stat
(200 units =
60 - 69 kg 35 mg
1mg)
70 - 79 kg 40 mg
80 - 89 kg 45 mg
90 kg 50 mg
Contraindications for fibrinolysis [11] The decision to thrombolyse a patient is made on an individual
basis by the MO taking into account absolute and relative contraindications and individual risk factors
for bleeding. If a patients only contraindication is hypertension please contact MO with a view to giving
tenecteplase. Discuss with coronary care unit as necessary
Absolute contraindications
Relative contraindications
Active bleeding or bleeding diathesis (excluding Current use of anticoagulation
menses)
Full dose GP llb/llla inhibitors with fibrinolytic
Significant closed head or facial trauma within 3
therapy, particularly in the elderly
months
Noncompressible vascular punctures
Suspected aortic dissection
Traumatic or prolonged (> 10 min) CPR
Any prior intracranial haemorrhage
Ischaemic stroke > 3 months ago, dementia or
Ischaemic stroke within 3 months
known intracranial abnormality (not covered in
Known structural cerebral vascular lesion
absolute contraindications)
Known malignant intracranial neoplasm
Severe uncontrolled or chronic hypertension
Recent major surgery (< 3 weeks)
Recent internal bleeding (within 4 weeks)
Advanced metastatic cancer
Active peptic ulcer
Pregnancy
Monitor for side effects
Continuous ECG monitoring / have external defibrillator ready during thrombolysis in case of shockable
reperfusion cardiac arrhythmias, including ventricular fibrillation See Cardiac arrhythmias
If side effects: consult MO immediately
[22] [12]
Schedule
Tenecteplase (Metalyse)
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
5. Follow up
As directed by MO
6. Referral / consultation
Consult MO on all occasions of chest pain
Resources
STEMI Clinical Pathway for non-interventional cardiac facilities
available at www.health.qld.gov.au/psq/pathways/docs/pathway_stemi.pdf
STEMI Management Plan for non-interventional cardiac facilities
available at www.health.qld.gov.au/psq/pathways/docs/pthwys_stm_mngmntpln.pdf
NSTEACS Clinical Pathway for non-interventional cardiac facilities
available at www.health.qld.gov.au/psq/pathways/docs/pathway_nsteacs.pdf
NSTEACS Management Plan available at
www.health.qld.gov.au/psq/pathways/docs/pathway_nsteac_mgt.pdf
Chest pain
Breathlessness
Breathlessness (may start suddenly waking up at night, worse when lying down)
Increased HR
Cough, with or without wheeze
Pink frothy sputum (in severe cases)
Crackles especially in lung bases
Lethargy, confusion
Oedema of the ankles or sacrum and an enlarged liver may co-exist as a sign of
right heart failure
These patients can look pre-terminal
Seen in conjunction with renal failure
Cyanosis
Ischaemic chest pain
Uncontrolled
Controlled copy
copy
V 1.0
87
Cardiovascular emergencies
2.
Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
Obtain patient history - include in history this episode and previous heart trouble
-- angina, heart attack, heart failure?
-- has patient had heart palpitations?
Current medicines
Perform standard clinical observations +
-- note HR and rhythm - is it irregular
-- note respiratory rate - is it fast?
-- O2 saturation
-- conscious state - monitor See Glasgow coma scale / AVPU
Perform physical examination:
-- inspect and palpate the skin - what is the colour? ashen, cyanosed, sweaty?
-- are peripheries cool?
-- check the capillary return? is it reduced?
-- auscultate the chest for air entry and added sounds - are there crackles
or wheeze?
-- palpate the abdomen for enlarged liver
-- inspect and palpate the ankles, front of legs, sacrum - is oedema present?
4. Management
88
Cardiovascular emergencies
Schedule
Continue rest in bed, sitting up with legs hanging down, until patient settles or is
evacuated / hospitalised
4
Frusemide
20 mg / 2 mL
IV
Adult only
40 mg
DTP
IHW
Duration
Stat
Further doses on
MO / NP order
Schedule
[16]
DTP
IHW
Tablet
Adult only
300 - 600 microgram
provided the systolic
BP is greater than 100
mmHg
600 microgram
Sublingual
Spray
400 microgram
Adult only
1 - 2 sprays
provided the systolic
BP is greater than 100
mmHg
Uncontrolled
Controlled copy
copy
V 1.0
Stat
If no significant
improvement repeat after
5 minutes to a max. of
3 doses provided not
hypotensive
Stat
If no significant
improvement repeat after
5 minutes to a max. of
3 doses provided not
hypotensive
[1]
89
Cardiovascular emergencies
Schedule
DTP
IHW
Duration
Adult only
(equivalent to 1 x
15 mg
Stat
Nitro-dur 15 patch
(= release rate 15 mg /
Patch
or 1 x Nitrodur10
Transdermal
24 hours)
plus 1 x Nitrodur
provided the systolic BP is
5 patch or 1 x
greater than 100 mmHg
Transiderm-Nitro 25
plus 1 x TransidermNitro 50 patch)
Provide Consumer Medicine Information: apply to clean dry skin on the chest area or upper arm
Management of associated emergency: consult MO
[22]
5. Follow up
Keep patient under close supervision until evacuated / hospitalised
As per MO instructions
6. Referral / consultation
Consult MO on all occasions of pulmonary oedema (left ventricular failure /
heart failure)
90
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
Chest pain
Acute pulmonary oedema
Hypotension / shock
Chest pain
Heart failure
Fast, slow or irregular HR / palpitations
Asymptomatic
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
Give O2 to maintain O2 saturation > 93% adult / > 95% child. If not maintained
consult MO See O2 delivery systems
Attach monitor / defibrillator - send copy of rhythm strip to MO
Perform rapid assessment +
-- rhythm
If hypotensive / shocked consult MO urgently
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
91
Cardiovascular emergencies
5. Follow up
If patient not evacuated / hospitalised, review next day and see next MO clinic with:
-- further tests e.g. repeat ECG, blood tests, chest x-ray as ordered by MO
6. Referral / consultation
Consult MO on all occasions of arrhythmia
[17]
Recommend
See Immediate management
The severity of the injury and risk of death is greatest with:
-- high voltage electricity e.g. lightning and power lines
-- low resistance e.g. wet skin
-- electrical pathway across the heart
-- prolonged exposure
Background
The electrical charge causes an entry wound (burn) that is often full thickness, with
potential underlying tissue damage that may be extensive and not immediately
apparent. There may be a similar exit (earthing) burn
Arrhythmias including ventricular fibrillation may occur, leading to cardiac arrest if
the charge crosses the heart. If it crosses the brain, unconsciousness may occur
Related topics
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
92
Remove patient from injury (only approach patient or surroundings after power is
turned off at mains)
Give O2 to maintain O2 saturation > 93% adult / > 95% child. If not maintained
consult MO See O2 delivery systems
Connect to ECG monitor / defibrillator
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
Rapid assessment +
-- O2 saturation
-- conscious state See Glasgow coma scale / AVPU
Insert IV cannula
Consult MO
3. Clinical assessment
4. Management
5. Follow up
If there has been no history of altered consciousness or cardiac arrhythmia, the
ECG is normal and the patient sustained only minor burns, the patient need
not be evacuated / hospitalised and can be allowed home after a few hours of
observation
Review daily initially for 2 - 3 days See Burns
See next MO clinic
6. Referral / consultation
Consult MO on all occasions of:
Chest pain
Acute pulmonary oedema
Hypertension
Acute post streptococcal glomerulonephritis (APSGN)
Irukandji syndrome
Uncontrolled
Controlled copy
copy
V 1.0
93
Cardiovascular emergencies
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
4. Management
94
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
Schedule
DTP
IHW
Duration
Stat
[19]
5. Follow up
6. Referral / consultation
2. Immediate management
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
95
Cardiovascular emergencies
4. Management
Schedule
Give analgesia
Prepare for evacuation / surgery
Ensure patient is nil by mouth
Rest affected limb
Consult MO urgently
The MO will:
-- arrange urgent evacuation / hospitalisation to a facility with appropriate
surgical capability
-- advise ongoing analgesia (IM / IV morphine and metoclopramide)
-- advise on heparinisation
8
Morphine
DTP
IHW / SM R&IP
96
Uncontrolled
Controlled copy
copy
V1.0
Cardiovascular emergencies
Schedule
Metoclopramide
DTP
IHW / SM R&IP
5. Follow up
As advised by discharging MO
6. Referral / consultation
MO will notify the referring hospital of situation
References
1.
Therapeutic Guidelines (2013). "Acute chest pain." Retrieved July, 2013.
2.
Chew D.P., Aroney C.N., et al. (2011). "Addendum to the National Health Foundation of Australia /
Cardiac Society of Australia and New Zealand Guidelines for the Management of Acute Coronary
Syndromes (ACS) 2006." Heart, Lung and Circulation: 1-16.
3.
Australian Resuscitation Council (2011). "Acute Coronary Syndromes Guideline 14." Retrieved October,
2012.
4.
Therapeutic Guidelines (2012). "Coronary heart disease." Retrieved October, 2012.
5.
Therapeutic Guidelines (2012). "Pericarditis." Retrieved October, 2012.
6.
NS579 Marshall K. (2011.). "Acute coronary syndrome: diagnosis, risk assessment and management."
Nursing Standard 25(23): 47-57.
7.
Kucia A.M. and Unger S.A. (2009). Acute Cardiac Care: A practical guide for nurses. Hoboken New
Jersey, Wiley-Blackhall.
8.
Australian Resuscitation Council (2011). "Acute coronary syndromes: presentation with ACS. Guideline
14.1." Retrieved October, 2012.
9.
Queensland Government (2012). "NSTEACS Management Plan For Non-Interventional Cardiac
Facilities." Retrieved October, 2012.
10. Australian Medicine Handbook (2012). "Metoclopramide." Retrieved June, 2012
11. Australian Resuscitation Council (2011). "Acute Coronary Syndromes: reperfusion strategy Guideline
14.3." Retrieved October, 2012
12. MIMS (2012). "Metalyse." Retrieved October, 2012.
13. Queensland Government (2012). "STEMI Management Plan For Non-Interventional Cardiac Facilities."
Retrieved October, 2012
14. Prof. Derek Chew (2011). Heart Foundation.
15. Australian Medicine Handbook (2012). "Thrombolytics." Retrieved October, 2012.
16. Therapeutic Guidelines (2012). "Acute cardiogenic pulmonary oedema." Retrieved October, 2012.
17. Therapeutic Guidelines (2012). "Electrical injury ". Retrieved October, 2012
18. Therapeutic Guidelines (2012). "Urgent reduction of blood pressure." Retrieved October, 2012.
19. Editorial Committee Primary Clinical Care Manual 8th edition 2013.
20. Marx J.A. ed. (2006). Rosens Emergency Medicine: Concepts and Clinical Practice. Philadephia,
Mosby Elsevier.
21. Therapeutic Guidelines (2013). "Stepwise approach to acute pain management." Retrieved July, 2013.
22. Queensland Government (2012). STEMI Management Plan ST-elevation Myocardial
Infarction
For
Non-Interventional
Cardiac
Facilities,.
Queensland
Health.
Brisbane.
23. Therapeutic Guidelines (2013). "Heart failure: pharmacological management." Retrieved July, 2013.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
97
Neurological emergencies
Meningitis
TIA and stroke
2. Immediate management
Give high flow O2. Maintain oxygen saturation 98% (within limitations of lung
function)
Perform rapid clinical assessment +
-- conscious state See Glasgow coma scale / AVPU
3. Clinical assessment
4. Management
Consult MO immediately
Beware of lowering elevated BP if there is any neurological deficit
Arrange urgent evacuation / hospitalisation
5. Follow up
6. Referral / consultation
Consult MO urgently in all cases of suspected subarachnoid haemorrhage
References
1.
Bederson J.B. and et al. (2009). "Guidelines for the management of aneurysmal subarachnoid
haemorrhage." Stroke 40(3): 994.
98
Uncontrolled
Controlled copy
copy
V1.0
Neurological emergencies
Uncontrolled
Controlled copy
copy
V 1.0
99
Neurological emergencies
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
Document:
-- date and time when signs / symptoms were first noted and how long they lasted
-- when the patient was last known to be well
Take as complete a patient history as possible allowing for severity of condition.
Obtain information from family and friends of patient if patient unable to provide
-- note previous history of TIA / stroke
-- document - risk factors such as hypertension, diabetes, smoker, obesity,
dyslipidaemia, is the patient usually physically active?
-- is there a history of atrial fibrillation (irregular heart beat)?
-- do they or did they have a headache? Do they feel dizzy?
-- has the patient's vision changed in one eye or both? Do they have double vision?
-- take medication history - does the patient take aspirin or warfarin?
Perform standard clinical observations +
-- O2 saturation
-- conscious state See Glasgow coma scale / AVPU
-- note pupil size and reaction [1]
-- 12 lead ECG [5]
Perform physical examination:
-- can the patient speak normally? speech slurred / altered in any way?
-- does the patient understand questions and obey commands?
-- does the patient have any weakness or altered sensation of limbs and / or
face, usually on one side of the body, e.g. drooping on one side of the face,
clumsy hand. Does the patient have a symmetrical smile?
-- did the patient walk in? describe their gait. Do they have difficulty walking,
loss of balance or have poor coordination?
Score patient according to ABCD tool
100
Uncontrolled
Controlled copy
copy
V1.0
1 point
1 point
2 points
1 point
1 point
1 point
Neurological emergencies
4. Management
Recommended action
5. Follow up
Patients with stroke / TIA will require evacuation / hospitalisation for neurological
6. Referral / consultation
Consult MO on all occasions of suspected TIA / stroke
References
1.
National Stroke Foundation (2010). "Clinical Guidelines for Stroke Management: Recommendations."
Retrieved October, 2012
2.
Royal Australian College of General Practitioners (2012). "Guidelines for preventive activities in general
practice, 8th edn." from www.racgp.org.au/your-practice/guidelines/redbook/
3.
National Stroke Foundation (2012). "Risk Factor Tick Test." Retrieved October, 2012, from
www.strokefoundation.com.au/prevent-stroke/
4.
National Stroke Foundation (2010). "Clinical Guidelines for Stroke Management ". Retrieved October,
2012, from www.strokefoundation.com.au/health-professionals/tools-and-resources/clinical-guidelinesfor-stroke-prevention-and-management/
5.
International Stroke Trial Collaborative Group (1997). "The International Stroke Trial (IST): a randomised
trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic
stroke." Lancet 349: 1569-1581.
6.
NACCHO/RACGP (2012). National guide to a preventive health assessment for Aboriginal and Torres
Strait Islander people 2nd edn. South Melbourne, The RACGP.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
101
2.
3.
Related topics
Chest injuries
Fractures, dislocations and sprains
Acute wounds
Burns
Spinal injuries
History of injury
Pain
Increased HR
Acute upper airway obstruction / choking
Respiratory distress, cyanosis
Hypotension / shock / pale / sweaty
Altered consciousness - confused, drowsy, unconscious, not breathing
Wounds, fractures, burns
102
Begin secondary survey only after any life saving interventions / management initiated in the
primary survey
F Perform a full set of vital signs and monitor BP, HR, respiratory rate,
O2 saturation, BGL, conscious state See Glasgow coma scale / AVPU
-- check pain score (0 - 10) if conscious
G Give pain relief to patient and comfort measures to patient and family
H Obtain patient history from patient / witnesses and perform head to toe
assessment
-- time of symptom onset or injury, Glasgow coma scale (or loss of
consciousness) immediately after the incident
-- circumstances and mechanism of injury - blunt or penetrating, velocity
-- duration of any altered level of consciousness from witnesses
-- first thing remembered by patient after injury
Uncontrolled
Controlled copy
copy
V 1.0
103
-----
Uncontrolled
Controlled copy
copy
V1.0
-- increasing respiratory distress and HR, with falling BP and falling GCS may
indicate tension pneumothorax
Tension pneumothorax is a life threatening emergency and is a treatable cause of potential
death in the severely injured patient. Check for bilateral air entry. Is there a fractured rib?
Tension pneumothorax requires urgent treatment. Consult MO unless circumstances do
not allow. Perform chest decompression / needle thoracentesis See Chest injuries
Uncontrolled
Controlled copy
copy
V 1.0
105
Vital signs
Adult
and / or
Injuries
and / or
Mechanism of injury
Ejection from vehicle
Motorcyclist impact > 30 kph
High speed motor vehicle collision > 60 kph
Vehicle roll over
Fatality in same vehicle
Prolonged extrication > 30 minutes
Pedestrian impact
Fall from height > 3 metres
Struck on head by falling object > 3 metres
Explosion
106
Uncontrolled
Controlled copy
copy
V1.0
4.
Management
After providing immediate management keep patient nil by mouth and warm
Provide analgesia
SeeSimple
Simple
back
analgesia
cover
See
analgesia
Note:
for procedural management e.g. plaster application, painful dressing
Collect blood for FBC, electrolytes, LFT, cross match and BGL
Insert indwelling urethral catheter (unless suspected urethral injury and / or blood
present at urethral meatus). Continuous measurement of urine output
Perform ECG
Morphine
DTP
IHW / SM R&IP
Uncontrolled
Controlled copy
copy
V 1.0
107
Schedule
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
8
DTP
IHW / SM R&IP
Fentanyl
100 microgram
/ 2 mL
IV
(IHW may not
administer IV)
Adult only
1.5 microgram / kg
to a max. of 100 microgram
Adult only
25 microgram increments
slowly, repeated every 10
minutes if required to a
max. of 100 microgram
Duration
Stat
Further doses
on MO / NP order
Schedule
DTP
IHW / SM R&IP
Metoclopramide
Duration
Stat
Further doses
Ampoule
10 mg / 2 mL
on MO / NP
order
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or children and
use with caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[6]
IM or IV
(IHW may not
administer IV)
108
Uncontrolled
Controlled copy
copy
V1.0
Adult only
10 mg
Schedule
Methoxyflurane
DTP
IHW / SM R&IP
5. Follow up
As per findings. Reassess primary survey and manage any life saving interventions
stay under observation until non affected or be discharged into the care of a
responsible non affected adult who accepts this responsibility
6. Referral / consultation
C
onsult MO as soon as possible with any findings from examination
Prepare patient for evacuation via air or road to facility with capability to address
Uncontrolled
Controlled copy
copy
V 1.0
109
110
Suspect tension
pneumothorax
Consider performing
needle thoracentesis
Suspect simple
pneumothorax
Suspect lung
contusion
Suspect haemothorax
Possible haemothorax
An obvious wound to the chest with or without an object Do not remove any
sticking out
object sticking out of
wound e.g. knife
Air sucking into chest. Cover with three sided occlusive
Open chest wound
dressing or proprietary dressing
Uncontrolled
Controlled copy
copy
V 1.0
111
4. Management
Consult MO in all cases
Give analgesia See Trauma and injuries
Tension pneumothorax
Tension pneumothorax is a life threatening emergency and is a treatable cause
of potential death in the severely injured patient . Tension pneumothorax requires
urgent treatment. Consult MO as soon as circumstances allow
-- perform immediate decompression by needle thoracentesis
-- insert a 14 G IV cannula through upper chest wall (2nd intercostal space,
midclavicular line) into thoracic cavity just above the upper edge of the rib
below (see diagram)
-- if tension pneumothorax is present, air will escape with a rush from the pleural
space under pressure with an easing of respiratory distress
-- if patient has only partly improved, or gets worse, check the cannula has not
kinked or the tension pneumothorax may have recurred, or there may be a
tension pneumothorax on the other side. Consult MO as may need to try
again on the other side
-- MO will insert a formal intercostal catheter prior to evacuation / hospitalisation
and attach to Heimlich valve or Portex ambulatory chest drainage system
Thoracic cavity
Rib
Neurovascular bundle
Simple pneumothorax
Monitor and await transfer
MO will insert a formal intercostal catheter prior to evacuation / hospitalisation
Haemothorax
Treat hypovolaemia, if respiratory distress ensues then treat as tension
pneumothorax
MO will advise quantities and rates of IV fluids to be given. It is usual to start with
sodium chloride 0.9% or Hartmanns solution and follow with blood
The MO will insert a formal intercostal catheter prior to evacuation / hospitalisation
See Shock
112
Uncontrolled
Controlled copy
copy
V1.0
Flail chest
Continue to provide airway and ventilation support as per MO instructions
If large, may require intubation and ventilation by MO prior to evacuation /
hospitalisation in a facility with intensive care capability
Broken rib
Consult MO who will likely advise oral analgesia, and review next day if no other
injury
Penetrating - open injuries
Sometimes called open pneumothorax including gunshot and stab wounds:
-- do not remove any object sticking out of wound e.g. knife. Pack around with
gauze soaked in sodium chloride 0.9% and secure
-- in the case of sucking chest wounds, seal the wound with an occlusive
dressing taped on three sides or proprietary device designed for this purpose
Consult MO who will advise antibiotics / analgesia and arrange evacuation
-- MO will insert a formal intercostal catheter prior to evacuation / hospitalisation
in a facility with appropriate surgical capability
K
eep patient nil by mouth
K
eep patient warm
5. Follow up
MO will advise ongoing management
Patients who are affected by drugs and / or alcohol should be encouraged to
stay under observation until non affected or be discharged into the care of a
responsible non affected adult who accepts this responsibility
6. Referral / consultation
I n all cases consult MO
Prepare patient for evacuation via air or road to facility with capability to address
chest injuries See Criteria for Early Notification of Trauma for Interfacility Transfer
Uncontrolled
Controlled copy
copy
V 1.0
113
Subarachnoid haemorrhage
DRS ABCD resuscitation / the collapsed patient
Glasgow coma scale / AVPU
O2 delivery systems
114
Maintain temperature
If GCS 8 or less, patient will need intubation and ventilation by MO prior to
evacuation / hospitalisation to an appropriate facility with intensive care and
neuro-surgical capability. These patients are unable to control their airway and
are at risk from aspiration. Provide airway, breathing and circulation support until
MO arrives
Begin secondary survey only after any life saving interventions / management initiated in the
primary survey
Alert
No response (Unresponsive)
Uncontrolled
Controlled copy
copy
V 1.0
115
4. Management
116
Uncontrolled
Controlled copy
copy
V1.0
5. Follow up
Urgent evacuation for CT scanning in adults and children with high
risk factors
See Decision Making for Escalation and CT Scanning
Consider transfer for CT scanning in children with intermediate risk factors
observation. After this time and if GCS is 15, in consultation with MO, patient may
be discharged into care of responsible person who should be given appropriate
head injury instructions
See Advice to patients who have received an injury to the head
stay under observation until non affected or be discharged into the care of a
responsible non affected adult who accepts this responsibility
If any alteration in condition reassess risk and consult MO
Review next day and at next MO clinic
6. Referral / consultation
Consult MO with any findings above or if at high risk of severe injury because of
circumstances
See Criteria for Early Notification of Trauma for Interfacility Transfer
Referral to Occupational Therapist for post traumatic amnesia test (PTA)
Advice to patients who have received an injury to the head [11]
Rest quietly for the day
Use ice packs over swollen or painful areas. Wrap ice cubes, frozen peas or a sports ice pack in a
towel. Do not put ice directly on the skin
Take simple pain killers (such as paracetamol) for any headache. Check the packet for the right dose
and use only as directed
If an injured patient is discharged in the evening, make sure they are woken several times during the
night. Set the alarm. Ensure the injured patient walks to the toilet or does an activity that allows you
to assess their coordination
Do not let the injured patient drive home
Do not leave them alone for the next 24 hours
Do not let them drink alcohol for at least 24 hours
Do not let them eat or drink for the first six to 12 hours (unless advised otherwise by the MO). Then
offer them food and drink in moderation
Do not let them take sedatives or other medication unless instructed
Return to the clinic immediately if the patient has repeated vomiting, blacks out or a seizure (fit), or
cannot be woken or is not responsive
Patient to return to clinic if they have any symptoms they or carer are concerned about
Uncontrolled
Controlled copy
copy
V 1.0
117
Medical emergency
Consult MO immediately
to arrange evacuation
Yes to any
CT scan is required
CT not available
Consult MO
Perform CT
No
If observations
remain in normal
range for 6 hours post
injury:
-- patient may be
discharged
-- into care of
responsible person
-- with head injury
advice sheet
Arrange MO review
next clinic
118
CT available
If observations
become
abnormal
or patient
deteriorates
Yes
Consult MO immediately
- will organise evacuation
Uncontrolled
Controlled copy
copy
V1.0
Intermediate
risk factors
Injury
High
risk factors
< 1 year
< 5 minutes
Possible
Mild agitation or altered
behaviour
3 or more
Impact only
Yes
No
Yes
No
Yes
Present
Yes
< 60 kph
1 - 3 metres
Moderate impact or
unclear mechanism
14 - 15
Nil
Present
Persistent or increasing
> 60 kph
> 3 metres
High speed / heavy
projectile or object
< 14
Present
Tense fontanelle in
children < 1 year of age
> 5 minutes
> 5 minutes
Abnormal drowsiness
Haematoma, swelling or
Penetrating injury
laceration > 5cm
Suspected depressed
skull fracture
Uncontrolled
Controlled copy
copy
V 1.0
119
History of injury
Isolated spinal injury:
-- spinal pain, tenderness
-- muscular weakness or paralysis of the arms or legs, numbness or pins and
needles in arms or legs, no matter how transient
-- weak / shallow (diaphragmatic) breathing
-- neurogenic hypotension - low BP with a normal HR
-- loss of bladder or bowel control, urinary retention
-- priapism (persistent and painful erection)
120
Uncontrolled
Controlled copy
copy
V1.0
It is preferable for the patient to be stabilised and evacuated from the scene
rather than transported in less than ideal circumstances. Lie flat on back on a
hard surface. Maintain head in neutral position using towel rolls / rigid cervical
collar and ensure neck is in alignment with body
Consult MO as soon as possible
Log roll
If necessary to move patient or examine patients spine on MO orders:
Minimum of three, preferably five people are required
One person should control patients head and neck (in rigid cervical collar). This
person should also be the team leader for the log roll and give instructions to the rest
of the team
Log roll the patient maintaining spinal alignment, especially avoiding flexion and
rotation (keep the patients nose in line with the belly button at all times)
Begin secondary survey only after any life saving interventions / management initiated in the
primary survey
4. Management
5. Follow up
Any patient who has any midline cervical spine pain or tenderness following injury
6. Referral / consultation
circumstances
See Criteria for Early Notification of Trauma for Interfacility Transfer
Uncontrolled
Controlled copy
copy
V 1.0
121
2.
Begin secondary survey only after any life saving interventions / management initiated in the
primary survey
122
4. Management
Give analgesia See Trauma and injuries
Blunt or non-penetrating injury:
Consult MO who will advise IV fluid quantities and rate and arrange evacuation
/ hospitalisation in an appropriate facility with surgical capability. If hypotensive
/ shocked with intra-abdominal injury in the absence of head injury - fluid
resuscitation may be conservative. Excessive fluid resuscitation may dilute
clotting factors and dislodge clots resulting in fatal intra-abdominal haemorrhage
Penetrating wound including gunshot and stab wounds:
Do not remove any object sticking out of wound e.g. knife. Pack around with
gauze soaked in sodium chloride 0.9% and secure, as may dislodge haematoma
or damage vessels
Pack open wound with sodium chloride 0.9% soaked pack
Do not replace exposed bowel or omentum. Cover with sodium chloride 0.9%
soaked packs
Consult MO who will advise IV fluid quantities / rate and antibiotics, and arrange
evacuation / hospitalisation in an appropriate facility with surgical capability
Keep patient nil by mouth
Keep patient warm
MO may advise to pass nasogastric tube if easy and no signs of facial or basal
skull fractures. Allow free drainage and aspirate periodically
Uncontrolled
Controlled copy
copy
V 1.0
123
5. Follow up
6. Referral / consultation
Consult MO with any findings as above or if at high risk of serious injury because
of circumstances
See Criteria for Early Notification of Trauma for Interfacility Transfer
References
1.
Queensland Government (2011). Closed Head Injury (Adult) Clinical Pathway Brisbane
2.
Raja A. and Zane R. D. (2012). "Initial management of trauma in adults. Primary survey." Retrieved
October, 2012.
3.
Queensland Government (2012). "RSQ Criteria for early notification of trauma." Retrieved October,
2012.
4.
Emergency Nurses Association (2007). TNCC - Trauma Nursing Core Course provider manual 6th
edition
5. Therapeutic Guidelines (2013). "Stepwise approach to acute pain management." Retrieved July, 2013.
6.
Australian Medicine Handbook (2012). "Metoclopramide." Retrieved June, 2012.
7.
Queensland Ambulance Service (2011). "Methoxyflurane." Retrieved January, 2013.
8.
Australian Medicine Handbook (2012). "Methoxyflurane." Retrieved October, 2012.
9.
Queensland Government (2012). Head Injury (children) Clinical Pathway. Brisbane, Queensland Health
10. American College of Surgeons Committee on Trauma (2008). Advanced Trauma Life Support for
Doctors, in ATLS Student Course Manual
11. Reed D. (2007). Adult Trauma Clinical Practice Guidelines, Initial Management of Closed Head Injury in
Adults, NSW Institute of Trauma and Injury Management.
12. Shlamovitz G., Mower W., et al. (2007). "Poor test characteristics for the digital rectal examination in
trauma patients." Annals of Emergency Medicine 50(1): 25-33.
13.
Advanced Paediatric Life Support Group (2011). Advanced Paediatric Life Support The Practical
Approach., Wiley-Blackwell.
14. MiMS (2013). "Morphine sulfate injection." Retrieved July, 2013.
15. Editorial Committee Primary Clinical Care Manual 8th edition 2013.
124
Uncontrolled
Controlled copy
copy
V1.0
2. Immediate management
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
125
4.
Management
126
Uncontrolled
Controlled copy
copy
V1.0
Schedule
Morphine
DTP
IHW / SM R&IP
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
8
Fentanyl
100 microgram
/ 2 mL
IV
(IHW may not
administer IV)
Adult only
1.5 microgram / kg
to a max. of 100 microgram
Adult only
25 microgram increments
slowly, repeated every 10
minutes if required to a
max. of 100 microgram
DTP
IHW / SM R&IP
Duration
Stat
Further doses
on MO / NP order
Uncontrolled
Controlled copy
copy
V 1.0
127
If nauseated or vomiting
Schedule
Metoclopramide
DTP
IHW / SM R&IP
5. Follow up
All fractures and dislocations should be reviewed at 24 hours. Record and report
6. Referral / consultation
Consult MO on all occasions for management of individual fractures
Stiffness of joints is a common problem with immobilisation in plaster / slings [1].
128
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
129
History of injury
Broken bone with break in the overlying skin
2. Immediate management
3. Clinical assessment
4. Management
5. Follow up
As per MO advice
6. Referral / consultation
Consult MO on all occasions
All compound fractures need antibiotics, and may need surgery for cleaning and
Uncontrolled
Controlled copy
copy
V1.0
O2 delivery systems
Shock
2. Immediate management
Give O2 to maintain O2 saturation > 93% adult / > 95% child. If not maintained
consult MO See O2 delivery systems
Insert largest possible IV cannula (14 G or 16 G)
It is usual to start with sodium chloride 0.9% or Hartmanns solution. MO will
advise quantities and rate
Pelvic binding should be applied as soon as possible and prior to x-ray [6]
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
131
4. Management
Consult MO
Give analgesia See Simple fracture of limbs
If stable pelvic fracture [1] MO may advise:
-- give analgesia
-- bed rest as pain symptoms dictate
-- attempt walking with aid as soon as comfortable
If unstable pelvic fracture the MO may:
-- order x-ray if available
-- organise evacuation / hospitalisation in an appropriate facility
-- only ask the patient be catheterised if proved no bladder neck injury (no blood
out of the urethra or in the urine and normal findings on rectal examination)
-- advise binding of the pelvis (if not already done). Wrap sheet or binder around
pelvis and tighten. Secure sheet e.g. with safety pins, sponge holding forceps.
This procedure can be very painful
5. Follow up
As per MO advice
6. Referral / consultation
Urgent consult with MO on all occasions of suspected fractured pelvis
2. Immediate management
Acute upper airway obstruction / choking
132
Uncontrolled
Controlled copy
copy
V1.0
3. Clinical assessment
4. Management
5. Follow up
If not evacuated / hospitalised, the patient should be with a responsible adult for
at least the first 24 hours due to the potential risk to the airway from bleeding
and swelling
Review next day
6. Referral / consultation
Consult MO on all occasions of suspected fractured mandible / jaw
Dental or faciomaxillary assessment is usually necessary, and the patient often
Uncontrolled
Controlled copy
copy
V 1.0
133
Recommend
Realign / reduce dislocation as soon as possible as the limb will become compromised
Consult MO. Minor dislocations may be realigned locally
Related topics
1.
2.
3.
Immediate management
Clinical assessment
4.
History of injury
As part of Trauma and injuries
Pain, swelling and deformity of the joint
Unwilling to move the joint. In upper limb dislocations, the patient often walks in
supporting the limb with the opposite one
Management
5.
Follow up
6.
Referral / consultation
134
1.
2.
3.
4.
History of injury
Pain
Swollen joint
Unable to weight bear
No fracture seen on x-ray
Management
5.
Follow up
6.
For mild / moderate sprains review patient in 48 hours and again in one week to
check progress. Consult MO if required
For severe sprain consult MO
Referral / consultation
In mild / moderate sprains - if pain free movement not achieved in 6 weeks refer
to MO / Physiotherapist if available
Uncontrolled
Controlled copy
copy
V 1.0
135
2. Immediate management
3. Clinical assessment
4. Management
136
Consult MO urgently
If not allergic, give morphine (preferable) or if allergic to morphine give fentanyl.
Contact MO for children
Give metoclopramide (adult) if nauseated or vomiting
Children should not receive metoclopramide (Maxolon) or prochlorperazine
(Stemetil) because of the high risk of dystonic reactions [8]. If an antiemetic is
required for a child the MO may advise ondansetron wafer
Arrange urgent evacuation for surgical release
Uncontrolled
Controlled copy
copy
V1.0
Schedule
Morphine
DTP
IHW / SM R&IP
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
8
Fentanyl
100 microgram
/ 2 mL
IV
(IHW may not
administer IV)
Adult only
1.5 microgram / kg
to a max. of 100 microgram
Adult only
25 microgram increments
slowly, repeated every 10
minutes if required to a
max. of 100 microgram
DTP
IHW / SM R&IP
Duration
Stat
Further doses
on MO / NP order
Uncontrolled
Controlled copy
copy
V 1.0
137
Schedule
Metoclopramide
DTP
IHW / SM R&IP
5. Follow up
As per MO advice
6. Referral / consultation
Consult MO on all occasions of suspected compartment syndrome
References
1.
Murtagh J. and Rosenblatt J. (2011). John Murtagh's general practice McGraw-Hill Australia Pty Ltd.
2.
Therapeutic Guidelines (2013). "Stepwise approach to acute pain management." Retrieved July, 2013.
3.
Australian Medicine Handbook (2012). "Metoclopramide." Retrieved June, 2012.
4.
Carstens J. (2011). "Plaster of paris: application. The Joanna Briggs Institute." Retrieved October, 2012.
5.
Yifan X. (2012). "Pelvic Fracture: Pelvic Sheeting and Circumferential Compresssion. The Joanna
Briggs Institute." Retrieved October, 2012.
6. Lee C. and Porter K. (2007). "The prehospital management of pelvic fractures." Emerg Med Journal
24(2): 130-133.
7.
Tintanelli E.J. (2011). Tintanelli's Emergency Medicine: A comprehensive study guide, seventh edition,
Mc Graw Hill Medical
8.
Therapeutic Guidelines (2012). "Drug-induced movement disorders." Retrieved October, 2012.
9.
MiMS (2013). "Morphine sulfate injection." Retrieved July, 2013.
10.
Editorial Committee Primary Clinical Care Manual 8th edition 2013.
138
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
2. Immediate management
Uncontrolled
Controlled copy
copy
V 1.0
139
Acute wounds
3. Clinical assessment
140
Acute wounds
4.
X-ray, if available
- if in doubt whether there is a fracture underlying the wound. Needs to be
treated as a compound fracture See Compound fractures
- to help localise a foreign body. Metal, bones and most glass are radio-opaque.
However some glass is not, and nor is wood, grass, plastic, stone. No foreign
body on x-ray does not exclude a foreign body in the wound, unless you are
sure it would be radio-opaque
- if in a facility where available, ultrasound with small parts probe is best
With wounds to the chest and abdomen, be wary of penetration through the body
wall. If this is possible, or you are concerned, consult MO
See Chest and / or Abdominal injuries
Management
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12
years and 50 kg
up to max. of
Stat
3 mg / kg / dose to a
1%
Ampoule
Subcutaneous
Do not repeat the total
50 mg / 5 mL
200 mg
max. dose at intervals
of < 1.5 hours
Child
up to max. of
3 mg / kg / dose
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[2] [3]
Schedule
Lignocaine
Uncontrolled
Controlled copy
copy
V 1.0
141
Acute wounds
Wound closure
There are 5 main options for wound closure
1. Leave it open to the air:
-- for grazes and very superficial cuts in clean dry areas of the body
2. Simple dressings:
-- for grazes and small cuts in moist areas (groins, armpits etc.) and areas of
the body prone to getting dirty
3. Adhesive skin strips e.g. Steristrips:
-- good for children, small lacerations, some facial wounds and finger
lacerations, skin tears in the elderly and especially for wounds over the
shin (even large ones)
-- dont work well in larger (> 2 - 3 cm) or gaping wounds, those under tension,
or wounds in very mobile parts of the body (joints). Dont use them if they
are likely to get wet or rub off. Suture instead
-- 3M Cavilon skin barrier wipe on the skin helps them stick
4. Sutures:
-- nylon or silk sutures are used for the skin:
5/0 or 6/0 for the face
4/0 or 5/0 for hands
3/0 for the back, soles and sometimes scalp and calf
4/0 everywhere else
-- absorbable sutures e.g. Vicryl rapide, can be used for deeper layers,
mucosa of the mouth and vagina
-- sutures cause a normal pink foreign body inflammation around the wound.
This is lessened with synthetic sutures
5. Skin glue e.g. Dermabond glue
-- skin glue is typically used in areas where:
5/0 or 6/0 non absorbable sutures are used e.g. face, torso and
extremities
the wound is less than 3 cm in length with edges easily held together
After repairing the wound, elevation is very important to lessen pain, swelling and
risk of infection
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
Suturing
The aim is to eliminate dead space in the wound, evert the skin edges (like
puckered lips) and bring skin edges together with the minimum of tension
-- clean and debride the wound first. Take your time
-- hair can be removed from the wound edges with scissors or a scalpel blade,
but keep it to a minimum - approximately 1 cm. Never remove eyebrows
-- do not suture a wound that needs a lot of tension to bring it together e.g.
where there has been tissue loss. Keep it clean and consult MO
-- enter the skin with the needle about 5 mm from the wound edge. Go straight
down, across, then straight up and exit the skin about 5 mm from the wound's
other edge
-- place the first suture halfway along the wound, and continue to divide the
wound in half with the other sutures. This will bring the edges together well.
The first suture makes it easier to put all the rest in, but it may lose tension
when the others are completed. If so, take it out and redo
-- when suturing a V or Y shaped wound, align the point of the V first
-- if the wound crosses wrinkles or skin creases, these must be lined up as well
as possible
-- dont be afraid to take sutures out again if they are in the wrong place
-- if you are not happy repairing any wound, dont do it [1]. Consult MO
[1]
Removal of sutures
Scalp 6 days
Face 3 - 5 days
Hands, arms 7 - 10 days
Trunk and legs 10 - 14 days
Some or all sutures may come out sooner if the wound becomes infected and
later if the wound does not look and feel firm yet. It may help to apply adhesive
skin strips e.g. Steristrips after removal
Uncontrolled
Controlled copy
copy
V 1.0
143
Acute wounds
Special lacerations
Face
-- only repair these if you are confident of getting a good result, as cosmetic
outcome is very important. They should be repaired within 6 - 8 hours of
injury. A dressing on the repaired wound is not always necessary. Be aware
that there may be damage to facial nerves
Inside the mouth
-- these heal very well without sutures, unless there is full thickness penetration
of the cheek, in which case they need specialised repair, consult MO. It will
look grey and sloughy after a few days, but mouth rinses after each meal will
help to keep it clean and it should be healed within a week
Lips
-- lips swell enormously when wounded. Lips often only need suturing if there is
gross displacement of large flaps. Small lacerations will heal without sutures
as for wounds inside the mouth
-- Note: if the wound crosses the edge of the lip onto normal skin (the vermilion
border) it needs to be realigned exactly to avoid an unsightly cosmetic result
Eyelid
-- if these are full thickness they need specialised repair. Consult MO
Fingers
-- finger lacerations - check for tendon and nerve damage
-- fingers swell after injury so ensure rings are taken off
-- sutures will pull out of the tissue as the finger enlarges, so keep sutures to a
minimum. Alternatively, use Steristrips
-- most finger lacerations can be treated without sutures. Use Steristrips
carefully to keep wound edges approximated. Circumferential or tightly
tensioned Steristrips can cause vascular occlusion
-- apply a non-adherent dressing e.g. Melolin, and bandage the whole finger
so that it stays straight (if the finger is straight, the wound edges will stay
together and it will heal). Review in 2 - 3 days
Finger tips
-- cuts to the finger tips often leave a flap of skin, which may or may not come
off
Skin flap not lost
-- reapply the flap over the wound and secure it loosely with Steristrips. Cover
with a non-adherent dressing, and bandage the finger to keep it straight.
Review in 2 - 3 days. Hopefully the flap will take and act as a graft onto the
wound. More often the flap will die off, but at least it covers the wound well
until it heals
Skin flap lost
-- fingers regenerate skin very well, especially in children. Clean the wound and
apply a vaseline gauze type dressing. If possible follow that with an absorbent
foam dressing or a non-adherent dressing, then bandage the finger. Review
daily. If large wounds (over 1 sq. cm) consult MO
Crush injuries
-- e.g. finger caught in a door - the finger is often lacerated. Leave the nail on
if at all possible. Clean and dress the finger, and review daily. Consult MO
and x-ray to look for an underlying fracture, which should be treated as a
compound fracture See Compound fractures
Amputations
-- surgical repair may be possible
-- clean the stump, and apply a simple sodium chloride 0.9% dressing to keep
it moist
144
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
-- put the amputated part in a clean plastic bag and seal it. Put this bag in a mix
of crushed ice and water (the amputated part should not get wet or frozen)
for transport
-- consult MO who will arrange evacuation / hospitalisation in an appropriate facility
-- dont forget to send the amputated part with the patient
Skin glue
A tissue adhesive glue can be used successfully to close superficial, smooth
and clean wounds. Skin glue is typically used in areas where:
-- 5/0 or 6/0 non absorbable sutures are used e.g. face, torso and extremities
-- the wound is less than 3 cm in length with edges easily held together
-- the wound is an uncontaminated superficial wound
-- skin glue should not be used in the following:
mucosal surfaces, mucocutaneous junctions, hands, feet, or joints
areas where wound is under tension
areas of high or prolonged moisture or dense hair or
in patients who have:
p
eripheral vascular disease
diabetes
prolonged corticosteroid use
a sensitivity to formaldehyde
Note: Skin glue should never be placed in the wound or subcutaneously as it
can cause necrosis or foreign body reaction and tattooing. Avoid contact around
eyes. Eye should be padded to avoid any glue dripping in the eye or onto the eye
lashes [4]
Uncontrolled
Controlled copy
copy
V 1.0
145
Acute wounds
Antibiotics
Are not needed for recent clean wounds, especially if cleaned properly
Should be used for:
-- compound fractures See Compound fractures
-- marine wounds See Marine lacerations
-- bites See Human (tooth-knuckle) and animal bites
-- established infection See Bacterial skin infections
Digital nerve block
Digital nerves run along each side of the phalanx. By infiltrating lignocaine
around the nerves, the digit is anaesthetised. Thumbs and great toes can be
more difficult to anaesthetise
-- technique (see diagram)
use 1% plain lignocaine. Never use lignocaine with adrenaline
use a sterile field
clean the digit with alcohol antiseptic
infiltrate the lignocaine near the digital nerve on each side of the dorsum
of the finger, avoiding the joint. Keep infiltration as close to the bone as
possible
use approximately 1 - 2 mL of lignocaine on each side (thumbs and
great toes may require more)
draw back regularly to avoid injecting into a blood vessel
Wait at least 5 minutes for the anaesthetic to take effect
146
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
Method 2.
1. Insert a hypodermic needle along the barbed
side of the hook, with the bevelled part of the
point towards the inside of the hooks curve
2. Pull gently on the shank to disengage the barb
inside of the hooks curve
3. Then push the needle gently downwards until
its hole locks over the barb
4. Rotate the hook shank slightly downward and
the hook curve upwards until the needle and
hook are removed through the original wound
Method 3.
1. Always have needle holding forceps holding
at least one end of the hook, so as not to lose
the hook
2. Grip the hook with needle holding forceps
advancing the hook through the tissue until
the barb end of the hook penetrates through
the skin at a separate location
3. Cut the eye off the hook with a pair of wire
cutters. Watch your eyes! Protect them as
part of the hook might cause damage when
cut with wire cutter
4. Grip it firmly and pull it out
[1]
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
147
Acute wounds
5. Follow up
All lacerations should be reviewed after 1 - 2 days, and again after 5 - 7 days
6. Referral / consultation
Consult MO as above and if:
148
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
Recommend
Consult MO
- if any marine lacerations, stings or wounds cannot be adequately excised and
cleaned
- if wounds are over chest or abdomen
- if wound not healing
- if patient is diabetic
- if patient has liver disease
Background
Wounds sustained in salt water e.g. coral cuts, are prone to infection with a wide
range of organisms
Related topics
1.
Acute wounds
Toxinolgy (bites and stings)
Tetanus immunisation
2.
Cut / laceration(s) from coral, oysters, bottles on the beach, sharp objects in fresh
water or salt water
Fish stings
Fever, cellulitis
Immediate management
3.
4.
Clinical assessment
Management
Uncontrolled
Controlled copy
copy
V 1.0
149
Acute wounds
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
250 mg
Adult and child 12
Capsule
500 mg
years
500 mg qid
Schedule
Cephalexin
7 - 10 days
Child < 12 years
Suspension
12.5 mg / kg / dose qid
to a max. of
500 mg qid
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[5][6]
125 mg / 5 mL
250 mg / 5 mL
Oral
and
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
Initial dose 200 mg
then 100 mg bd
Schedule
Doxycycline
150
50 mg
100 mg
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12 years
450 mg tds
Schedule
7 - 10 days
Child < 12 years
10 mg / kg / dose / tds
to a max. of 450 mg tds
There is no oral liquid, however a 50 mg / mL clindamycin solution can be made before each dose by:
-- dissolving the contents of 1 capsule in 2 mL water
-- draw this solution into a syringe and make the volume up to 3 mL
-- discard any excess solution so that the required dose remains in the syringe
-- mix the dose in juice or soft food to disguise the taste before giving
Provide Consumer Medicine Information: advise patient the use of clindamycin can lead to severe colitis
(inflammation of the bowel). If they experience diarrhoea while taking the medicine or up to several weeks
after the treatment contact their MO or return to the clinic and have a stool specimen taken for Cl. difficile.
[8]. Take until course completed
Management of associated emergency: consult MO
[6] [9]
Capsule
150 mg
Clindamycin
Oral
5. Follow up
All marine lacerations should be monitored closely as infection may spread rapidly
- instruct patient to return if any signs of infection e.g. redness, swelling, increase
in pain
Review at a minimum 1 - 2 days and again after 5 - 7 days, or earlier if necessary
6. Referral / consultation
Consult MO as above and if:
-- tendons, nerves and vessels are involved, any wound is not healing, infection,
wound over chest or abdomen
Uncontrolled
Controlled copy
copy
V 1.0
151
Acute wounds
2. Immediate management
3. Clinical assessment
4. Management
152
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedics must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Tablet
875 mg / 125 mg
Powder
for
suspension
125 mg / 31.25
mg per 5 mL
or
400 mg / 57 mg
per 5 mL
Provide Consumer Medicine Information: take with food. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
5 days
[10]
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Adult
1.5 g
Disposable
Stat
1.5 g
IM
Child
syringe
50 mg / kg / dose to a
max. of 1.5 g
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medication to warm up to room temperature, apply pressure with thumb (to the exact injection
site) 30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[10]
Schedule
Procaine penicillin
Uncontrolled
Controlled copy
copy
V 1.0
153
Acute wounds
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
200 mg
Tablet
400
mg bd
400 mg
Schedule
Metronidazole
5 days
Child
Suspension 200 mg / 5 mL
10 mg / kg / dose bd
to a max. of 400 mg bd
Provide Consumer Medicine Information: avoid alcohol while taking and for 24 hours after taking this
medicine. Take with food or immediately after food. Take until course completed
Management of associated emergency: consult MO
[10]
Oral
and
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Adult
Initial dose 200 mg
then
100 mg daily
Schedule
Tablet /
capsule
50 mg
100 mg
Doxycycline
5. Follow up
All bites should be reviewed daily, especially tooth-knuckle injuries. If swollen,
6. Referral / consultation
Consult MO for all tooth-knuckle injuries and for all bites that are not healing
Referral to Physiotherapist for hand therapy
154
Uncontrolled
Controlled copy
copy
V1.0
Acute wounds
Uncontrolled
Controlled copy
copy
V 1.0
155
Burns
156
Uncontrolled
Controlled copy
copy
V1.0
Burns
No
Minor burn:
Assess burn wound
Apply appropriate dressing
Arrange follow up dressing and review
Prescribe pain relief as required
Uncontrolled
Controlled copy
copy
V 1.0
157
Burns
9%
Paediatric
For every year of life after 12 months take 1%
from the head and add % to each leg, until the
age of 10 years when adult proportions
9%
Back 18%
18%
1%
Front 18%
18% 18%
9
Back 18%
Palmar
Palm + fingers = 1%
14% 14%
1%
involves
epidermis
only
Colour
Circulation
red
(and warm
to touch)
normal
increased
Sensation
Blisters
Healing time
present
none or
later (days) or
desquamation
within a few
days
Superficial involves
epidermis
mid dermal
and upper
burn
painful ++
yes
pink
hyperaemic
(superficial dermis, most
hypersensitive
(hours)
adnexal
partial
thickness)
structures
2nd
intact
involves
Mid - deep epidermis and
early.
dermal burn significant
pale pink
Usually large
may be
decreased
(mid - deep part of dermis,
and
/ blotchy
sluggish
sensation
partial
only deeper
rupture within
red
thickness)
adnexal
hours
2nd
structures
intact
Full
thickness
3rd
158
epidermis,
dermis and
white and /
cell adnexal
or charred
structures
destroyed
nil
Uncontrolled
Controlled copy
copy
V1.0
nil
no blistering
(epidermis
destroyed)
within 2 to 3
weeks by reepithelialisation
from epidermal
elements in
dermis
minimal scarring
longer than 2 to
3 weeks
high risk of
hypertrophic
scarring
no healing
granulation
and wound
contraction
leads to chronic
ulceration
Burns
Pain or painless - patient with full thickness burns may have no pain
Visible and / or hidden burns
Associated respiratory burns, respiratory distress with stridor and / or wheeze
Hypotension
Shock
Altered level of consciousness from hypotension, head injury or inhalation burn
Associated traumatic injuries from fall, blast, structure collapse
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
Perform primary and secondary surveys
Remove patient from danger (without endangering yourself)
P
ut out burning clothing e.g. rolling patient on the ground covered with a blanket
I f clothing still smouldering put out with large amounts of cool water
R
emove clothing as it holds heat against the skin
Remove rings, watches, jewellery and belts
Immediately cool burnt area for 20 minutes under cool running water (can be
tap water)
G
ive O2 to maintain saturation > 93% adult / > 95% child See O2 delivery systems
If you suspect inhalation burns, e.g. black soot around the nose, mouth or face,
burnt nasal hairs and altered voice, give O2 via a non-rebreathing mask - a
Hudson mask is not sufficient. Contact MO immediately. Consider intubation
early as swelling may occur and compromise airway
Give analgesia
Use cling wrap for initial dressing as keeps burn moist and allows easier
assessment on arrival at Burns Unit. Do not wrap circumferentially around a limb.
Wrap longitudinally to avoid circulatory compromise [1]
Consult MO as soon as possible as patient may require intubation and fluid
resuscitation [1]
Insert 2 large bore IV cannulas (14 G or 16 G for adults, 22 G for children, if
possible). Insert the largest possible in the circumstances, through unburnt skin
if possible but if necessary through a burnt area
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
159
Burns
Carefully inspect the mouth, nose and auscultate the chest for air entry and added
sounds to determine if respiratory tract burns
For patchy burns in an adult, the area of patients hand is about 1% (roughly work
out how many hands the burnt area covers)
If able to, photograph burn wounds and send by email once discussed with
relevant MO
Burns are tetanus prone wounds. Check last tetanus vaccination
See Tetanus immunisation
4. Management
Schedule
Consult MO who will arrange retrieval for patients with major burns and advice for
patients with minor burns See Burn referral criteria
Analgesia
-- MO will give order for analgesia in children
-- intravenous is the preferred route of administration for opioid analgesics for
severely injured patients if IV line insitu
-- give morphine (preferable) or if allergic to morphine give fentanyl. Give
metoclopramide (adult) if vomiting or nauseated
-- children should not receive metoclopramide (Maxolon) or prochlorperazine
(Stemetil) because of the high risk of dystonic reactions. If an antiemetic is
required for a child the MO will likely advise ondansetron wafer
8
Morphine
DTP
IHW / SM R&IP
160
Uncontrolled
Controlled copy
copy
V1.0
Burns
Schedule
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
8
Fentanyl
100 microgram
/ 2 mL
IV
(IHW may not
administer IV)
Adult only
1.5 microgram / kg
to a max. of 100 microgram
Adult only
25 microgram increments
slowly, repeated every 10
minutes if required to a
max. of 100 microgram
DTP
IHW / SM R&IP
Duration
Stat
Further doses
on MO / NP order
Schedule
Metoclopramide
DTP
IHW / SM R&IP
Uncontrolled
Controlled copy
copy
V 1.0
161
Burns
5. Follow up
Transfer to Burns Unit
Speech Pathologist may be required for ongoing management of patients with
respiratory burns
6. Referral / consultation
Consult MO regarding need for evacuation / hospitalisation in an appropriate
162
Uncontrolled
Controlled copy
copy
V1.0
Burns
Superficial - mid dermal burns. Note: the depth of a dermal thickness burn may
take up to 7 - 10 days to declare itself as superficial or deep [6]
Superficial:
-- cool burnt area with cool running water for 20 minutes. Can be performed
up to 3 hours after the burn / scald [8]. Cold water compresses (changed
frequently) can also be used [3]
-- clean with sodium chloride 0.9%
-- give pain relief as required
Epidermal burns e.g. sunburn will heal by itself in a few days
4. Management
Dressing for small burns
I f available, apply Acticoat dressing, use hypoallergenic tape e.g. Hypafix, for
dressing retention, keep moist with sterile / clean tap water, can use a fine mist
spray bottle, at least 3 times a day. Review in 3 days. Oil, e.g. olive oil, can be
used prior to dressing change to assist removal of tape. A non-adherent dressing,
e.g. Duoderm extra thin or Bactigras can be used as an alternative dressing
Do not apply open weave retention / fixation sheets e.g. Hypafix / Fixomull /
Mefix directly to superficial burn as very painful to remove. Can be applied over
Duoderm, Xeroform or Tricotex dressing
Uncontrolled
Controlled copy
copy
V 1.0
163
Burns
Silver sulphadiazine
Analgesia
- children and infants respond well to an initial therapeutic dose of intranasal
morphine absorption may be unreliable) until the pain subsides naturally after
1 - 2 hours. Consult MO
oral analgesia may be adequate for patients with some minor burns
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
Referral / consultation
164
until burn declares itself. Change dressings when necessary, every 2 - 3 days if
clean / not infected. Advise patient to try and avoid tank and / or bore water when
washing as increases infection risk
Infection is indicated by fever, increasing wound pain, redness, swelling and
purulent exudate. Take wound swab. Consult MO
See next MO clinic for any burns not healed in 10 days
Uncontrolled
Controlled copy
copy
V1.0
Burns
Burns
Visible burns - may be little or no skin changes with hydrofluoric acid burn
Pain
Hypotension / shock
History of exposure to chemical agent
Hydrofluoric acid exposure
Pain may be extreme and out of proportion to burn appearance due to deeper
tissue toxicity
Very rarely, low serum calcium, low serum magnesium or high serum potassium
leading to cardiac arrest (may follow absorption of hydrofluoric acid by the skin
from as little as a 2% body surface area burn with concentrated 70% hydrofluoric
acid solution)
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
T
ake precautions (gloves, plastic apron, goggles) to prevent contact with chemical
Remove contaminated clothing
I rrigate with large amounts of running water (if cement or lime burns, brush off
cement / lime dust and remove contaminated clothing before irrigating with large
amounts of running water)
3. Clinical assessment
I nclude in history circumstances of chemical burn, agent if known, and time injury
occurred See Major burns and Minor burns
Uncontrolled
Controlled copy
copy
V 1.0
165
Burns
4. Management
Consult MO
Do not attempt to neutralise the chemical as most resultant reactions produce
heat and will exacerbate the injury (except in the case of hydrofluoric acid)
Hydrofluoric acid burns
Consult MO for all hydrofluoric acid burns
Time from exposure to symptoms are dependent on concentration of agent
(> 40% within an hour and < 10% up to 24 hours)
Burns of 3 - 4% TBSA have caused deaths
Weak acid that penetrates tissues very well and binds to calcium and magnesium
Conversion of hydrofluoric acid to the calcium salt is not associated with heat
production and is achieved by covering the burn with gauze soaked in 10%
calcium gluconate solution. Alternatively 10 mL of 10% calcium gluconate solution
can be combined with 30 mL of water soluble gel and applied [9]
If pain and burning persist, MO may advise subcutaneous and / or intradermal
injection of 5% calcium gluconate solution through a needle into the hydrofluoric
acid - burned skin. A maximum dose of 1.0 mL of 5% calcium gluconate per
square centimetre of burned skin is recommended [19]
Injection is usually very painful and indicated only in small, localised exposures
Calcium chloride solution should not be used as it may cause tissue necrosis
Bitumen burns [5]
Consult MO for all bitumen burns
The cold bitumen will form a waterproof, sterile layer over the burn which will
prevent the burn from drying out. Should specialist advice indicate that removal
of the bitumen is necessary, the recommended medium for bitumen removal is
paraffin oil or orange oil - Desolvit [18]
Partial thickness bitumen burns - after adequate cooling, the bitumen should
be left in place and covered with a tulle dressing containing paraffin or a burn
ointment containing paraffin e.g. silver sulphadiazine (SSD)
Full thickness bitumen burns - active removal of the bitumen should be avoided
unless primary surgical treatment is being considered due to the location and
depth of the wound. In such cases bitumen removal is best carried out in the
operating theatre
Circumferential bitumen burns - where hot bitumen completely encircles a limb
or other body part the cooled and hardened bitumen may cause a constricting
effect. In the event of this occurring the adhering bitumen must be softened and
/ or split to prevent restriction of blood flow
Bitumen burns to the eye - no attempt should be made to remove the bitumen.
Refer urgently for specialist medical assessment and treatment
Do not use petrol, kerosene or acetone as these can cause toxicity
5. Follow up
See Major burns and Minor burns
6. Referral / consultation
See Major burns and Minor burns
Consult MO for all burns
166
Uncontrolled
Controlled copy
copy
V1.0
Burns
Antiseptic
dressing
Indication
When?
Superficial burns
Application
How?
Allow 2 - 5 cm margin
around wound
Can remain intact 2 - Do not use if
3 days
any infection
Low to moderately
Wafers up to 5 days
exudating wounds
if no signs of infection
Superficial to mid
dermal burns
Dermal thickness
burns
Conformable
Apply directly to
wound 2-3 layers for
acute wounds
Cover with
secondary dressing
Change every 2 - 3
days
Apply to moist
Silver
Broad spectrum
Mid dermal to full wound bed
e.g. Aquacel ag,
antimicrobial
thickness burns
Allow 2 - 5 cm
sodium
overlap
carboxymethycellulose Facilitates
Moderately
Cover with
(CMC) and 1.2% ionic debridement
exudating
secondary dressing
ag in fibrous material
wound
Review 7 - 10 days
Also Contreet H
Absorbs exudate
Leave intact until
healed
Wet Acticoat with
Silver
Dermal to full
water. Drain and
Broad spectrum
Acticoat / Acticoat 7
thickness burns
apply blue / silver
antimicrobial
2 layered / 3 layered
side down
protection
nanocrystalline ag
Grafts and donor Moisten secondary
coated mesh with inner
sites
dressing
Decreases
rayon layer
Replace 3 - 4 days
exudate formation
Also Contreet H
Infected wound
(Acticoat) or 7 days
(Acticoat 7)
Infected wounds
Silver
Dermal to full
e.g. silver sulphadiazine Reduces infection
thickness burns
(SSD) cream
if only available
option
Note /
precautions
Uncontrolled
Controlled copy
copy
V 1.0
Avoid if
chlorhexidine
sensitivity or
allergy
Soak off if
adhered to
wound bed
Exudate level
indicates
frequency
of dressing
change
Temporary skin
staining
Avoid if allergy
to silver
Avoid
hypothermia
Not
recommended
for most burns
due to changes
in wound
appearance
Apply to wound
and frequency
Cover with secondary of dressing
dressing
changes
required
Apply generous
amount to sterile
handtowel to ease
application
167
Environmental emergencies
Burns
Trauma and injuries
Signs and symptoms may occur immediately after a SCUBA dive or develop up
to 48 hours afterwards
Signs and symptoms include:
-- skin itching (the creeps), rashes, swelling, marbled appearance of skin
-- joint pain(s) (the bends) involving larger joints
-- tiredness, generally feeling unwell
-- chest pain, breathlessness, cough, coughing up blood (the chokes)
-- deafness, ringing in the ears, sensation of surroundings spinning (the staggers)
-- nausea, vomiting
-- numbness, muscle weakness, paralysis, urinary retention
-- headache, confused, drowsy, unconscious, fitting
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
168
Environmental emergencies
o not place patient in head down position as may increase bubbles in coronary
D
arteries [12]
Give high flow 100% O2 and continue until patient reaches hyperbaric chamber or
ordered by MO to remove
Insert IV cannula - aim to restore and maintain normal hydration (most divers are
dehydrated). IV sodium chloride 0.9% at least 10 - 20 mL / kg over 30 minutes on
MO instruction
Check BP and HR
Consult MO
3. Clinical assessment
4. Management
Consult MO
If to be evacuated
-- the patient will need to be kept flat until reaches hyperbaric chamber unless
MO advises otherwise
-- administer 100% O2 - must also be continued until patient reaches hyperbaric
chamber, unless this takes many hours. MO may advise air breaks
Oral clear fluids as advised by MO (if no altered level of consciousness)
Pain management - patients with severe pain require adequate analgesia
-- IV analgesia is the preferred route of administration for opioid analgesics for
DCI
-- if not allergic, give morphine (preferable) or pethidine and metoclopramide on
MO orders
-- nitrous oxide / O2 mix (Entonox) must not be used for DCI
Indwelling catheter (IDC) if required
If seizure occurs See Fits / convulsions / seizures for medication
Note: Aspirin should not be used for fear of promoting bleeding in any area of bubble
damage [10]
5. Follow up
All patients with symptoms after SCUBA diving should see an MO familiar with
diving injuries / illnesses as soon as can be arranged even if DCI has been
excluded in consultation with MO
Other conditions need consideration such as barotrauma of the middle ear,
including ruptured eardrum and inner ear, which can lead to permanent deafness
if not diagnosed early and treated See Traumatic rupture of the eardrum
6. Referral / consultation
Consult MO on all symptoms occurring up to 48 hours after SCUBA diving
Uncontrolled
Controlled copy
copy
V 1.0
169
Environmental emergencies
Burns
Trauma and injuries
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
170
Remove from cold environment, wet clothing, contact with cold surfaces, windy
environment
Dry patient if wet
Apply insulation between body and the environment e.g. blanket, space blanket
Uncontrolled
Controlled copy
copy
V1.0
Environmental emergencies
3. Clinical assessment
4. Management
Consult MO
If conscious - give warm oral fluids (not alcohol)
External warming
-- passive (rewarming rate 0.5 - 2C / hour achieved)
remove wet clothing (only if there is a dry blanket or other suitable cover)
cautiously apply external heat such as heat pack, body to body contact,
warm blankets
place in a warm environment
avoid burns by ensuring any heat source is warm or tepid but not hot
-- active external (rewarming 2C / hour achieved)
(where available) use heat sources such as Bair Hugger or Warm
Touch blankets
Generally aim to warm 0.5 - 2C / hour [15]
5. Follow up
Consult with MO prior to discharge, despite temperature
6. Referral / consultation
Consult MO for all patients for advice on management and arrange evacuation /
Uncontrolled
Controlled copy
copy
V 1.0
171
Environmental emergencies
Hypoglycaemia
Heat stroke
Core temperature of 41C or above [17]
Confused, drowsy, seizures, altered
consciousness, altered neurological
signs [17]
Hot dry skin
Abnormal glucose level
Cardiovascular collapse
(cardiac arrhythmias, clotting disorder)
Muscle weakness, cramps and pain
2. Immediate management
Heat stroke
DRS ABCD resuscitation / the collapsed patient
172
Aggressively cool
-- place patient in cool place, with full circulating air, remove unnecessary
clothing
-- place ice packs (wrapped) over large blood vessels of axillae (armpits), neck
or groin (do not place ice directly against skin)
-- spray or sponge the torso and limbs with tepid water and then fan
-- aim to cool at least 0.1C / minute
Consult MO
High flow O2 via non-rebreather mask
Insert IV cannula
Connect to ECG monitor
Uncontrolled
Controlled copy
copy
V1.0
Environmental emergencies
3. Clinical assessment
4. Management
Heat exhaustion
Specific cooling is not required
Remove patient from hot environment / trigger
Give oral fluids e.g. water (or Gastrolyte / Hydralyte if available) unless
vomiting is present
IV sodium chloride 0.9% will provide more rapid recovery, but rarely needed
Monitor temperature
Consult MO
Heat stroke
See Immediate management of heat stroke
Consult MO - arrange evacuation / hospitalisation
5. Follow up
Consult with MO prior to discharge, despite temperature
6. Referral / consultation
Consult MO for all heat stroke patients to advise on management and arrange
evacuation / hospitalisation
Uncontrolled
Controlled copy
copy
V 1.0
173
Environmental emergencies
References
1.
Therapeutic Guidelines (2012). "Burns: acute pain management." Retrieved October, 2012.
2.
Lund C.C. and Browder N.C. (1944). "The estimation of areas of burns." Surg Gynecol Obstet 79: 352-358.
3.
Connolly S. ACI Statewide Burn Injury Service (2011). "Clinical Practice Guidelines: Burn Patient
Management." Retrieved October, 2012, from
www.aci.health.nsw.gov.au/networks/burn-injury/resources
4.
Australian Medicine Handbook (2012). "Metoclopramide." Retrieved June, 2012.
5.
Australian Asphalt Pavement Association (2011). "Advice to medical professionals ". Retrieved October,
2012, from www.aapa.asn.au/
6.
The Royal Children's Hospital Melbourne (2012). "Burns." Retrieved October, 2012.
7.
Australian Medicine Handbook (2012). "Silver sulfadiazine." Retrieved October, 2012.
8.
Editorial Committee Primary Clinical Care Manual 8th edition 2013.
9.
Therapeutic Guidelines (2012). "Toxicology: hydrofluoric acid (hydrogen fluoride)." Retrieved October,
2012.
10. Webb R. (2010). Introductory course in diving and hyperbaric medicine. The Australian and New Zealand
Hyperbaric Medicine Group.
11. Bennett M.H., Lehm J.P., et al. (2012). "Recompression and adjunctive therapy for decompression
illness." Cochrane Database of Systematic Reviews. Retrieved October, 2012.
12. de Watteville G.A. (1993). "Critical assessment of Trendelenburgs position in the acute phase after a
diving accident." Schweiz Z Sportmed 41(3): 123-125.
13. PEMSoft (2012). "Hypothermia." Retrieved October, 2012.
14. Australian Resuscitation Council (2009). "Hypothermia: First Aid and Management. Guideline 9.3.3 ".
Retrieved October, 2012, from www.resus.org.au/
15. UpToDate (2012). "Accidental hypothermia in adults." Retrieved October, 2012.
16. Therapeutic Guidelines (2012). "Cold-related illness." Retrieved October, 2012.
17. Therapeutic Guidelines (2012). "Heat-related illness." Retrieved October, 2012.
18. Australian & New Zealand Burn Association (2013 (in press)). "Bitumen burns." 2013.
19. Tintanelli E.J. (2011). Tintanelli's Emergency Medicine: A comprehensive study guide, seventh edition,
Mc Graw Hill Medical
20. Therapeutic Guidelines (2013). "Stepwise approach to acute pain management." Retrieved July, 2013.
21. MiMS (2013). "Morphine sulfate injection." Retrieved July, 2013.
174
Uncontrolled
Controlled copy
copy
V1.0
Nose bleed
Swallowing or spitting up blood if from posterior part of the nose
Increased HR, hypotension / shock if heavy or continuing loss
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
4. Management
If bleeding continues, consult MO, who will likely advise insertion of an anterior
nasal pack - see diagram on following page
If bleeding continues or you suspect blood is coming from the posterior part of the
nose, consult MO who will likely advise posterior nasal packing
Patients should only be discharged with nasal packing following advice from the MO
Patients discharged with nasal packing should be prescribed a penicillin or firstgeneration cephalosporin to prevent sinusitis - consult MO
Oral analgesics should also be considered
Uncontrolled
Controlled copy
copy
V 1.0
175
Merocel nasal tampons are the easiest to use [1]. However a Kaltostat pack
or vaginal tampon can be used
176
Apply lubricant jelly to the nares (do not apply to tampon as it will cause the
tampon to expand) to facilitate placement
expands on contact with blood or other liquid
After the nasal tampon is inserted it may be necessary to drip sodium chloride
0.9% or water into the nostril to achieve full expansion of the tampon if the bleeding
has decreased at the time of insertion
Tape the string to the nose and trim ends
Remove nasal tampon after 24 hours
Moisten the nasal tampon with sodium chloride 0.9% before removing [1]
Complications include septal hematomas and abscesses from traumatic packing,
sinusitis, neurogenic syncope during packing, and pressure necrosis secondary
to excessively tight packing
Uncontrolled
Controlled copy
copy
V1.0
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
5% lignocaine
up to a max. 5 sprays / nostril
- 0.5%
Child
Spray
Intranasal
Stat
phenylcaine HCL
2 - 4 years 1 spray / nostril
4 - 8 years 2 sprays / nostril
8 - 12 years 3 sprays / nostril
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[2]
Schedule
Lignocaine / phenylephrine
5. Follow up
6. Referral / consultation
Consult MO for all cases that require anterior or posterior nasal packing or where
Uncontrolled
Controlled copy
copy
V 1.0
177
Gastrointestinal emergencies
Abdominal pain
No appetite, nausea, vomiting
Cant pass wind, constipation
Vomiting up blood (haematemesis) or passing blood or tar-like (melena) bowel
motions See Upper gastrointestinal bleeding and Rectal bleeding
Fever, sweats, rigors
Jaundice
Abdominal wall pain / lump
Scrotal pain See Testicular / scrotal pain
Abdominal distension or mass
Inability to pass urine
Vaginal bleeding
Increased HR
Hypotension / shock
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
178
Gastrointestinal emergencies
3.
Clinical assessment
Right
upper
quadrant
Left
upper
quadrant
Right
lower
quadrant
Left
lower
quadrant
Uncontrolled
Controlled copy
copy
V 1.0
179
Gastrointestinal emergencies
4. Management
5. Follow up
If in consultation with MO, patient not evacuated / hospitalised and allowed home,
6. Referral / consultation
Consult MO in all cases of acute abdominal pain
180
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal emergencies
Right
hypochondriac
Right
Right lumbar
lumbar
urinary tract
infection
renal colic
Epigastric
Umbilical
Right
iliac
Right iliac
appendicitis
tubal / ectopic
pregnancy
ovarian cyst
PID
irreducible or
strangulated
hernia
(usually men)
testicular torsion
Epigastric
gastritis or gastric /
duodenal ulcer
pancreatitis
heart attack
ruptured aortic aneursym
Hypogastric
Umbilical
irreducible or strangulated
umbilical hernia
ruptured aortic aneurysm
gastroenteritis
small bowel obstruction
inflammatory bowel disease
early appendicitis
Left hypochondrial
pneumonia
pancreatitis
ruptured spleen
Left
hypochondriac
Left iliac
diverticulitis
tubal / ectopic pregnancy
ovarian cyst
PID
irreducible or strangulated
hernia
testicular torsion
Hypogastric
urinary tract infection
large bowel obstruction
acute retention of urine
uterine fibroid complication
PID
tubal / ectopic pregnancy
testicular torsion
Uncontrolled
Controlled copy
copy
V 1.0
181
Gastrointestinal emergencies
Alcohol withdrawal
Epigastric and / or right upper quadrant and / or left upper quadrant pain
Off food, nausea, vomiting
Vomiting up blood (haematemesis) or passing tar-like bowel motions (melena)
Increased HR
Hypotension / shock
2. Immediate management
3. Clinical assessment
182
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal emergencies
Mild
Annoying pain but
not aggravating or distressing
Normal BP, HR, respiratory rate,
temperature
Moderate
Patient moving about, restless
with aggravating pain
HR slightly increased
BP slightly increased
Severe
Patient keeping still and very
distressed with pain
HR increased
BP raised or low (hypotension /
shock)
4. Management
The severity of the pain and the other findings of the patient will guide management,
e.g. acute pancreatitis may cause hypotension / shock and respiratory distress.
The severity of pain is subjective however objective indications such as vital signs
and clinical findings will also guide management
Mild
Give antacid e.g. Gastrogel / Mylanta (dose according to label) and / or
metoclopramide 10 mg IM
Do 12 lead ECG, fax / scan / email to MO
Take bloods for LFT (if not done in the last 3 months), check BGL
If doesnt respond to antacid and / or antiemetic within 30 minutes, consider as
moderate or severe
Schedule
Metoclopramide
DTP
IHW / SM R&IP
Uncontrolled
Controlled copy
copy
V 1.0
183
Gastrointestinal emergencies
Moderate
5.
Follow up
6.
Referral / consultation
184
If chronic alcohol misuse patient to have oral thiamine 100 mg tds. It is important
to give oral thiamine tds and not as a daily dose
Be aware of the potential over the following days to develop withdrawal symptoms
in a heavy drinker who ceases drinking abruptly See Alcohol withdrawal
If allowed home, review next day
Offer advice and information regarding the harmful effects of excessive alcohol
intake. There is good evidence to show that an MO or Health Care Workers
See Alcohol misuse
See next MO clinic
Consult MO as above
If referrral for chronic alcohol misuse is required See Alcohol misuse
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal emergencies
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
185
Gastrointestinal emergencies
4. Management
Consult MO
-- if haematemesis small or coffee ground only in vomitus MO may advise
metoclopramide 10 mg IM stat
-- Proton Pump Inhibitor (PPI) such as omeprazole oral or esomprazole IV
Arrange evacuation / hospitalisation once haemodynamically stable
5. Follow up
6. Referral / consultation
Consult MO on all occasions of upper gastrointestinal bleeding
Bright red blood loss (haemorrhoids or bowel cancer). Dark red blood can be
differentiated from melena by mixing it with tap water - changes to red while
melena stays black
Melena (black, tar-like bowel motion, foul smelling: blood changed by digestion in
upper gastrointestinal tract)
Anaemia
Anorexia / vomiting
Weight loss
Ineffective urge to pass a bowel motion
Abdominal pain
Fever
Obvious worm infestation
Diarrhoea / constipation
2. Immediate management
186
Gastrointestinal emergencies
3. Clinical assessment
4. Management
If bleeding not heavy or continuing consult MO who may advise topical treatment
for haemorrhoids short term laxative
Treat for worms where clinically indicated
If heavy blood loss - patient will require evacuation
5. Follow up
All patients over 50 years to have 2 yearly faecal occult blood test (FOBT) until
6. Referral / consultation
All patients with rectal bleeding need to be assessed by an MO
Uncontrolled
Controlled copy
copy
V 1.0
187
Gastrointestinal emergencies
2. Immediate management
3. Clinical assessment
3. Management
188
Uncontrolled
Controlled copy
copy
V1.0
Genitourinary emergencies
MO will likely advise to pass nasogastric tube. Allow free drainage and aspirate
periodically
If available MO may order erect and supine abdominal x-ray (looking for dilated
bowel loops and air fluid levels) and erect chest x-ray (looking for gas under the
diaphragm)
Keep nil by mouth
Insert indwelling urinary catheter
It is normal to start with IV sodium chloride 0.9% or Hartmanns solution. MO will
advise quantities and rate
Check potassium (if not already collected)
5. Follow up
When back in the community: bowel obstruction has a high likelihood of recurrence
6. Referral / consultation
Consult MO. All cases of suspected bowel obstruction will need to be evacuated
/ hospitalised
Pain - colicky, sharp, burning and localised to the flank or groin. Pain in the tip of
the penis may be due to a stone in the bladder
Nausea and vomiting are often associated
Fever
Blood in the urine (haematuria), visible or on urinalysis
2. Immediate management
Uncontrolled
Controlled copy
copy
V 1.0
189
Genitourinary emergencies
3.
Clinical assessment
4.
Management
Schedule
Morphine
DTP
IHW / SM R&IP
190
Uncontrolled
Controlled copy
copy
V1.0
Genitourinary emergencies
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
Schedule
Fentanyl
100 microgram
/ 2 mL
IV
(IHW may not
administer IV)
Adult only
1.5 microgram / kg
to a max. of 100 microgram
Adult only
25 microgram increments
slowly, repeated every 10
minutes if required to a
max. of 100 microgram
DTP
IHW / SM R&IP
Duration
Stat
Further doses
on MO / NP order
Ketorolac trometamol
30 mg / mL
IM
DTP
IHW / SM R&IP
Duration
Stat
Provide Consumer Medicine Information: precautions - gastrointestinal irritations (after several doses),
other NSAID, hypertension, heart failure, CVS, infections, platelet aggregation, poor renal function, elderly,
pregnancy, breastfeeding
Management of associated emergency: consult MO
[8] [9] [10]
and / or
Uncontrolled
Controlled copy
copy
V 1.0
191
Genitourinary emergencies
Schedule
Metoclopramide
DTP
IHW / SM R&IP
5. Follow up
If the pain settles, the patient should be advised to continue high oral fluid intake
including through the night, to flush stone(s) through, and to strain all urine (for
stones) at home
Review the next day
Next MO clinic and likely referral for IVP, CT scan, and / or renal ultrasound
6. Referral / consultation
Consult MO on all occasions
192
Uncontrolled
Controlled copy
copy
V1.0
Genitourinary emergencies
2. Immediate management
3. Clinical assessment
4. Management
Adequate analgesia may relieve urethral spasm enough to be able to pass urine
spontaneously. Encourage to move around if possible, rather than lie in bed
Sit patient in warm bath and tell them to try and urinate into the bathwater
If does not pass urine spontaneously, MO will request patient be catheterised. It is
important not to use excessive force to push the catheter through the obstructed
urethra
Measure and record all urine output
Perform urinalysis
Send MSU or catheter catch urine for MC/S
If unable to catheterise easily, MO will attempt on evacuation / hospitalisation and
may insert suprapubic catheter instead
Depending on the clinical circumstances, and the volume of urine drained, the
MO may advise the catheter be removed or left insitu
5. Follow up
6. Referral / consultation
Consult MO on all occasions of acute retention of urine
Epididymo-orchitis
Uncontrolled
Controlled copy
copy
V 1.0
193
Genitourinary emergencies
2. Immediate management
Consult MO urgently
MO will organise immediate evacuation / hospitalisation to facility with appropriate
surgical capability for the patient with testicular torsion
MO will advise analgesia - IM / IV opioid and metoclopramide
3. Clinical assessment
4. Management
Differential
diagnoses
Torsion
Age
Epididymo-orchitis
very severe
moderate
significant
Associated
symptoms
Examination
Effect of
elevating
scrotum
relief of pain
Onset
Severity of
pain
Fever
Torsion
Testicular torsion is an emergency requiring urgent surgery. If there is to be any
chance of saving the testis, the MO will arrange urgent evacuation / surgery and
advise analgesia - IM / IV opioid and metoclopramide
Keep nil by mouth
Epididymo-orchitis
See Epididymo-orchitis
5. Follow up
If MO decides to treat as acute epididymo-orchitis and not to evacuate / operate:
6. Referral / consultation
Consult MO on all occasions of testicular / scrotal pain
194
Uncontrolled
Controlled copy
copy
V1.0
Genitourinary emergencies
References
1.
The Royal Children's Hospital Melbourne (2011). "Epistaxis." Retrieved September, 2012.
2.
MiMS (2013). "Lignocaine-Phenylephrine hydrochloride." Retrieved April, 2013.
3.
National Health and Medical Research Council (2009). "Australian Guidelines to Reduce Health Risks
from Drinking Alcohol." Retrieved August, 2012, from www.nhmrc.gov.au/guidelines/publications/ds10
4.
Australian Medicine Handbook (2012). "Metoclopramide." Retrieved June, 2012.
5.
Australian Cancer Network Colorectal Cancer Guidelines Revision Committee ( 2008 ). "Clinical practice
guidelines for the prevention, early detection and management of colorectal cancer." The Cancer Council
Australia and Australian Cancer Network from www.nhmrc.gov.au/guidelines/publications/cp106
6.
Holdgate A. and Pollock T. (2009). "Nonsteroidal anti-inflammatory drugs (NSAIDS) versus opioids for
acute renal colic." The Cochrane Library(2).
7.
Therapeutic Guidelines (2013). "Stepwise approach to acute pain management." Retrieved July, 2013.
8.
Therapeutic Guidelines (2012). "Nonsteroidal anti-inflammatory drugs: adult dosing schedules of
NSAIDS." Retrieved September, 2012.
9.
Therapeutic Guidelines (2013). "Ketorolac." Retrieved March, 2013.
10. Australian Medicine Handbook (2013). "Ketorolac." Retrieved March, 2013.
11. Leong, S., R. Roe, et al. (2005). "No frills management of epistaxis." Emerg Med J 22: 470-472.
12. Australian Medicine Handbook (2012). "Combination antacids." Retrieved September, 2012.
13. MiMS (2013). "Morphine sulfate injection." Retrieved July, 2013.
14. Editorial Committee Primary Clinical Care Manual 8th edition 2013.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
195
Use universal precautions in all poisoning cases (gloves, plastic gown and
mask) See Cyanide, Organophosphates and Paraquat / Diquat poisoning for
specific advice
If breathing, turn on to side in recovery position while obtaining more information
(some poisons may cause both vomiting and sedation sufficient enough to result
in aspiration)
Do not administer O2 routinely. If required, give O2 to maintain O2 saturation
> 93% adult / > 95% child. If not maintained, consult MO
See O2 delivery systems
3. Clinical assessment
Undertake a Risk Assessment by obtaining a full history including details of poisoning
Risk assessment
Agent taken
Route of exposure
Dose
Time of exposure
Intent of exposure
Has any treatment been
attempted
Patient factors
Clinical course
Clinical status of patient
Uncontrolled
Controlled copy
copy
V 1.0
197
4. Management
198
Uncontrolled
Controlled copy
copy
V1.0
Activated charcoal
MOs are advised to consult the PIC 13 11 26 for information on the appropriate use
of activated charcoal
The administration of activated charcoal to paediatric patients should be a very rare
event, as most children are not exposed to life threatening doses of poisons and can
be safely managed with good supportive care. The use of activated charcoal in the
paediatric age group should only occur after discussion with the PIC / Clinical Toxicologist
Activated charcoal binds to poisons in the gut and prevents absorption. It is not effective
for cyanide, alcohols, iron, lithium, potassium and other electrolytes, acids, alkalis or
petroleum products
Activated charcoal is usually ineffective if given more than 1 hour post-ingestion.
However with some medicines there may be advantage in administering activated
charcoal after this time, or in repeat doses
Caution is required with the use of activated charcoal in patients who are not intubated
because of problems with aspiration. An important example is the drowsy patient with
an unstable airway, particularly those who are reluctant to take the activated charcoal,
given that it may cause vomiting
In summary, activated charcoal should only be given if the patient can self administer
without any assistance from treating staff. All patients who are, or are at risk of becoming
drowsy, unconscious or fitting will need airway protection and will need intubation prior
to administration of activated charcoal
There is no evidence that the use of sorbitol or other cathartic agent provides any
benefit over activated charcoal alone and they are no longer indicated
Schedule
Nil
Form
Strength
Suspension
50 g / 250 mL
Activated charcoal
Give on advice of PIC / MO / NP
Route of
Recommended
administration
dosage
Oral
Giving the activated
charcoal to a child from
a covered container may
increase its acceptance
(the colour can be
off putting).
Activated charcoal via the
nasogastric or orogastric
tube may be considered.
The patient must be able
to protect their airway or
have it secured
e.g. intubation
Adult
50 g
Child
1g / kg / dose
to max. of
50 g
NON
DTP
Duration
Activated charcoal can
be repeated on MO
orders
There are some
medicines
(carbamazepine,
theophylline, quinine,
colchicine and
phenobarbitone,
digoxin, aspirin) whose
elimination may be
enhanced with repeat
dosing
e.g. 25 - 50 g
4 - 6 hourly
Uncontrolled
Controlled copy
copy
V 1.0
199
5. Follow up
6. Referral / consultation
Consult MO on all occasions if the substance taken is known or suspected to
be toxic
Specific poisons
Anticholinergic agents adult / child
200
Peripheral nervous system effects e.g. dilated pupils, red, dry skin, mouth and
axilla and urinary retention, reduced bowel sounds, tachycardia and hyperthermia
Effects may be delayed and cyclical
2. Immediate management
See Immediate management under Poisoning / overdose general approach
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
201
4. Management
The risk assessment is based on the dose ingested, serum valproate levels (if
available) and the status of the patient, especially the level of CNS depression
Consult MO who will advise further management. Evacuation / hospitalisation
may be required
Large ingestions will require intubation and ventilation. Activated charcoal 50 g
should be given post intubation
Hypotension (BP < 90 mmHg) should be treated with IV fluid. On rare occasions
inotropes will be required to maintain blood pressure
Haemodialysis may be required in a patient with life threatening toxicity
Toxicity can be delayed and prolonged due to erratic absorption and the
anticholinergic properties of carbamazepine
GIT toxicity e.g. bowel obstruction (ileus)
Central nervous system depression: cerebellar effects e.g. nystagmus and
dysarthria, sedation progressing to coma, seizures (rare)
Cardiovascular effects e.g. tachycardia and hypotension and rarely QRS
prolongation with ventricular arrhythmias
4. Management
Uncontrolled
Controlled copy
copy
V1.0
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
203
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
Most ingestions of SSRIs require only observation. Some may need symptomatic
treatment for any symptomatic serotonin toxicity e.g. benzodiazepines
Ingestions of citalopram and escitalopram should be managed in consultation
with MO and PIC 13 11 26 (24 hours)
2. Immediate management
See Immediate management under Poisoning / overdose general approach
Patients who arrive with a decreased level of consciousness will often require
intubation and ventilation
Commence continuous cardiac monitoring
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
204
If unconscious
See Immediate management under Poisoning / overdose general approach
Consult MO who will advise further management which may include:
-- fluid load with sodium chloride 0.9% if hypotensive (BP < 90 mmHg)
-- QRS widening associated with haemodynamic compromise should receive
IV sodium bicarbonate (1 - 2 mmol / kg)
-- seizures should be managed with benzodiazepines e.g. midazolam 5 mg or
diazepam 10 mg See Fits / convulsions / seizures
-- consideration should be given to administering activated charcoal (50 g) post
intubation via an NGT
Patients with hypotension, ventricular arrhythmias and / or ongoing seizures
and / or not responsive to the above treatment should be discussed with a
Clinical Toxicologist
Uncontrolled
Controlled copy
copy
V1.0
Typical
e.g. chlorpromazine, haloperidol, pericyazine
In addition to Poisoning / overdose general approach
Recommend
C
onsult MO first for all patients with antipsychotic overdose. PIC 13 11 26 (24 hours)
Background
Although grouped as a class, these agents have different toxicities in overdose
Uncontrolled
Controlled copy
copy
V 1.0
205
2. Immediate management
See Immediate management under Poisoning / overdose general approach
Patients who arrive with a decreased level of consciousness will often require intubation
and ventilation
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
Olanzapine
-- mild to moderate decreased level of consciousness rarely leading to coma,
sedated delirium and other anticholinergic toxicity e.g. tachycardia
Quetiapine
-- tachycardia and hypotension, decreased level of consciousness progressing
to coma in large ingestions
Risperidone
-- tachycardia and dystonic reactions, rarely hypotension. Decreased level of
consciousness does not occur
2. Immediate management
See Immediate management under Poisoning / overdose general approach
Patients who arrive with a decreased level of consciousness will often require
intubation and ventilation
3. Clinical assessment
4. Management
206
2. Immediate management
See Immediate management under Poisoning / overdose general approach
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
In addition, patients with salicylate toxicity require an arterial blood gas (ABG),
repeated salicylate levels and biochemistry e.g. electrolytes, renal function
4. Management
5. Follow up
See Follow up under Poisoning / overdose general approach
6. Referral / consultation
Patients who have ingested more than 300mg / kg, or have any evidence of
acidosis, may require treatment in a critical care area. This may require retrieval
to a larger centre in consultation with a Clinical Toxicologist
Uncontrolled
Controlled copy
copy
V 1.0
207
2. Immediate management
See Immediate management under Poisoning / overdose general approach
Apply high flow O2 via a non rebreathing mask. A Hudson mask is not sufficient
See O2 delivery systems
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
Carboxyhaemoglobin levels are a poor marker of exposure and hence prognosis
4. Management
Consult MO
High flow O2 as above for at least 6 hours. Ongoing O2 therapy may be considered
in patients with ongoing clinical effects. These patients should be discussed with
a Clinical Toxicologist. Hyperbaric O2 is no longer recommended for most carbon
monoxide exposures.
Note: In carbon monoxide poisoning, a pulse oximeter will record a misleading normal
O2 saturation
5. Follow up
See Follow up under Poisoning / overdose general approach
6. Referral / consultation
Patients with ongoing symptoms or pregnant patients should be discussed with
a Clinical Toxicologist
208
Uncontrolled
Controlled copy
copy
V1.0
Burns to the lining of the mouth, oesophagus and stomach. The lips and mouth
should be inspected for signs of burns, including blisters, redness and swelling.
However, a clear mouth does not necessarily indicate a clear oesophagus
Stridor, dyspnoea or dysphonia indicate airway injury which may be life threatening
Signs associated with oesophageal inflammation: pain or difficulty with swallowing,
excessive drooling, irritability, pulling at lips or tongue, vomiting, abdominal pain
2. Immediate management
Initial management is to wipe out the mouth with a cloth, then rinse with water.
No further fluids should be given
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
209
CNS effects e.g. headache, weakness, confusion, drowsiness, coma and seizures
CVS effects e.g. hypotension, tachycardia, ECG changes, arrhythmias and
cardiorespiratory arrest can occur
GIT effects e.g. nausea and vomiting
Respiratory distress and cyanosis from hypoxia
2. Immediate management
See Immediate management under Poisoning / overdose general approach
Patients with a decreased level of consciousness and / or respiratory failure will
require early intubation and ventilation
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
ake precautions (gloves, plastic gown and mask) to prevent contact with cyanide
T
directly or off the patient (particularly from the liquid form of cyanide)
Remove the patient from the source of contamination to fresh air
Give high flow O2 via a non rebreathing mask. A Hudson mask is not sufficient
See O2 delivery systems
Consult MO who in consultation with the PIC may recommend the use of an
antidote, of which there are several available
MO will arrange evacuation / hospitalisation to an appropriate facility
CNS effect e.g. confusion, drowsiness, decreased level of consciousness and coma
CVS effects e.g. tachycardia and hypotension
Respiratory effects e.g. aspiration, which may result in pneumonitis, with coughing,
gagging, wheezing and respiratory distress
GIT effects e.g. vomiting, nausea
Onset can be rapid with severe toxicity developing within the hour
2. Immediate management
See Immediate management under Poisoning / overdose general approach
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
210
Uncontrolled
Controlled copy
copy
V1.0
4. Management
May require O2 to maintain O2 saturation > 93% adult / > 95% child. If not
maintained consult MO
Insert IV cannula if any signs of sedation and have midazolam ready in case of
seizures See Fits / convulsions / seizures
Consult MO who will advise further management and arrange evacuation /
hospitalisation
The use of activated charcoal is contraindicated given the rapid onset of symptoms
and the risk of aspiration
All patients should be observed for 6 hours
Avoid giving any food / liquid containing dairy for at least 2 hours following
ingestion in order to limit absorption
2. Immediate management
See Immediate management under Poisoning / overdose general approach
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
May require O2 to maintain saturation > 93% adult / > 95% child. If O2 saturation
not maintained consult MO
Do not induce vomiting or administer activated charcoal
See following table
Uncontrolled
Controlled copy
copy
V 1.0
211
Types of hydrocarbons
Type
Examples
Vaseline
Motor oil
Other lubricating oils
Kerosene
Lighter fluid
Mineral turpentine
Low-viscosity:
Petrol & diesel
systemic toxicity
Pine oil
- associated with
possible
potential for marked
CNS effects similar
to eucalyptus oil
High-viscosity
Low-viscosity:
known systemic
toxicity
Camphor,
Chlorinated
insecticides
Benzene
Toluene
Risk of
Risk of
pneumonitis systemic toxicity
Management
Low
Low
High
Low
CNS toxicity
can occur,
whether due
to an asphyxia
effect, or a direct
hydrocarbon effect
High
High
Particularly
severe effects
include cardiac
arrhythmias and
seizures
5. Follow up
Review the next day and the day after given the possibility of delay in respiratory
symptoms
Consult MO if any chest symptoms or signs of increased HR or temperature
212
Phase 1
Significant GIT toxicity manifesting as severe nausea, vomiting, abdominal pain,
haematemesis and bloody diarrhoea (haemorrhagic gastroenteritis). These
effects may be delayed, but are usually seen within 6 hours if a sufficient amount
has been ingested. Hypotension from fluid loss can occur
Phase 2
A quiet or window phase where the GIT toxicity settles prior to systemic toxicity
commencing
Phase 3
Systemic toxicity manifesting as multiorgan failure with cardiovascular collapse,
renal failure, metabolic acidosis, hepatotoxicity and CNS toxicity. These life
threatening effects usually occur between 6 and 48 hours after the exposure
2. Immediate management
See Immediate management under Poisoning / overdose general approach
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
A plain abdominal x-ray may show residual whole tablets or a concretion (a hard
usually inorganic mass) which may indicate the use of whole bowel irrigation.
This decision should be made in consultation with a Clinical Toxicologist
4. Management
Iron levels at the 4 - 6 hours post ingestion can predict toxicity. In addition patients
with iron ingestion require a number of other investigations including electrolytes,
renal and liver function, blood gases, full blood count and an abdominal x-ray
IV fluids should be administered to ensure adequate circulating volume and
replacement of fluid loss
Activated charcoal is ineffective
Whole bowel irrigation may be useful for large exposures (over 60 mg / kg)
Consult MO or a Clinical Toxicologist
Consult MO who will organise evacuation / hospitalisation. Desferrioxamine is
an antidote that will be needed in serious cases. This can be brought with the
retrieval team
Uncontrolled
Controlled copy
copy
V 1.0
213
4. Management
4. Management
214
Consult MO
Most patients will do well with symptomatic and supportive care
All patients should receive IV fluid and have their renal function checked
Upper GIT irritation symptoms can be managed with IV / oral proton
pump inhibitors
Uncontrolled
Controlled copy
copy
V1.0
Opioids adult
Recommend
Consult MO first for all patients with opioid overdose. The PIC 13 11 26 (24 hours)
Background
Toxicity from opioids cannot be predicted solely from the dose ingested due to
differing tolerance in opioid dependent patients
Note: activated charcoal is not routinely indicated. A good outcome is expected with
supportive care and antidote administration as necessary. The onset of symptoms is also
usually rapid, making airway protection essential if considering any form of decontamination
People who have overdosed on slow release opioids and those with renal impairment
may have delay in the onset of symptoms therefore need longer period of observation
Consult MO
May require O2 to maintain saturation > 93% adult / > 95% child. If O2 saturation
is not maintained consult MO See O2 delivery systems
Hypoxia in patients with opioid ingestion mandates an assessment of CO2
Give naloxone if depressed level of consciousness or respiratory rate. Care
and clinical justification needs to be considered prior to inducing withdrawal in
patients who are regular users of opioids as complications could include seizures
and arrhythmias which may be fatal
MO may order further doses or IV infusion of naloxone. Naloxone has a short half
life and the patient may relapse as the naloxone wears off
The endpoint should be a patient with a respiratory rate > 12 respirations per
minute and easily responsive to verbal stimuli. Complete reversal of opioids is
not required and can lead to undesirable effects e.g. acute opioid withdrawal,
agitation, pulmonary oedema
Uncontrolled
Controlled copy
copy
V 1.0
215
DTP
IHW / SM R&IP
Authorised Indigenous Health Worker may administer one dose then must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
Dilute 0.4 mg with sodium chloride
0.9% to a total of 8 mL = 0.05 mg
/ mL
IV
Give 0.05 mg (1 mL) to
Stat
0.2 mg (4 mL)
of this dilution as required to meet
Further doses
endpoint (resp. > 12 rpm and easily on MO / NP order
Ampoule
0.4 mg / mL
responsive to verbal stimuli)
Can be repeated at
intervals of 2 - 3 mins
to a max. of 2 mg
Adult
IM
0.4 mg
Schedule
Naloxone hydrochloride
216
GIT effects e.g. nausea, vomiting, diarrhoea, cardiovascular effects - shock can
occur with some organophosphate poisonings. It is unknown whether this is
organophosphate toxicity or toxicity from the dilutent e.g. hydrocarbon solvent
Cholinergic toxicity
Muscarinic effects (effects on parasympathetic nervous system):
-- vomiting, diarrhoea, urination, miosis (small or contracted pupil), bronchorrhea
(excessive mucous from the air passages of the lung), bronchospasm,
lacrimation (tears) and salivation
Uncontrolled
Controlled copy
copy
V1.0
2. Immediate management
See Immediate management under Poisoning / overdose general approach
Although decontamination of the patient and avoidance of secondary contamination
is important it must not take precedence over the resuscitation of the patient
3. Clinical assessment
4. Management
Carbamates
Clinical presentation is identical to organophosphate ingestions. The duration of effects are
usually briefer and sometimes are less severe. Oximes are not indicated. Some carbamate
products are mixed with methanol which can be the major toxicity encountered. As for
organophosphate exposures, patients with carbamate ingestion should be discussed with
a Clinical Toxicologist
Uncontrolled
Controlled copy
copy
V 1.0
217
4. Management
218
Consult MO
If the amount of paracetamol ingested is near to, or greater than the calculated
toxic dose, the patient may require evacuation / hospitalisation
Activated charcoal can be offered to cooperative adult patients who present within
2 hours of ingestion and have taken a toxic dose
Uncontrolled
Controlled copy
copy
V1.0
Schedule
Form
Strength
NON DTP
Must be ordered by
MO / NP
Acetylcysteine (Parvolex)
Route of
administration
Recommended dosage
Duration
Adult
Initially 150 mg / kg IV in 200 mL
glucose 5% over 60 minutes
Ampoule
200 mg /
1 mL
IV
Administered within
8 hours of ingestion
Then 100 mg / kg in 1 L
glucose 5% over 16 hours
(total dose 300 mg / kg in 21 hours)
Provide Consumer Medicine Information: contact the PIC 13 11 26 for advice
Management of associated emergency: consult MO
[7]
5. Follow up
Discharge patient in consultation with MO
6. Referral / consultation
MO consult PIC 13 11 26 for chronic exposure
Uncontrolled
Controlled copy
copy
V 1.0
219
2. Immediate management
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
Treatment must be rapid. Delays will greatly increase risk of toxicity and death
Take precautions (gloves, plastic gown and mask) to prevent contact with paraquat
Do not give O2 initially unless ordered by MO (O2 enhances pulmonary toxicity of
paraquat)
Consult MO who may advise O2 if O2 saturation falls below 90%. Most exposures
will require evacuation / hospitalisation to an appropriate facility. Base line
spirometry is of use for monitoring disease progression
Uncontrolled
Controlled copy
copy
V1.0
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
CNS symptoms e.g. ataxia, uncoordination, sedation and rarely CNS depression
CVS symptoms e.g. tachycardia, hypotension (postural)
Psychiatric e.g. euphoria, agitation, anxiety, delusions and hallucinations
4. Management
Consult MO
Most patients toxicity will resolve with time and simple supportive care
Occasionally sedation e.g. oral diazepam may be required
Uncontrolled
Controlled copy
copy
V 1.0
221
CNS effects e.g. rapid onset of CNS depression with coma and agitation / delirium
upon waking
CVS effects e.g. bradycardia and hypotension
Other effects e.g. vomiting, hypothermia
2. Immediate management
See Immediate management under Poisoning / overdose general approach
Patients who arrive with a decreased level of consciousness may require
intubation and ventilation
3. Clinical assessment
See Risk assessment under Poisoning / overdose general approach
4. Management
Consult MO
Most patients can be managed in the left lateral position to maintain an adequate
airway as the duration of toxicity is brief. Rarely intubation / ventilation is required
IV fluids for hypotension and re-warming for hypothermia
Recommend
Immediate management if fitting See Fits / convulsions / seizures
Related topics
Fits / convulsions / seizures
Mental health behavioural emergencies
Acute asthma
Pneumonia - adult and child
222
2. Immediate management
3. Clinical assessment
4. Management
Consult MO
MO may advise treatment See Acute asthma and Pneumonia - adult and child
if evidence of chest signs and symptoms
May require O2 to maintain O2 saturation > 93% adult / > 95% child
See O2 delivery systems
If patient is sufficiently agitated to interfere with care and oral sedation is
appropriate - oral administration of diazepam will usually be adequate
Acutely disturbed or heavily sedated patients should not be left alone
Regularly assess vital signs and GCS until either the patient recovers or is
evacuated / hospitalised
When caring for patients with signs of petrol sniffing, be mindful of the effects on
balance and coordination, particularly following administration of diazepam
Uncontrolled
Controlled copy
copy
V 1.0
223
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Tablet
2 mg
5 mg
Diazepam
Adult
5 mg with second
5 mg dose if required to
a max. of 10 mg
Oral
Stat
Further doses
on MO / NP order
5. Follow up
If allowed home, patient should be discharged into the care of a responsible
person
Review daily for 2 to 3 days (respiratory symptoms in particular may be delayed)
See next MO clinic
Further management of petrol sniffing is a difficult problem. The best approach is
community based, involving community council, health staff and family. Alcohol,
Tobacco and Other Drug Service (ATODS) and Mental Health Services may be
able to advise or assist
Teachers, Sport and Recreation Officers and apprenticeship schemes all play a
role in instilling self-esteem in the youth of communities
6. Referral / consultation
Consult MO as above and if:
-- GCS < I4, abnormal clinical observations, chest symptoms or signs, any
significant other findings
-- diazepam is required
-- patient is assessed as being a risk to themselves or others
224
Uncontrolled
Controlled copy
copy
V1.0
4. Management
References
1.
Therapeutic Guidelines (2012). "Toxicology: resuscitation." Retrieved September, 2012.
2.
Murray L., Daly F., et al. (2011). Toxicology Handbook. Australia, Elsevier
3.
Therapeutic Guidelines (2012). "Toxicology: decontamination." Retrieved September, 2012.
4.
Hypertox (2012). Retrieved September, 2012, from
www.serpanalytics.com/site/curriculum.toxicology.wikispaces.net
5.
Isbister G.K., Buckley N. A., et al. (2007). "Serotonin toxicity, a practical approach to diagnosis and
treatment." Medical Journal of Australia 187(6): 361-365.
6.
Daly F.S. and and et al. (2008). "Guidelines for the management of paracetamol poisoning in Australia
& New Zealand - explanation and elaboration." Medical Journal of Australia 188(5): 296-302.
7. Australian Medicine Handbook (2012). "Acetylcysteine." Retrieved September, 2012
8.
Therapeutic Guidelines (2012). "Substance use disorders: hallucinogens." Retrieved September, 2012.
9.
Therapeutic Guidelines (2012). "Toxicology." Retrieved September, 2012.
10. Australian Medicine Handbook (2012). "Naloxone." Retrieved November, 2012.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
225
Related topics
Tetanus immunisation
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
226
Aim to delay lymphatic spread of venom and possible systematic effects while the
patient is transported to a facility where they can be managed and antivenom can be
administered if necessary
Keep the patient as calm and still as possible
Note time of snakebite
Avoid unproven and harmful techniques such as tourniquets, ice, cutting, sucking
Check for evidence of bite (if pre-hospital bandage not applied. If bandaged do
not remove):
-- lack of any bite / fang marks does not exclude envenomation
-- fang marks may look like minor scratches
-- multiple random fang marks may indicate that massive envenomation has
occurred
-- opposite may occur with significant bite marks and no envenomation
Do not wash the wound as a swab may be required later for the Snake Venom
Detection Kit (SVDK)
Uncontrolled
Controlled copy
copy
V1.0
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
227
-- number of strikes
-- first aid measures used
-- time of bandage application
Perform standard clinical observations +
-- O2 saturations
-- level of consciousness See Glasgow coma scale / AVPU
-- urinalysis for blood. If positive could be red blood cells (bleeding), haemoglobin
(red blood cell breakdown) or myoglobin (muscle breakdown). Keep some
urine (second catch) in case it is needed for use with the SVDK following a
negative test on the bite site
Do not remove bandage - cut a small window to obtain a swab for SVDK
(if antivenom available)
Palpate the lymph nodes draining the bite site for signs of tenderness
Check for evidence of paralysis
-- muscles of eyes and face affected first - drooping of eyelids, uncoordinated
eye movements, double vision, loss of full range of eye movements
-- impaired respiratory effort or peripheral weakness
Check for evidence of abnormal bleeding - gums, urine (as above), bite site and
IV site
Check for evidence of rhabdomyolysis - muscle tenderness and weakness
Note: point of care testing is not to be used as a substitute for formal laboratory testing.
False negatives have been reported in envenomed patients
4. Management
Consult MO immediately
Ensure limb is appropriately bandaged and apply further bandages as necessary
without removing the first bandage
Insert IV cannula
Monitor vital signs and urine output
Collect blood for FBC, U/E, CK and coagulation tests (INR, aPTT, a D Dimer).
This can be sent with the patient
If hypotension / shock is present, commence sodium chloride 0.9% or Hartmanns
solution. MO will advise volumes and rate
Nil by mouth
MO will arrange evacuation / hospitalisation if required to a facility that has:
-- sufficient antivenom stocks, monitored resuscitation area, on site pathology
Uncontrolled
Controlled copy
copy
V1.0
When definite envenomation has occurred, delay in treatment could be life threatening.
Consult MO and give snake antivenom. The choice of antivenom will be based on clinical
examination. Rarely a patient will be so unwell that they will require antivenom before
appropriate assessment.
Indications for antivenom
Laboratory evidence of envenoming e.g. coagulopathy
Clinical evidence of envenoming e.g. neurotoxicity
all cases where antivenom is considered should be discussed with a
--
Clinical Toxicologist
-- the recommended dosage of antivenom is 1 ampoule of the appropriate
monovalent antivenom or in rare cases 1 ampoule of polyvalent. More than
one ampoule is usually not required
-- patients receiving antivenom should be in a resuscitation area where an
allergic reaction can be managed
-- envenomed patients receiving antivenom can have their pressure
immobilisation bandage removed once antivenom has been administered
-- draw up adrenaline and keep close at hand in the event of an allergic reaction
/ anaphylaxis to the antivenom (0.5 mL of 1:1000 for adults)
-- check BP and HR every 5 minutes while antivenom is being administered
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Schedule
Form
Strength
Route of
administration
Recommended
dosage
Duration
Adult and
child 5 years
1 ampoule
diluted
in 500 mL (1:10)
Slow IV infusion
Slow IV infusion via
with sodium chloride
over at least 15
a second infusion
Brown 1000 units
0.9% or Hartmann's
minutes
line into the side
Ampoule
Tiger 3000 units
arm of the main
Death adder 6000 units
Child < 5 years
IV line
Taipan 12000 units
1 ampoule
King brown 18000 units
diluted in 250 mL
(1:5) with sodium
chloride 0.9% or
Hartmann's
Provide Consumer Medicine Information: allergic reaction / anaphylaxis can occur; also serum sickness
as a delayed adverse reaction (serum sickness takes many days or weeks to occur whereas anaphylaxis
is immediate)
Management of associated emergency: check O2 supply, self inflating resuscitator, oropharyngeal airways
and suction apparatus. If patient develops a significant allergic reaction to the antivenom (itching of the
skin, hives, angioneurotic oedema, hypotension / shock, loss of consciousness)
-- stop the infusion of antivenom
-- give adrenaline IM 0.01 mg / kg (adult or child) up to a max. of 0.5 mg (0.5 mL of 1:1,000 solution)
lateral thigh [2] [4] See Anaphylaxis and severe allergic reaction
1 ampoule contains
40,000 units in 50 mL
[3]
Uncontrolled
Controlled copy
copy
V 1.0
229
5.
Check when the patient had last tetanus vaccination See Tetanus immunisation
Follow up
If antivenom is used, complete and send off the questionnaire that comes with
each ampoule. This is very important for increasing our epidemiological and
clinical knowledge on snakebites
antivenom. The features are rash, fever and polyarthralgias or polyarthritis [3].
The use of prophylactic steroids to reduce the incidence of serum sickness is
controversial and should be discussed with the Clinical Toxicologist
6.
Referral / consultation
Related topics
1.
2.
3.
Clinical assessment
4.
Include in history:
- description of spider (if seen)
- time of bite
- geographical location where bite occurred
- site and feature of bite
Perform standard clinical observations
Perform physical examination of all systems
Management
230
5. Follow up
6. Referral / consultation
Consult MO if severe or persistent local or systemic symptoms
2. Immediate management
DRS ABCD resuscitation / the collapsed patient - managed in an area with
cardiorespiratory and resuscitation equipment if possible
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
231
4. Management
Insert IV cannula
Nil by mouth
Consult MO who may arrange evacuation / hospitalisation for administration of
antivenom. If antivenom is required an initial 2 ampoules are recommended.
Further doses may be required in severe envenomation [6]
Do not remove the pressure immobilisation bandage unless the patient is either
asymptomatic or if the patient is symptomatic and antivenom is available and / or
after 2 - 4 ampoules have been administered
Do 12 lead ECG
Check when the patient had last tetanus vaccination See Tetanus immunisation
5. Follow up
6. Referral / consultation
Consult MO on all occasions of suspected funnel-web spider bite
Uncontrolled
Controlled copy
copy
V1.0
Recommend
Do not apply pressure immobilisation bandage [1]
Related topics
Tetanus immunisation
1.
2.
3.
Clinical assessment
4.
Management
Note: do not apply a pressure immobilisation bandage for redback spider bites
Envenoming is not life threatening and resuscitation is rarely required
Uncontrolled
Controlled copy
copy
V 1.0
233
Schedule
DTP
IHW / SM R&IP
Morphine
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
8
DTP
IHW / SM R&IP
Fentanyl
100 microgram
/ 2 mL
IV
(IHW may not
administer IV)
Adult only
1.5 microgram / kg
to a max. of 100 microgram
Adult only
25 microgram increments
slowly, repeated every 10
minutes if required to a
max. of 100 microgram
Duration
Stat
Further doses
on MO / NP order
234
Uncontrolled
Controlled copy
copy
V1.0
5.
spider should be considered for a trial of the antivenom. Discuss with Clinical
Toxicologist via the PIC 13 11 26
advice from a Clinical Toxicologist should be sought
Check when the patient had last tetanus vaccination See Tetanus immunisation
Follow up
6.
Referral / consultation
Recommend
Do not apply pressure immobilisation bandage [1]
Related topics
Tetanus immunisation
1.
2.
3.
Clinical assessment
4. Management
Reassure patient
Apply an ice pack to sting / bite site
Clean the wound with antiseptic or wash with soap and water to help prevent
secondary infection
Give analgesia
SeeSimple
Simple
back
analgesia
cover
See
analgesia
Uncontrolled
Controlled copy
copy
V 1.0
235
5. Follow up
6. Referral / consultation
Consult MO as above or if systemic symptoms
Note: ticks and scrub mites may carry rickettsia that cause tick typhus and scrub typhus.
Febrile illnesses associated with a rash can be fatal. Consult MO
236
4. Management
Procedure for removal of tick
It is important to remove all ticks as soon as possible after discovery
When located, the tick is carefully removed with every attempt made to remove
all of the tick
The tick should be grasped as close to the skin as possible using fine forceps or
tick removal device See diagram below. Once grasped the tick is then removed
by applying gentle outward traction [1]
Take care not to squeeze the body of the tick or use any methods which may
agitate the tick, such as applying heat or using kerosene or methylated spirits,
as these methods may cause the tick to inject further saliva / toxin into the body
An alternative method is the knot method. Make a loose half-hitch in a thread
such as a piece of dental floss or suture material. The open knot is slipped over
the tick as close as possible to the skin and then pulled taut. The embedded tick
then usually flips out
Clean the wound with antiseptic or wash with soap and water to help prevent
secondary infection
Apply a cold compress to help reduce pain and swelling [7]
It is normal for a tick bite to remain slightly itchy for several weeks, however if
other symptoms develop, then an MO should be consulted
Check when the patient last had tetanus vaccination See Tetanus immunisation
5. Follow up
would quickly dissipate, but this is not the case. The extent of the paralysis may
worsen for up to 48 hours after the removal of the tick [1]
Consult MO if any signs of tick bite paralysis. The MO will arrange evacuation /
hospitalisation
6. Referral / consultation
Consult MO if tick bite paralysis or suspect tick typhus
Uncontrolled
Controlled copy
copy
V 1.0
237
4. Others
Linear erythematous
Minimal skin markings
eruption with discrete oval
with possible red rash
wheals
3. Bluebottle
(Physalia)
2. Irukandji syndrome
q
Wash with water and
remove any tentacles
Provide analgesia
Vinegar is not
recommended
See Bluebottle
(Physalia) sting
Related topics
DRS ABCD resuscitation / the collapsed patient
238
Uncontrolled
Controlled copy
copy
V1.0
2.
Immediate management
DRS ABCD resuscitation / the collapsed patient
Consult MO for required resuscitation medicines
Even if respiratory or cardiac arrest, and no antivenom available, continue
CPR (EAR ECC) until MO advises to stop
3.
Liberally douse the sting area and all adherent tentacles with vinegar, for at least
30 seconds
Restrain the patient if necessary. Severe pain may cause irrational behaviour and
Clinical assessment
4.
Management
Uncontrolled
Controlled copy
copy
V 1.0
239
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may administer one dose then
consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 5 years
1 ampoule (20,000 units)
Stat
diluted to
Give slowly over
10 mL (1:10) with
5 - 10 minutes
sodium chloride 0.9% or
Additional doses may
20,000
Hartmann's
Ampoule
IV
be given on MO / NP
Child < 5 years
units
order (repeat doses up
1 ampoule (20,000 units)
to max. of 6 ampoules
diluted to
if patient remains in
5 mL (1:5) with sodium
cardiac arrest)
chloride 0.9% or
Hartmann's
Provide Consumer Medicine Information: allergic reaction / anaphylaxis can occur; also serum sickness
as a delayed adverse reaction (serum sickness takes many days or weeks to occur whereas anaphylaxis
is immediate)
Intramuscular antivenom is not recommended and should not be used in the prehospital setting. Evidence
has demonstrated that intramuscular antivenom does not reach the systemic circulation within hours in
patients with haemodynamic compromise
Management of associated emergency: check O2 supply, self inflating resuscitator, oropharyngeal airways
and suction apparatus. If patient develops a significant allergic reaction to the antivenom (itching of the
skin, hives, angioneurotic oedema, hypotension / shock, loss of consciousness)
-- stop the infusion of antivenom
-- give adrenaline IM 0.01 mg / kg (adult or child) up to a max. of 0.5 mg (0.5 mL of 1:1,000 solution) lateral
thigh [2] [4] See Anaphylaxis and severe allergic reaction
[8]
Schedule
5. Follow up
All patients with envenomation from box jellyfish will need evacuation /
hospitalisation
6. Referral / consultation
as circumstance allow
240
Uncontrolled
Controlled copy
copy
V1.0
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
241
Schedule
Morphine
DTP
IHW / SM R&IP
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
8
Fentanyl
DTP
IHW / SM R&IP
242
5.
Follow up
6.
Evacuate / hospitalise
Referral / consultation
Recommend
Relieve pain by immersing affected limb (or shower) in water as hot as patient can
tolerate (45C). Put both limbs in hot water to gauge heat. Use with caution in young
children and those with poor peripheral circulation e.g. elderly and diabetic [8]
Do not use vinegar
1.
2.
3.
4.
Include in history:
- time of sting
Perform standard clinical observations
Perform physical examination:
- site, size and features of sting
Management
Immerse affected area in water (or shower) as hot as patient can tolerate (45C).
Put both limbs in hot water to gauge heat. Use with caution in young children
and those with poor peripheral circulation e.g. elderly and diabetic. Continue until
resolution of pain, or for at least 20 minutes [8]
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
Referral / consultation
Uncontrolled
Controlled copy
copy
V 1.0
243
Include in history:
-- time of sting
-- description of jellyfish if seen
-- first aid measures
Conduct standard clinical observations
Perform physical examination:
-- site, size and features of sting
4. Management
Follow up
Review if any indication of systemic symptoms such as nausea, headache
or malaise
6. Referral / consultation
Consult MO if:
244
Uncontrolled
Controlled copy
copy
V1.0
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
Continue CPR (EAR ECC) until MO advises to stop
Apply a pressure bandage over the wound site and involved limb
Apply a splint to immobilise the limb
3. Clinical assessment
Include in history:
-- time of sting (if possible)
-- first aid measures
-- indication of time of commencement of paralysis
Perform standard clinical observations +
-- pay particular attention to cardio / respiratory system and neurological
assessment
Perform physical examination:
-- site, size and features of sting
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
245
5. Follow up
Do not remove pressure bandage if envenomation by blue-ringed octopus or cone
shell is suspected, the bandage should be left insitu until evacuated / hospitalised
in an appropriate facility
6. Referral / consultation
Consult MO in all cases of suspected blue-ringed octopus or cone shell
envenomation
Immediate and intense pain
Local swelling, bruising, puncture marks
Mechanical trauma from barb
Barb or spine insitu
Tissue necrosis and infection and potentially, gangrene
Stonefish sting
Systemic effects are rare [1]
Nausea, vomiting, dizziness, shortness of breath
Cardiovascular signs
Bullrout sting
In severe cases headache and vomiting
Stingray envenomation
Increasing local pain which spreads to the entire limb, swelling and a characteristic
bluish white appearance of the wound
Systemic effects are rare, they include nausea, vomiting, muscle cramps,
diarrhoea, sweating, syncope and cardiac arrhythmias
2. Immediate management
Pain relief - immerse affected area in water (or shower) as hot as patient can
tolerate (45C). Put both limbs in hot water to gauge heat. Use with caution
in young children and those with poor peripheral circulation e.g. elderly
and diabetic. Continue until resolution of pain, or for at least 90 minutes [8]
3. Clinical assessment
246
Include in history:
-- circumstances of injury
-- time of injury
Standard clinical observations
Perform physical examination:
-- inspect site of injury See Acute wounds
Uncontrolled
Controlled copy
copy
V1.0
4. Management
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Pratice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12
years and 50 kg
Stat
up to max. of
1%
3 mg / kg / dose to a total
Do not repeat the total
Ampoule
Subcutaneous
50 mg / 5 mL
max. infiltration of 200 mg
max. dose at intervals
of < 1.5 hours
Child
up to max. 3mg / kg / dose
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[10] [11]
Schedule
Lignocaine
5. Follow up
Uncontrolled
Controlled copy
copy
V 1.0
247
6. Referral / consultation
Consult MO with:
Include in history:
-- time of injury
-- first aid measures used
Perform standard clinical observations
Perform physical examination:
-- site, size and features of injury
4. Management
Wash the wound site. Do not remove penetrating barbs, especially those affecting
the chest and abdomen [15]
Pain relief - immerse affected area in water (or shower) as hot as patient can
tolerate (45C). Put both limbs in hot water to gauge heat. Use with caution in
young children and those with poor peripheral circulation e.g. elderly and diabetic.
Continue until resolution of pain or for at least 90 minutes [8]
Apply local pressure for bleeding
Oral paracetamol may be sufficient analgesia or an intravenous opioid may be
necessary. Give morphine or if allergic to morphine give fentanyl
See Simple analgesia
248
Uncontrolled
Controlled copy
copy
V1.0
Schedule
DTP
IHW / SM R&IP
Morphine
If allergic to morphine give fentanyl. Note: fentanyl has a rapid onset of action
Schedule
DTP
IHW / SM R&IP
Fentanyl
100 microgram
/ 2 mL
IV
(IHW may not
administer IV)
Duration
Adult only
1.5 microgram / kg
to a max. of 100 microgram
Adult only
25 microgram increments
slowly, repeated every 10
minutes if required to a
max. of 100 microgram
Stat
Further doses
on MO / NP order
5. Follow up
Advise daily wound care and review as required See Fish stings
6. Referral / consultation
Transport to hospital or medical intervention for possible wound debridement
Uncontrolled
Controlled copy
copy
V 1.0
249
Recommend
Pain relief - immerse affected area in water (or shower) as hot as patient can tolerate
(45C). Put both limbs in hot water to gauge heat. Use with caution in young children
and those with poor peripheral circulation e.g. elderly and diabetic
1.
Local pain
Embedded or broken off spines
2.
3.
Clinical assessment
4.
Include in history:
- time of injury
Perform standard clinical observations
Perform physical examination
- site, size and features of injury
Management
See
SeeSimple
Simpleanalgesia
analgesia
5.
Follow up
6.
Referral / consultation
1.
2.
250
3.
Clinical assessment
4.
Include in history:
- time of sting
Perform standard clinical observations
Perform physical examination:
- site, size and features of sting
Management
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
Referral / consultation
1.
neurological:
hot and cold sensation reversed such that cold items give a hot sensation
and vice versa
breathlessness
gastrointestinal:
2.
3.
Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
251
4. Management
Consult MO
If bradycardia (slow HR), hypotension or moderate to severe symptoms - insert
IV cannula
Ciguatoxin may be passed through breast milk. Assessment of breastfed infants
and advice with regard to the safety of breastfeeding may be necessary
5. Follow up
6. Referral / consultation
Consult MO in all cases of suspected ciguatera poisoning
References
1.
Murray L., Daly F., et al. (2011). Toxicology Handbook. Australia, Elsevier
2.
Therapeutic Guidelines (2012). "Anaphylaxis." Retrieved September, 2012.
3.
Therapeutic Guidelines (2012). "Snake bite." Retrieved September, 2012.
4.
Australian Prescriber (2011). "Anaphylaxis." Retrieved September, 2012.
5.
Isbister G.K. and Gray M.R. (2003). "White-tail spider bite: a prospective study of 130 definite bites by
Lampona species." Medical Journal of Australia 179(4): 199-202.
6.
Therapeutic Guidelines (2012). "Spider bite." Retrieved September, 2012.
7.
Australian Resuscitation Council (2012). "Envenomation - Tick Bites and Bee, Wasp and Ant Stings
Guideline 9.4.3." Retrieved September, 2012.
8.
Therapeutic Guidelines (2012). "Marine envenoming." Retrieved September, 2012.
9.
Queensland Health, Irukandji Taskforce Guidelines for the Emergency Management of Irukandji
Syndrome. 2007.
10. Therapeutic Guidelines (2013). "Acute postoperative pain: regional and local administration of local
anaesthetics and opioids." Retrieved March 2013.
11. Therapeutic Guidelines (2013). "Pharmacological management of pain in children: local anaesthetics."
Retrieved March, 2013.
12. Australian Resuscitation Council (2011). "Envenomation - pressure immobilisation technique Guideline
9.4.8." Retrieved September, 2012.
13. Therapeutic Guidelines (2013). "Marine poisoning ". Retrieved March, 2013.
14. White J. (2013). A Clinician's Guide to Australian Venomous Bites and Stings. Incorporating the up
dated CSL Antivenom Handbook. Victoria
15. Australian Resuscitation Council (2001). "Envenomation fish stings Guideline 9.4.7." Retrieved April, 2013.
16. Therapeutic Guidelines (2013). "Stepwise approach to acute pain management." Retrieved July, 2013.
17. MiMS (2013). "Morphine sulfate injection." Retrieved July, 2013.
18. Editorial Committee Primary Clinical Care Manual 8th edition 2013.
252
Uncontrolled
Controlled copy
copy
V1.0
Section 3
General
Section 3
General
Contents
Mild and moderate allergic reaction
Respiratory problems
Nervous system problems
Mouth and dental problems
Eye problems
Urinary tract problems
Skin problems
Foot infection with diabetes
Chronic wounds
Communicable diseases
Chronic diseases
254
Uncontrolled
Controlled copy
copy
V1.0
2. Immediate management
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
255
4. Management
Consult MO if suspected irritant is a medicine, before recommending to cease
Mild allergic reaction (only if indicated)
Topical applications can be used to relieve itch / skin irritation
Oral promethazine or loratadine (non sedating antihistamine) [4] may be given
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 30 kg
10 mg
Child 2 - 12 years < 30 kg
Stat
5 mg
Tablet
10 mg
Oral
then once daily while
Child 1 - 2 years
symptoms present
2.5 mg
(tablet can be quartered and
crushed)
Provide Consumer Medicine Information: can be crushed with water or food
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[5]
Schedule
Schedule
Loratadine
Promethazine
or
DTP
IHW / IPAP
Authorised Indigenous Health Worker may administer one dose then consult MO / NP
Isolated Practice Area Paramedic must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Form
Strength
Tablet
10 mg
25 mg
Route of
administration
Elixir
5 mg / 5 mL
Recommended dosage
Child 2 - 12 years
0.125 mg / kg tds
and 0.5 mg / kg nocte
Duration
Stat
and while symptoms
present
Uncontrolled
Controlled copy
copy
V1.0
Promethazine injection
5. Follow up
Mild allergic reaction - review the next day and if no symptoms or findings review
at next MO clinic
Moderate allergic reaction - monitor response, discharge in consultation with MO
Document in medical record Allergic to
Promptly report any significant adverse event following immunisation (AEFI)
directly to Queensland Health by completing an AEFI form available at
www.health.qld.gov.au/immunisation/documents/adverse_event_immun.pdf
and fax to number on form. Queensland Health will forward on to the TGA.
There is no need to complete a TGA form.
For adverse reactions caused by medicines, report directly to the TGA Australian
Adverse Reaction Reporting System available at www.tga.gov.au/hp/problem.htm
If practising outside Queensland report adverse reactions caused by
immunisations and medicines directly to the TGA Australian Adverse Reaction
Reporting System available at www.tga.gov.au/hp/problem.htm
It may be appropriate to talk about ID bracelets (e.g. Medicalert) that carry
medical information such as allergies on them
Arrange MO follow up
6. Referral / consultation
Consult MO for moderate allergic reaction
Referral to an Allergist may need to be considered to identify the allergen(s)
Resources
Action plans available at: www.allergy.org.au
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
257
Respiratory problems
Pneumonia - adult
Acute asthma
Acute rheumatic fever (ARF)
Acute post streptococcal glomerulonephritis
(APSGN)
Acute bacterial sinusitis
Immunisation program
Acute otitis media (AOM) with acute perforation
Acute otitis media (AOM) without perforation
258
Respiratory problems
2.
3.
4.
Management
If the patient:
diagnoses See Pneumonia - adult, Acute asthma and COPD
- has a cough productive of mucopurulent sputum (bronchitis), consult MO and
treat See Pneumonia - adult
- has facial pain or tenderness See Acute bacterial sinusitis
Treat fever, aches and pains with paracetamol or aspirin. Aspirin may be gargled
for sore throat. Do not use aspirin in children.
For children with URTI See Upper respiratory tract infection (URTI) - child
Other symptomatic treatments e.g. steam inhalation and lemon and honey drinks
Schedule
Aspirin soluble
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult only
Tablet
300 mg
Oral
2 tablets every 4 - 6 hours
Stat
to max. 12 tablets / day
Provide Consumer Medicine Information: aspirin must not be given to children
Management of associated emergency: consult MO
[8]
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
259
Respiratory problems
Phenoxymethylpenicillin
Benzathine penicillin
DTP
(Bicillin LA)
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Disposable
Adult
900 mg
IM
Stat
syringe
900 mg
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[7]
Schedule
260
Uncontrolled
Controlled copy
copy
V1.0
Respiratory problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
150 mg
Adult
Tablet
Oral
10 days
300 mg
300 mg daily
Provide Consumer Medicine Information: should be taken on an empty stomach, 15 minutes before food.
Take until course completed
Management of associated emergency: consult MO
[7]
Schedule
Roxithromycin
5. Follow up
6. Referral / consultation
Consult MO as above or if symptoms persist despite symptomatic treatment
Uncontrolled
Controlled copy
copy
V 1.0
261
Respiratory problems
then palpate the maxillary sinuses on each side of the nose to cheekbones does the patient feel pain?
4.
Management
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
Referral / consultation
Pneumonia adult
Recommend
For patients with moderate / severe pneumonia See Immediate management
Offer patients at risk of pneumonia (those with co-existent illnesses such as chronic
diseases, alcohol misuse, previous splenectomy, impaired immunity), Pneumococcal
See Immunisation program
Consider melioidosis as possible cause of severe pneumonia in northern Australia
particularly in patients who have diabetes + / - alcohol misuse and especially in the
wet season. It has less classical symptoms and signs and may be resistant to initial
treatment
Background
A common condition, especially in Aboriginal and Torres Strait Islander peoples and
Related topics
262
Uncontrolled
Controlled copy
copy
V1.0
O2 delivery systems
Respiratory problems
Shortness of breath
Cough with sputum (a dry cough is typical of atypical pneumonia)
Fever, rash
Rapid breathing
Pleuritic chest pain (sharp pain made worse by deep breath)
Cyanosis
Confusion, drowsiness, loss of consciousness
Hypotension / shock
2. Immediate management
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
263
Respiratory problems
Mild pneumonia
Treat fever and pleuritic chest pain with paracetamol or aspirin (do not use
aspirin in children). For children See Paediatric section
SeeSimple
Simpleanalgesia
analgesia
See
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Tablet
300 mg
Aspirin soluble
Oral
Adult only
2 tablets every 4 - 6 hourly
to max. 12 tablets / day
Stat
5.
Follow up
Patients with mild pneumonia who are not evacuated / hospitalised should be
reviewed daily. Consult MO if the patient is not improving
See next MO clinic
If a smoker, encourage the patient to stop See Smoking
Immunisation Handbook
6.
Referral / consultation
References
1.
Australasian Society of Clinical Immunology and Allergy (2012). "Anaphylaxis." Retrieved July, 2012,
from www.allergy.org.au/health-professionals/hp-information/asthma-and-allergy/anaphylaxis
2.
3.
Therapeutic Guidelines (2012). "Urticaria." Retrieved July, 2012.
4.
Therapeutic Guidelines (2012). "Dosing of oral antihistamines used in dermatology (Table 4.1)."
Retrieved July, 2012.
5.
Australian Medicine Handbook (2012). "Loratadine." Retrieved July, 2012.
6.
Australian Medicine Handbook (2012). "Promethazine." Retrieved July, 2012.
7.
Therapeutic Guidelines (2012). "Pharyngitis and / or tonsillitis." Retrieved September, 2012.
8.
Australian Medicine Handbook (2012). "Aspirin." Retrieved September, 2012.
9.
Therapeutic Guidelines (2012). "Rhinosinusitis." Retrieved September, 2012.
10. Therapeutic Guidelines (2012). "Moderate to severe community - acquired pneumonia in adults-inpatient
treatment." Retrieved September, 2012.
11.
Therapeutic Guidelines (2012). "Mild community - acquired pneumonia in adults - outpatient treatment."
Retrieved September, 2012.
264
Uncontrolled
Controlled copy
copy
V1.0
Respiratory problems
HIV infection
History and physical examination - adult and child
Usually, abnormal respiratory symptoms and signs but may present with symptoms
and signs emanating from the genitourinary system, meninges, cervical lymph
nodes, skeletal system or indeed any organ or system
Extra-pulmonary TB often mimics other diseases
Cough for more than three weeks, haemoptysis (coughing blood)
Pleuritic chest pain and breathlessness, unresolved pneumonia
Hoarse voice
Unexplained weight loss
Night sweating, fever of unknown origin
Doesnt look and feel well, with past history of, or close contact with TB
Painless and non tender swelling of lymph nodes
Persistent low back pain with a fluctuant swelling at the groin or loin
Headache, photophobia, confusion, neck stiffness of 1 to 8 weeks duration
Pus cells in the urine but no growth on MC/S
Uncontrolled
Controlled copy
copy
V 1.0
265
Respiratory problems
Consider HIV test. TB may be the initial presentation in HIV positive people.
Perform chest x-ray
4. Management
5. Follow up
Follow up treatment should be done in consultation with specialised health
6. Referral / consultation
Call the Queensland Tuberculosis Call Centre 1300 367 840 who will direct
clinicians to a regional TB Control Centre
References
1.
Australian Prescriber (2012). "Testing for tuberculosis." Retrieved September, 2012. Available from
www.australianprescriber.com/magazine/33/1/12/18
266
Uncontrolled
Controlled copy
copy
V1.0
Head injury
Subarachnoid haemorrhage (SAH)
TIA and stroke
Uncontrolled
Controlled copy
copy
V 1.0
267
2.
3.
Immediate management
Consider snakebite
Clinical assessment
Perform a complete patient history noting current medications, alcohol and other
drug use, may be snakebite
Perform standard clinical observations +
- BGL
- conscious state See Glasgow coma scale / AVPU
Perform physical examination - inspect skin for rashes
-
4.
location of the pain, such as around one eye or over the scalp
the degree of pain experienced
onset and duration of the headache - does patient wake with pain?
other symptoms, such as visual disturbances, vomiting, a sore neck, fever
Management
5.
Follow up
6.
Referral / consultation
268
Consult MO for all secondary headaches. Patients will need referral for further
investigation as appropriate
Consider referral for counselling and / or stress management for people with
primary headaches
Uncontrolled
Controlled copy
copy
V1.0
Head injuries
Fractured mandible / jaw
Traumatic rupture of the eardrum
2. Immediate management
Avulsed (knocked out) adult tooth
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
269
4.
Management
Dentist (or Dental clinic visit) preferably within 24 hours if dental pulp is exposed
(red soft tissue)
In most cases, pain is due to exposure of dentine or dental pulp, and is usually
reversible if dental treatment is provided early. If a Dentist is not available
orthodontic wax or other inert material (such as Blu tack) may be used to cover
the broken tooth / teeth and decrease pain
Reposition tooth /
either by folding aluminium foil over them or using beeswax. This is intended to
be a temporary measure only. Patient will require evacuation for further treatment
by Dentist
Advise soft diet for 2 weeks and chlorhexidine (0.2%) mouthwash twice a day
while the tooth is splinted
Administer analgesia
If a tooth appears to be missing and has not been found at the site of the accident,
assess if patient has inhaled the tooth using chest x-ray [2]
Advise soft diet for 2 weeks and chlorhexidine (0.2%) mouthwash twice a day
while the tooth is splinted
270
Uncontrolled
Controlled copy
copy
V1.0
Doxycycline
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
administration
Duration
Adult
Initial dose 200 mg
then 100 mg daily
Tablet /
capsule
50 mg
100 mg
Oral
7 days
Provide Consumer Medicine Information: take with food. Do not take at the same time as iron, calcium or
antacids. Avoid excess exposure to sunlight - can cause photosensitivity. Take until course completed
Management of associated emergency: consult MO
[2]
Schedule
Amoxycillin
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Form
Strength
Capsule
250 mg
500 mg
Suspension
125 mg / 5 mL
250 mg / 5 mL
Route of
administration
Recommended dosage
Duration
Oral
7 days
Uncontrolled
Controlled copy
copy
V 1.0
271
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12
years
300 mg tds
Capsule
150 mg
Oral
5 days
Child < 12 years
7.5 mg / kg / dose tds
to a max. of 300 mg tds
There is no oral liquid, however a 50 mg / mL clindamycin solution can be made before each dose by:
-- dissolving the contents of 1 capsule in 2 mL water
-- draw this solution into a syringe and make the volume up to 3 mL
-- discard any excess solution so that the required dose remains in the syringe
-- mix the dose in juice or soft food to disguise the taste before giving
Provide Consumer Medicine Information: advise patient the use of clindamycin can lead to severe colitis
(inflammation of the bowel). If they experience diarrhoea while taking the medicine or up to several weeks
after the treatment contact their MO or return to the clinic and have a stool specimen taken for Cl.difficile
[3]. Take until course completed
Management of associated emergency: consult MO
[10]
Schedule
Clindamycin
5. Follow up
Consult MO or Dentist
Refer for next Dentist clinic visit
Educate regarding good oral hygiene such as:
6. Referral / consultation
Consult Dentist or MO on all occasions
Temporary splint / bridge is only intended for overnight stabilisation of the tooth
Evacuation for a patient will be required for further treatment
272
Uncontrolled
Controlled copy
copy
V1.0
Dental pain
Tooth / teeth sensitive to hot / cold
Bad breath (halitosis) and / or bad taste in mouth
Tooth decay - hole in tooth, broken down tooth, darkened tooth
Facial swelling and / or dental abscess (gum boil)
Probable cause
Inflammation of the tooth nerve
Management
Analgesics if indicated, especially
NSAID if not contraindicated
Antibiotics not indicated
Avoid foods that provoke pain
Uncontrolled
Controlled copy
copy
V 1.0
273
Yes
No
See Toothache
No
Yes
See Dental abscess
4.
Management
If severe consult MO
If associated tenderness, swelling, redness See Dental abscess
Lignocaine lotion
DTP
(Seda Lotion)
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
Schedule
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
administration
Lotion
2.5%
Topical
Duration
Supply in
Dip cotton bud in lotion and
original pack
apply to biting surface of
(15 mL).
tooth until numbed.
Advise patient to use
Max. of every 2 hours
for 2-3 days only
Provide Consumer Medicine Information: not for use in infants. Caution with hot drinks as numbness
can result in burns
Management of associated emergency: consult MO
[14]
274
Uncontrolled
Controlled copy
copy
V1.0
5. Follow up
--------
6. Referral / consultation
If severe consult MO / Dentist
Uncontrolled
Controlled copy
copy
V 1.0
275
4.
Management
Ensure patient can maintain oral intake and hydration (especially in children)
Initial management of mouth ulcers must address possible causes of the ulcers,
such as trauma within the mouth
- minor ulcer < 5 mm in diameter - lasts 5 - 10 days without scarring. Usually
-
major ulcer > 8 mm - can persist for up to 6 weeks. Usually occur on lips, soft
palate and fauces (back of the mouth to the pharynx) and tongue
- non healing ulcers - consider squamous cell carcinoma
- recurrent ulcers - consider Behet syndrome, aphthous ulcers or neutropenia.
Check serum iron and folate [16]
If in pain, give analgesia: paracetamol
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
Ulcers persisting for longer than three weeks are potentially serious and patients
should be referred to a Dentist or MO [18]
Referral / consultation
Recommend
Consult MO for patients with facial swelling who present with severe trismus (reduced
1.
2.
These patients require evacuation and should not be sent away with oral antibiotics
Immediate management
DRS ABCD resuscitation / the collapsed patient
276
Uncontrolled
Controlled copy
copy
V1.0
3.
Clinical assessment
4.
Management
Schedule
Amoxycillin
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Capsule
250 mg
500 mg
Oral
125 mg / 5 mL
Suspension
250 mg / 5 mL
5 days
Uncontrolled
Controlled copy
copy
V 1.0
277
Schedule
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Tablet
875 mg / 125 mg
125 mg / 31.25
mg per 5 mL
Oral
Child < 12 years
Powder
22.5 mg / 3.2 mg / kg / dose
for
up to max. of
suspension 400 mg / 57 mg
875 mg / 125 mg bd
per 5 mL
Provide Consumer Medicine Information: take with food. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
5 days
[10]
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12 years
300 mg tds
Capsule
150 mg
Oral
Child < 12 years
5 days
7.5 mg / kg / dose tds
to a max. of 300 mg tds
There is no oral liquid, however a 50 mg / mL clindamycin solution can be made before each dose by:
-- dissolving the contents of 1 capsule in 2 mL water
-- draw this solution into a syringe and make the volume up to 3 mL
-- discard any excess solution so that the required dose remains in the syringe
-- mix the dose in juice or soft food to disguise the taste before giving
Provide Consumer Medicine Information: advise patient the use of clindamycin can lead to severe colitis
(inflammation of the bowel). If they experience diarrhoea while taking the medicine or up to several weeks
after the treatment contact their MO or return to the clinic and have a stool specimen taken for Cl. difficile
[3]. Take until course completed
Management of associated emergency: consult MO
[6]
Schedule
Clindamycin
5. Follow up
See Dentist as soon as possible
Review swelling daily for next 5 days
278
Uncontrolled
Controlled copy
copy
V1.0
6.
Referral / consultation
Consult Dentist and MO
Bleeding soon after tooth extraction (Note: a small amount of bleeding is normal
following a dental extraction and requires no treatment)
4. Management
If bleeding is profuse (flowing) reassure the patient and advise them to sit calmly
and upright:
Apply pressure (bite) at the site of the bleed with gauze roll for 15 minutes
If there is an MO / Dentist / NP on site they may be able to:
-- infiltrate local anaesthetic with a vasoconstrictor (e.g. lignocaine with
adrenaline solution) close to the site, apply hemostatic agents such as a
gelatin sponge or Surgicel (if available) and
-- suture the socket with a dissolving suturing material
If bleeding continues beyond these measures, systemic causes should be
investigated
Alternatively bite on gauze at the site of the bleed soaked in lignocaine 1% with
adrenaline solution. Consult MO / Dentist
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural and Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
1% lignocaine
Topical Ampoule with 1:100,000
apply to gauze
5 mL
Stat
adrenaline
(bite on gauze roll)
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[7]
Schedule
5. Follow up
Uncontrolled
Controlled copy
copy
V 1.0
279
6.
Referral / consultation
Background
Dry socket / alveolar osteitis presents as postoperative pain in and around an
extraction socket. Pain increases in severity between 1 - 4 days after extraction [8]
2.
3.
Extremely painful socket 24 - 72 hours after tooth extraction. Some pain after
an extraction is normal and can usually be managed with paracetamol
Bad breath (halitosis) and / or bad taste in mouth
Partial or total disintegrated blood clot in socket
Obtain patient history including dental history - when dental extraction occurred,
smoking habits (patients are advised not to smoke for 24 - 48 hours after an
extraction as this may delay healing)
Perform standard clinical observations
Perform physical examination:
- inspect oral cavity with care - an empty socket without a clot is very tender
- how well can patient open mouth? does the patient have halitosis?
4. Management
Irrigate socket gently with sodium chloride 0.9% to remove debris and place Alvogyl
(antiseptic and analgesic) dressing loosely into socket if available. Dressing does not
require removal later. Note: Alvogyl should not be used if patient is allergic to iodine
If Alvogyl not available irrigate socket gently with sodium chloride 0.9%
Give analgesia
See
SeeSimple
Simpleanalgesia
analgesia
5.
Follow up
280
-- gentle warm sodium chloride 0.9% mouth rinses - at least 4 times daily
-- twice daily toothbrushing with fluoride toothpaste
-- daily cleaning between the teeth with floss or interdental brushes
-- limit sugary and acidic snacks and drinks
Promote smoking cessation
Advise regular dental checkups when available
6. Referral / consultation
Consult Dentist or MO as above
Dental abscess
Red, swollen gums that bleed easily, plaque + calculus, rarely painful (gingivitis)
Gum recession, loose / missing teeth, bad breath, bleeding and / or swollen gums,
not normally painful (periodontitis)
Localised swelling, pain, infection (acute periodontal abscess)
See Dental abscess
Very painful ulcers on the gums, possibly greyish in colour, bad mouth odour,
fever may be present (acute ulcerative gingivitis)
Poorly controlled diabetes
Uncontrolled
Controlled copy
copy
V 1.0
281
4.
Management
SeeSimple
Simpleanalgesia
analgesia
See
Oral antibiotics are rarely required for either gingivitis or periodontitis. If not allergic,
give metronidazole for acute ulcerative gingivitis. For periodontal abscess
See Dental abscess
Antibiotic therapy alone without professional cleaning and oral hygiene
improvement will lead to recurrence or progression [18]
Management of uncontrolled diabetes
Promote smoking cessation
Schedule
Metronidazole
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
200 mg
Adult
Tablet
400 mg
400 mg bd
Oral
5 days
Child
200 mg /
Suspension
10 mg / kg / dose bd
5 mL
to a max. of 400 mg bd
Provide Consumer Medicine Information: avoid alcohol while taking and for 24 hours after taking this
medicine. Take with food or immediately after food. Take until course completed
Management of associated emergency: consult MO
[7] [12]
5.
Follow up
282
6. Referral / consultation
See Dentist / Therapist as soon as possible
In infants, discrete white patches that are easily removed (bleed on removal) and
resemble milk curd
Joined patches may be found on the tongue, roof of mouth, inside the cheeks and
on the gums
Severe cases may show ulceration
May present in:
-- irritable infant or feeding problem
-- patient with ill fitting dentures
-- patient with immunosuppression illness e.g. leukaemia, HIV
-- patient with history of taking medicines (antibiotic, inhaled or systemic
corticosteroids) [9]
White fixed lesion (with or without history of smoking / alcohol use)
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
283
DTP
IHW / IPAP / SRH
Authorised Indigenous Health Worker, Isolated Practice Area Paramedic and Sexual and Reproductive
Health Program Authorised Registered Nurse may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child
100,000 units
Suspension
Topical
1 mL topically then
7 - 14 days
/ mL
swallowed qid
Provide Consumer Medicine Information: continue for one week after symptoms resolve. Place under
the tongue or in the buccal cavity. Use after eating, not before. If breastfeeding treat nipples. Take until
course completed
Management of associated emergency: consult MO
[9]
Schedule
Nystatin
Miconazole
or
Schedule
DTP
IHW / IPAP/ SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic and Sexual and Reproductive
Health Program Authorised Registered Nurse may proceed may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 2 years
2.5 mL topically then
swallowed qid
7 - 14 days
Gel
2%
Topical
Child 6 months to 2 years
1.25 mL topically then
swallowed qid
Provide Consumer Medicine Information: miconazole can potentiate the effect of warfarin [9]. Continue for
one week after symptoms resolve. Use after eating - place directly in mouth and on tongue. If breastfeeding
treat nipples. Take until course completed
Management of associated emergency: consult MO
[9]
5. Follow up
6. Referral / consultation
Consult MO or Child Health Nurse as above
284
Uncontrolled
Controlled copy
copy
V1.0
References
1.
Therapeutic Guidelines (2012). "Nonsteroidal anti-inflammatory drugs used in dentistry." Retrieved July, 2012.
2.
Therapeutic Guidelines (2012). "Tooth avulsion (knocked - out tooth)." Retrieved July, 2012.
3.
MIMS (2012). "Clindamycin ". Retrieved July, 2012.
4.
Kingon A. (2009). "Solving dental problems in general practice." Australian Family Physician 38(4): 211-216.
5.
Therapeutic Guidelines (2012). "Gingivitis." Retrieved July, 2012.
6. Therapeutic Guidelines (2012). "Periodontal abscess." Retrieved July, 2012.
7.
Editorial Committee, Primary Clinical Care Manual 8th edition 2013.
8.
Therapeutic Guidelines (2012). "Alveolar osteitis (dry socket)." Retrieved July, 2012.
9.
Therapeutic Guidelines (2012). "Oral candidiasis." Retrieved July, 2012.
10. Therapeutic Guidelines (2012). "Dentoalveolar surgical infections." Retrieved July, 2012.
11. Mediline Plus (2012). "Clove." Retrieved November, 2012, from
www.nlm.nih.gov/medlineplus/druginfo/natural/251.html
12. Therapeutic Guidelines (2012). "Acute ulcerative gingivitis." Retrieved November, 2012.
13. Therapeutic Guidelines (2012). "Oral mucosal disease: ulcerative conditions: general considerations."
Retrieved December, 2012.
14. MIMS (2012). "Seda lotion." Retrieved November, 2012.
15. 3M (2012). "Cavit Temporary Filling Material." Retrieved November, 2012, from
www.products3.3m.com/catalog/au/en005/healthcare/espe_dental/node_82381VQ6KZgs/root_D58K9TX3VWgv/vroot_6T33SD8659ge/bgel_ZDZ56S0C0Sbl/gvel_6NN4NHRDXZgl/theme_au_espedental_3_0/command_AbcPageHandler/output_html
16. Murtagh J. and Rosenblatt J. (2011). John Murtagh's general practice McGraw-Hill Australia Pty Ltd.
17. Therapeutic Guidelines (2012). "Recurrent aphthous ulcerative disease." Retrieved November, 2012.
18. Therapeutic Guidelines (2012). "Periodontitis." Retrieved December, 2012.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
285
Eye problems
History
It is important to establish:
Is the eye disorder a result of trauma?
-- a history of how the injury was sustained is vital
-- in any high velocity injury, a penetrating injury must be strongly suspected
-- if there has been a forceful blunt injury, suspect a blow out fracture of the orbit
The nature of visual symptoms:
-- loss of vision, pain or grittiness, redness, discharge, double vision
-- one or both eyes affected?
-- rate of onset
-- associated symptoms e.g. flashing lights, floaters, haloes around lights
Any past history of eye problems:
-- current medical problems e.g. diabetes or autoimmune disease
-- medicines that can affect the eyes, eye drops / ointment used?
-- does the patient wear contact lenses? any surgery on the eyes?
Any family history of eye problems e.g. in chronic glaucoma there is a 1:10 risk
in first degree relatives
Examination
Visual acuity (VA)
Test VA of each eye using a Snellen chart at 6 metres in good light. Vision should be
tested with the patients usual distance glasses or contact lenses
VA is recorded as 2 numbers. The first number is the distance the patient is from the
chart in metres e.g. 6. The second number is under the smallest line of letters the
patient was able to see e.g. 6/5, 6/6, 6/12, etc.
If any abnormality, check VA with the patient looking through a pinhole
If the patient cannot read the top line at 6 metres the patient can move closer to the
chart e.g. 3 metres. The first number then becomes 3
Further assessment may involve Snellen E or animal charts if literacy issues or counting
fingers, hand movements or perception of light if marked visual loss
A visual acuity of 6/6 does not exclude a serious eye condition [1]
Examine the eye systematically
Ensure good lighting and use magnification
Check the cornea, sclera, conjunctiva, eyelid and periorbital areas. Check the
movements of the eye are equal and there is no double vision.The lower lid should be
pulled down to examine the conjunctival lining. Care should be taken not to apply any
pressure to the globe if there is any suggestion of a penetrating eye injury. The lids can
be separated by using traction over the orbital margins thus avoiding any pressure.
Never try to pry the eyelids of a child apart to see the eye
286
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
If there is a strong suspicion of a penetrating eye injury place a rigid shield on the eye
and evacuate the patient to an appropriate facility
If the patient has a red eye or a history of a foreign body or a sensation of grittiness in
the eye, the inner aspect of the upper eyelid should be examined by everting the lid
See Diagram and procedure for eversion of the eyelid for technique. Eversion of the
upper eyelid should not be done if there is any suggestion of a penetrating eye injury
The anterior chamber (between the cornea and iris) should be examined for the
presence of blood (hyphaema) or pus (hypopyon)
Uncontrolled
Controlled copy
copy
V 1.0
287
Eye problems
Ask the patient to look down, pull the eyelid gently down and away from the eye. Place
the end of a cotton bud across the top of the eyelid
Pull the lashes and lid margin out and upward. Place cotton bud at the lid crease and
3. apply very light pressure. Evert the eyelid over the cotton bud to expose the underside
of the upper eyelid
4. Hold the eyelid in this position while you remove the cotton bud
Having assessed the underside of the lid and performed what procedures are necessary,
ask the patient to blink. The lid will return to its normal position. The inside of the lower
5.
lid is assessed by placing your thumb or index finger on the skin below the lower lid and
pressing downward. Ask the patient to look upward, to the left and to the right
Eye Tips
Do
99
99
99
99
288
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
Penetrating
eye injury
Blunt eye
injury
Chemical
burn to eye
Flash burn
to eye
Foreign
body /
corneal
abrasion
See
History of
trauma
(bacterial, viral,
allergic, chlamydial)
Conjunctivitis
See
Usually both
eyes affected
Conjunctiva
diffusely
inflamed
Clear or
mucopurulent
discharge
VA is normal
No staining of
cornea with
fluorescein
Corneal
ulceration
See
Unilateral
Conjunctiva
diffusely
inflamed
Clear or
mucopurulent
discharge
VA only
affected if
ulcer large or
central
Cornea
stains with
fluorescein
Episcleritis and
scleritis
See
Unilateral
Localised
inflammation
of sclera
May be
a watery
discharge
VA normal
No staining
of cornea
with
fluorescein
No
Yes
Acute glaucoma
See
Acute iritis
See
Unilateral
Nausea and
vomiting
Semi-dilated,
fixed pupil
Cloudy
cornea
VA impaired
Consult MO
Unilateral
Photophobia,
small +/irregular pupil
Inflammation
more
pronounced
on the sclera
adjacent to the
cornea
VA normal
early but
impaired later
No staining of
cornea with
fluorescein
Eye problems
289
Eye problems
Corneal ulceration
Penetrating eye injury
2. Immediate management
3. Clinical assessment
4. Management
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Eye drops
0.4%
Oxybuprocaine
Topical
Stat
Provide Consumer Medicine Information: oxybuprocaine eye drops should never be used for ongoing pain
relief and should never be given to the patient to self administer
Management of associated emergency: consult MO
[3]
290
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
Most corneal foreign bodies can be removed by irrigating with sodium chloride
0.9%. Gently syringe or use an IV bag with a giving set and regulator fully open
If unsuccessful use moistened cotton bud. Gently wipe the cornea with the bud,
many foreign bodies will stick to it
If foreign body still present, an 18 G needle may be used, if the clinician is
experienced to perform, as the cornea is very thin 0.5 to 1.0 mm:
- attached to a 2 mL syringe to provide support
- steady your hand on the patients cheek
- using the tip of the needle, gently dislodge the foreign body out
- then irrigate with sodium chloride 0.9%
Consult MO
- if foreign body over or near pupil
- if unsuccessful or uncertain regarding skill at removal of foreign body
Metal foreign bodies may leave a rust ring. This can be gently scraped away with
an 18 G needle (again only if clinician is experienced to perform) and irrigated
with sodium chloride 0.9%
If foreign body successfully removed or simple corneal abrasion only, instill
chloramphenicol eye ointment into the eye
Treat with chloramphenicol eye drops during the day and ointment at night
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Ointment
1%
Nocte
Topical
7 days
Drops
0.5%
1 drop qid
Provide Consumer Medicine Information: advise the patient to discard drops / ointment after one month.
Can be stored at room temperature once opened.
Management of associated emergency: consult MO
[4]
Schedule
Chloramphenicol
Analgesia - paracetamol
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
staining
Consult MO if:
- visual acuity deteriorates at any time
Chloramphenicol eye drops during the day (more comfortable) and / or ointment
at night (more effective) should be continued for 7 days
See next MO clinic
Referral / consultation
Uncontrolled
Controlled copy
copy
V 1.0
291
Eye problems
2. Immediate management
3. Clinical assessment
4. Management
Consult MO if:
-- large or central (over pupil) corneal abrasion
-- decreased visual acuity
Apply chloramphenicol eye ointment into the eye
Explain to the patient the importance of not rubbing the eye(s)
Explain to the patient to apply chloramphenicol eye drops during the day and
ointment at night
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Schedule
Oxybuprocaine
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Eye drops
0.4%
Topical
1 - 2 drops for pain
Stat
Provide Consumer Medicine Information: oxybuprocaine eye drops should never be used for ongoing pain
relief and should never be given to the patient to self administer
Management of associated emergency: consult MO
[3]
292
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Ointment
1%
Nocte
Topical
3 days
Drops
0.5%
1 drop qid
Provide Consumer Medicine Information: advise the patient to discard drops / ointment after one month.
Can be stored at room temperature once opened
Management of associated emergency: consult MO
[1] [4]
3
Schedule
Chloramphenicol
Analgesia: paracetamol
SeeSimple
Simpleanalgesia
analgesia
See
5. Follow up
6.
Referral / consultation
Consult MO as above
Recommend
Immediate and prolonged eye irrigation for chemical burns [1]
Consult MO regarding chemical burns to the eyes in all instances
Poisons Information Centre 13 11 26 available 24 hours
Patients with alkaline chemical burns to the eyes require urgent assessment by an
Ophthalmologist
Background
Alkaline substances include - lime, mortar and plaster, drain cleaner, oven cleaner,
ammonia [1]
Alkali burns are more harmful to the eye [1]. May result in rupture of the globe within
24 hours if not treated
1.
2.
Immediate management
Consult MO urgently
Irrigate copiously with sodium chloride 0.9%. Use an IV bag with giving set and
set regulator fully open
Instil local anaesthetic drops (oxybuprocaine eye drops) to affected eye(s)
Evert the eyelid and clear the eye of any debris / foreign body that may be present
by sweeping the conjunctiva with moistened cotton bud
Uncontrolled
Controlled copy
copy
V 1.0
293
Eye problems
Review the patients pain level every 10 minutes and instil another drop of local
anaesthetic (oxybuprocaine eye drops) as required on MO instructions
After 1 litre of irrigation review
Wait 5 minutes after ceasing the irrigation and check pH with litmus paper (should
be between 6.5 and 8.5)
Continuous irrigation is required for 30 minutes [1]
3. Clinical assessment
4. Management
Oxybuprocaine
5. Follow up
If severity of chemical burn to eye does not require evacuation follow up according
to MO instructions
Most will be treated as corneal abrasions using chloramphenicol eye drops and /
6. Referral / consultation
Consult MO urgently on all occasions of chemical burns to the eyes
294
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
Related topics
Head injury
2. Immediate management
onsult MO immediately
C
If ruptured globe of eye has occurred contact MO urgently
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
295
Eye problems
Nausea is common in eye injuries and vomiting can aggravate the injury. Treat
adults with metoclopramide or prochlorperazine
Children should not receive metoclopramide (Maxolon) or prochlorperazine
(Stemetil) because of the high risk of dystonic reactions. If an antiemetic is
required for a child the MO may advise ondansetron wafer or IV
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Eye drops
0.4%
Oxybuprocaine
Topical
Stat
Provide Consumer Medicine Information: oxybuprocaine eye drops should never be used for ongoing
pain relief and should never be given to the patient to self administer
Management of associated emergency: consult MO
[3]
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
IM or IV
Stat
Adult only
Ampoule
10 mg / 2 mL
(IHW may not
Further doses on
10 mg
administer IV)
MO / NP order
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or children and
use caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[5]
Schedule
Schedule
Metoclopramide
Prochlorperazine
or
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Adult only
Tablet
5 mg
Oral
Stat
20 mg
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or people < 18
years and use caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV.
See Mental health behavioural emergencies
[6]
296
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
5. Follow up
I f not evacuated / hospitalised follow up according to MO instructions
Review next day and re-examine eye
Review in 7-10 days as patients with significant hyphaema are at risk of re-
bleeding
6. Referral / consultation
Consult MO on all occasions of blunt eye injury
2. Immediate management
ive O2 via Hudson mask to maintain O2 saturation > 93% adult / > 95% child. If
G
O2 saturation not maintained consult MO See O2 delivery systems. The eye has
a high O2 requirement and it is important to maintain this when injured
Consult MO
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
297
Eye problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
IM or IV
Stat
Adult only
Ampoule
10 mg / 2 mL
(IHW may not
Further doses
10 mg
administer IV)
on MO / NP order
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or children and
use with caution in women < 20 years of age
Schedule
Metoclopramide
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[5]
or
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult only
Tablet
5 mg
Oral
Stat
20 mg
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or people < 18
years and use caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[6]
Schedule
298
Prochlorperazine
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
5. Follow up
All patients with penetrating eye injury require evacuation / hospitalisation under
6. Referral / consultation
Consult MO on all occasions of suspected penetrating eye injury
2. Immediate management
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
299
Eye problems
5. Follow up
6. Referral / consultation
Consult MO:
Usually presents with swelling (oedema) of the lids in one eye that may be red
The eye is painful
Often there is a prior history of sinusitis, generally unwell, often with a fever
Swelling and redness of the conjunctiva
Any alteration in visual acuity (VA), pupillary response, restricted or painful eye
movements are suggestive of orbital cellulitis
Visual acuity is normal in periorbital cellulitis
There is no staining of the cornea with fluorescein
Tenderness over the sinuses
Restriction of eye movements
2. Immediate management
Consult MO
3. Clinical assessment
4. Management
300
Eye problems
Note: In severe cases the patient will require ENT and Ophthalmological consultation
regarding surgical intervention to preserve sight
Periorbital cellulitis - consult MO who will advise appropriate antibiotics and follow up
5. Follow up
If not evacuated, will require IV antibiotics and close supervision and monitoring
in consultation with MO
See next MO clinic
6. Referral / consultation
Consult MO on all occasions of suspected orbital cellulitis
Red eyes that feel gritty, may begin in one eye and spread to the other
Both eyes are uniformly red because of widespread engorgement of conjunctival
vessels
Purulent discharge
May have difficulty opening eyes due to sticking of eye lashes in the morning
There may be a history of contact with a person with conjunctivitis
btain a comprehensive patient history with particular note of contact with other(s)
O
with conjunctivitis
Perform standard clinical observations
Examine both eyes:
-- starting with VA - VA should be normal in bacterial conjunctivitis
-- there is no staining of the cornea with fluorescein
-- note type of discharge from eye
4. Management
Wash hands and use separate box of tissues for patient to clean eyes to avoid
infection of the other eye or others [1]
The eyes should be cleaned (always from the inside out) and irrigated of any
discharge regularly with sodium chloride 0.9% or cooled boiled water
To clean eye lids stroke lids outwards
Instruct the patient about hygiene e.g. frequent washing of hands, avoid sharing
towels etc.
Treat with chloramphenicol eye drops or ointment
Uncontrolled
Controlled copy
copy
V 1.0
301
Eye problems
DTP
IHW / IPAP
Authorised IndigenousHealth Worker and Isolated Practice Area Paramedic must consult MO / NP
Schedule
Chloramphenicol
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
administration
Ointment
1%
Nocte
Drops
0.5%
Topical
Duration
7 days
Provide Consumer Medicine Information: advise the patient to discard drops after one month. Can be
stored at room temperature once opened
Management of associated emergency: consult MO
[4]
5. Follow up
6. Referral / consultation
Refer to MO if vision is affected, condition does not improve after 2 days of
Red eyes that feel gritty. Classically begins in one eye and spreads to the
other (especially adenoviral, which is associated with preauricular lymph node
enlargement)
Both eyes are diffusely red and may have watery discharge
Burning sensation [1]
History of viral upper respiratory tract infection
May be epidemic - pink eye or red eye
302
Eye problems
4. Management
Wash hands and use separate box of tissues for patient to clean eyes to avoid
infection of other eye or other people [1]
Symptomatic relief can be provided by:
-- cool compresses [1]
-- simple eye lubricants - drops or gel
The eyes should be cleaned (always from the inside out) and irrigated of
any discharge regularly with sodium chloride 0.9% or cooled boiled water
Instruct the patient about hygiene e.g. frequent handwashing, avoid sharing
towels etc.
Reassure patient that condition is self limiting however may take weeks to heal [1]
MO will prescribe aciclovir (Zovirax) ointment 5 times a day for the most
important viral condition - herpes simplex keratitis [1]
5. Follow up
6. Referral / consultation
Refer to MO if lasting longer than 3 weeks, photophobia and marked decrease in
Consult MO as above
Uncontrolled
Controlled copy
copy
V 1.0
303
Eye problems
2.
3. Clinical assessment
Obtain a comprehensive patient history with particular note of contact with other(s)
with conjunctivitis
Perform standard clinical observations
Examine both eyes:
-- starting with VA. VA is normal in allergic conjunctivitis
-- there is no staining of the cornea with fluorescein
-- note type of discharge from eye
4. Management
5. Follow up
If first episode review the patient next day and repeat examination of both eyes
6. Referral / consultation
304
Review antenatal / birth history notes (if available) otherwise contact facility where
baby born
Examine eyes
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
4. Management
5. Follow up
Result of MC/S and treat STI in parent
6. Referral / consultation
Consult MO / Paediatrician
Patients are usually children with a history of chronic bilateral conjunctivitis with
a mucopurulent discharge
Both eyes are red and can have a watery or mucopurulent discharge
Lymphoid aggregates in the conjunctiva give the characteristic follicles most
easily seen on the inner upper eyelid
4. Management
5. Follow up
Uncontrolled
Controlled copy
copy
V 1.0
305
Eye problems
6. Referral / consultation
Consult Ophthalmologist if corneal damage
Patients usually present with a painful red eye, though some ulcers are painless
There may be a watery discharge due to reflex lacrimation
Purulent discharge may be present with bacterial ulcers
Inflammation in the anterior chamber of the eye may lead to a collection of pus
called a hypopyon
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Eye drops
0.4%
Oxybuprocaine
Topical to eye
Stat
Provide Consumer Medicine Information: oxybuprocaine eye drops should never be used for ongoing
pain relief and should never be given to the patient to self administer
Management of associated emergency: consult MO
[3]
306
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
4. Management
5. Follow up
If not evacuated / hospitalised review daily until healed
Consult MO if:
6. Referral / consultation
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
307
Eye problems
5.
Follow up
6.
Referral / consultation
Recommend
Consult MO immediately
Urgent Ophthalmologist referral within 24 hours [1]
Background
Several groups of patients are at risk including those who have had past attacks of
iritis, those with a seronegative arthropathy and those who have had infections such
as herpes zoster (shingles) of the ophthalmic nerve, syphilis and / or tuberculosis
1.
2.
3.
Immediate management
Clinical assessment
4.
Consult MO
Management
Consult MO (if not already done) and discuss management including whether:
- can be treated with topical steroids
- evacuation / hospitalisation for Ophthalmologist review within 24 hours is
required
Analgesia: paracetamol
SeeSimple
Simpleanalgesia
analgesia
See
308
Uncontrolled
Controlled copy
copy
V1.0
Eye problems
5. Follow up
If not evacuated / hospitalised review daily and consult MO on each review
See next MO visit
6. Referral / consultation
Consult MO on all occasions if acute iritis is suspected
2. Immediate management
Consult MO urgently
3. Clinical assessment
4. Management
5. Follow up
If not evacuated review daily, consult MO on each review
See next MO visit
6. Referral / consultation
Consult MO on all occasions acute glaucoma suspected
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
309
Eye problems
References
1.
NSW Department of Health (2009). "Eye Emergency Manual An Illustrated Guide 2nd edition." Retrieved
July 2012, from www.aci.health.nsw.gov.au/__data/assets/pdf_file/0013/155011/eye_manual.pdf
2.
Jacobs D.S. (2011). "Corneal abrasions and corneal foreign bodies." Retrieved July, 2012, from
www.uptodate.com/contents/corneal-abrasions-and-corneal-foreign-bodies
3.
Therapeutic Guidelines (2012). "Some eye drops used in the emergency department." Retrieved July, 2012.
4.
Therapeutic Guidelines (2012). "Conjunctivitis." Retrieved July, 2012.
5.
Therapeutic Guidelines (2012). "Eye trauma: penetrating trauma (ruptured globe)." Retrieved July, 2012.
6.
Australian Medicine Handbook (2012). "Prochlorperazine." Retrieved July, 2012.
7.
Therapeutic Guidelines (2012). "Chlamydia trachomatis conjunctivitis." Retrieved November, 2012.
8.
Therapeutic Guidelines (2012). "Acute angle-closure glaucoma." Retrieved November, 2012.
310
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
311
4. Management
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Adult
Tablet
300 mg
Oral
3 days
300 mg daily
Provide Consumer Medicine Information: best taken before bed time. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[2]
Schedule
Trimethoprim
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Duration
Form
Strength
administration
dosage
250 mg
Adult
Capsule
Oral
5 days
500 mg
500 mg bd
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[2]
Schedule
312
Cephalexin
Uncontrolled
Controlled copy
copy
V1.0
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
Tablet
300 mg
Oral
14 days
300 mg daily
Schedule
Trimethoprim
Provide Consumer Medicine Information: best taken before bedtime. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[2]
5. Follow up
Check culture and sensitivity results and consult MO if organism resistant to
antibiotics given
Consult MO if symptoms persist, recur or worsen after treatment in men or women
All patients other than the initial uncomplicated lower urinary tract infection in a
non pregnant woman may need urological investigations. See next MO clinic
6. Referral / consultation
Consult MO as above
References
1.
Laboratory tests online (2012). Retrieved July, 2012.
2.
Therapeutic Guidelines (2012). "Acute cystitis in adults." Retrieved July, 2012.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
313
Skin problems
Examination
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
Acute wounds
How to collect a wound
Marine lacerations
swab / culture
Acute post streptococcal glomerulonephritis (APSGN) Acute abdominal pain
Acute rheumatic fever (ARF)
Cellulitis / erysipelas
Upper respiratory tract infection - adult and child
Uncontrolled
Controlled copy
copy
V 1.0
315
Skin problems
3. Clinical assessment
4. Management
Consult MO:
-- if BP or urinalysis is abnormal it may indicate the presence of APSGN
-- if patient is systematically unwell
-- if patient has fever See Cellulitis / erysipelas
-- if recurrent infections in individual or family
In mild / isolated cases e.g. single lesion:
-- remove crusts and debris by soaking in soap and water
-- then clean with soap and water
-- clothing / bedding / towels of patient and close contacts should be washed in
hot water and dried in direct sunlight
-- personal hygiene, especially hands and fingernails, should be emphasised
In severe / widespread cases e.g. 2 or more lesions:
-- take MC / S culture swabs from lesions See How to collect a wound swab / culture
-- commence oral antibiotic. Until culture results are available, suspect
Staphylococcus aureus as a pathogen. Medicines that are active against
S. aureus will also cover S. pyogenes
-- use measures outlined above for skin sores, clothing and personal hygiene
In situations where Streptococcus pyogenes is confirmed or suspected e.g. in
Aboriginal and Torres Strait Islander communities use penicillin as first choice, if
not allergic
Advise parent / carer / patient that impetigo is highly infectious and that the child /
patient should exclude themselves from contact with others e.g. by not attending
school, pre-school or child care centre until they have taken antibiotics for at least
24 hours [2]
Sores on exposed areas must be covered with a watertight dressing [2]
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Capsule
250 mg
Adult
Tablet
500 mg
500 mg qid
10 days
Oral
Child
Suspension 150 mg / 5 mL
12.5 mg / kg / dose qid
to a max. of 500 mg qid
Provide Consumer Medicine Information: should be taken on an empty stomach, to 1 hour before meals.
Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[1]
Schedule
316
Phenoxymethylpenicillin
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
Benzathine penicillin
DTP
(Bicillin LA)
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
3 kg to < 6 kg 225 mg
6 kg to < 10 kg 337.5 mg
Disposable
900 mg
IM
10 kg to < 15 kg 450 mg
Stat
syringe
15 kg to < 20 kg 675 mg
20 kg 900 mg
Use a concentration of 442 mg / mL when measuring part doses. Refer to product information
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[1]
Schedule
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
250 mg
Adult
Capsule
Oral
10 days
500 mg
500mg qid
Provide Consumer Medicine Information: should be taken on an empty stomach, to 1 hour before
meals. Take until course completed
Management of associated emergency: consult MO See Anaphylaxis and severe allergic reaction
[1]
Schedule
Dicloxacillin
or
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
250 mg
Adult
Capsule
500 mg
500 mg qid
Oral
Child
10 days
125 mg / 5 mL
Suspension
12.5mg / kg / dose qid
250mg / 5 mL
to a max. of 500mg qid
Provide Consumer Medicine Information: take to 1 hour before food. Take until course completed
Management of associated emergency: consult MO See Anaphylaxis and severe allergic reaction
[1]
Schedule
Flucloxacillin
Uncontrolled
Controlled copy
copy
V 1.0
317
Skin problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
250 mg
Adult and child 12
Capsule
500 mg
years
1 g bd
Oral
10 days
125 mg / 5 mL
Suspension
Child < 12 years
250 mg / 5 mL
25 mg / kg / dose bd
to a max. of 1 g bd
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[1]
Schedule
Cephalexin
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12
years
450 mg tds
Capsule
150 mg
Oral
10 days
Child < 12 years
10 mg / kg / dose tds
to a max. of 450 mg tds
There is no oral liquid, however a 50 mg / mL clindamycin solution can be made before each dose by:
-- dissolving the contents of 1 capsule in 2 mL water
-- draw this solution into a syringe and make the volume up to 3 mL
-- discard any excess solution so that the required dose remains in the syringe
-- mix the dose in juice or soft food to disguise the taste before giving
Provide Consumer Medicine Information: advise patient the use of clindamycin can lead to severe colitis
(inflammation of the bowel). If they experience diarrhoea while taking the medicine or up to several
weeks after the treatment contact MO or return to clinic for stool specimen taken for Cl difficile [8].
Take until course completed
Management of associated emergency: consult MO
[17] [7]
Schedule
318
Clindamycin
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
Or for children with allergy to penicillin where it is more practical (than dissolving
clindamycin capsule) for parents or multiple members of the family are being
treated use
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Child
4 mg / 20 mg / kg /
8 mg / 40 mg
Suspension
Oral
dose bd up to a max.
7 days
per mL
of
160 mg / 800 mg bd
Provide Consumer Medicine Information: take with food and protect skin from sun. Take until course
completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[16] [17]
Schedule
Trimethoprim / sulfamethoxazole
for mild impetigo in non remote settings use mupirocin 2% skin ointment
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Workers and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Ointment or cream
2%
Topical to sores
tds
7 days
Provide Consumer Medicine Information: avoid contact with eyes and mouth. Complete course
Management of associated emergency: consult MO
[1]
Schedule
5. Follow up
Review daily initially. Consult MO if not improving
If antibiotics have been given for impetigo review in 2 weeks and check BP
and urinalysis
Consult MO if abnormal blood pressure and / or urinalysis
See Acute post streptococcal glomerulonephritis (APSGN)
6. Referral / consultation
Consult MO as above
Uncontrolled
Controlled copy
copy
V 1.0
319
Skin problems
320
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
4.
Management
Incision of abscess
Do not incise any boils in children; or boils in adults if affecting hands, face or
Do not inject into the abscess because this causes increased pain
Incise the abscess using a scalpel blade. A cross cut incision may be appropriate
to prevent the wound from closing prematurely
Express the pus by gently separating the edges of the incision. Do not squeeze
Irrigate the wound cavity copiously using sodium chloride 0.9% via a 20 mL
syringe with a blunt 18 G needle
In large abscess insert a ribbon gauze wick to prevent premature closure and
aid drainage of pus
After adequate drainage has occurred, lesions should then be covered with a
dry dressing
Dressings should be changed at least daily
Antibiotics are not always needed, as furuncles tend to wall off from the
surrounding tissues
Regardless of whether antibiotics are used a swab should be taken for
microbiology to look for MRSA
Antibiotics are indicated when there is a fever, enlargement of regional lymph
See Cellulitis / erysipelas
Uncontrolled
Controlled copy
copy
V 1.0
321
Skin problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12
years and 50 kg
Stat
up to max. of
1%
3 mg / kg / dose to a total
Do not repeat the total
Ampoule
Subcutaneous
50 mg / 5 mL
max. infiltration of 200 mg
max. dose at intervals
Child
of < 1.5 hours
up to max. of 3 mg / kg /
dose
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[5] [6]
Schedule
Lignocaine
5. Follow up
Review the patient daily initially to assess progress and change dressings
At the first review remove the wick, if present, and gently express any residual
pus. If a lot of pus is expressed, again insert another ribbon gauze wick
disease
6. Referral / consultation
Consult MO as above
Acute wounds
Marine lacerations
Folliculitis / furunculosis (boils) / carbuncles
Bacterial skin infections
Acute post streptococcal glomerulonephritis (APSGN)
Bone and joint infection - child
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
Usually there is a preceding history of skin trauma or skin disease followed within
a day or two by erythema (redness), tenderness and heat
Erythema which intensifies and spreads
Local pain is sometimes quite marked
Tender regional lymph node involvement is common
Systemic symptoms - malaise, fever and rigors may develop rapidly
Erysipelas is hot, shiny and bright red and has a sharply defined border, in contrast
to other forms of cellulitis
Wispy lymphangitis along the medial aspect of a limb
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
323
Skin problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Capsule
250 mg
Adult
Tablet
500 mg
500 mg qid
Schedule
Phenoxymethylpenicillin
10 days
Child
10 mg / kg / dose qid
to a max. of 500 mg qid
Provide Consumer Medicine Information: should be taken on an empty stomach, to 1 hour before
meals. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Suspension 150 mg / 5 mL
Oral
[7]
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Adult
1.5 g daily
Disposable
1.5 g
IM
Child
3 days
syringe
50 mg / kg / dose daily
to a max. of 1.5 g daily
Provide Consumer Medicine Information: complete course
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[7]
Schedule
324
Procaine penicillin
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Workers and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
250 mg
Adult
Capsule
Oral
10 days
500 mg
500mg qid
Provide Consumer Medicine Information: should be taken on an empty stomach, to 1 hour before
meals. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[7]
Schedule
Dicloxacillin
Or
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
250 mg
Adult
Capsule
500 mg
500 mg qid
Schedule
Flucloxacillin
10 days
Child
12.5mg / kg / dose qid
to a max. of 500mg qid
Provide Consumer Medicine Information: should be taken to 1 hour before food. Take until course
completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
125 mg / 5 mL
Suspension
250mg / 5 mL
Oral
[7]
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
250 mg
Adult and child 12
Capsule
500 mg
years
500 mg qid
Oral
10 days
125 mg / 5 mL
Suspension
Child < 12 years
250 mg / 5 mL
12.5 mg / kg / dose qid
to a max. of 500 mg qid
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[7]
Schedule
Cephalexin
Uncontrolled
Controlled copy
copy
V 1.0
325
Skin problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and children 12 years
450 mg tds
Capsule
150 mg
Oral
Child < 12 years
10 days
10 mg / kg / dose tds
to a max. of 450 mg tds
There is no oral liquid, however a 50 mg / mL clindamycin solution can be made before each dose by:
-- dissolving the contents of 1 capsule in 2 mL water
-- draw this solution into a syringe and make the volume up to 3 mL
-- discard any excess solution so that the required dose remains in the syringe
-- mix the dose in juice or soft food to disguise the taste before giving
Provide Consumer Medicine Information: advise patient the use of clindamycin can lead to severe colitis
(inflammation of the bowel). If they experience diarrhoea while taking the medicine or up to several weeks
after the treatment contact MO or return to clinic for stool specimen taken for Cl. difficile [8]. Take until
course completed
Management of associated emergency: consult MO
[7]
Schedule
Clindamycin
5. Follow up
6. Referral / consultation
Consult MO as above
Skin problems
4. Management
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
For 2 weeks after
Cream
2%
Topical
bd
resolution
Provide Consumer Medicine Information: clean and dry affected area before application. Complete
course
Management of associated emergency: consult MO
Schedule
Miconazole
Uncontrolled
Controlled copy
copy
V 1.0
[10]
327
Skin problems
or
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Liquid
2-3
For 2 weeks after
1%
Topical
Cream
times daily
resolution
Provide Consumer Medicine Information: complete course
Management of associated emergency: consult MO
Schedule
Clotrimazole
[11]
5. Follow up
Review the patient in 2 weeks
See next MO clinic if:
6. Referral / consultation
Consult MO as above
328
Cutaneous candidiasis:
-- has a predilection for moist skin folds
-- consists of itchy red macerated areas of skin with nearby smaller red areas of
involvement (satellite lesions)
-- common locations include the groin and genitals, armpits, between the
buttocks, under pendulous breasts, between the folds of skin on the abdomen
and between the digits
Vaginal candidiasis:
-- patients present with a thick white cheesy vaginal discharge associated with
burning or itching and sometimes dysuria
-- it may spread to the labia and perineal areas
Oral candidiasis See Oral thrush / candidiasis
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
4. Management
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Recommended
Duration
Form
Strength
administration
dosage
Cream
2%
Topical
bd
For 2 weeks after resolution
Provide Consumer Medicine Information: clean and dry affected area before application. Complete
course
Management of associated emergency: consult MO
[10]
Schedule
Miconazole
or
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Recommended
Duration
Form
Strength
administration
dosage
Liquid
1%
Topical
2 - 3 times daily
For 2 weeks after resolution
Cream
Provide Consumer Medicine Information: complete course
Management of associated emergency: consult MO
[11]
Schedule
Clotrimazole
5. Follow up
Review the patient in 2 weeks
See next MO clinic
6. Referral / consultation
Consult MO as above
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
329
Skin problems
4. Management
330
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
Schedule
Nil
NON
DTP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Apply liberally over and
25 mg / mL
beyond the affected area.
Repeat daily for
Shampoo
Topical
(2.5 %)
Leave on 10 minutes then
2 weeks
wash off
Management of associated emergency: consult MO
or
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Apply liberally over and
beyond the affected area.
Shampoo
2%
Topical
Repeat daily for 10 days
Leave on 10 minutes then
wash off
Provide Consumer Medicine Information: complete course
Management of associated emergency: consult MO
[15]
Schedule
Ketoconazole shampoo
5. Follow up
6. Referral / consultation
Consult MO as above
Recommend
Notify all cases to the local Public Health Unit - complete case report available from:
www.health.qld.gov.au/ph/documents/cdb/notif_conditions_rpt.pdf
Think of leprosy with any unexplained peripheral lesion or any chronic skin lesion
which fails to respond to conventional treatment
Because leprosy has a strong social stigma attached, confidentiality is especially
important
Skin lesions, nerve pain, numbness and tingling, weakness, ulcers and injuries
Areas of skin discolouration may appear coppery on dark skin and pink on fair skin
Limb deformities and chronic ulceration and scarring on hands and feet as a
result of trauma to areas with loss of sensation
Weakness, particularly the small joints in the hands and feet
Sharp shooting pains in the legs, arms, body and face are rare
Eye pain and worsening vision
Lagophthalmos (unable to completely close eyes)
Loss of eyebrows and lashes
Uncontrolled
Controlled copy
copy
V 1.0
331
Skin problems
Obtain a complete patient history. Enquire specifically about the presence and
duration of lesions, nerve pain, numbness and tingling, weakness, ulcers and
injuries, eye pain and worsening vision. Ascertain previous possible exposure
to leprosy
Perform standard clinical observations
Perform physical examination:
-- inspect and palpate the entire skin surface for lesions which can include
macules, papules, plaques, nodules and urticaria-like lesions. Patches may
appear coppery on dark skin and pink on fair skin. (Sometimes the only
lesions may be on the buttocks)
-- skin lesions
good immunity (tuberculoid leprosy) is characterised by
pale patches (never totally white), may be red in light skins, single
or few in number, with well demarcated edge (may be a little
thickened), anaesthesia to light touch (e.g. with a piece of cotton
wool), destruction of hair follicles and loss of sweat and sebaceous
glands
little or no immunity (lepromatous leprosy) is characterised by
skin lesions are multiple, often a coppery or violaceous colour, no
anaesthesia to touch and showing leprosy bacilli on skin smears
-- nerve damage
peripheral neuropathy affects most commonly the ulnar nerve, which is
thickened, and may be tender in the groove behind the elbow. Damage
to the ulnar nerve leads to anaesthesia first, then to loss of motor
function, then to deformity in the area of the 4th and 5th fingers
other nerves involved are:
posterior tibial (anaesthesia of the sole of the foot)
common peroneal (foot-drop)
radial (wrist drop)
facial (lagophthalmus i.e. inability to fully close the eye)
trigeminal (leading to corneal anaesthesia): nerve damage affects
both sensory and motor functions (sensation is more often the first
symptom)
-- the nose (lepromatous leprosy)
mucoid discharge, containing high levels of bacteria
ulceration of the mucosa may occur
there may be destruction of the septum and adjacent bone
-- the eyes (lepromatous leprosy)
iritis, corneal scarring
-- other lesions
swelling of infected lymph glands which may breakdown and discharge
testicular atrophy
4. Management
332
Consult MO
Untreated acute reactions can cause functional loss that can become irreversible
very rapidly, within hours or days
Multi-dose therapy (MDT) of diagnosed cases is the key to achieving cure in
the individual and breaking the cycle of transmission. MDT consists of three
medicines - dapsone, rifampicin and clofazimine
Public Health Unit will provide contact tracing of household / family and provide advice
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
5. Follow up
Ensure patient is compliant with medicines. Involve family members as much as
possible
It is vital to teach the patient to avoid injury, mainly burns of the hands and friction
damage to the feet due to loss of sensation. Encourage the wearing of suitable
footwear
Ensure the patient receives regular long term follow up. Reinforce to patient
and family members that the patient should present if they have any sudden or
increasing weakness / numbness or skin problems
All patients with leprosy require life long follow up
6. Referral / consultation
Consult MO on all occasions if leprosy is suspected
Consult Public Health Unit for advice and support on leprosy and contact tracing
Skin parasites
Scabies adult / child
Recommend
Inspect all skin surfaces in patients with marked itchiness looking for scabetic lesions
Simultaneous treatment of all family members and close personal contacts is crucial
otherwise reinfestation is inevitable
Provide a second treatment 1 week after first treatment to kill all eggs
Severe crusted scabies (Norwegian scabies) requires very intensive treatment.
Notify all cases to the local Public Health Unit - complete case report available at:
www.health.qld.gov.au/ph/documents/cdb/notif_conditions_rpt.pdf
Background
Scabies is caused by a mite that burrows into the skin. An allergic reaction to the
presence of the mite is responsible for the signs and symptoms [12]
Usually spread by skin to skin contact, although clothing and bedding can be a
source of infestation. The mite can live away from the skin for 1 - 2 days or, if near a
host e.g. in bed linen, for up to 4 days
Multiple family members / householders tend to be affected
Secondary bacterial infection occurs frequently
Dog scabies is a different species to human scabies and it is very unlikely that dogs
play any significant role in maintaining scabies transmission in humans
Related topics
Impetigo
Acute post streptococcal glomerulonephritis (APSGN)
No signs or symptoms
As a family member / household contact of primary case
Marked itchiness
Excoriations, eczematous eruptions and secondary bacterial infection are the
most common skin lesions
Scabetic lesions are usually small raised itchy nodules that are typically found
in the softer hairless skin areas e.g. between fingers and toes, elbows, wrists,
genitalia, buttocks, axillae and head in infants
Uncontrolled
Controlled copy
copy
V 1.0
333
Skin problems
Burrows, e.g. on hands, are diagnostic of scabies but often difficult to find. They are
short and superficial and have a small distal vesicle overlying the site of the female mite
Crusted (Norwegian) scabies occurs when literally thousands of mites are present
rather than the usual 3 - 50. It is not a different species. It is usually associated
with immunocompromised, mentally or physically incapacitated people and is
highly contagious. The itchiness may be unexpectedly mild
4. Management
Schedule
Permethrin 5% (Lyclear)
NON
DTP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Approximate requirements
for a single application
Stat
Adult and Child 12 years
Wash off in
up to 1 tube 30 g
8 - 24 hours
Child aged 5 - 12 years
Cream
5%
Topical
of 1 tube 30g
Repeat
Child aged 1- 5 years
treatment
of 1 tube 30 g
in 7 days
Infant aged 6 months - 1 year
of 1 tube 30g
Provide Consumer Medicine Information: apply to cool, dry, and clean skin from neck down, rub in
thoroughly. In central and northern Australia, in infants and older people, scabies above the neck is
common and treatment should be applied to the face and hair (avoiding eyes and mucous membranes).
Complete course
Management of associated emergency: consult MO
[12]
334
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
5. Follow up
the eggs may not be killed by the first treatment. The 1 week interval gives the
surviving eggs time to hatch
After topical treatment consider other diagnosis, unidentified source of reinfestation
or co-morbid condition (HIV infection). May require supervised treatment or
specialist referral. Oral ivermectin may be required
Itchiness after treatment is common and can last up to a month or more, especially
if nodular scabies is present. This does not indicate treatment failure
6. Referral / consultation
Consult MO if recurrent or chronic case or crusted (Norwegian) scabies
Consult Public Health Unit if crusted scabies. Intensive treatment and household
Uncontrolled
Controlled copy
copy
V 1.0
335
Skin problems
Impetigo
Obtain patient history See Assessment and examination of skin, hair and nails
Perform physical examination of the scalp and hair:
-- eggs (nits) cemented securely to the hairs may be seen by the naked eye on
close inspection of the scalp but may persist for many months after successful
treatment
-- finding many nits close to the scalp is more significant
-- mobile lice may also be seen
-- thorough use of a fine toothed comb is a faster and more effective way of
finding live lice, especially if thick white hair conditioner can be used to comb
through hair to find lice
Inspect the nape and occiput of the neck for excoriations and papules - signs of
secondary bacterial infection See Impetigo
4. Management
336
Treat any secondary bacterial infection at the same time. Permethrin 1% can be
applied to open lesions
An effective non-chemical method of treatment is:
-- apply sufficient thick white hair conditioner to dry hair to completely cover the
scalp and hair from roots to tips. Hair conditioner on dry hair stuns the lice
and stops them crawling for about 20 minutes [13]
-- use an ordinary comb to detangle hair and evenly distribute the conditioner
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
Schedule
-- divide the hair into sections and comb from roots to tips using a fine tooth
head lice comb
-- after each stroke, wipe comb onto a white tissue, checking the comb and
tissue for head lice. Comb the whole head, checking for lice
-- put all the tissues into a plastic bag, tie the top and put the bag in a rubbish bin
-- repeat every day until no lice are found over 10 - 14 consecutive days
Permethrin 1% is the chemical treatment of choice [13]. Permethrin 1% can be
applied to open lesions
Nil
Permethrin 1%
NON
DTP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Stat
Apply to dry hair, rub
Repeat the
vigorously and thoroughly
treatment after 7
through the hair to ensure
days as treatment
Shampoo
1%
Topical
complete coverage. Leave on
will not
for a minimum of 20 minutes
kill all the eggs
then wash thoroughly with
(eggs hatch in
water
7 days)
Provide Consumer Medicine Information: avoid contact with eyes, mouth and inside nose. Complete
course
Management of associated emergency: consult MO
[13]
Do not apply chemical treatment more than once per week. If three treatments
have not worked use the non-chemical method of treatment described above
Removal of nits after effective chemical treatment is not necessary but may be
psychologically important and can be done with a fine tooth head lice comb and
thick, white hair conditioner by combing from the roots to the tips
All family members and close personal contacts should be treated simultaneously
Contaminated combs, hairbrushes and hats should be washed in hot water or
dried in direct sunlight for a day
5. Follow up
Review the patient 7 days after last treatment (eggs hatch in 7 days) as treatment
6. Referral / consultation
Consult MO if persistent or recurrent head lice
See Queensland Health Fact Sheet at:
access.health.qld.gov.au/hid/InfectionsandParasites/Parasites/headLice_fs.asp
Head lice website at:
www.health.qld.gov.au/headlice/default.asp
Uncontrolled
Controlled copy
copy
V 1.0
337
Skin problems
Candidiasis
Impetigo
Redness, weeping
Irritability, especially with nappy changing
4. Management
Consult MO or Child Health Nurse if severe or not improving after simple measures
Change nappies frequently
When changing nappy do not use soap, rather a soap substitute. If using nappy
wipes use alcohol free and soap free ones
Apply a barrier cream such as Sudocrem (zinc oxide 15.25%) [14] or zinc and
castor oil, which usually has 7.5% zinc to prevent progression
Avoid plastic pants or nappy liners [14]
Expose the skin to air wherever feasible
If there are satellite lesions See Candidiasis
If there is evidence of secondary bacterial infection See Impetigo
5. Follow up
If mild, review in one week
If moderate, review daily initially.
not improving
6. Referral / consultation
Consult Child Health Nurse or MO as above
338
Uncontrolled
Controlled copy
copy
V1.0
Skin problems
References
1.
Therapeutic Guidelines (2012). "Impetigo." Retrieved July, 2012.
2.
Queensland Government, Time Out, Public Health Unit, Editor. 2010.
3.
Therapeutic Guidelines (2012). "Boils and carbuncles (acute furunculosis)." Retrieved August, 2012.
4.
Therapeutic Guidelines (2012). "Folliculitis." Retrieved August, 2012.
5.
Therapeutic Guidelines (2013). "Acute postoperative pain: regional and local administration of local
anaesthetics and opioids." Retrieved March, 2013.
6.
Therapeutic Guidelines (2013). "Pharmacological management of pain in children: local anaesthetics."
Retrieved March, 2013.
7.
Therapeutic Guidelines (2012). "Cellulitis and erysipelas." Retrieved August, 2012.
8.
MIMS (2012). "Clindamycin ". Retrieved July, 2012.
9.
Therapeutic Guidelines (2012). "Tinea." Retrieved August, 2012.
10. Australian Medicine Handbook (2012). "Miconazole." Retrieved August, 2012.
11. Australian Medicine Handbook (2012). "Clotrimazole (skin)." Retrieved August, 2012.
12. Therapeutic Guidelines (2012). "Scabies." Retrieved August, 2012.
13. Therapeutic Guidelines (2012). "Head lice." Retrieved August, 2012.
14. Therapeutic Guidelines (2012). "Nappy rash." Retrieved August, 2012.
15. Therapeutic Guidelines (2012). "Pityriasis versicolor." Retrieved August, 2012.
16. Therapeutic Guidelines (2012). "Recurrent staphylococcal skin infection." Retrieved December, 2012.
17. Dr Enzo Binotto (2012). Staff Specialist, Infectious Diseases and Clinical Microbiology, Cairns Base Hospital.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
339
Recommend
Consult MO or specialist diabetic foot service for any patient who has diabetes and
has a foot lesion / infection
Early treatment with appropriate antibiotics and wound care may prevent the need for
the patient with diabetes to be evacuated, hospitalised and undergo an amputation
Reducing pressure or improving vascularisation is required to heal a diabetic
foot ulcer
Background
Foot infections in patients with diabetes are a serious complication that frequently
lead to amputation
Precipitating causes of foot ulceration and infection include: friction in ill fitting shoes,
untreated or self treated callus, foot injuries, burns, corn plaster, nail infections, heel
friction when immobile, foot deformities, poor self foot care and awareness of risks,
diabetic peripheral neuropathy - sensory loss
Related topics
4
1.
Chronic wounds
340
Uncontrolled
Controlled copy
copy
V1.0
4. Management
Consult MO if / for:
-- systemic toxicity present, metabolic instability, poor observance with therapy
or wound care, or poor home support, focal infection evidenced by purulent
discharge, surrounding or ascending cellulitis or visible bone
-- limb threatening ischaemia i.e. absent pedal pulses with one or more of the
following: rest pain, gangrene or ischaemic ulcer
-- antibiotic order if MRSA is cultured
For severe cases or if systemically unwell consult MO who may advise:
-- blood cultures, IV cannula, IV antibiotics
-- evacuation and hospitalisation
Manage hyperglycaemia in consultation with MO and Diabetes team (if available).
Insulin may be required in the short term to control BGL
Check footwear and ensure correct fit. Leave footwear off if compromises infected foot
Encourage rest and elevation of foot
If deep penetrating ulcer is present or lesion not healing consider osteomyelitis
-- an x-ray is useful
Determine in consultation with specialist Diabetic Foot Service type of primary
dressing (and secondary dressing where required) See Chronic wounds
The most likely organisms to infect a superficial ulcer are Staphylococci,
Streptococci and sometimes anaerobes. Consult MO who will order:
-- for mild to moderate infection with no evidence of osteomyelitis or septic
arthritis, use: amoxycillin / clavulanate or cephalexin plus metronidazole and
for patients hypersensitive to penicillin: ciprofloxacin plus clindamycin [4]
If MRSA is suspected or cultured consult MO who will order rifampicin 300 mg bd
plus sodium fusidate 500 mg bd [5]
5. Follow up
Review the patient daily initially to assess progress and change dressings
Provide ongoing education on good foot care practises
Ensure feet are inspected at each visit
6. Referral / consultation
Consult MO on all occasions
Refer to Diabetes Educator if available for education on preventing infections
All presentations must be referred to the high risk foot service or other specialist
team for assessment, for pressure relief and long term management
Resources available at:
www.health.qld.gov.au/psq/Networks/diabetes.asp
www.health.nsw.gov.au/pubs/2004/pdf/lowerlimb_diabetes.pdf
www.health.wa.gov.au/woundswest/home/
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
341
Diabetes
4. Management
342
Chronic wounds
5. Follow up
Follow up patient after discharge from hospital, monitor wound, glycaemia control,
6. Referral / consultation
Consult MO on all occasions
Refer to Diabetes Educator, if available, for education on preventing infections
Refer for surgical management
Diabetes
Acute wounds
Dressings for acute wounds and minor burns
Infection in the foot of patient with diabetes
Uncontrolled
Controlled copy
copy
V 1.0
343
Chronic wounds
Ulcer:
-- pressure injury
-- arterial ulcers (secondary to atherosclerosis)
-- venous ulcers (secondary to peripheral vascular disease [PVD])
Consider unusual infections such as meliodiosis and atypical mycobacteria
(e.g. Mycobacterium ulcerans), underlying osteomyelitis, skin malignancy and
inflammatory conditions (Pyoderma gangrenosum)
4. Management
5. Follow up
As determined in consultation with MO
6. Referral / consultation
Consult MO
For non-healing leg ulcer MO will refer to Vascular Surgeon for assessment of
Uncontrolled
Controlled copy
copy
V1.0
Chronic wounds
lymphoedema
autoimmune
Location
Ulcer bed
Appearance
Venous ulcer
Past history of varicose veins
+/- DVT, trauma, surgery to
leg, or multiple pregnancies.
Aching and swelling worse at
end of day relieved with
leg elevation
Between the malleolus and
the lower calf.
Majority of venous ulcers
are located over the
medial malleolus
Fibrinous material at the
ulcer bed with moderate to
heavy exudate
Infection
Capillary refill
time
Surrounding
skin
Pigmented (haemosiderin
deposition), oedema,
atrophy blanche (white
scar formation), indurated
(lipodermatosclerosis)
Vascular status Pulses generally present
and palpable
Arterial
Normal
Brachial Index An ABI of 0.9 or higher is
(ABI) measured normal
by Doppler
ultrasonography
Primary Clinical Care Manual 2013
Arterial ulcer
History of smoking,
intermittent claudication.
Painful, especially after
exertion and leg elevation
Neuropathic ulcer
History of numbness,
paresthesia, burning.
Loss of sensation in foot.
Common in patients with
diabetes mellitus
Patients with neuro ischaemic ulcers may not feel pain
Frequently occurs distally
Sites of pressure
and over bony prominences e.g. metatarsal heads,
heels and toes
Uncontrolled
Controlled copy
copy
V 1.0
345
Chronic wounds
All exudating wounds should have the skin area around the wound protected from maceration by applying
Cavilon wipe or zinc cream. Hydrocolloid sheet window will prevent periwound skin from regular dressing
changes. Not in feet of a patient with diabetes
Foot wounds in people with diabetes should not be left for more than 3 days without checking / redressing
Alginate products are indicated for leg ulcers, pressure sores, cavity wounds
and donor sites. Also good as an initial treatment for bleeding wounds as they
possess haemostatic properties
Diabetic foot wounds should not be left for more than 3 days without checking /
redressing
Hydrogels (dry to sloughy wounds)
Polymers consisting of up to 95% water can take up the shape of a wound and
provide moisture
Marked cooling effect, therefore useful in thermal burns, minor burns, grazes,
lacerations and donor sites
Examples are DuoDERM Gel, IntraSite Gel and Comfeel Purilon Gel [3]
Indicated for leg ulcers, minor burns, donor sites, pressure sores
Useful as a secondary dressing, but should not be used for fragile skin
Hydrocolloid dressings (used for low - moderate exudate wounds)
Polymer that forms a soft gel, which enables removal with little damage to tissue
Indicated for superficial leg ulcers, pressure wounds, burns and donor sites
Examples include DuoDERM, and Comfeel paste / powder / ulcer dressing [3]
346
Uncontrolled
Controlled copy
copy
V1.0
Chronic wounds
Foam dressings (for medium - high exudate wounds) primary or secondary dressing
Non-adherent dressings - exudate to provide a moist wound environment
Thermally insulating e.g. maintain a wound core temperature of 37C
Most foams are not waterproof and can be applied directly to the wound
Indicated for granulating cavity wounds, ulcers, donor sites and minor burns
Examples include Hydrasorb, Lyofoam, Allevyn [3]
Cavicare contains two components that create a foam when mixed. This liquid is
poured into the wound, fitting the contours of the wound and can be used for 7 days
Diabetic foot wounds should not be left for more than 3 days without checking /
redressing
Silver impregnated dressings
Broad spectrum antimicrobial agent and has been impregnated into a variety of
dressing mediums
Indicated for infected, acute or chronic wounds
Examples: Polymem silver, Acticoat, Aquacel Ag, Biatain Ag [3]
Hypertonic saline (Curasalt - 20% saline)
Is impregnated, pre-saturated gauze dressing
Cleans, drains infected wounds, promotes softening and removal of necrotic tissue,
debris, pus and bacteria via osmotic action
Indicated for infected, moderate - heavy exudating wounds and sloughy draining
hypergranulation
Do not cut sheet dressing, apply to wound bed, choose secondary dressing that will
promote moist wound healing
Change at least daily - best result by changing twice daily. Is not active unless used
in this manner
Contraindicated in dry eschar or slough, granulating, epitheliating tissue as may
cause bleeding due to osmotic drawing on tissue. Not recommended on tendon,
bone or muscle
Medical honey
Low water concentration of medical honey delivers an osmotic drawing at the
wound bed, facilitating debridement and cleaning of the wound
Indicated for infected wound, acute and chronic wounds, necrotic / sloughy wounds
and malodorous wounds
Apply directly to wound bed or dressing approximately 3 mm thick. May be beneficial
to apply honey to tulle gras and then apply to wound
Change according to amount of exudates and level of contamination e.g daily,
third daily
Silicone
A silicone contact layer has been applied to various dressing mediums - provides
gentle adhesion and removal
Skin tears, abrasions, partial thickness wounds
Comes in wound contact layer (Mepitel and foam Mepilex)
Cadexomer iodine (Iodosorb)
Apply 3 mm thick, apply gauze and secondary dressing
Microbeads that contain 0.9% iodine
Exudate is absorbed, product gels and iodine is progressively released into wound
Comes in powder, ointment and dressing form
For use on low to moderate exudating wounds, infected wounds
Iodine provides broad spectrum antimicrobial effect
Do not use in pregnancy, thyroid disease, iodine sensitivities or for longer than
3 months
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
347
Chronic wounds
Is the wound starting to epithelialise, or has the granulation tissue become level with the
edges of the wound?
Yes
No
Foam
Hydrocolloid
Film
Note: be aware of fragile skin
No
Alginate packing
(Do not pack plantar foot wounds)
Honey
Iodosorb
Hypertonic saline (Curasalt)
promotes cleansing
Requires secondary dressing
Foam
Highly absorbent pad
Recommend regular dressing changes
Uncontrolled
Controlled copy
copy
V1.0
Chronic wounds
Granulating wounds
Note: All suggested dressings are in accordance with moisture balance wound principles
and the manufacturers instructions
No
Minimal exudate
Hydrocolloid sheet
Foam
Silicone
Minimal exudate
Hydrocolloid paste or sheet
Hydrocolloid dressings are shown as the primary dressing choice in granulating wounds
because:
The hypoxic environment they create accelerates the formation of new blood
vessels (angiogenesis)
They are waterproof, conformable, self-adherent and do not need a secondary
dressing
Hypergranulation can be a raised, red, moist, gelantinous area, treat with:
-- double layer foam and retention tape
-- hypertonic saline (Curasalt)
MO order required for silver nitrate application
Low exudate
Hydrocolloid
Hydrogel
Honey
Hypertonic saline
Foam
Uncontrolled
Controlled copy
copy
V 1.0
349
Chronic wounds
Fungating wounds
Note: All suggested dressings are in accordance with moisture balance wound principles and the
manufacturers instructions
No
No
Malodorous wounds
Malodorous wounds will improve with appropriate systemic and local wound care,
for example frequent daily dressing changes
Antimicrobial dressings
Silver
Cadexomer iodine
Medical honey
References
1.
Carville K. (2012). Wound care manual. Osborne Park Western Australia, Silver Chain Foundation
2.
Bryan R. and Nix D. (2007). Acute & Chronic Wounds Current Management Concepts. St Louis,
Missouri, Mosby.
3.
Therapeutic Guidelines (2012). "Wound dressings." Retrieved August, 2012.
4.
Therapeutic Guidelines (2012). "Diabetic foot infections." Retrieved August, 2012.
5.
Therapeutic Guidelines (2012). "Osteomyelitis." Retrieved August, 2012.
350
Uncontrolled
Controlled copy
copy
V1.0
Communicable diseases
Communicable diseases
Acute hepatitis A adult / child
Recommend
Vaccinate according to National Immunisation Program schedule and advise
avoidance of risk factors
Notify all cases to the local Public Health Unit - see details below
Perform contact tracing
Background
Transmission is by the faecal-oral route, from contaminated food, rarely through sexual
contact in people who participate in sexual practises that involve oral - anal contact
Incubation period is between 2 weeks and 6 weeks (average 28 - 30 days). Hepatitis
A is self limiting (duration around 6 months) and never becomes chronic
The virus is excreted in the stools for two weeks before illness is apparent and
continues for up to one week after onset of jaundice
Two cases constitute an outbreak
Related topics
Immunisation program
1.
No symptoms
Clinical presentation:
2.
3.
Clinical assessment
4.
Obtain comprehensive patient history - specifically ask about contact with others
with the disease, environmental circumstances, history of travel and medicines
Perform standard clinical observations
Perform physical examination
Management
Uncontrolled
Controlled copy
copy
V 1.0
351
Communicable diseases
5.
Food handlers and child care workers with proven or presumed hepatitis A should
not work for at least 1 week from the onset of jaundice
Active immunisation should occur if appropriate in consultation with MO or Public
Health Unit
Follow up
6.
Referral / consultation
Consult MO on all occasions jaundice detected or hepatitis A is suspected
352
Acute Hepatitis C
No symptoms
Clinical presentation:
Pain in the abdomen, nausea, vomiting, weakness and tiredness
Rash
Detection of hepatitis B virus PCR / NAT (nucleic acid testing) with no documented
hepatitis B virus infection
Uncontrolled
Controlled copy
copy
V1.0
Communicable diseases
2.
3.
Clinical assessment
4.
Management
5.
Follow up
6.
Referral / consultation
Uncontrolled
Controlled copy
copy
V 1.0
353
Communicable diseases
1.
No symptoms
Clinical presentation:
Jaundice, anorexia
Nausea
Lethargy
2.
3.
Clinical assessment
4.
Management
354
Uncontrolled
Controlled copy
copy
V1.0
Communicable diseases
5. Follow up
6. Referral / consultation
Common viral symptoms - fever, chills, headache, loss of appetite, nausea and malaise
There may also be preceding URTI symptoms - nasal discharge, sore throat, cough
Joint symptoms of pain and stiffness - any joint may be affected though most
commonly the ankles, knees, fingers, wrists and elbows, tenderness of the palms
and soles
Joint swelling in more severe cases
Rash - may or may not be present, transient, usually maculopapular and not itchy
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
355
Communicable diseases
5. Follow up
6. Referral / consultation
Virus
See Queensland Health fact sheets at:
http://access.health.qld.gov.au/hid/InfectionsandParasites/index.asp
See NSW fact sheet at: www.health.nsw.gov.au/factsheets/infectious/index.asp
356
Severe dengue
Dengue with any of the following:
-- low blood pressure (shock)
-- fluid accumulation in lungs with respiratory distress (pulmonary oedema)
-- severe bleeding
-- severe organ involvement - liver (AST / ALT > 1000 on blood tests), brain
(altered level of consciousness), heart and other organs
Uncontrolled
Controlled copy
copy
V1.0
Communicable diseases
2.
3.
Immediate management
Clinical assessment
4.
Complete patient history - ask about travel especially overseas and past history
of dengue
Perform standard clinical observations
Inspect skin for rashes, palpate joints for pain / swelling, lymph nodes
(lymphadenopathy), abdomen for tenderness / enlarged liver (hepatomegaly)
Management
Consult MO
Take blood for:
- FBC (low white cells and platelets are common)
- Dengue serology - after at least 5 days following onset of symptoms
- NS1 antigen (a rapid test) - all patients up to 9 days following onset of symptoms
If mosquitoes bite a person with dengue, they may pass dengue onto other people
Wear insect repellent during the day
Spray under furniture / beds with surface spray to help kill mosquitoes
Give paracetamol for fever, aches and pains. Do not use aspirin, methyl salicylate
(found in some topical pain relief preparations) and other NSAID e.g. Ibuprofen
as they can lead to bleeding [4]
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
Referral / consultation
References
1.
Queensland Government (2012). "Hepatitis C Queensland Health Guidelines for Public Health Units."
Retrieved August, 2012.
2.
Queensland Government (2011). "Queensland Dengue Management Plan 2010-2015." Retrieved
August, 2012, from www.health.qld.gov.au/dengue/documents/dengue-mgt-plan.pdf
3.
Queensland Government (2011). "Dengue. Queensland Health Guidelines for Public Health Units."
Retrieved August, 2012, from www.health.qld.gov.au/cdcg/index/dengue.asp
4.
World Health Organization (WHO and the Special Programme for Research and Training in Tropical
Diseases (TDR) (2009). "Dengue guidelines for diagnosis, treatment, prevention and control
haemorrhagic fever: diagnosis, treatment, prevention and control ". Retrieved August, 2012.
5.
Queensland Government (2010). "Hepatitis B - sexual health contacts." Retrieved August, 2012.
6.
Rezende G., Rogue-Afonso AM., et al. (2003). "Viral and clinical factors associated with the fulminant
course of Hepatitis A infection." Hepatology 38(3).
7.
Queensland Government (2010). "Hepatitis A - sexual health contacts." Retrieved August, 2012.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
357
Chronic diseases
Recommend
Guidelines state for benzathine penicillin to be given no more than 4 weeks apart
(28 days but can also be every 21 days for high risk patients). Prescribing every
month (30 - 31 days) is an acceptable alternative only if it is considered that this will
substantially improve adherence e.g. 5th day of every month
The Australian guideline for prevention, diagnosis and management of acute
rheumatic fever and rheumatic heart disease (2nd edition) 2012 [1] refer to benzathine
penicillin as benzathine penicillin G (BPG) these are the same
1.
2.
3.
4.
Immediate management
Clinical assessment
Check and complete care items on the patients rheumatic fever and rheumatic
heart disease care plan
Management
Benzathine penicillin
DTP
(Bicillin LA)
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Route of
Form
Strength
Recommended dosage
Duration
administration
Child < 20 kg
450 mg
Disposable
As ordered by
900 mg
IM
syringe
MO / NP
Adult and child 20 kg
900 mg
Use a concentration of 442 mg / mL when measuring part doses. Refer to product information
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[1]
Schedule
358
Uncontrolled
Controlled copy
copy
V1.0
Chronic diseases
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Route of
Recommended dosage
Duration
Form
Strength
administration
Tablet
250 mg
Adult and child
As ordered by
Capsule
500 mg
Oral
250 mg bd
MO / NP
Suspension 150 mg / 5 mL
Schedule
Phenoxymethylpenicillin
Provide Consumer Medicine Information: should be taken on an empty stomach, to 1 hour before meals
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[1]
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Capsule
250 mg
Erythromycin
Oral
Suspension 200 mg / 5 mL
As ordered by
MO / NP
[1]
5. Follow up
Fill out injection card
Complete Register
Discuss strategies to ensure patient returns for next injection
6. Referral / consultation
For ongoing assistance with secondary prophylaxis contact the RHD Register
References
1.
RHDAustralia (ARF/RHD writing group) and National Heart Foundation of Australia and the Cardiac
Society of Australia and New Zealand (2012). "Australian guideline for prevention, diagnosis and
management of acute rheumatic fever and rheumatic heart disease. Quick reference guides (2nd
edition)." from www.rhdaustralia.org.au/sites/default/files/quick_reference_guides_0.pdf
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
359
Chronic diseases
Diagnosis of asthma
4. Management
Prior to supply of medicines discuss with patient, any medication allergies, inhaler
technique, smoking and passive smoking (if applicable), possible problems taking
medicines
Supply medicines according to MO / NP order
DTP
IHW
Authorised Indigenous Health Worker supply on MO / NP instruction if less than 6 months since last
medical consultation
Route of
Recommended
Form
Strength
Duration
administration
dosage
Tablet / Inhaler
As ordered by
As ordered by
As ordered by
Oral / inhalation
/ Nebules
MO / NP
MO / NP
MO / NP
Inhalers - relievers
Inhalers - preventers Inhalers Tablets for asthma
Prednisolone
Beclomethasone
combinations
Salbutamol
Budesonide
Budesonide /
Montelukast
Eformoterol
Eformoterol
Salmeterol
Fluticasone
Cromoglycate
Fluticasone /
Terbutaline
Ipratropium bromide
Nedocromil
Salmeterol
Indacaterol
Ciclesonide
Provide Consumer Medicine Information: long acting Beta agonists must be used with inhaled steroids
because if used alone in asthma may increase morbidity and mortality [2]
Management of associated emergency: consult MO
Schedule
3 and 4
Respiratory medicines
5. Follow up
Complete Asthma Action Plan
Further follow up according to current edition Chronic Disease Guidelines
6. Referral / consultation
All children and adolescents with asthma should be reviewed by an MO
Children and adolescents with severe asthma require specialist referral
360
Uncontrolled
Controlled copy
copy
V1.0
Chronic diseases
Breathlessness
Acute asthma
Pneumonia - adult
Diagnosis of COPD
2. Immediate management
3.
See Breathlessness
Clinical assessment
4. Management
DTP
IHW
Authorised Indigenous Health Worker supply on MO / NP instruction if less than 6 months since last
medical consultation
Route of
Recommended
Form
Strength
Duration
administration
dosage
As ordered by
As ordered by
As ordered by
Tablet / Inhaler
Oral / inhalation
MO / NP
MO / NP
MO / NP
Inhalers - relievers
Inhalers - preventers Inhalers - combinations Tablets
Beclomethasone
Budesonide /
for COPD
Eformoterol
Budesonide
Eformoterol
Prednisolone
Salbutamol
Ciclesonide
Fluticasone / Salmeterol Theophylline
Salmeterol
Fluticasone
Terbutaline
Ipratopium bromide
Tiotropium bromide
Indacaterol
Provide Consumer Medicine Information: long acting Beta agonists must be used with inhaled steroids
because if used alone may increase morbidity and mortality [2]
Management of associated emergency: consult MO
Schedule
3 and 4
Respiratory medicines
5. Follow up
6. Referral / consultation
Pulmonary rehabilitation program
Uncontrolled
Controlled copy
copy
V 1.0
361
Chronic diseases
Hypertension adult
Related topics
Diagnosis of hypertension
2. Immediate management
3. Clinical assessment
4. Management
DTP
IHW
Authorised Indigenous Health Worker supply on MO / NP instruction if less than 6 months since last
medical consultation
Route of
Recommended
Duration
Form
Strength
administration
dosage
As ordered by
As ordered by
As ordered by
Tablet / Capsule
Oral
MO / NP
MO / NP
MO / NP
ACEI angiotensin
Beta-Blockers
Others
Calcium Blockers Diuretics
converting
Atenolol
Frusemide
Glyceryl trinitrate
Dihydropyridine
enzyme
inhibitor
Bisoprolol
Amlodipine
Amiloride
Hydralazine
Lisinopril
Carvedilol
Nifedipine
Indapamide
Isosorbide
Perindopril
Labetalol
Hydrochloromononitrate
Lercanidipine
Ramipril
Metoprolol
thiazide
Methyldopa
Felodipine
Trandolapril
Nebivolol
Prazosin
ARB
Propranolol
Non-dihydropyridine
angiotensin receptor
Diltiazem
blockers
Verapamil
Irbesartan
Schedule
3 and 4
Antihypertensives
Candesartan
Telmisartan
Provide Consumer Medicine Information
Management of associated emergency: consult MO
5. Follow up
6. Referral / consultation
According to Queensland Health current edition Chronic Disease Guidelines
362
Uncontrolled
Controlled copy
copy
V1.0
Chronic diseases
Diabetes
Hypertension
Urinary tract infections - adult and child and in pregnancy
Acute post streptococcal glomerulonephritis (APSGN)
Check and complete care items on CKD patient care plan according to stage of
kidney disease
4. Management
DTP
IHW
Authorised Indigenous Health Worker supply on MO / NP instruction if less than 6 months since last
medical consultation
Form
Strength
Route of administration Recommended dosage
Duration
Tablet /
As ordered by
As ordered by
As ordered by
Oral
Capsule
MO / NP
MO / NP
MO / NP
Beta-blockers
Calcium Blockers Phosphate binders (bones) Fibrates
Atenolol
Amlodipine
Calcium Carbonate
Gemfibrozil
Bisoprolol
Diltiazem
Aluminium Hydroxide
Fenofibrate
Carvedilol
Nifedipine
Sevelamer
Metoprolol
Verapamil
Lanthanum
Others
Propranolol
Magnesium asparate
Ezetimibe
Diuretics
Others for bones
ACEI angiotensin
Frusemide
Calcitriol
Platelet Inhibitors
converting enzyme
Indapamide
Cinacalcet
Aspirin
inhibitor
Cholecalciferol
Clopidogrel
HydrochloroLisinopril
thiazide
Perindopril
Statins
Erythropoietin agonists
Ramipril
Atorvastatin
Epoetin alfa
Others
ARB angiotensin
Pravastatin
Epoetin beta
Isosorbide
receptor blockers
Rosuvastatin
Darbepoetin alfa
mononitrate
Irbesartan
Simvastatin
Methoxy Polyethylene
Glyceryl trinitrate
Candesartan
Glycol Epoetin Beta
Provide Consumer Medicine Information. Management of associated emergency: consult MO
Schedule
Renal medicines
Uncontrolled
Controlled copy
copy
V 1.0
363
Chronic diseases
5. Follow up
Complete CKD care plan according to current edition Chronic Disease Guidelines
6. Referral / consultation
According to care items on chronic kidney disease care plan
Check and complete care items on chronic heart disease care plan
4. Management
Prior to supply of medicines discuss with patient any medicine allergies and any
problems patient has taking medicines
Supply medicine according to MO / NP order
DTP
IHW
Authorised Indigenous Health Worker supply on MO / NP instruction if less than 6 months since last
medical consultation
Route of
Recommended
Form
Strength
Duration
administration
dosage
Tablet /
As ordered by
As ordered by
As ordered by
Oral
Capsule
MO / NP
MO / NP
MO / NP
Beta-Blockers
ACEI
Calcium Blockers
Statins
angiotensin converting
Atenolol
Atorvastatin
Amlodipine
enzyme
inhibitor
Bisoprolol
Diltiazem
Pravastatin
Lisinopril
Carvedilol
Nifedipine
Rosuvastatin
Perindopril
Metoprolol
Verapamil
Simvastatin
Ramipril
Propranolol
Nebivolol
Fibrates
Diuretics
ARB angiotensin receptor Frusemide
Gemfibrozil
blockers
Antiarrythmics
Ethacrynic acid
Fenofibrate
Irbesartan
Digoxin
Bumetanide
Candesartan
Amiodarone
Others
Spironolactone
Platelet
Inhibitors
Sotalol
Ezetimibe
Aspirin
Flecainide
Isosorbide mononitrate
Clopidogrel
Glyceryl trinitrate
Ticagrelor
Rivaroxaban
Schedule
3 and 4
Cardiac medicines
Uncontrolled
Controlled copy
copy
V1.0
Chronic diseases
5.
Follow up
6.
Referral / consultation
According to care plan items on CHD care plan
Related topics
1.
2.
3.
4.
Hypoglycaemia
Diabetes in pregnancy
Infection in the foot of patient with diabetes
Osteomyelitis in the foot of patient with diabetes
Diabetic ketoacidosis (DKA)
Immediate management
Clinical assessment
Check and complete care items on diabetes / diabetes in pregnancy / high risk
foot care plan(s)
Management
Prior to supply of medicines discuss with patient any medicine allergies and any
problems patient has taking medicines
Supply medicine according to MO / NP order
DTP
IHW
Authorised Indigenous Health Worker supply on MO / NP instruction if less than 6 months since last
medical consultation
Route of
Recommended
Form
Strength
Duration
administration
dosage
As ordered by
As ordered by
As ordered by
Tablet / injection
Oral / subcutaneous
MO / NP
MO / NP
MO / NP
Metformin or
Glibenclamide
Gliclazide or
Metformin ER
Gliclazide MR
Pioglitazone
Sitagliptin
Glimepiride
Glipizide
Linagliptin
Liraglutide
Exenatide
Schedule
Diabetic medicines
Uncontrolled
Controlled copy
copy
V 1.0
365
Chronic diseases
DTP
IHW
Authorised Indigenous Health Worker supply on MO / NP instruction if less than 6 months since last
medical consultation
Route of
Recommended
Form
Strength
Duration
administration
dosage
As ordered by
As ordered by
As ordered by
Injection
Subcutaneous
MO / NP
MO / NP
MO / NP
Short acting
Long acting
Insulin Glulisine (Apidra)
Insulin Glargine (Lantus)
Insulin Aspart (Novorapid)
Insulin Determir (Levemirv)
Insulin Isophane (Protaphane)
Lispro (Humalog)
Schedule
Insulin
Mixture
Insulin neutral 30% / isophane 70% (Mixtard 30 / 70)
Insulin aspart 30 % / aspart protamine 70% (Novomix 30)
Insulin lispro 25% / lispro protamine 75% (Humalog Mix 25)
Insulin lispro 50% / lispro protamine 50% (Humalog Mix 50/50 )
Provide Consumer Medicine Information
Management of associated emergency: See Hypoglycaemia
5. Follow up
6. Referral / consultation
According to care items on diabetes / diabetes in pregnancy / high risk foot care
plan(s)
Uncontrolled
Controlled copy
copy
V1.0
Section 4
Mental health
and
substance misuse
Section 4
Mental health and substance misuse
Contents
Mental health presentation, history and assessment
Mental state examinations
Risk screening tool
Suicide risk assessment guide
Suicidal behaviour and risk
Mental health behavioural emergencies
Delirium
Dementia
Psychotic disorders
Mood disorders
Eating disorders
Sleep probems
Alcohol misuse
Acute alcohol intoxication
Alcohol withdrawal
Smoking
Drugs and other substances
368
Uncontrolled
Controlled copy
copy
V1.0
ollow the same procedure as for a patient presenting with a physical problem
F
and include a mental health history, performing a Mental State Examination
(MSE) and the individual level of risk
Consider the culture of the patient you are assessing
Always ensure the safety of yourself, the patient and others
All mental health assessments must conclude with a mental health management
plan, clearly identifying the immediate interventions that reflect the assessment
findings
Consult MO / Mental Health Practitioner / Psychiatrist at any time
At all times promote the safety of the patient, yourself and others by providing a
safe environment and considering the safety of others for whom the patient has
care responsibilities e.g. children, elderly and other vulnerable people
Select a safe environment for assessment / interview / discussion
Remain calm, quiet and non-threatening [2]
Remember the patient may be experiencing extreme fear from internal threats,
provide reassurance
Explain who you are and what you are doing
Uncontrolled
Controlled copy
copy
V 1.0
369
Identify any children (0 - 18 years) for whom the patient has care responsibilities
Consider the impact of the patients mental illness on their ability to safely care
for children, if applicable
Involve the family and significant others, including Aboriginal and Torres Strait
Islander Health Workers in assessment and management
Be supportive and listen to the patient
Use of ongoing therapeutic relationship with the patient is optimal [2]
Work in pairs if possible
370
Uncontrolled
Controlled copy
copy
V1.0
Cultural considerations
Cultural factors may have a significant bearing on the patients state of mind e.g.
sorcery, having been sung or boned, puri puri, or transgressions of cultural law
and subsequent fear of punishment may present as anxiety, depression or psychosis
E
ccentric behaviour is often tolerated in Aboriginal and Torres Strait Islander
communities so people with mental illness will often present later when more
obvious signs become apparent or the family reports a change in usual behaviour
C
o-morbidity with substance use disorders is common
H
istory from family members and advice from Aboriginal and Torres Strait
Islander Health Workers is extremely important
Consider involvement of interpreters (including telephone) and / or Mental Health
or Transcultural Mental Health Workers for culturally and linguistically diverse
populations
Use Aboriginal and Torres Strait Islander Cultural Information Gathering Tool
available at http://qheps.health.qld.gov.au/mentalhealth/docs/atsi-cultural-info.pdf
Uncontrolled
Controlled copy
copy
V 1.0
371
It is important for all health staff to be able to use the same terminology when
discussing diagnosis and management
An MSE should be used for patients who present during any mental health
presentation
Severity of symptoms may not be apparent unless identified in a structured way
Included with the MSE and the mental health history is the risk screen that
identifies level of risk for suicide, self harm, vulnerability and violence
The MSE involves making observations and asking questions under headings,
including appearance, behaviour, speech, mood and affect, perception, thought,
judgement, insight and cognition See MSE observations and questions
372
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
373
Suicide attempt or
suicidal thoughts
Intentionality
lethality
access to means
previous suicide
attempt(s)
Substance use
Current misuse of
alcohol and other drugs
Corroborative history
Family carers
medical records
other service providers /
sources
High risk
Severe depression
Medium risk
Moderate depression
some sadness
Command hallucinations
or delusions about dying Some symptoms of
psychosis
Pre-occupied with
hopelessness,
Some feelings of
despair, feelings of
hopelessness
worthlessness
Moderate anger, hostility
Severe anger, hostility
Continual / specific
Frequent thoughts
thoughts
Evidence of clear
multiple attempts of low
intention
lethality
An attempt with high
repeated threats
lethality (ever)
Current substance
intoxication, abuse or
dependence
Unable to access
information, unable to
verify information or
there is a conflicting
account of events to that
of those of the patient
at risk
Patient is refusing help
Risk of substance
intoxication, abuse or
dependence
Access to some
information
Some doubts to
plausability of patient's
account of events
Low risk
Nil or mild depression,
sadness
No psychotic symptoms
feels hopeful about
the future
No / mild anger, hostility
Strengths and
Patient is ambivalent
Patient is accepting of
supports (coping and
moderate
help
connectedness)
Lack of supportive
connectedness
Therapeutic alliance
Expressed
relationships / hostile
few relationships
forming
communication
relationships
Highly connected /
availability of supports
Available but unwilling
good relationships and
willingness / capacity to Not available or unwilling / unable to help
supports
support patient(s)
/ unable to help
consistently
safety of patient and
Consistently willing and
others
able to help
Reflective practice
Low assessment
High assessment
Level and quality
confidence or high
confidence / low
of engagement
changeability or
changeability
changeability of risk
no rapport, poor
level
engagement
Good rapport,
assessment confidence
engagement
in risk level
No (foreseeable) risk: following comprehensive suicide risk assessment, there is no evidence of current
risk to the patient. No thought of suicide or history of attempts and has a good social support network
374
Uncontrolled
Controlled copy
copy
V1.0
On completion of mental health history and assessment, take action based on the
level of risk identified
Action:
Low risk - document and ensure mental health practitioner informed. If patient
is intent on leaving ensure a follow up plan is in place
Medium risk - encourage patient to stay. Contact Mental Health Practitioner or
MO immediately. If unavailable call Psychiatrist
High risk - encourage patient to stay. Urgent contact with Mental Health
Practitioner / MO / Psychiatrist and if necessary, with their support, utilise Mental
Health Act 2000. If unable to contact Mental Health Practitioner / MO / Psychiatrist
and patient leaves, inform police with suggestion that an Emergency Examination
Order may be necessary.
Continue to attempt contact with Mental Health Practitioner / MO / Psychiatrist
Resources
Protocols for the delivery of social emotional wellbeing and mental health services
in Aboriginal and Torres Strait Islander communities [1]
Activate: mind and body www.activatemindandbody.com.au
National standards for mental health services available at
www.health.gov.au/internet/publications/publishing.nsf/Content/mental-pubs-n-servst10-toc
Mental Health Alcohol and Other Drugs Directorate - Statewide Mental Health forms
available at http://qheps.health.qld.gov.au/mentalhealth/clinical_docs.htm
MSE training is available online from Queensland Centre for Mental Health Learning
www.health.qld.gov.au/qcmhl/mhworkforce.asp
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
375
376
ttempted suicide
A
Unexplained injury or physical signs and self harm is suspected
Verbalises suicidal ideas / suicidal intent
Depressive symptoms
Anxiety symptoms
Psychotic symptoms / illness (especially patients who are agitated / distressed or
experiencing command auditory hallucinations)
Organic brain syndrome or acute confusional state
Chronic medical illness, especially when this is associated with severe pain
Distress associated with a recent psychosocial stressor or loss e.g. bereavement,
marital separation, relationship breakdown, loss of job
Give particular consideration to patients in high risk groups, including:
-- young males < 25 years
-- older males > 65 years
-- people with depression or schizophrenia
-- substance abuse
-- people who are widowed / recently separated / have experienced a relationship
break-up
-- Aboriginal and Torres Strait Islander peoples
Uncontrolled
Controlled copy
copy
V1.0
Considerations for assessing self harm in Aboriginal and / or Torres Strait Islander
peoples when alcohol is involved
When considering risk factors when working with Aboriginal and Torres Strait
Islander peoples, the following factors need to be considered:
-- social precipitants such as recent events even if they appear trivial
-- recent self harm episodes or behaviour that has occurred by others in
the community
When alcohol is a current factor with threatened or attempted self harm consider
the following:
-- set a high criterion for accepting that the situation is safe
-- situations involving intoxication and / or impulsivity are usually not safe
-- liaise early with a Psychiatrist
-- prevent further drinking and keep the patient engaged or supervised until
the situation is clarified
-- reassure and observe in a safe environment
-- communicate clearly with relatives and local staff
-- use medicines with clear indications
-- ensure active follow up [13]
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
4. Management
ased on the findings from the mental health history and assessment is the
B
patient low, medium or high risk for suicide?
Consult MO / Life Promotion Officer / Mental Health Worker (including Transcultural
Mental Health Worker if relevant and available). MO will discuss with Psychiatrist
Stabilise any medical condition. Manage airway and cervical spine in patients
who have attempted suicide by hanging
See Acute upper airway obstruction and choking and Spinal injuries
Uncontrolled
Controlled copy
copy
V 1.0
377
I n consultation with MO, patient and support people, determine the most
appropriate and available management setting
The management process must be planned, coordinated and documented
Utilisation of the provisions of the Mental Health Act (2000) (or relevant Act if
outside Queensland) may be required
Carers and / or families of the patient should be contacted and provided with clear
and concise information regarding the involuntary provisions of the Mental Health
Act (2000)
Refer to local protocols which should specify lines of responsibility and provide
access to senior clinicians
Ongoing management is to support the safety of the patient while the underlying
mental health problem is treated
Reassess
5. Follow up
Discuss follow up plan with MO / Psychiatrist
Criteria for considering whether a patient with suicidal behaviour / ideation should
go home:
-- acute problems identified, addressed and resolved
-- patient no longer feels suicidal
-- patient agrees to seek help if suicidal ideas recur
-- patient is not demented, intoxicated, sedated, delirious or psychotic
-- patient does not have access to lethal means such as firearms or medicines
-- follow up arrangements have been documented with a copy given to the
patient and support(s) have been mobilised
-- treatment has been arranged for any current mental health problems
-- family / supports understand and agree with management plan
If a suicide attempt has been made, a mental health history and assessment,
general medical assessment, MSE, suicide risk assessment and risk management
plan must be made before discharge by a trained Mental Health Practitioner / MO
/ Psychiatrist
6. Referral / consultation
378
referral to mental health or medical services and should not be left alone until
help arrives
Involuntary admission under the provisions of the Mental Health Act (2000) (or
relevant Act if outside Queensland) may be required if the patient demonstrates
risk to self or others See Mental health behavioural emergencies. The rationale
and decision to transfer / hospitalise a patient should be made on clinical grounds
with involvement of the patient and family
Patients identified as medium to high risk following assessment should have
follow up contact within 24 hours with a relevant mental health care provider.
Follow up should be linked to the risk assessment
Where appointments are not kept, assertive follow up must be undertaken.
Information covering 24 hour access and support options must be given to all
patients being managed in the community
Contingency planning requires the clinician and the patient at risk and / or family
/ carer to anticipate likely escalations of risk such as:
-- deterioration of family relationships
-- increase in symptoms
-- temporary unavailability of the clinician
Management in the community is not appropriate when suicide risk escalates
beyond the available level of care, support from the health service and family and
social supports
Uncontrolled
Controlled copy
copy
V1.0
Confusion, delirium
Withdrawn behaviour e.g. refusing to talk or eat
Strange behaviour e.g. talking to people who are not there, unable to stand still,
awake all night, inappropriate anger or sadness, becoming suspicious of people
or things in surroundings
Suicidal ideation or attempt (past or current)
Deliberate self harm
Uncontrolled
Controlled copy
copy
V 1.0
379
2. Immediate management
nsure safety of patient presenting, self and others, particularly children (from
E
conception to 18 years)
-- see patient in safe environment, have an exit
-- if the patient is a risk to safety, enlist the help of police or others, have them
visibly close by, but not to frighten or intimidate the patient
-- terminate an interview if you are feeling frightened, do not be brave
-- do not approach if patient has a weapon
-- do not be in a position where you could be trapped by the patient
Explain what is happening at all times. Reassure the patient and avoid
confrontation
Consult MO / Psychiatrist as early as possible
3. Clinical assessment
4. Management
380
Uncontrolled
Controlled copy
copy
V1.0
Medication considerations:
-- oral medicine - attempt to persuade the patient to take oral medicine. A
patient may agree to medicines if they are told the benefits of taking the
medicine e.g. clear some of their disturbing thoughts / remove some of
their distress
--
intramuscular medicines - if the patient is highly agitated / aroused and
disturbed and physical intervention is required, intramuscular medicine is first
choice - discuss with MO
-- intravenous sedation is occasionally necessary, but has greater risk of serious
side effects e.g. cardiorespiratory depression and cardiac arrhythmias, and
must only be done when full resuscitation equipment is available
-- oral antipsychotic and benzodiazepine combination may be needed to provide
sufficient sedation - combining an antipsychotic and benzodiazepine is safer
than giving a high dose of just one of these medicines
-- care must be taken with patients who present intoxicated. There is a risk of
respiratory depression if benzodiazepines are administered. A small dose of
antipsychotic medicine is often preferable
-- reduced medicine doses to be used in the elderly or in those who are
dehydrated, intoxicated, medically compromised or who have not had an
antipsychotic medicine previously
-- dystonia - acute tonic muscle spasms, often of the tongue, jaw, eyes and
neck, but sometimes of the whole body. Sometimes occurs during the first
few days of antipsychotic medicine administration
Acutely disturbed or heavily sedated patients must not be left alone and should
be regularly observed [5]
-- if awake observe patient every 15 minutes for 1 hour, then every 30 minutes
for 2 hours or until evacuated. Include standard clinical observations +
GCS
sedation score
O2 saturations
-- if asleep observe patient every 5 minutes for 30 minutes, then every 15
minutes for 30 minutes, then every 30 minutes for 1 hour, then hourly for the
next 4 hours or until evacuated. Include standard clinical observations +
GCS
sedation score
O2 saturations
Management of agitation / arousal [5]
-- consult MO
-- never use lorazepam and olanzapine (intramuscular) simultaneously
and never within 1 hour of each other
-- no sedation protocol is 100% safe. Sedation is used when de-escalation fails.
Confirm no other medical cause of patients altered mental state
-- benzodiazepines are the recommended first line treatment for this group of
patients
-- frequent adequate monitoring of the sedated patient is essential. Patients
should be placed in recovery position, apply O2, observe and record vital
signs regularly
-- aim for rousable drowsiness - sleepy when undisturbed but rousable and
cooperative to voice or pain
Uncontrolled
Controlled copy
copy
V 1.0
381
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse must consult MO / NP unless
circumstances do not allow, in which case notify the MO / NP as soon as circumstances allow
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult only
1 mg
Tablet
1 mg
Oral
Do not exceed 8 mg
Stat
total in 24 hours (by any
route)
Provide Consumer Medicine Information: causes sedation and respiratory depression
Management of associated emergency: consult MO
[6] [4]
Schedule
382
Lorazepam
Uncontrolled
Controlled copy
copy
V1.0
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse must consult MO / NP unless
circumstances do not allow, in which case notify the MO / NP as soon as circumstances allow
Route of
Form
Strength
Recommended dosage
Duration
administration
2.5 mg
Stat
Tablet
5 mg
Adult only
Further doses on MO
10 mg
/ NP order. With order
5 - 10 mg
Oral
to max. of
may repeat 2 - 4 hours
5 mg
Wafer
20 mg / 24 hours
according to
10 mg
clinical response
Provide Consumer Medicine Information: can cause postural hypotension and sedation
Management of associated emergency: consult MO
[6] [4]
Schedule
Olanzapine
Uncontrolled
Controlled copy
copy
V 1.0
383
Consult MO if:
-- O2 saturations < 93% adult / < 95% child and does not increase to at least 96%
with application of O2
-- HR < 50 bpm or > 120 bpm
-- BP < 90 / 60 or > 170 / 90 mmHg
-- GCS < 12
If dystonic side effects occur give benztropine
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Tablet
2 mg
Benztropine
Oral
Adult
IM preferable if
2 mg to a max. of
Ampoule
2 mg / 2 mL
symptoms are
4 mg in 24 hours
distressing
Provide Consumer Medicine Information: can be sedating
Management of associated emergency: consult MO
Stat
Further doses on
MO / NP order
[6]
5. Follow up
If a patient has required sedation and is not evacuated consider the following:
-- u
nderlying mental disorders (dementia, delirium, psychosis, depression) and
the impact of these on patient capacity / safety at home
-- intoxicated patient should not be considered safe until they are sober
If not evacuated / hospitalised, follow local protocols or MO instructions for
observation and management
Consider the immediate safety needs of any children for whom the patient has
care responsibilities. Protocol for considering and responding to the needs of
children for whom a person with a mental illness has care responsibilities is
available at: http://www.health.qld.gov.au/directives/docs/ptl/qh-hsdptl-029-5.pdf
Provide patient and family / carer with copy of management plan
6. Referral / consultation
Follow MO instructions for this presentation
Arrange comprehensive mental health assessment
384
Uncontrolled
Controlled copy
copy
V1.0
Evacuation by air
A
patient may need to be evacuated to the nearest Authorised Mental Health
Service (AMHS) either with their consent or under the provision of the Mental
Health Act 2000
I f the patient is to be evacuated by the RFDS, there needs to be reliable IV access
and they will need to be sedated and physically restrained using RFDS wrist and
ankle restraints. Keep patient nil by mouth
I t is suggested that explanation and gentle persuasion be used to ensure a
patient understands the need for sedation and physical restraint, i.e. the patient
may agree to physical restraints if they are assured they will be removed as
soon as the aircraft is safely landed
N
ight flights are to be avoided if possible because of the known disorientating
effect on people and the limited landing options if a problem develops in flight
Consider safety and care arrangements for dependent children (if relevant)
Mental Health Act 2000
If the patient requires evacuation / hospitalisation to an appropriate facility and does not consent, the
relevant Mental Health Act forms need to be completed to permit involuntary assessment, as follows:
Request for Assessment
This form can be completed by any adult (not employee or relative of person making Recommendation for
Assessment), and
Recommendation for Assessment
This form can be completed by any doctor or Authorised Mental Health Practitioner (these are specifically
designated Mental Health Workers). When there is no local MO the evacuating MO can complete this form.
Once these two forms are completed the patient can be taken to the AMHS and the assessment process
begins. If no MO or Authorised Mental Health Practitioner is present it is likely that the Recommendation
for Assessment form will not be completed.
In non urgent cases a person may apply to a Magistrate or Justice of the Peace for a
Justice Examination Order.
This allows an Authorised MO to go to where the patient is located in order to conduct an examination to
determine if a Recommendation for Assessment form is required.
Available at: www.health.qld.gov.au/mha2000/jeo.asp
Emergency Examination Order
In urgent cases this form can be completed by a Police Officer, Ambulance Officer or Psychiatrist. This
authorises a patient to be taken to an AMHS for an assessment which must take place within six hours of
arriving at the AMHS. In the absence of an available AMHS, the local Department of Emergency Medicine
becomes an AMHS for the purpose of assessment.
Request for Police Assistance
If required, this third form is used when requesting police assistance in any circumstances. Generally a
health staff member will accompany the patient during transfer.
If the patient is already being treated under a Community Involuntary Treatment Order (ITO), the treating
Psychiatric Registrar or Psychiatrist should be contacted. After hours, contact the on-call Psychiatric
Registrar or Psychiatrist at the appropriate Authorised Mental Health Service. Immediate return of the
patient to the AMHS with the assistance of the police can be arranged. If an inpatient admission is required,
a change of ITO category to inpatient must be completed.
Uncontrolled
Controlled copy
copy
V 1.0
385
Delirium
2. Immediate management
3. Clinical assessment
386
Uncontrolled
Controlled copy
copy
V1.0
Delirium
4. Management
5. Follow up
As per MO instructions and medical cause of delirium
6. Referral / consultation
Consult MO on all occasions of suspected delirium as delirium is a medical
Uncontrolled
Controlled copy
copy
V 1.0
387
Dementia
Dementia adult
Recommend
Consult with and involve the patients family / carers, GP and health support services
Utilise non-pharmacological strategies as a first-line measure to manage the
symptoms of dementia, including environmental, behavioural and social strategies
Refer to current edition of Chronic Disease Guidelines available at
www.health.qld.gov.au/cdg/docs/cdg_demen_gdline.pdf
Related topics
Delirium
History and physical examination - adult
2. Immediate management
3. Clinical assessment
388
Uncontrolled
Controlled copy
copy
V1.0
Dementia
4. Management
5. Follow up
ccording to MO instructions
A
Prepare a management plan with family and carer
Offer ongoing support and encouragement to patient and carer(s)
Monitor compliance with medical treatment
Continue to promote the preventative environmental and clinical practice
strategies to slow progression of dementia
Monitor safety, vulnerability and future care needs e.g. driving and elder abuse
6. Referral / consultation
Resources
All tools available through Statewide Dementia Clinical Network website
http://qheps.health.qld.gov.au/psq/networks/dementia.htm
Alzheimer's Australia www.fightdementia.org.au/
Commonwealth Department of Health and Ageing www.health.gov.au/dementia
National Dementia Hotline 1800 100 500
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
389
Psychotic disorders
ositive signs and symptoms (signs and symptoms in addition to what the patient
P
normally has):
-- delusions
-- hallucinations
-- disorganised thought and speech
-- disorganised behaviour
Negative signs and symptoms (signs and symptoms that have been taken away
from what the patient normally has):
-- social withdrawal and isolating self
-- flattened affect
-- restricted speech fluency
-- lack of drive. This needs to be differentiated from major depression by a
mental health professional
Family member may seek help because of strange, disruptive or frightening
behaviour by one of their family
First presentation - often late adolescence to mid thirties but can be at any time
Irritability and a lower threshold for anger
Suicidal thoughts or behaviours
Elevated or depressed mood
2. Immediate management
3. Clinical assessment
390
Uncontrolled
Controlled copy
copy
V1.0
Psychotic disorders
4. Management
5. Follow up
As per MO instructions
Psycho-education
Family support and education
6. Referral / consultation
C
onsult MO as above
Refer to Mental health services:
-- i f psychosis is suspected
-- if there is a significant risk of suicide or danger to others, psychotic symptoms
or severe agitation
If alcohol or drug use is also a problem, referral to ATODS with patient consent
Consider referral to community agencies in all other cases where symptoms
persist and / or where the patient has a poor or non existent support network
Uncontrolled
Controlled copy
copy
V 1.0
391
Mood disorders
392
Mood disorders
2. Immediate management
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
393
Mood disorders
-- utilise serial rating scales, e.g. Beck depression inventory available at:
http://www.cawt.com/Site/11/Documents/Members/EvaluationBeckDepression
Inventory1.pdf or Hamilton depression rating scale, available at:
http://www.psy-world.com/online_hamd.htm to provide objective information
regarding progress [10]
-- in the case of perinatal depression, potential for harm to the fetus or the
breastfed infant must be carefully balanced with the harm to mother and
infant if the mother remains untreated. Medicines should only be prescribed
with the input of the woman and her significant others [9]
Hypericum perforata (St Johns Wort, available from health food stores) is often
taken for milder symptoms of depression, both acute and chronic. It should not
be combined with other antidepressants and caution may be needed with diet.
Interactions with other prescribed medicine may also occur
Patients taking such preparations should be warned of the possibility of serious
interactions with antidepressants and other medicines and advised to discuss
its continuing use with an MO
5. Follow up
According to MO instructions
Monitor medication compliance and risk
After improvement, make contingency plans with the patient if signs of relapse
occur
O
ffer ongoing support and encouragement
Ensure observance with medicine(s)
Encourage use of psychological therapies
6. Referral / consultation
Consider referral to Mental Health Services if:
394
Uncontrolled
Controlled copy
copy
V1.0
Mood disorders
2. Immediate management
3. Clinical assessment
4. Management
5. Follow up
As per MO instructions
6. Referral / consultation
C
onsult MO as above
Refer to Mental Health Services if:
-- m
ania is suspected
-- there is a significant risk of self-harm, suicide or danger to others, psychotic
symptoms or severe agitation
Uncontrolled
Controlled copy
copy
V 1.0
395
Mood disorders
396
Uncontrolled
Controlled copy
copy
V1.0
Mood disorders
2. Immediate management
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
397
Mood disorders
5. Follow up
According to MO instructions
Offer ongoing support and encouragement
Encourage use of psychological therapies
6. Referral / consultation
Consult MO as above
Non-urgent referral to Mental Health Services is advised if the patients symptoms
398
Uncontrolled
Controlled copy
copy
V1.0
Eating disorders
Note: Due to the mortality and morbidity associated with anorexia nervosa, the information
in this section relates mainly to patients with or at risk of anorexia
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
Uncontrolled
Controlled copy
copy
V 1.0
399
Eating disorders
-----------
3. Clinical assessment
4. Management
Acute presentation for adult / adolescent See Immediate management
Consult MO who will arrange evacuation / transfer to regional psychiatric facility
If possible to obtain IV access insert IV cannula
Take bloods for electrolytes (if possible)
Prepare the patient for transfer
Ongoing management for adult / adolescent
Regular monitoring of BP, HR, weight, electrolytes, nutritional intake, ECG and BMI
Review by local Mental Health Service / Psychiatrist for treatment of mental health
problems and monitoring of suicide risk
Monitor nutritional intake and exercise
Monitor vomiting and use of laxatives, stimulants and diuretics
Gain information from family members where possible
Review by Dietitian if available
400
Uncontrolled
Controlled copy
copy
V1.0
Sleep problems
5. Follow up
According to management plan with family and carer (as appropriate) with visiting
6. Referral / consultation
Uncontrolled
Controlled copy
copy
V 1.0
401
Sleep problems
3. Clinical assessment
4. Management
5. Follow up
O
ffer ongoing support and encouragement
Encourage the use of relaxation techniques. May need to advocate to local
6. Referral / consultation
Consult MO
Consider referral to a sleep laboratory (if available) if more complex sleep disorders
402
Uncontrolled
Controlled copy
copy
V1.0
Alcohol misuse
Alcohol withdrawal
Alcohol related epigastric pain
Fits / convulsions / seizures
Immunisation program
2. Immediate management
Uncontrolled
Controlled copy
copy
V 1.0
403
Alcohol misuse
3. Clinical assessment
404
btain a full patient history including medication history, alcohol and drug use
O
Perform standard clinical observations + BGL
-- conscious state See Glasgow coma scale / AVPU
-- confusion, eye signs (paralysis of extra-occular muscles), walking abnormality
and poor nutrition (signs of Wernicke's encephalopathy)
Physical examination for injury:
-- MO may order pathology to check for alcohol related disease processes
Assess harmful or hazardous levels of drinking (frequency, quantity)
Assess alcohol dependence. Key features include:
-- strong desire or compulsion to use alcohol, loss of control over ones drinking
behaviour
-- difficulty controlling alcohol use
-- withdrawal (anxiety, tremors, sweating) when drinking is ceased
-- tolerance e.g. drinks large amounts of alcohol without appearing intoxicated
-- continued alcohol use despite harmful consequences
-- relief of withdrawal symptoms by drinking
-- useful resource / tool such as AUDIT-C questionnaire is available at:
www.racgp.org.au/download/Documents/Guidelines/Redbook8/redbook8.pdf
or Queensland Alcohol and Drug Withdrawal Clinical Practice Guidelines
available at http://qheps.health.qld.gov.au/schsd/docs/clin/qh_detox_guide.pdf
Assess patient's readiness to change their drinking behaviour:
-- pre-contemplation - not concerned about drinking
-- contemplation - actively thinking about change
-- planning to change - concerned about drinking / ready for change
-- action - carrying out lifestyle change / drinking behaviour
-- maintenance - maintaining the change over a long time
-- relapse - returned to previous drinking or dropped the new healthy behaviour.
This is a normal part of the change process
Uncontrolled
Controlled copy
copy
V1.0
Alcohol misuse
4. Management
Low risk drinking i.e. not dependent on alcohol, below safe limits for quantity and
frequency
Encourage to maintain sensible habits, simple education about the effects of
alcohol and safe limits
Moderate risk i.e. hazardous amounts or frequency but not dependent
Advise to cut down
Give information about safe levels
Give brief intervention
Quantify the patient's alcohol consumption:
-- explain where this fits in relation to safe, hazardous and harmful drinking levels
--
link existing alcohol-related problems to drinking
--
begin to explore whether the patient is contemplating change
-- if they are, provide information and suggestions for change appropriate to
circumstances. If they are not, in a non-judgemental manner note concern,
acknowledge the patients decision and encourage follow up of the presenting
issue
High risk drinking behaviour (harmful drinking)
It is likely that the patient's drinking is harmful to their health and / or lifestyle,
that they have a drinking problem, physical dependency on alcohol is likely, and
detoxification is required
Give information on strategies on how to cut down to safe drinking levels
See Tips for patients to cut down to safe drinking levels
Refer to specialist services such as ATODS for assessment (preferably conducted
whilst the patient is in hospital) and counselling
Uncontrolled
Controlled copy
copy
V 1.0
405
Alcohol misuse
406
Uncontrolled
Controlled copy
copy
V1.0
Alcohol misuse
5. Follow up
The assessment and management of alcohol misuse usually occurs over time.
6. Referral / consultation
Consult MO as above and consider referral to / for:
Resources
Queensland Alcohol and Drug Withdrawal Clinical Practice Guidelines available at
http://qheps.health.qld.gov.au/schsd/docs/clin/qh_detox_guide.pdf
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
407
Alcohol misuse
Alcohol withdrawal
Fits / convulsions / seizures
Mental health behavioural emergencies
Alcohol misuse
Head injury
Mental health presentation, history
and assessment
408
Alcohol misuse
Intoxication and chronic abuse of alcohol increases the frequency and severity
of injury
Never assume that an alteration in a patients level of consciousness is due to
intoxication alone
Always re-examine a patient when sober
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
3. Clinical assessment
4. Management
onsult MO if:
C
-- GCS < 14, abnormal observations or BGL or any significant other findings
-- diazepam may be required to prevent acute withdrawal after discharging home
-- patient is assessed as being at risk to themselves or others
If signs and symptoms of Wernickes encephalopathy present or patient has
suspected or is at high risk of Wernicke's encephalopathy MO will order IM or IV
thiamine tds for at least 3 days. This is a vitamin emergency
Commence ongoing oral thiamine at least 100 mg tds [15]
An intoxicated patient should not be left alone
Regularly assess vital signs and GCS until either the patient sobers up or patient
is evacuated / hospitalised. Always act on a GCS below 14 and one that is falling
5. Follow up
If chronic alcohol misuse commence patient on oral thiamine 100 mg tds. Giving
thiamine in divided doses tds is very important and not as a daily dose
Be aware of the potential over the following days to develop withdrawal symptoms
in a heavy drinker who ceases drinking abruptly See Alcohol withdrawal
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
409
Alcohol misuse
6. Referral / consultation
C
onsult MO as per management
Consider referral to ATODS:
410
Uncontrolled
Controlled copy
copy
V1.0
Alcohol misuse
Recommend
Treat any alcohol dependent patient presenting in a state of established withdrawal
as a potential medical emergency. Delirium tremens (DTs) is a medical emergency
with a significant mortality rate if not treated appropriately
Wernickes encephalopathy is a vitamin emergency
-- all patients with suspected Wernicke's encephalopathy require IM or IV infusion of
thiamine 200 mg tds for at least 3 days, in conjunction with oral thiamine 100 mg tds
-- patients at high risk of Wernicke's encephalopathy require IM or IV infusion of
thiamine 200 mg daily for at least 3 days, in conjunction with oral thiamine at
least 100 mg tds
-- MO will order IV / IM thiamine [14]
Children and youth should be managed with a Specialist
Conduct a rapid assessment including past and recent history, particularly relating to
past withdrawals, DT, seizures and other medical conditions
Background
The course of withdrawal depends on:
-- the severity of dependence
-- illnesses such as physical and mental health disorders
-- psychological factors e.g. the physical environment, fears and expectations [14]
Related topics
Alcohol misuse
Glasgow coma scale / AVPU
ariable symptoms depending on degree of dependence and time since last drink
V
Mild withdrawal [14]
-- tremor, nausea
-- high pulse rate
-- high blood pressure
-- raised temperature
-- anxiety, agitation / restlessness
-- insomnia
Severe withdrawal [14]
-- seizures may occur (usually within the first 48 hours of cessation of drinking)
-- delirium tremens usually develops 2 - 5 days after stopping or significantly
reducing alcohol consumption. The usual course is 3 days but it can be up to
14 days. Its clinical features are:
confusion and disorientation, extreme agitation or restlessness - the
patient often requires restraining
gross tremor
autonomic instability (e.g. fluctuation in BP or pulse), disturbance of fluid
balance and electrolytes, raised temperature
severe hyperactivity, severe tremor, severe agitation
paranoid ideation, typically of delusional intensity
distractibility and accentuated response to external stimuli
hallucinations affecting any of the senses, but typically visual (highly
coloured, animal form)
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
Fits / convulsions / seizures
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
411
Alcohol misuse
T
he immediate aim is to modify the withdrawal and increase the safety of the
patient over the next 3 to 4 days
There is no simple way of predicting whether a withdrawal will be serious or
straightforward
I f confused or withdrawn, strange, aggressive or acutely disturbed behaviour:
-- ensure the safety of the patient, yourself and others
-- do not approach the patient if they have a weapon and dont put yourself in a
position where you could be trapped by patient
-- explain what is happening at all times, the patient may be frightened. Reassure
the patient and avoid confrontation
-- the patient may be in a hyper stimulated state. Attend to the patient in a quiet
room with low light, in the company of a familiar person, friend or relative
-- if restraint is required consult MO
-- for additional information See Managing anger
3. Clinical assessment
btain a full patient history including past episodes, amount, type and duration of
O
alcohol and any drug and / or medicine intake, nutrition intake
Document when last drink consumed
Check for withdrawal from other sedatives (similar presentation) e.g.
benzodiazepines and intoxication with stimulants e.g. amphetamines
Take standard clinical observations + note in particular:
-- elevated HR, BP, or temperature, O2 saturation, BGL
-- conscious state See Glasgow coma scale / AVPU
-- confusion, eye signs (paralysis of extra-occular muscles), walking abnormality
and poor nutrition (signs of Wernicke's encephalopathy)
Alcohol withdrawal scale - Clinical Institute Withdrawal Assessment (CIWA-Ar)
or Alcohol Withdrawal Scale (AWS) available from Queensland Alcohol and Drug
Withdrawal Clinical Practice Guidelines
http://qheps.health.qld.gov.au/schsd/docs/clin/qh_detox_guide.pdf
Observe outstretched hands for tremor
Expose and examine the patient systematically starting at the head and progressing
downwards to the toes. Do not let the patient get cold, maintain privacy and cover
with a blanket. Look and feel for any abnormalities / signs of injury
4. Management
412
Uncontrolled
Controlled copy
copy
V1.0
Alcohol misuse
onitor clinical observations hourly and Glasgow coma scale until the patient
M
recovers or patient is evacuated / hospitalised
Always act on Glasgow coma scale < 14 or falling Glasgow coma scale
Diazepam is the sedative of choice for alcohol withdrawal [14]. Consult MO if
medically compromised. Underlying disease or infection should be attended to
If patient is fitting, has delusions or having hallucinations give diazepam IV.
Administer with ready access to emergency equipment
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Stat
2 mg
Adult
Tablet
Oral
Further doses
5 mg
10 mg
on MO / NP order
Provide Consumer Medicine Information: causes sedation and respiratory depression
Management of associated emergency: consult MO
[15]
Schedule
Diazepam
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
Slow IV injection
5 mg undiluted with
Stat
Do not give IM,
second 5 mg dose if
Ampoule 10 mg / 2 mL
required to a max. of 10
Further doses
absorption is
on MO / NP order
unreliable
mg. Give slowly at a
max. rate of 5 mg / min
Provide Consumer Medicine Information: causes sedation and respiratory depression
Management of associated emergency: consult MO
[19] [20]
Schedule
Diazepam
5. Follow up
If chronic alcohol misuse give 100 mg oral thiamine tds. Giving thiamine in divided
Uncontrolled
Controlled copy
copy
V 1.0
413
Smoking
acamprosate
Offer advice and information regarding the harmful effects of excessive alcohol
intake See Alcohol misuse. There is good evidence to show that advice from a
health professional can be influential in modifying drinking patterns
6. Referral / consultation
Consult MO as above and if:
-- GCS < I4, abnormal clinical observations, BGL, any significant other findings
-- thiamine or diazepam is required
-- patient is assessed as being at risk to themselves or others
Consider referral:
-- to obtain advice from ATODS, if no mental illness is present
-- for targeted counselling, if available, to help deal with psychological
consequences of drinking e.g. psychological or relationship counselling
-- for hospital inpatient detoxification if motivated but cannot be detoxified in the
community
-- Mental Health Services if there is a severe mental illness or if symptoms of
mental illness persist after detoxification and abstinence
-- if enforced abstinence at outstations or camps organised by the community or
utilising other organisations e.g. Alcoholics Anonymous, have had some success
-- Alcohol and Drug Information Service 1800 177 833 or 07 3236 2414 in
Brisbane area
-- NSW Drug and Alcohol Information Services 1800 422 599
Antenatal care
414
Smoking
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
415
Smoking
5. Follow up
Review in one week and offer further encouragement and support
Information may be given to patient on the harmful effects of smoking and it may
be months later that the patient returns to you and requests assistance to quit
6. Referral / consultation
Consult MO, consider referral to ATODS Health Worker / Service if available
416
Uncontrolled
Controlled copy
copy
V1.0
Overdose
Asking for help to quit
Under the influence
Altered level of consciousness
Drug induced psychosis
2. Immediate management
3. Clinical assessment
4. Management
I f patient admits to using drugs / substances - ask which substance and provide
brief education regarding health risks
Consult MO if required
5. Follow up
As per MO instructions
6. Referral / consultation
Consult MO and consider referral to:
Uncontrolled
Controlled copy
copy
V 1.0
417
References
1.
Haswell-Elkins M. and and et al. (2009). Protocols for the delivery of social emotional wellbeing and
mental health services in Aboriginal and Torres Strait Islander communities: guidelines for health workers,
clinicians, consumers and carers. Cairns, Australian Integrated Mental Health Initiative, Aboriginal and
Torres Strait Islander Stream in North Queensland for Northern Area Health Service, Queensland Health.
2.
Central Australian Rural Practitioners Association (2009). CARPA Standard Treatment Manual - A clinic
manual for primary health care practitioners in remote and rural communities in Central and Northern
Australia. Alice Springs, CARPA.
3.
beyondblue (2012). "Fact sheet Chronic physical illness and depression." Retrieved August, 2012, from
www.beyondblue.org.au
4.
Queensland Government (2012). "Procedure for Acute Behavioural Disturbance Management (including
acute sedation) in Queensland Health Authorised Mental Health Services." Retrieved August, 2012.
5.
Queensland Health (2009). "Amphetamine Intoxication - emergency Department Clinical Management
(Sedation protocols)." Retrieved August, 2012. Available from
www.health.qld.gov.au/atod/documents/psychostimulantsedat.pdf
6.
Therapeutic Guidelines (2012). "Behavioural emergencies in acute psychiatric settings: oral medication".
Retrieved August, 2012.
7.
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV
4th ed. Washington DC, American Psychiatric Association.
8.
Sadock B.J., Sadock V.A., and Ruiz P., Kaplan and Sadocks Comprehensive Textbook of Psychiatry.
2009, Philadelphia: Lippincott Williams & Wilkins
9.
beyondblue (2011). "Clinical practice guidelines Depression and related disorders - anxiety, bipolar
disorder and puerperal psychosis - in the perinatal period." Retrieved August, 2012, from
www.beyondblue.org.au
10. beyondblue (2012). "Guide to the management of depression in primary care. A guide for health
professionals." Retrieved August, 2012, from www.beyondblue.org.au
11. Royal Australian College of General Practitioners (2012). "Guidelines for preventive activities in general
practice, 8th edn." from www.racgp.org.au/your-practice/guidelines/redbook/
12. National Health and Medical Research Council (2009). "Australian Guidelines to Reduce Health Risks
from Drinking Alcohol." Retrieved August, 2012, from www.nhmrc.gov.au/guidelines/publications/ds10
13. Commonwealth of Australia (2012). "Alcohol Treatment Guidelines for Indigenous Australians." from
www.alcohol.gov.au/internet/alcohol/publishing.nsf/Content/AGI02
14. Queensland Government (2012). "Queensland Alcohol and Drug Withdrawal Clinical Practice
Guidelines." Retrieved August, 2012, from qheps.health.qld.gov.au/schsd/docs/clin/qh_detox_guide.pdf
15. Therapeutic Guidelines (2013). "Alcohol withdrawal." Retrieved July, 2013.
16. MIMS (2012). "Clozapine." Retrieved August, 2012.
17. Solberg L. and et al. (2001). "Patient satisfaction and discussion of smoking cessation during clinical
visits." Mayo Clinic Proceedings 76(2): 138.
18. Sciamanna C. and et al. (2004). "Visit satisfaction and tailored health behaviour communications in
primary care." Am J Prev Med 26(5): 426-430.
19. Therapeutic Guidelines (2012). "Delirium tremens." Retrieved August, 2012.
20. The Society of Hospital Pharmacists of Australia (2011). "Australian Injectable Drugs Handbook fifth
edition." Retrieved August, 2012, from aidh-hcn-com-au.cknservices.dotsec.com/index.php
21. Queensland Government (n.d.). Adult Mental Health Services - User Guide - Standardised Suite of
Clinical Documentation Queensland Health (cited from Southern Health in Victoria). Cairns.
22. Queensland Government (2012). "Mental Health Services Risk Screening Tool." Retrieved
November, 2012.
418
Uncontrolled
Controlled copy
copy
V1.0
Section 5
Sexual and
reproductive health
Section 5
Sexual and reproductive health
Contents
Women and antenatal health
Hypertension and premature events
Labour birth and postnatal care
Contraception
Sexually transmitted infections (STIs)
420
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
421
When collecting the Pap smear, consider including a ThinPrep specimen as per
Queensland Health guidelines for the use of liquid based cytology, in the presence of
excessive or purulent vaginal secretions or blood [4]. In other States contact your local
pathology service for advice
There are three different Pap smear sampling tools available for use. These are:
1. Ayres spatula
2. Cervix sampler (also known as the broom)
3. Cytobrush
In deciding on choice of tools the practitioner needs to have an understanding of
the need to sample the transformation zone and the relationship of this zone to the
squamocolumnar junction. It is important to use the appropriate sampling tool in the
correct manner to collect the best sample
1.
Ayres spatula
Place the end of the spatula in the cervical os and rotate the spatula three
times
2. Cervix sampler
Place the tip of the cervix sampler into the endocervical canal and rotate
the broom three to five times in the same direction keeping the bristles
in contact with the cervix
3. Cytobrush
Gently insert the brush into the cervical os until resistance is felt keeping
the brush in sight within the cervical os
Rotate one quarter of a turn (not recommended for use during pregnancy)
If using a cytobrush always use it after the spatula or the cervix sampler,
as the cytobrush tends to cause slight bleeding which may obscure
the cells
422
Uncontrolled
Controlled copy
copy
V1.0
Note:
Pregnant women
The wooden Ayres spatula plus a cotton swab or cervix sampler is preferred
when collecting a Pap smear
The broom of the sampler can also be sent for ThinPrep testing if needed
because the smear is contaminated with mucous
Do not use the cytobrush in pregnancy because of the potential for contact
bleeding and the anxiety this causes [4]
Vaginal vault smears
Use either spatula or a cervix sampler
HPV DNA testing
Is recommended as a test of cure for women who have been treated for high
grade squamous intraepithelial lesion (HSIL)
If a conventional Pap smear is also required (as will usually be the case), collect
this first using the desired collection device(s). Then collect a second specimen
for HPV DNA using the cervical sampler included in the Hydrid Capture 2
collection OR
Collect and prepare a conventional Pap smear using a plastic Ayres spatula and
cytobrush or Cervex brush (broom). Thoroughly rinse the collection devices
in a ThinPrep (PreservCyt) vial. The ThinPrep vial can be used for both
cytology and HPV DNA testing if required
The pathology form needs to be clearly marked for Cytology and HPV DNA
Test of Cure if both are required [5]
Specimens collected
Apply the collected specimens gently to the slide in an even spreading motion
If two sampling tools are used both samples should be placed on the one slide
Fix the slide immediately (within 30 seconds) with cytospray holding the spray
5 - 10 cm from the slide and spray 2 - 3 times to cover the slide
Allow to air dry
When to test for an STI?
See Sexually transmitted infections (STIs)
The threshold for STI testing, especially in young women < 29 years of age and in remote
areas where bacterial STIs are common, is low. In this context, collect an endocervical
PCR swab for chlamydia and gonorrhoea and a high vaginal PCR swab for trichomonas.
If STI diagnosed - repeat Pap smear following treatment
Uncontrolled
Controlled copy
copy
V 1.0
423
4. Management
On return of sample result [3]
Pap smear report
Management
Negative smear within normal limits
Unsatisfactory
424
Discuss with the woman how she would like to receive her Pap smear result,
(phone, face-to-face or letter) and explain that the test is a screening tool and
does not detect all abnormalities
Offer health promotion / education on other womens health issues such as sexual
assault, domestic violence, continence, breast care / screening, menopause,
contraception, pregnancy (including perinatal mental health) and sexual health
as required
Explain breast self awareness from: http://www.health.qld.gov.au/breastscreen/
5. Follow up
Give result of Pap smear to patient and inform her when next Pap smear is due.
Women with an abnormal Pap smear result who are currently being investigated,
treated or followed up should have Pap smears according to the NHMRC
guidelines [3] or by the treating Gynaecologists recommendations
STI results including contact tracing See Sexually transmitted infections (STIs)
6. Referral / consultation
Refer abnormalities to MO / NP
Refer for concerns regarding menstruation, presence of abnormal bleeding -
Antenatal care
Queensland Maternity and Neonatal Clinical Guidelines
The Primary Clinical Care Manual (PCCM) is the primary guide for the Scheduled Medicines
Rural and Isolated Practice Registered Nurse (SM R&IP) and other Advanced Practice
Nurses, Aboriginal and Torres Strait Islander Health Workers and Medical Officers working
outside the hospital system. In most instances, the Queensland Maternity and Neonatal
Clinical Guidelines relate to practice within maternity units within hospitals. This edition of
the PCCM aligns with relevant Queensland Maternity and Neonatal Clinical Guidelines.
The PCCM is to be used where there are unplanned births. Facilities where planned births
occur are advised to refer to the Queensland Maternity and Neonatal Clinical Guidelines.
In the event that a woman in preterm labour or threatened preterm labour or other urgent
pregnancy complications presents to a facility which does not have a maternity service,
early contact should be made with the appropriate MO. Where the RFDS provides primary
medical cover for a facility the RFDS MO on call is the appropriate first point of medical
contact. The MO will ring Retrieval Services Queensland (RSQ) at the QEMS Coordination
Centre (QCC) 1300 799127 if interfacility transfer is necessary or if specialist advice is
required. RSQ will be able to coordinate specialist obstetric and / or neonatal advice as
required regarding management and if needed, evacuation to an appropriate obstetric /
neonatal service.
This is a joint statement by the Statewide Maternity and Neonatal Clinical Network, Royal
Flying Doctor Service (Queensland Section), Retrieval Services Queensland and the Rural
and Remote Clinical Support Unit (R&R CSU) which is responsible for the production of
the PCCM.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
425
Recommend
Queensland Health mandates use of the Queensland Pregnancy Health Record in
all its facilities. Other jurisdictions may use other protocols. The Pregnancy Health
Record is available at: www.health.qld.gov.au/psq/pathways/docs/pregancy_rec.pdf
The first antenatal visit by MO or Midwife should ideally occur after the first missed
period, preferably before 12 weeks gestation
If a woman presents late, perform all antenatal care activities recommended for first
antenatal visit plus those which correspond to current gestation, especially if greater
than 32 weeks gestation
A minimum of five antenatal visits should be offered / provided to women with low
risk pregnancies with an aim of seven to nine visits in total
Consider perinatal mental health
Related topics
Missed period
Urinary symptoms
4. Management
426
The antenatal care schedule will depend on the individual womans needs. Routine
reviews recommended in the Queensland Pregnancy Health Record are at:
-- MO and Midwife first visit preferably before 12 weeks
-- further visits at 12 - 18, 20, 24, 28, 30 - 32, 34, 36, 38, 40, 41 weeks (20, 36 and
40 week visits with MO and / or hospital staff where planned birth is to occur)
In centres where there is no Midwife refer women for antenatal care to visiting
MO following the same schedule
Transfer care to referring obstetric service in consultation with obstetric staff at 36
weeks gestation or earlier according to womans needs
From first visit provide antenatal education on smoking, alcohol and other drug use
in pregnancy, healthy nutrition, physical activity, mental health and the importance
of the early years of a childs life as per Queensland Pregnancy Health Record
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
427
History
Gynaecological, medical, haematological (blood) conditions, surgical, family, psychosocial,
obstetric, sexual
Social factors domestic / social environment (SAFE Start)
-- domestic violence, substance misuse
-- social / family support (and availability of support services)
-- financial situation (and availability of support services)
Dietary (including food security)
Dental
Immunisation
Medication - all pre-existing medicines reviewed for safety in pregnancy
Perform assessment
Complete physical examination [6] including breast examination
Calculate obstetric risk score. Can be utilised to inform Midwife Risk Evaluation in deciding models
of care
If amniocentesis or CVS requested, dates uncertain, last menstrual period unknown or diabetes
present perform dating ultrasound 8 - 11 weeks
Examination of abdomen if > 12 weeks
Listen to and document fetal heart sound and rate (FHR) if > 12 weeks
Discuss [6]
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
429
Blood pressure (seated), urine dipstick / MSU repeated (if indicated), weight (if BMI is high or low)
Weeks / gestation, fundal height (cm), presentation, descent / fifths above brim, FHR, FM, liquor
Maternal counselling including tobacco / alcohol / other drug cessation (if applicable)
Breastfeeding
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
431
Score
Less than 20
20 - 29
Weight > 90 kg
30 - 34
Weight < 50 kg
35 or more
Drinks alcohol
> 1 drink twice a week
Multiple Pregnancy
Parity
0
1-2
4 or more
Social factors
Present pregnancy
Score
Blood pressure
Unsupported mother
(no stable union)
Stillbirth
Established diabetes
Neonatal death
Gestational diabetes
Cardiac disease
2 or more terminations
Caesarean sections
Recurrent UTI
Antepartum haemorrhage
Endocrine disease
Postpartum haemorrhage
Legend
High risk
= 8 or more
Medium risk = 3 to 7
Low risk
= 0 to 2
A risk score less than 8 does not indicate an
absence of risk
432
Uncontrolled
Controlled copy
copy
V1.0
Diabetes in pregnancy
Type 1, type 2 and gestational diabetes mellitus
Recommend
W
omen taking regular medicines, including oral anti-hyperglycaemic agents,
antihypertensive agents and statins / fibrates, should promptly consult MO /
Pharmacist regarding the need for and safety of use of these medicines in pregnancy
O
ral glucose tolerance test (OGTT) is the diagnostic test for gestational diabetes
Background
D
iabetes is either pre-existing (type 1 or type 2) or gestational diabetes mellitus (GDM)
Related topics
See flowcharts for:
Management of women with gestational diabetes
Management of women with type 1 and type 2 diabetes
Protocol for commencing insulin during pregnancy
For diagnosis of GDM perform: 75 g OGTT. Positive 75 g OGTT = fasting venous glucose
5.1 mmol / L and at 1 hour venous plasma glucose 10.0 mmol / L and at 2 hours venous
plasma glucose 8.5 mmol / L - performed at 24 - 28 weeks gestation or earlier if clinically
indicated
Uncontrolled
Controlled copy
copy
V 1.0
433
4. Management
Management aims
Keep fasting capillary BGL 5.0 mmol / L
Keep 2 hour post-prandial (after meals) capillary BGL 6.7 mmol / L
A blood glucose level under 3.5 mmol / L is classed as hypoglycaemia and should
be treated
Maternal blood glucose level should be monitored for 24 hours postpartum and if
indicated continued for longer
5. Follow up
Culturally appropriate education of women with diabetes should be provided
6. Referral / consultation
Review by Obstetrician as early as possible after diagnosis to institute program
434
Uncontrolled
Controlled copy
copy
V1.0
No
BGL above target
Continue current
management
Uncontrolled
Controlled copy
copy
V 1.0
435
Obstetric review
Combined
Diabetes / Antenatal Clinic
Morphology ultrasound
18 - 24 weeks for structural anomalies
or cardiac anomalies
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
437
References
1.
Australian Government Department of Health and Ageing (2012). "BreastScreen Australia Program."
Retrieved September 2012, from www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/
breastscreen-about
2.
Australian Government (2013). "The Australian Immunisation Handbook 10th edition." Retrieved April,
2013.
3.
National Health and Medical Research Council (2005). "Screening to prevent cervical cancer: guidelines
for the management of asymptomatic women with screen-detected abnormalities." Retrieved June,
2012, from www.nhmrc.gov.au/guidelines/publications/wh39
4.
Queensland Government (2012). "Queensland Health Guidelines for the use of Liquid Based Cytology."
Retrieved November, 2012.
5.
Queensland Government (2011). "Queensland Health Policy and Procedure for HPV DNA 'Test of Cure'."
Retrieved August, 2012.
6.
Royal Australian and New Zealand College of Obstetricians and Gynaecologists (2009). "Pre-pregnancy
Counselling and Routine Antenatal Assessment in the absence of pregnancy complications (C-Obs-3)."
Retrieved June 2012, from www.ranzcog.edu.au/component/docman/doc_view/1225-c-obs-03broutine-antenatal-assessment-in-the-absence-of-pregnancy-complications.html?Itemid=341
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists ( 2011). "Vitamin
7.
and Mineral Supplementation in Pregnancy (C-Obs 25)." Retrieved June, 2012, from www.ranzcog.edu.
au/documents/doc_view/958-c-obs-25-vitamin-and-mineral-supplementation-in-pregnancy.html
8.
National Health and Medical Research Council (2010). "NHMRC Public Statement: Iodine supplementation
for pregnant and breastfeeding women." Retrieved June, 2012, from
www.nhmrc.gov.au/guidelines/publications/new45
9.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (2011). "Guidelines
for the use of Rh (D) Immunoglobulin (Anti-D) in obstetrics in Australia (C-Obs 6)." Retrieved June
2012, from http://www.ranzcog.edu.au/womens-health/statements-a-guidelines/college-statementsand-guidelines.html?showall=&start=1
10. Nankervis A., McIntyre D., et al. (2012). "ADIPS Consensus Guidelines for the Testing and Diagnosis of
Gestational Diabetes Mellitus in Australia." Retrieved September, 2012.
11. Queensland Maternity and Neonatal Clinical Guideline Program (2010). "Early onset Group B Streptococcal
disease." Retrieved June, 2012, from www.health.qld.gov.au/qcg/html/publications.asp
12. Humphrey M.D., The beneficial use of risk scoring in a remote and high risk pregnant population. Aust
NZ J Obstet Gynaec, 1995. 35: p. 139-143.
13. Queensland Government (2012). "Pregnancy Health Record." Retrieved October, 2012.
14. NACCHO/RACGP (2012). National guide to a preventive health assessment for Aboriginal and Torres
Strait Islander people 2nd edn. South Melbourne, The RACGP.
438
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
439
Hypertension in pregnancy
1. May present with
4. Management
Consult MO / Obstetrician
Women with a systolic blood pressure of 160 mmHg or more (taken at rest,
on at least 2 occasions 30 minutes apart) and / or diastolic blood pressure of
100 mmHg or more should be urgently investigated and admission to hospital for
investigation should be considered:
-- maternal and fetal investigations must be performed to exclude pre-eclampsia
-- ongoing close monitoring is required to detect the development of
pre-eclampsia
-- collect urine for protein creatinine if protein on urinalysis 2+ or more
-- full blood count, LFT, urea, creatinine, electrolytes, LDH and urate
-- fetal welfare assessment by fetal heart rate with doppler and fundal height
measurement
If BP 140 / 90 mmHg but 160 / 100 mmHg, no symptoms, no proteinuria
-- repeat BP after 10 minutes, if BP settles to <140 / 90 mmHg review next day
-- if BP still 140 / 90 mmHg consult MO
5. Follow up
Frequency of blood pressure monitoring will be determined by womans individual
Women
6. Referral / consultation
Always refer to MO / Obstetrician
440
Uncontrolled
Controlled copy
copy
V1.0
Gestation
Urine dipstick for protein (significant if 2 +)
Weight
Ask re symptoms of pre-eclampsia (headache, visual disturbances, nausea and
vomiting, upper abdominal pain, sudden large weight gain)
Ask re fetal movements
Examine for signs of pre-eclampsia (generalised oedema, epigastric or right upper
quadrant tenderness, hyperreflexia and ankle clonus)
Fetal heart rate and symphysio-fundal height
Pre-existing
hypertension
If BP 140 / 90
mmHg discuss
management plan
with MO
If no known
underlying cause or
pre-existing condition
consult MO
If proteinuria 2+
and / or symptoms /
signs of
pre-eclampsia
present (rare <
20 weeks) MO
consultation should
be prompt
Chronic
hypertension
(essential,
secondary,
white coat)
If BP 140 / 90
mmHg (or rise in
systolic
BP 30 mmHg and /
or rise in diastolic
BP 15 mmHg)
notify MO
If proteinuria
2 + and / or
symptoms / signs
of pre-eclampsia
also present, MO
consultation should
be prompt
Pre-eclampsia
superimposed on
chronic
hypertension
New
hypertension
If new hypertension
with BP 140 / 90
mmHg (or rise in
systolic
BP 30 mmHg and /
or rise in diastolic
BP 15 mmHg)
and no proteinuria or
symptoms / signs of
pre-eclampsia
notify MO
Arrange to review all
clinical assessment
in 24 hours
No proteinuria
Ask woman to
re-attend
immediately if
symptoms of
pre-eclampsia arise
Gestational
hypertension
Uncontrolled
Controlled copy
copy
V 1.0
If new hypertension
with BP 160 / 100
mmHg or
BP 140 / 90 mmHg
with proteinuria 2
+ and / or symptoms
/ signs of preeclampsia
Urgently consult
MO re potential
need for eclampsia
prophylaxis and
/ or hypotensive
medication prior to
expedited transfer to
a specialist maternity
service
Pre-eclampsia
441
Pre-eclampsia
includes eclampsia
Recommend
W
omen who have pre-eclampsia must be evacuated / hospitalised under the care of
an Obstetrician
T
hose who required nifedipine, hydralazine or magnesium sulfate (MgSO4) or have
proteinuria require urgent evacuation / hospitalisation in an obstetrics facility
Facilities where planned births occur are advised to refer to the Queensland Maternity
and Neonatal Guideline "Hypertensive disorders of pregnancy" [2]
Background
A
woman with severe pre-eclampsia may feel well and have no symptoms at all
Gently restrain the woman to avoid fit-induced trauma, clear her airway as soon
as it is safe to do so and place her in the left lateral position (recovery position)
Consult MO
Magnesium sulfate (MgSO4) may be ordered to prevent / manage fitting. Caution
is required if magnesium sulfate and nifedipine are used concurrently. However,
MgSO4 remains the first line choice for management of eclamptic seizures
If the woman is in labour, perform vaginal examination after fit stops as birth may
be imminent
In addition to Clinical assessment observe conscious state
See Glasgow coma scale / AVPU
O2 saturations
3. Clinical assessment
442
Uncontrolled
Controlled copy
copy
V1.0
4. Management
If BP > 160 / 100 mmHg
Consult MO who may advise to give oral nifedipine or IM hydralazine
Insert a large bore IV cannula
Prepare the woman for evacuation to a referral maternity facility
Monitor (every 15 - 30 minutes until evacuated):
-- fetal HR
-- maternal vital signs
-- uterine contractions
-- measure and test all urine output
Women who have pre-eclampsia must be evacuated / hospitalised. Those
who required nifedipine, hydralazine or magnesium sulfate (MgSO4) or have
proteinuria require urgent evacuation / hospitalisation in an obstetrics facility
-- keep nil by mouth
-- MO may request the woman be catheterised
-- nurse in quiet area with subdued light
If BP > 135 / 85 mmHg but < 160 / 100 mmHg, no symptoms, no proteinuria
-- repeat BP after 10 minutes, if BP settles to < 135 / 85 mmHg review next day.
If BP still > 135 / 85 mmHg consult MO
Schedule
Nifedipine
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Form
Strength
Route of
administration
Recommended dosage
Duration
Stat
Dose can be repeated
Oral
10 mg - 20 mg
after 30 - 45 minutes on
MO / NP orders
Caution with use of nifedipine in women with rheumatic heart disease as pulmonary oedema may occur.
Concomitant use of magnesium sulfate and nifedipine is not absolutely contraindicated but care must be
taken since hypotension may result. A patient being treated with nifedipine should not be given a bolus of
magnesium sulfate [3]. Not recommended for use in combination with salbutamol tocolytic infusion.
If hypotension occurs nifedipine and magnesium sulfate should be ceased and reviewed by MO
Provide Consumer Medicine Information: advise the woman that nifedipine may cause facial flushing,
headaches, nausea and increased HR
Management of associated emergency: consult MO
[4] [2]
Tablet
(not controlled
release)
10 mg
20 mg
Uncontrolled
Controlled copy
copy
V 1.0
443
Schedule
NON DTP
Must be ordered by MO / NP
Hydralazine
Recommended dosage
Initial dose
5 mg - 10 mg via slow IV injection
Repeated doses 5 mg IV 20 minutes apart if
required (up to max. 15 mg)
Cease hydralazine if maternal pulse greater
IV injection
than 130 beats / minute
20 mg powder for
Maintenance
Ampoule
IV infusion
reconstitution
Commence at 2 mg / hour
via controlled
(IV via controlled infusion device)
infusion device
Increase every 10 minutes by 2 mg / hour
increments until BP stable
Max. infusion rate 10 mg / hour
If maternal pulse greater than 125 beats / minute
consider ceasing infusion
Detailed information available in Appendix C of Queensland Maternity and Neonatal Clinical Guideline:
Hypertensive disorders of pregnancy, found at www.health.qld.gov.au/qcg/html/publications.asp
Provide Consumer Medicine Information: hypotension and tachycardia
Management of associated emergency: consult MO
[2]
Magnesium sulfate
NON DTP
(MgSO4)
Must be ordered by MO / NP
Magnesium sulfate infusion must be ordered by an MO / NP. Follow local work instructions for the
dilution and preparation of magnesium sulfate
Route of
Form
Strength
Recommended dosage
administration
Schedule
Loading
4 g bolus over 20 minutes
Ampoule
for dilution
in sodium
chloride
0.9%
Magnesium
sulfate
concentrated
injection
2.47 g in
5 mL
(50%)
IV infusion
via controlled
infusion device
Maintenance
1 g / hour for 24 hours depending on
clinical parameters
If impaired renal function reduce
maintenance dose to 0.5 g / hour
Persistent seizures
Give a further 2 g bolus over 5 minutes
May be repeated in a further 2 minutes
if seizures persist
The woman should be warned that she may experience transient hot flushing. ECG monitoring is not required
Detailed information available in Appendix E of Queensland Maternity and Neonatal Clinical Guideline:
Hypertensive disorders of pregnancy, found at www.health.qld.gov.au/qcg/html/publications.asp
Management of associated emergency: consult MO
[2]
444
Uncontrolled
Controlled copy
copy
V1.0
5. Follow up
I
f not evacuated / hospitalised review according to MO instructions
Consult MO if BP raised again
See next MO clinic
Check blood pressure 12 weeks post partum - if not normotensive consult MO
6. Referral / consultation
Chronic hypertension
Essential, secondary, white coat
Recommend
A
ny woman with pre-existing hypertension who becomes pregnant should be cared
for in consultation with Physician and Obstetrician
A
void angiotensin converting enzyme (ACEI) inhibitors angiotensin ll receptor
antagonists and diuretics in pregnancy [2]
Background
Blood pressure 140 / 90 mmHg with no apparent cause, in women prior to pregnancy
or before 20 weeks gestation, or in pregnancy and taking antihypertensives, is
considered essential hypertension [2]. Where there is high prevalence of hypertension
in the population essential hypertension may be detected at antenatal visits
Secondary hypertension may be due to chronic kidney disease, renal artery stenosis,
diabetes, endocrine disorders or coarctation of the aorta
Uncontrolled
Controlled copy
copy
V 1.0
445
Ectopic pregnancy
1. May present with
Pain - lower abdominal, right iliac fossa, left iliac fossa, suprapubic or shoulder
tip. Pain usually precedes bleeding and pain is the predominant symptom
Vaginal bleeding
Pallor, increased HR
Hypotension / shock
Right or left sided mass or tenderness on bimanual examination
Rigid abdomen with rebound tenderness
No sign of intrauterine pregnancy on ultrasound
2. Immediate management
Consult MO urgently
If blood loss is heavy or continuing or there is increased HR or hypotension / shock:
-- insert large bore IV cannula (14 G or 16 G if possible)
-- See DRS ABCD resuscitation / the collapsed patient
-- commence IV sodium chloride 0.9% or Hartmanns solution. MO will advise
quantities and rate
-- the aim is to keep HR < 120, systolic BP > 100 mmHg, urine output
> 0.5 mL / kg / hr
Take blood for FBC, U/Es and group and x-match
Give O2 See O2 delivery systems
3. Clinical assessment
4. Management
446
onsult MO who will advise analgesia (preferably IV opioid or IM) and arrange
C
evacuation / surgery immediately
Keep nil by mouth
MO may request the woman be catheterised
Uncontrolled
Controlled copy
copy
V1.0
5. Follow up
Consider grief counselling if appropriate
All Rh (D) negative women should be offered Anti D [5] See Rh D immunoglobulin
If applicable follow up STI test results and treat
6. Referral / consultation
Consult MO on all occasions of suspected ectopic pregnancy
Uncontrolled
Controlled copy
copy
V 1.0
447
4. Management
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Schedule
Ampoule
500 microgram
/ 1 mL
Ergometrine
IM
500 microgram
Stat
IV
(IHW and IPAP may
250 microgram
not administer IV)
Provide Consumer Medicine Information: administer slowly over at least one minute to avoid hypotension
Management of associated emergency: consult MO
[6]
5. Follow up
Consider grief counselling for parents who have experienced miscarriage /
6. Referral / consultation
Consult MO on all occasions of vaginal bleeding in pregnancy
448
Uncontrolled
Controlled copy
copy
V1.0
Rh D immunoglobulin
2. Immediate management
onsult MO urgently
C
If blood loss is heavy or continuing or increased HR or hypotension / shock:
-- insert large bore IV cannula (14 G or 16 G if possible)
-- commence IV sodium chloride 0.9% or Hartmanns solution. MO will advise
quantities and rate . The aim is to keep HR < 120 mmHg , systolic BP > 100
mmHg, urine output > 0.5 mL / kg / hour
Take blood for FBC, U/Es, group and x-match and clotting factor
Give O2 See O2 delivery systems
Lie woman in left or right lateral position - not supine
Uncontrolled
Controlled copy
copy
V 1.0
449
3. Clinical assessment
4. Management
5. Follow up
Offer grief counselling for parents who have experienced antepartum haemorrhage
6. Referral / consultation
Consult MO on all occasions of vaginal bleeding in pregnancy
450
Uncontrolled
Controlled copy
copy
V1.0
4. Management
Acute cystitis
Advise increased fluid intake
Before result of MC/S is available treat with cephalexin unless allergic to penicillin
or other beta-lactam antibiotics or amoxycillin / clavulanate acid
Amoxycillin (only recommended if susceptibility of the organism is proven) [7]
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
451
DTP
IHW / SM R&IP / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Midwife may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
250 mg
Capsule
Oral
500 mg bd
5 days
500 mg
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[7]
Schedule
Cephalexin
or
DTP
IHW / SM R&IP / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Midwife may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg / 125 mg
Oral
500 mg / 125 mg bd
5 days
Provide Consumer Medicine Information: take with food. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[7]
DTP
IHW / SM R&IP / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Midwife may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
50 mg
Capsule
Oral
100 mg bd
5 days
100 mg
Do not use in women at or near term or delivery because of the risk of neonatal haemolytic anaemia in
G6PD deficient patients. Not for use in patients with renal impairment
Provide Consumer Medicine Information: take with food or milk. Take until course completed
Management of associated emergency: consult MO
[7]
Schedule
Nitrofurantoin
Pyelonephritis
Consult MO, patient will need IV antibiotics and evacuation / hospitalisation
Asymptomatic bacteriuria (antenatal screening)
If woman not allergic and susceptibility of the organism is proven [7] treat with
amoxycillin
452
Uncontrolled
Controlled copy
copy
V1.0
DTP
IHW / SM R&IP / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Midwife may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
250 mg
Capsule
Oral
250 - 500 mg tds
7 days
500 mg
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[7] [8]
Schedule
Amoxycillin
5. Follow up
6. Referral / consultation
Consult MO as above
Uncontrolled
Controlled copy
copy
V 1.0
453
3. Clinical assessment
4. Management
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Loading dose
Stat
600 mg
IV (IM only if
1.2 g
Commence
Vial
1.2 g
IV cannulation
Maintenance dose
maintenance dose 4
unsuccessful)
3g
600 mg 4 hourly
hours after loading dose
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[9]
Schedule
Benzylpenicillin
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
IV (IM only if
Stat
600 mg
then commence
Ampoule
600 mg / 2 mL
IV cannulation
unsuccessful)
8 hourly
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Schedule
Lincomycin
[9]
5. Follow up of neonate
If adequate intrapartum antibiotic cover, observe for signs of sepsis and take
Uncontrolled
Controlled copy
copy
V1.0
6. Referral / consultation
prophylaxis
Paediatrician
Draining liquid from vagina - colour of liquid may be clear, blood stained, meconium
(green to black), yellow
Vaginal spotting or show
History of gush followed by continuing leak
Pool of fluid in the posterior vaginal fornix is suggestive of liquor
Cord prolapse
Intrauterine infection
Regular uterine activity (preterm labour)
Lower back pain
Lower abdominal cramping
Pelvic pressure
Infection (STI or non STI)
2. Immediate management
Uncontrolled
Controlled copy
copy
V 1.0
455
3. Clinical assessment
4. Management
Consult MO:
-- may request evacuation / hospitalisation in an obstetrics facility
-- may recommend commencement of oral or IV antibiotic in consultation with
receiving facility
Complete bed rest prior to evacuation
If the gestation is between 24 and 34 weeks and in labour MO will order
betamethasone 11.4 mg IM to accelerate fetal lung maturation [10]
See Prevention of neonatal respiratory distress syndrome
Women with uterine activity who require transfer should be considered for tocolysis
[10] prior to evacuation to suppress labour See Suppression of preterm labour
A history of group B Streptococcus colonisation or of recurrent herpes genitalis is
important in deciding upon the necessary urgency of evacuation
5. Follow up
Women who have a positive swab / urine for group B Streptococcus in the current
6. Referral / consultation
Consult MO on all occasions of suspected prelabour with or without preterm
rupture of membranes
456
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
457
2. Immediate management
onsult MO. If birth is imminent prepare for birth See Normal labour and birth
C
Prepare neonatal resuscitation equipment See Neonatal resuscitation
3. Clinical assessment
4. Management
458
Antibiotics [10]
Prophylactic antibiotics for group B Streptococcus are not recommended in threatened
preterm labour, but should be administered in established preterm labour
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Stat
If contractions persist after 30
Oral
Tablet
minutes repeat 20 mg
10 mg
(not
20 mg
If contractions persist after a
20 mg
Chew the tablet to
controlled
further 30 minutes repeat 20
aid rapid
release)
mg on MO / NP order if BP
absorption
stable
Schedule
Nifedipine
5. Follow up
F
ollow up MSU results and treat See Urinary tract infection in pregnancy
Follow up STI results and treat See Sexually transmitted infections (STIs)
Women who have a positive swab / urine for group B Streptococcus in the current
6. Referral /consultation
Consult MO on all occasions of suspected preterm labour
Uncontrolled
Controlled copy
copy
V 1.0
459
Recommend
Give corticosteroid therapy to women between 24 and 34 weeks gestation who are
at risk of preterm birth within the next 7 days
Background
Corticosteroids given to women in early labour assist fetal lung maturation and
reduce the risk of respiratory distress syndrome, intracerebral haemorrhage and / or
necrotising enterocolitis after birth [12]
Repeat courses of corticosteroids should not be used routinely [13]
Related topics
4. Management
Schedule
DTP
IHW / Mid
Betamethasone injection
5.7 mg / mL
IM
11.4 mg
Duration
Stat
Further doses on
MO / NP orders
Uncontrolled
Controlled copy
copy
V1.0
5. Follow up
Evacuation / hospitalisation for ongoing management
6. Referral / consultation
Consult MO on all occasions of premature labour before treatment
2. Immediate management
If the umbilical cord is known or suspected to be either present behind intact membranes
or prolapsed with ruptured membranes:
Call for help and consult MO urgently
Assist mother into the knee-chest position (see diagram) or place two pillows
under the buttocks or lie on left side with head tilted down
Hold the presenting part off the cord using your fingers
Avoid touching the cord
Give O2 See O2 delivery systems
Check fetal heart sound and rate
Uncontrolled
Controlled copy
copy
V 1.0
461
3. Clinical assessment
ake complete history (if time allows and not documented in antenatal notes)
T
including: past reproductive, current pregnancy, sexual history
Perform clinical observations +
-- fetal HR, sound and movement
-- assess gestation from LNMP / early pregnancy ultrasound
Physical examination including
-- check fundal height
Where possible a second person will be required to assist
4. Management
5. Follow up
R
equires urgent caesarean section if fetus alive
Grief counselling as indicated
All Rh (D) negative women should be given Anti D [5]
6. Referral / consultation
Consult MO on all occasions of umbilical cord presentation or prolapse
References
1.
Lowe S.A. and et al (2009). "Guidelines for the management of hypertensive disorders of pregnancy."
Aust NZ J Obstet Gynaec 49(3): 242-246.
2.
Queensland Maternity and Neonatal Clinical Guideline Program (2010). "Hypertensive disorders of
pregnancy. Updated May 2012." Retrieved June, 2012.
3.
Australian Medicines Handbook (2012). "Magnesium sulfate." Retrieved June, 2012.
4.
Therapeutic Guidelines (2012). "Management of pre-eclampsia." Retrieved June, 2012.
5.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (2011). "Guidelines
for the use of Rh (D) Immunoglobulin (Anti-D) in obstetrics in Australia (C-Obs 6)." Retrieved June, 2012,
from www.ranzcog.edu.au/womens-health/statements-a-guidelines/college-statements-and-guidelines.
html?showall=&start=1
6.
Queensland Maternity and Neonatal Clinical Guideline Program (2011). "Early pregnancy loss."
Retrieved June, 2012.
7.
Therapeutic Guidelines (2012). "Acute cystitis in adults." Retrieved June, 2012.
8.
Australian Medicine Handbook (2012). "Amoxycillin." Retrieved August, 2012.
9.
Queensland Maternity and Neonatal Clinical Guideline Program (2010). "Early onset Group B
Streptococcal disease." Retrieved June, 2012, from www.health.qld.gov.au/qcg/html/publications.asp
10. Queensland Maternity and Neonatal Clinical Guideline Program (2009). "Assessment and management
of preterm labour." Retrieved June 2012, from www.health.qld.gov.au/qcg/html/publications.asp
11. Therapeutic Guidelines (2012). "Nifedipine." Retrieved June, 2012.
12. Roberts D. and Dalziel S. (2006). "Antenatal corticosteroids for accelerating fetal lung maturation for
women at risk of preterm birth Issue 3 ". Retrieved June, 2012.
13. Australian Medicine Handbook (2012). "Preterm labour." Retrieved June, 2012.
462
Uncontrolled
Controlled copy
copy
V1.0
Neonatal resuscitation
Group B Streptococcus prophylaxis
Postpartum haemorrhage
Rh D immunoglobulin
2. Immediate management
Uncontrolled
Controlled copy
copy
V 1.0
463
3. Clinical assessment
ake a complete history if not already taken during antenatal care including:
T
-- past reproductive history
-- current pregnancy
-- mental health history
Perform standard clinical observations:
-- assess gestation from last normal menstrual period (LNMP) / early pregnancy
ultrasound
-- vaginal loss: liquor, blood, meconium
-- fetal heart rate (FHR)
-- uterine contractions: frequency, duration, strength
Perform physical examination including:
-- fundal height in relation to xiphisternum
-- fetal lie and presentation (cephalic, breech)
4.
Management
A decision needs to be made as to whether birth will take place in the community or
whether urgent evacuation is appropriate. This will depend on parity of the woman,
stage of labour at presentation, labour progression and the staff availability / mix at
the facility. Such a decision needs to be undertaken in consultation with the relevant
evacuation provider e.g. RFDS MO. Specialist obstetric and / or neonatal advice
may be obtained, if necessary, via QCC (Queensland Emergency Medical System
Coordination Centre) 1300 799 127
Ruptured membranes but not in labour
In the absence of any contraindications, all efforts should be made to transfer to an
appropriate maternity unit. If diagnosis is uncertain, only a speculum examination
should be performed and digital vaginal examination should be avoided unless a
cord prolapse is considered possible
Fetal fibronectin testing (fFN)
If the diagnosis of labour is uncertain at preterm gestations, fFN testing of a
vaginal swab sample may be appropriate after discussion with an MO. A fFN
test should be performed before a digital vaginal examination is undertaken. The
presence of blood or amniotic fluid in the vagina may make the result unreliable.
Recent sexual intercourse may make a test result difficult to interpret or may
result in a false positive result, however a negative result is valid
fFN is most useful when a negative result is obtained - in this instance, there is a
less than 2% likelihood of birth within the next 72 hours, unless a new pregnancy
complication arises. A positive result is associated with an approximately 50%
chance of birth within the next 72 hours
Fetal observation in 1st stage of labour
Fetal HR (FHR) is auscultated towards the end of, and for at least 30 seconds
after, the end of a contraction, to hourly. Normal range is 110 - 160 / min.
After a contraction there should be no deceleration (slowing of) FHR, if there is a
drop in FHR after contractions, ask the woman to change her position (women in
labour should not lie flat on their back due to potential supine hypotension)
464
Uncontrolled
Controlled copy
copy
V1.0
Maternal observations
hourly (minimum) - contractions (number in 10 minutes), vaginal loss, heart
rate
2 hourly - abdominal palpation, bladder emptying
4 hourly - BP, temperature, urinalysis
Vaginal examinations individualised to womans needs - typically 4 hourly, until
the cervix is 8 cms dilated, then 2 hourly - assessment of cervical dilatation may
need to be more frequent than would normally be undertaken in a maternity unit,
to allow for early decision making if progress is abnormal
Partogram [1]
When the cervix reaches 4 cm - 5 cm dilatation, which for practical purposes
demarcates the latent phase of labour from the active phase of labour, warning (or
alert) and action lines should be drawn on the partogram, as demonstrated below
-- X - cervical dilatation as measured at vaginal examination
-- O - descent of the head as measured on abdominal examination
ncourage the woman to drink to thirst and maintain nutritional intake, monitor
E
for nausea and dehydration and take action as appropriate. Offer light food as
desired
Support
-- appropriate family member / support present
-- adequate explanation, encouragement and reassurance
Consult MO if delay in progress
-- if progress of cervical dilatation / descent of the head crosses the warning
(or alert) line on the partogram, this will give an early indication of the
need for transfer to referral maternity facility or intervention. In the setting
of management of unexpected labour in a facility which does not manage
planned births this is of particular importance
-- if cervical dilatation / descent of the head crosses the action line on the partogram
the likelihood of a successful vaginal birth with continuation of the current
management plan is unlikely and management should be carefully reviewed
P
ain management as per womans individual requirement
-- try mobilisation, shower, massage, heat therapy
-- if requested by the woman, use nitrous oxide and O2 (Entonox)
-- if all other pain relief strategies are unsatisfactory and the woman requests
further pain relief, she is not allergic and if birth is not imminent - give morphine
in a single injection with or without metoclopramide. Morphine is opioid of choice
in the first stage of labour. Prior to administration of opioid perform vaginal
examination to determine progress of labour and exclude imminent birth
Uncontrolled
Controlled copy
copy
V 1.0
465
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Duration
Form
Strength
Recommended dosage
administration
Up to 70% max.
Titrated according to
Inhalation
nitrous oxide
requirements
As required
Gas
self administered
mixed with
O2 30%
If using separate cylinders of nitrous oxide and O2 ensure correct mixture ratios
Provide Consumer Medicine Information: self administered by woman
Management of associated emergency: caution in the presence of Vitamin B12 deficiency. Consult MO
[2]
Schedule
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Duration
Form
Strength
Recommended dosage
administration
Stat
0.1 mg - 0.2 mg / kg
Ampoule
10 mg / mL
IM / SC
Further doses on
to a max. of 10 mg
MO / NP order
Provide Consumer Medicine Information: advise can cause nausea and vomiting, drowsiness
Management of associated emergency: caution in those with significant renal / liver disease. Respiratory
depression is rare. If it should occur give naloxone See Poisoning / overdose - opioids. Note: as naloxone
counteracts the opioid, it may cause the return of severe pain
[18]
Schedule
Morphine
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
IM or IV
Adult only
Ampoule
10 mg / 2 mL
(IHW may not
Stat
10 mg
administer IV)
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or children and
use with caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[4]
Schedule
466
Metoclopramide
Uncontrolled
Controlled copy
copy
V1.0
Transition
The period between the end of first stage and the commencement of the second stage
of labour - maternal expulsive efforts. Women can become restless, fearful or may vomit.
Attending staff should remain with the woman and be supportive and encouraging.
4. Management
Support and encourage the woman. Assist her to select a position in which she
is most comfortable (she may change positions frequently). There may be some
advantage in encouraging the mother to change her position if there is slow
progress in the second stage of labour
Delay pushing if no urge to push
Maternal observations - temperature and BP - 4 hourly (unless BP elevated in
which case take hourly), maternal heart rate hourly, abdominal palpation,
vaginal examination - if indicated, contractions - continuous assessment
Bladder - monitor and encourage emptying
Offer oral fluids between contractions
Assess discomfort and pain
Support the womans natural instincts in relation to pushing
Document time of spontaneous rupture of membranes, note colour consistency
and odour of liquor
If head is visible with contractions prepare for birth
Use nitrous oxide and O2 if required for analgesia
R
ecord fetal HR after each push by the woman - if fetal HR drops after contractions,
ask the woman to change her position (a labouring woman should not lie flat on
their back due to potential supine hypotension)
C
onsult MO if delay in progress (nulliparous woman 1 hour in passive second
stage {if no urge to push}, 2 hours in active second stage / multiparous woman
after 1 hour in active second stage)
Uncontrolled
Controlled copy
copy
V 1.0
467
Birth
hen the head is visible with contractions, encourage the woman to adopt a
W
comfortable position - she may stand, kneel on all fours, or lie in a lateral position
or in an upright sitting position
Put on personal protective equipment
Support the womans own expulsive efforts
The head will stretch the perineum as it slowly comes down with contractions
When the perineum is thin and the head stretches the labia apart between
contractions, the head will birth with the next two or three contractions
The anus (not the perineum) may be covered with a peripad
Using hands on to flex the fetal head or hands poised to stop sudden expulsion
has no affect on perineal trauma - hands on reduces postpartum perineal pain
Encouraging the woman to pant with contractions or to push between contractions
will help slow the birth and may protect the perineum from trauma of the head.
The head will birth and extend freeing the babys chin. With the next contraction,
the head will turn
Encourage the womans expulsive efforts until the anterior shoulder slips under
the symphysis pubis, then when the anterior shoulder is visible support the baby
and lift the baby towards the mothers abdomen
Look at the clock, note time of birth, document time
Check the uterus for another baby, the top of the uterus should be no higher than
the umbilicus and firm
Give oxytocin to the mother
In women with previous history of post partum haemorrhage (PPH) or at risk of
PPH:
-- give oxytocin + ergometrine maleate (Syntometrine) with metoclopramide
(unless ergometrine is contraindicated e.g. woman is hypertensive, diastolic
BP > 90 mmHg and / or she has cardiovascular disease)
-- in the event that ergometrine is contraindicated, insert IV cannula during
labour if there is time and give only oxytocin
The cord is clamped when cord pulsation ceases, earlier if baby requires
resuscitation (active management of the third stage is recommended). Two cord
clamps are placed not less than 2 cm from the baby's skin. The cord is cut using
sterile scissors between the two clamps by the accoucheur, mother or other
person
Collect cord blood
Oxytocin
DTP
(Syntocinon)
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
5 International
Stat
units / mL
May be repeated once
Ampoule
IM or IV
10 International units
10 International
in the event of persistent
units / mL
heavy bleeding
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[5]
Schedule
468
Uncontrolled
Controlled copy
copy
V1.0
[5]
with or without
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Ampoule
10 mg / 2 mL
Metoclopramide
IM or IV
(IHW may not
administer IV)
Adult only
10 mg
Stat
Further doses on
MO / NP order
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or children and
use with caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[4]
Uncontrolled
Controlled copy
copy
V 1.0
469
eep the baby warm. Pass baby to mother (prevent neonatal hypothermia)
K
Keep baby skin-to-skin with mother for at least the first hour to assist baby with
warmth, bonding, adaptation to extra-uterine life and facilitate breastfeeding [6]
The sex of the newborn is identified to the agreement of mother and support
person(s)
The Apgar score is used to evaluate and record the newborns condition at
one minute after birth and again at five minutes and ten minutes after birth
Apgar score
Apgar Scoring is a method of providing an objective assessment of the neonates condition at 1, 5 and 10
minutes after birth. It is not for determining action taken in resuscitation.
The 10 minute score is the best predictor of long term outcome but still has a poor predictive value.
Min score = 0 / Max score = 10
Score
0
1
2
HR
Absent
Respiratory effort
Absent
Crying / good
Colour
Blue / white
Tone
Limp
Slow / irregular
Pink body, blue
extremities
Poor tone
Absent
Grimace
Cough / sneeze
Pink
Active and flexed
470
Uncontrolled
Controlled copy
copy
V1.0
Hold the cord loosely i.e. without any pulling / traction and wait until the uterus is
well contracted again
With the next contraction, repeat controlled cord traction with counter traction
Uncontrolled
Controlled copy
copy
V 1.0
471
A plastic cord clamp is placed not less than 2 cm from the babys skin
15 - 30 minute observations (HR, respiratory rate / presence or absence of
respiratory distress, temperature, cord, tone, colour, skin warmth) for the first 2
hours and then only as indicated. Ensure adequate lighting for observation and
position newborn to ensure patent airway
Bare weigh and give vitamin K injection (with informed consent) and at birth
immunisations See Immunisation program
Schedule
Nil
Phytomenadione - Vitamin K
(Konakion)
NON
DTP
Form
Strength
Route of administration
Recommended dosage
Ampoule
2 mg / 0.2 mL
IM to newborn
immediately after birth
1 mg stat
5. Follow up
Women who have an unplanned birth in a facility that does not undertake planned
6. Referral / consultation
Rh D immunoglobulin
Recommend
Rh D immunoglobulin is indicated for the prevention of Rh D sensitisation in Rh D
negative women
Administer Rh D immunoglobulin as soon as possible after the sensitising event, but
always within 72 hours [8]
Offer routine antenatal anti-D prophylaxis to all non-sensitised pregnant women who
are Rh D negative at 28 weeks and 34 weeks gestation
Screen for antibodies with blood sample from mother at 28 weeks before the first
routine prophylactic injection is given
Related topics
472
ensitising events in the first trimester (up to and including week 12 of gestation).
S
A dose of 250 International units Rh D immunoglobulin (minidose) should be
offered to every Rh D negative woman with no preformed anti-D antibodies to
ensure adequate protection against immunisation for the following indicators:
-- threatened miscarriage
-- miscarriage
-- termination of pregnancy
-- ectopic pregnancy
-- chorionic villus sampling
Sensitising events beyond the first trimester (after week 12 of gestation). A dose
of 625 International units Rh D immunoglobulin should be offered to every Rh
D negative woman with no preformed anti-D antibodies to ensure adequate
protection against immunisation for the following indicators:
-- genetic studies (chorionic villus sampling, amniocentesis and cordocentesis)
-- abdominal trauma considered sufficient to cause feto-maternal haemorrhage
--
each occasion of revealed or concealed antepartum haemorrhage
(where a woman suffers unexplained uterine pain, the possibility of a
concealed antepartum haemorrhage should be considered, with a view to
immunoprophylaxis)
-- external cephalic version (performed or attempted)
-- miscarriage or termination of the pregnancy
-- intrauterine death
Antenatal prophylaxis (at 28 weeks and 34 weeks of gestation)
-- universal prophylaxis with Rh D immunoglobulin is recommended for pregnant
women who are Rh D negative with no preformed anti-D antibodies
-- Rh D immunoglobulin, in the form of 625 International units should be offered
at 28 weeks and again at 34 weeks, to all Rh D negative women with no
preformed anti-D antibodies
-- it is essential that women are screened again for pre-existent anti-D and
that a blood sample is taken before the first routine prophylactic injection is
given at 28 weeks. The result of the test does not need to be available before
administration
-- repeat screening is not necessary before the second administration at 34
weeks
P
ostpartum
-- a dose of 625 International units Rh D immunoglobulin should be offered to
every Rh D negative woman giving birth except when the baby is known to be
Rh D negative
-- Rh D immunoglobulin should not be given to women with pre-existing anti-D
antibodies, except where this is known to be due to antenatally administered
Rh D immunoglobulin
-- if it is unclear whether the anti-D detected in the mothers blood is passive
from the anti-D administration or preformed, consult MO. If there is continuing
doubt, Rh D immunoglobulin should be administered
-- the magnitude of Feto-Maternal Haemorrhage (FMH) should be assessed by
a method capable of quantifying a haemorrhage of 6 mL of fetal red cells
(12 mL whole blood). For FMH of 6 mL red cells, further doses should be
administered sufficient to prevent maternal immunisation
-- administration of 625 International units Rh D immunoglobulin is sufficient to
prevent immunisation by FMH of up to 6 mL of fetal red cells (12 mL whole
blood)
Uncontrolled
Controlled copy
copy
V 1.0
473
4. Management
Consult MO
-- administration of 250 International units Rh D immunoglobulin (minidose) is
sufficient to prevent immunisation by FMH of 2.5 mL of fetal red cells (5 mL
whole blood)
-- administration of 625 International units Rh D immunoglobulin is sufficient to
prevent immunisation by FMH of up to 6 mL of fetal red cells (12 mL whole
blood)
Note: give anti-D, test maternal blood for antibodies, if pathology result shows greater FMH
give more anti-D within 72 hours
Schedule
Rh D immunoglobulin
DTP
Mid
Strength
Route of
administration
Recommended dosage
Duration
250
International
units
Ampoule
625
International
units
Deep, slow
intramuscular
injection
(if more than 5 mL
is required give in
divided doses in
different sites)
Stat
Antenatal prophylaxis
(28 and 34 weeks)
625 International units
Postpartum
(unless the baby is known to be
Rh D negative) 625 International units
Contraindications: in the maternity setting Rh D immunoglobulin should not be given to: a baby; an Rh D
positive woman; an Rh D negative woman with preformed anti-D antibodies
Provide Consumer Medicine Information
Management of associated emergency: as per local care manual consult MO
[8]
474
Uncontrolled
Controlled copy
copy
V1.0
5. Follow up
Where FMH quantitation shows that FMH greater than that covered by the dose
6. Referral / consultation
F
or sensitising events beyond the first trimester consult with MO
If it is unclear whether the anti-D detected in the mothers blood is passive from
leeding from the genital tract during the third stage of labour or within 24 hours
B
of birth
Haemorrhage may occur before or after the placenta is delivered
2. Immediate management
DRS ABCD resuscitation / the collapsed patient
If blood loss is heavy or continuing or there is increased maternal HR or signs of
hypotension / shock:
Summon help
Send someone to consult MO
Ensure standard precautions
Lie woman flat and reassure
Rub uterus firmly to stimulate contraction of uterus
Administer O2 via mask See O2 delivery systems
Keep woman warm
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
475
Ensure active management of third stage has occurred i.e. oxytocin given
Insert 2 large bore (greater than 16 G) IV cannula
-- collect group and x-match, FBC, coagulopathy
-- commence IV fluids, usually starting with Hartmanns solution - do not wait
for signs of shock. Use rapid infusion sets, pump sets or pressure bags. MO
will order fluids including:
2 - 3 litres of crystalloid fluid
blood component therapy as necessary and available in the event that
significant crystalloid fluid is required
aim for HR < 120, systolic BP > 100 mmHg, urine output > 0.5 mL / kg / hour
-- check clinical observations every 5 minutes
Administer uterotonic (e.g. oxytocic) medicine (as a second dose):
-- Syntocinon (oxytocin alone is as effective as Syntometrine but has fewer
side effects)
-- ergometrine, provided it is not contraindicated i.e. not hypertensive (diastolic
BP not 90 mmHg or history of hypertension) and no heart disease
-- misoprostol must be used with Specialist Staff or Country Medical
Superintendent oversight
Pass an in / out urinary catheter or insert an indwelling catheter
If bleeding continues and the womans condition continues to deteriorate
commence bimanual compression until MO assistance arrives - avoid vigorous
massage
3. Clinical assessment
4. Management
476
Aortic Compression
Bimanual Compression
Oxytocin
DTP
(Syntocinon)
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
10
5 International
IM
International
units
units / mL
Ampoule
Stat
10 International
5
IV (slowly)
units / mL
International units
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[5] [9]
Schedule
Uncontrolled
Controlled copy
copy
V 1.0
477
If placenta delivered and bleeding heavy or continues give ergometrine (as well
as oxytocin), provided not contraindicated, i.e. not hypertensive (diastolic BP not
> 90 mmHg) and no heart disease
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP. Do
not proceed if ergometrine / oxytocin not previously given
Midwife may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
IM
or
Stat
500 microgram /
Ampoule
IV (slowly)
250 microgram
1 mL
(IHW and IPAP
May be repeated once
may not administer IV)
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[11] [9]
Schedule
Ergometrine maleate
DTP
IHW / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
IM or IV
Stat
Adult only
Ampoule
10 mg / 2 mL
(IHW may
Further doses on
10 mg
not administer IV)
MO / NP order
Provide Consumer Medicine Information: not for use in patients with Parkinson's disease or children and
use with caution in women < 20 years of age
Management of associated emergency: dystonic reactions e.g. oculogyric crisis is extremely rare (unless
repeated doses or in children). If oculogyric crisis develops in an adult give benztropine 2 mg IM or IV
See Mental health behavioural emergencies
[4]
Schedule
Metoclopramide
NON
DTP
Misoprostol must be ordered by MO who has oversight of a Country Medical Superintendent or RFDS
Principal MO (oversight may be distant oversight)
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Tablet
200 microgram
Misoprostol
Per rectum
478
Uncontrolled
Controlled copy
copy
V1.0
Stat
[9]
Primary Clinical Care Manual 2013
5. Follow up
6. Referral / consultation
Consult MO urgently on all occasions of primary postpartum haemorrhage
2. Immediate management
3. Clinical assessment
T
ake complete history including:
-- details of delivery and completeness of placenta and membranes
Perform standard clinical observations
Perform physical examination including:
-- palpate abdomen for palpable uterus and tenderness
-- perform sterile speculum examination:
is blood coming through os?
is os open with products of conception protruding?
is there offensive cervical discharge?
-- if blood loss not heavy do an STI check
See Sexually transmitted infections (STIs)
Uncontrolled
Controlled copy
copy
V 1.0
479
4. Management
Consult MO
If os is open, heavy bleeding and / or products seen MO may advise:
-- removal of products with sponge forceps
-- commencement of IV antibiotics
-- evacuation / hospitalisation (may require curettage of retained products of
conception under general anaesthesia)
Keep nil by mouth
Monitor amount and rate of blood loss
If os is closed and fever or offensive cervical discharge MO may advise IV
antibiotics
If os is closed and bleeding not heavy, MO may advise oral antibiotics and advise
bed rest at home
5. Follow up
6. Referral / consultation
Consult MO on all occasions of secondary postpartum haemorrhage
Fetal distress
Rigid, white, thick perineum as head crowns
Delayed second stage
Instrumental delivery
Breech delivery
Prematurity
2. Immediate management
3. Clinical assessment
480
Physical examination including inspect the perineum, note elasticity and identifying
reason for performing episiotomy and document
Uncontrolled
Controlled copy
copy
V1.0
4. Management
Schedule
Lignocaine
DTP
Mid
Ampoule
Strength
1%
50 mg / 5 mL
Route of
administration
Recommended dosage
Duration
Local infiltration
Adult
up to max. of
3 mg / kg / dose to a total
max. infiltration of 200 mg
Stat
[12]
Repair of the perineum
Repair after birth of baby and delivery of placenta, unless bleeding perineum. May be
left for repair in receiving hospital
T
horoughly inspect the perineum and vaginal walls
I nfiltrate the perineum and vaginal wall with 1% lignocaine
W
ait until the area is anaesthetised before commencing the repair
Episiotomy
U
se 2.0 vicryl undyed suture material on biggest needle
5. Follow up
W
ash perineum daily and after opening bowels
Change perineal pads every 4 to 6 hours or more frequently if heavy lochia
Give advice on diet - at least 8 glasses of water / fluids per day and healthy diet
to prevent constipation
Avoid sexual intercourse until the perineal wound heals
6. Referral / consultation
Non Midwives consult MO on all occasions of impending birth where episiotomy
may be required
Uncontrolled
Controlled copy
copy
V 1.0
481
Neonatal resuscitation
[13]
Recommend
See Immediate management flowchart
If time allows always prepare neonatal resuscitation equipment items prior to delivery
in the order in which they would be used (see flowchart)
Effective ventilation is the key to successful neonatal resuscitation [13]. Ventilation
should be established before considering and administering neonatal naloxone
Never administer neonatal naloxone to the infant of a mother with opioid addiction (or
on methadone maintenance). Sudden reversal of chronic opioid action can cause
severe life-threatening withdrawal symptoms, including refractory seizures
Facilities where planned births occur are advised to refer to the Queensland Maternity
and Neonatal Clinical Guideline on Neonatal resuscitation [14] and all facilities are
advised to refer to the Queensland Maternity and Neonatal Clinical Guidelines on
Neonatal Stabilisation for Retrieval
Where the RFDS provides primary medical cover for a facility the RFDS MO on call
is the appropriate first point of medical contact. The MO will undertake assessment,
management and transfer with specialist as necessary (facilitated through Retrieval
Services Queensland 1300 799 127)
Background
Neonatal resuscitation equipment is required in all facilities in the event of unplanned
delivery
The most important interventions in neonatal resuscitation are ensuring the airway
is open
If the infant is not breathing, provide effective positive pressure ventilation
If a mother received opioids within 4 hours of birth, her newborn may experience
some degree of respiratory depression due to transplacental medication effect
Neonatal naloxone is not a resuscitation medicine
Unresponsive newborn
Newborn with low or absent HR
Newborn with poor colour - blue / white
Absent or poor respiratory effort
Newborn with poor muscle tone (limp)
Meconium
2. Immediate management
3. Clinical assessment
482
4. Management
Temperature
-- for term and near term newborn baby dry and remove wet linen
-- for very premature newborns
increase air temperature to 26C if possible
immediately after birth place the baby in a polyethylene bag (cover the
body only with plastic leaving head exposed) or under a polyethylene
sheet without drying and continue such care until temperature is stable
[14]. Examples of food or medical grade heat resistent plastic include
ziplock bag, oven bag, neo-wrap, plastic wrap
as soon as possible after the baby is born cover the head, as babies
lose most heat through their head. Do not cover baby's head with plastic
Uncontrolled
Controlled copy
copy
V 1.0
483
DTP
IHW / SM R&IP / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Midwife may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Neonate
Stat
Ampoule
0.4 mg / mL
IM or IV
0.1 mg / kg / dose Can be repeated every 2 - 3
to a max. of 0.4 mg minutes on MO / NP orders
Schedule
Naloxone hydrochloride
5. Follow up
M
other and baby should be subsequently managed in maternity service
It is important post birth to facilitate mother / baby attachment and initiate
The health of the neonate will determine follow up when returning home but will
For asymptomatic well baby with risk factors for hypoglycaemia [15]:
-- check BGL at 1, 2 and 4 hours of age and then every 4 - 6 hours until monitoring
is ceased (aim BGL is 2.6 mmol / L for 24 hours)
-- OR
-- pre second feed. This should be within 3 hours of birth, then check pre-feeds
until monitoring ceased (aim BGL is 2.6 mmol / L for 24 hours)
-- if BGL 1.5 - 2.5 mmol / L offer feed immediately, recheck BGL after 30 - 60
minutes
-- if BGL is persistently less than 2.0 mmol / L, MO will discuss with Neonatologist
6. Referral / consultation
484
Uncontrolled
Controlled copy
copy
V1.0
Yes
Stay with mother
Routine care
Prevent heat loss
Ongoing evaluation
No
Prevent heat loss
Ensure open airway
Stimulate
HR below 100?
Gasping or apnoea
No
No
Yes
Laboured breathing or
persistent cyanosis?
Yes
Positive pressure
ventilation
SpO2 monitoring
HR below 100?
Yes
Ensure open airway
Reduce leaks
Consider increasing
pressure and O2
HR below 60?
Yes
Add chest compressions 3 compressions to each breath
100% O2
Consider intubation or LMA
HR below 60?
Yes
Venous access
Adrenaline
Consider volume expansion
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
485
4. Management
486
ive paracetamol
G
Discuss possible causes with the mother, reinforcing appropriate breastfeeding
management and specific treatment strategies related to the identified cause
Continue to breastfeed baby
The baby can feed from the breast that is affected (but often this is too painful or
baby will refuse this breast)
If the baby is not feeding on the affected breast it should be expressed every
3 - 4 hours
With advice and support the mother can independently manage the condition
Assess mothers risk factors which may have contributed to occurrence e.g. nipple
trauma, maternal or neonatal infections, milk stasis, ineffective milk removal,
trauma and anaemia
Uncontrolled
Controlled copy
copy
V1.0
Encourage the mother to wear unrestrictive clothing and ensure that her bra, if
she wears one, is supportive but not tight
Encourage the mother to rest, drink to thirst and maintain a healthy diet
Apply warm packs just prior to, or during feeds and encourage gentle massage
DTP
IHW / SM R&IP / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife and Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
250 mg
Capsule
Oral
500 mg qid
5 days
500 mg
Provide Consumer Medicine Information: should be taken to 1 hour before food, considered safe for
breastfeeding women. Does not accumulate in breast milk and levels in breast milk are undetectable 6
hours after dosage. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[16]
Schedule
Flucloxacillin
DTP
IHW / SM R&IP / IPAP / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife and Scheduled Medicine Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
250 mg
Capsule
Oral
500 mg qid
5 days
500 mg
Provide Consumer Medicine Information: considered safe for breastfeeding women. Does not accumulate
in breast milk and levels in breast milk are undetectable 6 hours after dosage. Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[16]
Schedule
5.
Cephalexin
If a breast abscess is suspected consult MO. Incision and drainage under general
anaesthesia is usually necessary
Follow up
Uncontrolled
Controlled copy
copy
V 1.0
487
6. Referral / consultation
Postnatal check up
Recommend
It is recommended that the postnatal visit occurs at 6 weeks post delivery. However
the postpartum visit should be individualised to reflect the womans needs [17]
To be performed by experienced practitioner
Refer to current edition of Chronic Disease Guidelines - Diabetes in pregnancy
available at: www.health.qld.gov.au/cdg/default.asp
Related topics
488
Take complete birth history (from the woman plus discharge summary)
-- Specific enquiry on vaginal bleeding, perineal/caesarean wound pain,
tiredness, backache, urinary symptoms, bowel movements, rectal bleeding,
breast and nipple tenderness, sleep patterns and mood
-- Check antenatal record for Blood Group, if Rh Neg, confirm Anti D has been given
-- Confirm birth details - vaginal or caesarean delivery, gestation?
-- socioeconomic status
-- parity (primipara, completed family)
-- personal choice and previous experience with contraceptive methods
-- past medical history, present illness, family history
-- stability of relationship and need for protection against STI
Perform standard clinical observations + (Pap & OGTT if indicated)
Physical examination including
-- wound (if caesarean) or perineum
-- breasts and nipples (if indicated)
-- palpate uterine fundus (vaginal delivery only)
-- skin and hair
Uncontrolled
Controlled copy
copy
V1.0
4. Management
5. Follow up
6. Referral / consultation
Consult MO / Midwife
References
1.
National Institute for Health and Clinical Excellence ( 2008 (corrected)). "Intrapartum care: care of healthy
women and their babies during childbirth. National Collaborating Centre for Womens and Childrens
Health." Retrieved June, 2012, from www.nice.org.uk/nicemedia/pdf/CG55FullGuideline.pdf
2.
Therapeutic Guidelines (2012). "Nitrous oxide." Retrieved June, 2012.
3.
Therapeutic Guidelines (2012). "Parenteral opioids for labour pain." Retrieved June, 2012.
4.
Australian Medicine Handbook (2012). "Metoclopramide." Retrieved June, 2012.
5.
Australian Medicine Handbook (2012). "Oxytocin." Retrieved June, 2012.
6.
Queensland Maternity and Neonatal Clinical Guidelines Program (2010). "Breastfeeding initiation."
Retrieved June, 2012, from www.health.qld.gov.au/qcg/documents/g_bf5-0.pdf
7.
Australian Medicine Handbook (2012). "Vitamin K." Retrieved June, 2012.
8.
National Blood Authority (2003). "Guidelines on the prophylactic use of Rh D immunoglobulin (anti-D) in
obstetrics." Retrieved June, 2012, from www.nba.gov.au/pubs/pdf/glines-anti-d.pdf
9.
Queensland Maternity and Neonatal Clinical Guidelines Program (2012). "Primary postpartum
haemorrhage." Retrieved December, 2012
10. Perinatal Emergency Referral Service (2006). "Post Partum Haemorrhage." Retrieved August, 2012,
from www.pers.org.au/
11. Humphrey M.D, The Obstetrics Manual revised ed. 1999: McCraw-Hill Book Company.
12. Therapeutic Guidelines (2013). "Acute postoperative pain: regional and local administration of local
anaesthetics and opioids." Retrieved March, 2013
13. Australian Resuscitation Council (2010). "Airway Management and Mask Ventilation of the Newborn
Infant. Guideline 13.4 ". Retrieved June, 2012.
14. Queensland Maternity and Neonatal Clinical Guidelines Program (2011). "Neonatal resuscitation."
Retrieved June, 2012, from www.health.qld.gov.au/qcg/documents/g_resus5-0.pdf
15. Queensland Maternity and Neonatal Clinical Guidelines Program (2010). "Neonatal hypoglycaemia and
blood glucose level monitoring." Retrieved June, 2012, from
www.health.qld.gov.au/qcg/documents/g_hypogly5-0.pdf
16. Therapeutic Guidelines (2012). "Mastitis." Retrieved June, 2012.
17. Piejko E. (2006). "The postpartum visit. Why wait 6 weeks?" Australian Family Physician 35(9): 674 678.
18.
MiMS (2013). "Morphine sulfate injection." Retrieved July, 2013.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
489
Contraception
Contraception adult
Recommend
This section is based on Family Planning New South Wales (FPNSW), Family
Planning Queensland (FPQ), Family Planning Victoria (FPV) Contraception: An
Australian Clinical Practice Handbook 3rd edition 2012. Please refer to Contraception
Handbook for comprehensive information for the safe supply of contraception
Contraception is always initiated by MO / NP
Recommend simultaneous use of condoms and other contraception methods for
protection against HIV and other STIs when a risk of STI / HIV transmission exists [1]
Background
Properly used, contraception reduces the rate of fertility to between < 1% (sterilisation,
implants and injectable progestogen) and 25% (coitus interruptus)
Even methods with higher failure rates can help with birth spacing
Related topics
Sexually transmitted infections (STIs)
Health check - women
490
Contraception
Hormonal contraception
-- combined hormonal contraception ("The Pill" or vaginal ring NuvaRing)
-- progestogen only Pill (Mini-pill)
-- long-acting hormonal contraception
injectable progestogen (Depo-Provera, Depo-Ralovera)
progestogen releasing subdermal implant (Implanon)
progestogen releasing intrauterine device or system (Mirena)
intrauterine contraceptive device (IUCD)
-- emergency hormonal contraception
Barrier methods
-- condom (male and female), diaphragm
Sterilisation
-- tubal sterilisation, vasectomy
Natural methods
-- fertility awareness based methods
-- coitus interruptus (withdrawal)
-- lactational amenorrhoea
-- abstinence
The WHO and UK Medical Eligibility Criteria (MEC) for contraceptive use takes
into account a patients personal characteristics (age, history of pregnancy) and
a patient's pre-existing medical conditions (e.g. diabetes, hypertension) [5]
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
491
Contraception
5. Follow up
Information on what to do if contraceptive method fails
When to return for clinical follow up
6. Referral / consultation
MO / NP for assessment and prescription
Referral to MO / specialist with skills for contraceptive implants, IUCD and
sterilisation
492
Initial assessment by MO / NP
Clinical assessment See Contraception including:
-- contraception needs
-- methods of contraception available
-- choice of contraception
-- WHO / UKMEC for contraceptive use
-- pregnancy test where indicated (a negative test does not always exclude
pregnancy and recent conception)
-- BP, weight, BMI
-- menstrual pattern
Uncontrolled
Controlled copy
copy
V1.0
Contraception
Medical condition
Breastfeeding and less than 6 weeks postpartum
Migraine with aura at any age
Ischaemic heart disease, stroke, TIA (current or past)
Smoking 15 cigarettes / day in a woman aged 35 years
BP systolic 160 or diastolic 95 mmHg
Vascular disease
Diabetes with vascular complications or of > 20 years
History of VTE / currently on anticoagulants
Known thrombogenic mutation
Major surgery with prolonged immobilisation
Breast cancer
Active viral hepatitis, severe decompensated cirrhosis,
hepatocellular adenoma or carcinoma
SLE with positive (or unknown) antiphospholipid antibodies
Raynaud's disease with lupus anticoagulant
Medical condition
Uncontrolled
Controlled copy
copy
V 1.0
493
Contraception
494
Interactions
-- liver enzyme inducing medicines which may render the pill and other hormonal
contraceptives less protective:
most anticonvulsants
many antiretroviral medicines used for HIV management
rifampacin, rifamycin
some herbal products e.g. St Johns Wort See Depression
-- additional contraceptive precautions are not required during or after courses
of antibiotics that do not induce liver enzymes. Detailed information on
medication interactions with hormonal contraceptives can be obtained from
Australian Contraception Handbook [5], MO / NP / Family Planning Qld /
Pharmacist or Drug interactions with hormonal contraception [2] available at:
www.fsrh.org/
Side effects:
-- unscheduled bleeding
-- nausea
-- breast tenderness
-- acne (usually improves)
-- headache
-- reduced libido
-- mood changes
-- weight gain
-- chloasma
-- amenorrhoea
Uncontrolled
Controlled copy
copy
V1.0
Contraception
Additional device related side effects reported by users of the vaginal ring are
-- increased vaginal discharge
-- device discomfort
-- expulsion of the ring
-- discomfort for either partner during sex
4. Management
Confirm that it is less than 12 months since last MO / NP assessment for oral
contraceptive pill prescription
Form
Strength
DTP
IHW / SRH
Route of
administration
Management of associated emergency: signs of DVT / PE with sudden pain and swelling of leg or increased
shortness of breath and chest pain
[3]
Vaginal ring e.g. NuvaRing is a soft plastic ring which is inserted into the vagina.
It contains oestrogen and progestogen and is 99% effective when used properly. A
new ring is inserted into the vagina every 4 weeks. After insertion the ring is left in
place for 3 weeks, then removed and a new ring inserted a week later [4]. Women
who request a vaginal ring will be assessed for suitability by MO / SRH / NP
Uncontrolled
Controlled copy
copy
V 1.0
495
Contraception
Yes
Take the pill most recently missed
straight away
This may mean 2 pills in one day
Any other missed pills can be
discarded
Use condoms for 7 days
No
Take the pill straight away
This may mean 2 pills in one day
The pill will continue to work
496
Uncontrolled
Controlled copy
copy
V1.0
Contraception
5. Follow up
Patients should be reviewed after the first 3 - 4 cycles on the pill or ring to:
-- check BP
-- discuss side effects and review any problems in pill taking or ring use
Patients on the combined oral contraceptive pill or ring should be followed up
every 12 months by an MO / NP
6. Referral / consultation
MO / NP
Uncontrolled
Controlled copy
copy
V 1.0
497
Contraception
Initial assessment by MO / NP
Clinical assessment See Contraception including:
-- contraception needs
-- method of contraception available
-- choice of contraception
-- WHO / UKMEC for contraceptive use
498
Uncontrolled
Controlled copy
copy
V1.0
Contraception
Medical condition
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
499
Contraception
Missed pills
-- if any more than 3 hours late with a progestogen only pill (POP) (27 hours
or more since last one taken) contraceptive efficacy will be lost for the next
48 hours so the pill is considered missed. If a pill is missed take it as
soon as possible and the next one at the normal time. Advise abstinence or
additional methods of contraception during the next 48 hours (3 consecutive
pills) and emergency contraception if any unprotected intercourse takes place
Lactation
-- excreted in breast milk. Dosage to infant is extremely small and not found
to affect milk quality, quantity or infant growth or development. Suitable for
breastfeeding women
Vomiting and / or severe diarrhoea
-- due to the risk of incomplete absorption, additional methods of contraception
should be used during the illness and for 48 hours (3 consecutive
pills) following
Interactions - medicines which may render the pill less protective
-- see Combined hormonal contraception
-- antibiotics do not affect the absorption of the progestogen only pill
-- detailed information on drug interactions with hormonal contraceptives can
be obtained from the Australian Contraception Handbook [5], Family Planning
Queensland or Drug Interactions with Hormonal Contraception [2] available
at: www.fsrh.org/
-- the progestogen only pill is not recommended in those taking liver enzyme
inducing medicines
Irregular vaginal bleeding
-- irregular vaginal bleeding is a known side effect of progestogen only pill.
Troublesome spotting occurs in some women. In this instance consult MO
and refer the patient to the next MO clinic as necessary. Other causes of
abnormal bleeding, particularly pregnancy, cervical pathology (polyps, cancer)
or infection related bleeding need to be considered
5. Follow up
6. Referral / consultation
MO / NP
Contraception
500
Contraception
Medical condition
501
Contraception
4. Management
Schedule
DTP
IHW
502
Irregular vaginal bleeding is not common with the use of injectable progestogen
contraception. However, bleeding history should be checked before each
dose is given. If any doubt about normality of bleeding pattern perform
Health check - women and refer to MO / NP
Some patients may experience side effects such as weight gain, breast tenderness
and mood change with injectable hormonal contraception, but the incidence is
low. Patients who experience side effects require review by an MO / NP
Interactions
-- liver enzyme inducing medicines including antiretrovirals do not affect the
efficacy of depot medroxyprogesterone acetate. It is therefore a good choice
of contraception for women taking these medicines
Uncontrolled
Controlled copy
copy
V1.0
Contraception
5. Follow up
months by an MO
Delayed return of fertility and amenorrhoea may occur after discontinuing
treatment. This is normal and in the vast majority normal fertility and normal
periods will return within a year. If in doubt consult MO / NP or refer to next
MO clinic
6. Referral / consultation
MO / NP
Uncontrolled
Controlled copy
copy
V 1.0
503
Contraception
Taking medicine that interferes with hormonal contraception and unprotected sex
has occurred in appropriate time frame for emergency contraceptive pill (ECP)
Medical condition
There are no evidence based strong contraindications to hormonal
emergency contraception [5]
Medical condition
Current DVT / PE
Breast cancer (current or past)
Inflammatory bowel disease affecting absorption
Acute intermittent porphyria
4. Management
504
Uncontrolled
Controlled copy
copy
V1.0
Contraception
DTP
IHW / IPAP / SRH / Mid
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Midwife and Sexual and Reproductive Health Program Authorised Registered Nurse may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Recommended
Form
Strength
Duration
administration
dosage
Stat
Within 72 hours (3 days) of the
Tablet
1.5 mg
Oral
1.5 mg
first episode of unprotected
sexual intercourse
Note: Approved for use up until 72 hours after unprotected sexual intercourse: there is proven effectiveness
up until 96 hours (4 days). It may be provided up until 120 hours however there is a five times increase in
the risk of pregnancy if it is given on the fifth day if compared with administration within the first 24 hours
Provide Consumer Medicine Information: the dose should be repeated (with the addition of an antiemetic)
if vomiting occurs within 2 hours of it being administered. Vomiting more than 2 hours after either dose
is not considered to affect effectiveness. This medicine is affected by liver enzyme inducing medicines.
Women who are currently taking or have ceased a liver enzyme inducing medicine within 28 days should
be advised to use a 3 mg dose [5].
Management of associated emergency: consult MO
[8]
Schedule
Levonorgestrel
5. Follow up
All patients require follow up to exclude pregnancy and STI, if at risk, at the MO
6. Referral / consultation MO / NP
Diaphragm adult
Soft non latex device which acts as a cervical barrier. Placed over the cervix before
intercourse and left in place for at least 6 hours after intercourse
Needs to be fitted by a trained Health Care Worker who will assess the woman, fit the
correct size device and teach the woman how to insert and remove it
Manufacturer's advice is to use with spermicidal creams however these creams are not
currently available in Australia
Failure rates higher than other methods. Typical use efficacy rate is 88% [5]
Size of diaphragm needs to be reassessed with an increase or decrease in weight of
3 or more kilograms
Diaphragms should be checked for deterioration. With proper care they may last up
to 2 years
Uncontrolled
Controlled copy
copy
V 1.0
505
Contraception
Uncontrolled
Controlled copy
copy
V1.0
Contraception
Sterilisation adult
Uncontrolled
Controlled copy
copy
V 1.0
507
Contraception
-- sperm is in pre-cum which lubricates the penis before ejaculation and can
remain alive in the female genital tract for several days
Lactational amenorrhoea
-- can be 98% effective as contraceptive for up to 6 months after childbirth as
long as remain amenorrheic and fully breastfeeding
-- must be fully breastfeeding (no complements of milk or solids) and regularly
breastfeeding including night feeds
-- ovulation occurs before the first menstrual bleed, so care must be taken with
this method
References
1.
Queensland Government, Queensland Sexual Health Clinical Management Guidelines 2010,
Queensland Health: Brisbane.
2.
Faculty of Sexual and Reproductive Healthcare Clinical Guidance (2011 (Updated January 2012)).
"Drug Interactions with Hormonal Contraception." Retrieved August, 2012, from www.fsrh.org/
3.
Therapeutic Guidelines (2012). "Combined oral contraception." Retrieved August, 2012.
4.
Family Planning Queensland (2012). "The contraceptive vaginal ring - NuvaRing." Retrieved August,
2012, from www.fpq.com.au/publications/fsBrochures/Fs_NuvaRing.php
5.
Family Planning New South Wales (FPNSW) Family Planning Queensland (FPQ) Family Planning
Victoria (FPV) (2012). Australia Contraception: An Australian Clinical Practice Handbook 3rd edition.
6.
Family Planning Queensland (2011). "DMPA-Depo medroxyprogesterone acetate." Retrieved July,
2012, from www.fpq.com.au/pdf/Fs_DMPA.pdf
7.
Australian Medicine Handbook (2012). "Medroxyprogesterone." Retrieved August, 2012.
8.
Therapeutic Guidelines (2012). "Postcoital (emergency) contraception." Retrieved July, 2012.
508
Uncontrolled
Controlled copy
copy
V1.0
Symptomatic cases and contacts of individuals with a known STI must be treated
at first presentation (presumptive treatment). Do not wait for pathology results
Timely (immediate) contact tracing and treatment of sex partners is essential to
avoid reinfection
People diagnosed with chlamydia or gonorrhoea need to be re-screened at 3
months as one third of patients will be reinfected
If someone tests positive for an STI, offer testing for other common STIs, and for
HIV, hepatitis B and hepatitis C See Investigations / testing
Pelvic inflammatory disease (PID) must be considered in the presence of low
abdominal pain in sexually active women in whom other causes have been
excluded See Low abdominal pain in female - adult
For a patient with genital sores, always call the Public Health Nurse, Syphilis
Register for advice on 1800 032 238 or email
North-Qld-Syphilis-Surveillance-Centre@health.qld.gov.au
Asymptomatic screening is important and should be offered annually in high risk
populations or where prevalence rates are high
Uncontrolled
Controlled copy
copy
V 1.0
509
When
Annually
(at a minimum)
What
chlamydia
gonorrhoea
trichomonas
syphilis
chlamydia
510
Uncontrolled
Controlled copy
copy
V1.0
Perform examination
If a patient has no symptoms and is not a contact, examination is often not
necessary
The extent and nature of the examination depends on the history and may include:
-- the mouth, the skin (rash), lymph nodes for swelling or tenderness
-- the abdomen for tenderness See Acute abdominal pain and
Low abdominal pain in female - adult
-- the external genitalia including the perianal area for rashes, lumps, sores or
skin splits
-- in men - urethra for discharge and inflammation. Testes and epididymis for
tenderness or swelling
-- women - vulva / vagina / cervix for inflammation, discharge, bleeding
-- bi-manual examination for tenderness and masses (if practitioner experienced)
Take tests / investigations for STIs
All STI testing must be done with the patient's knowledge and informed consent.
Pre-test information and discussion is particularly important in relation to HIV
testing See HIV infection
The local Sexual Health Service will provide advice if needed
A full STI check includes tests / investigations for
Chlamydia
Gonorrhoea
Trichomonas
Syphilis
HIV
Hepatitis B* (if not immune)
Hepatitis C (also offered for surveillance purposes)
If there is a genital sore, in addition to the above, collect tests for genital ulcer
disease (GUD) See Genital sores / ulcers
STI tests should be appropriate to the sex acts performed (oral, anal, vaginal) e.g. men
who have sex with men (MSM), also take throat swabs (chlamydia / gonorrhoea PCR
and culture and sensitivity) and anal swabs (chlamydia / gonorrhoea PCR and MC/S)
*Hepatitis B immune status should be established and vaccination offered if not immune and not
chronically infected See Hepatitis. If immune or documented to be fully vaccinated, it is not necessary
to repeat at each STI check. If chronically infected see current edition of the Chronic Disease
Guidelines for recommended monitoring available at www.health.qld.gov.au/cdg/default.asp
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
511
Blood test
2 x serum gel tubes of blood
OR
Has discharge from penis
(self collected or
by health care provider)
3 x external urethral swabs for:
-- dry swab for gonorrhoea
and chlamydia PCR
-- dry swab for trichomonas
PCR
-- charcoal swab and slide for
MC/S (gonorrhoea)
(Do not insert swab into urethra.
Milk penis, so discharge visible)
and
Uncontrolled
Controlled copy
copy
V1.0
OR
First Catch Urine (FCU)
(self collected)
For chlamydia, gonorrhoea
trichomonas PCR
-- 20 - 30 mL of first part of
stream of urine
Pathology form: include clinical notes e.g. relevant history, symptoms of STI, or routine asymptomatic screen. Ensure
Aboriginal and Torres Strait Islander status is ticked where appropriate (for health planning). First part of stream.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
513
STI management
Medication management
Symptomatic cases and contacts of individuals with a known STI must be treated
at first presentation (presumptive treatment). Do not wait for pathology results
Once only treatment is highly effective for chlamydia / gonorrhoea. Proof of
cure test is not necessary
If single dose treatments are used, watch the patient take the medicine and
document this in the medical record
All STI pathology must be followed up / reviewed and treated within one week of
testing
Check for allergies prior to treatment e.g. to penicillin, or other beta-lactam
antibiotics (includes ceftriaxone), the quinolones (includes ciprofloxacin), the
erythromycin group of antibiotics (includes azithromycin) or to metronidazole
Contact tracing / partner notification
Timely (immediate, on day of presentation) contact tracing and treatment of sex
partners is essential to avoid reinfection
Contacts of individuals with a known STI must be treated on the day of presentation.
Do not wait for pathology results
How to perform contact tracing
The aims of contact tracing are:
-- to prevent reinfection
-- to identify individuals who may be infected and would benefit from treatment
-- to interrupt on-going transmission of disease
Confidentiality of all parties must be maintained
-- names of all contacts from the previous 6 months or as relevant to STI
-- the name of the index case must never be disclosed to the contacts
-- document in the contacts medical record that they need immediate
treatment for the diagnosed STI and testing for the other common STI
-- do not write the name of the index case in the contacts medical record, do
not write the name of the contact in the medical record of the index case
-- the patient may choose to inform their contacts themselves or may want
the clinic staff to do this
-- if clinic staff are initiating contact tracing, three attempts (telephone or home
visits) should be made and documented
-- notify the appropriate health service staff if a named contact is outside your
health centres area
-- maintain an information system to track notification and treatment of contacts
as applies in your region
-- consult the MO, Sexual Health Clinic or Contact Tracing Support Officer if
you need advice or help with contact tracing:
Far North Queensland 07 4226 4777
Townsville, Mackay, Mount Isa 07 4778 9600
Sunshine Coast, Wide Bay, Central Queensland 07 5470 5244
Brisbane Metro North 07 3837 5611
Brisbane Metro South, Gold Coast, West Moreton, Darling Downs and South
West 07 3176 7587
514
Uncontrolled
Controlled copy
copy
V1.0
STI follow up
Encourage follow up one week after presentation / treatment
-- check:
adherence with medication and symptom resolution
check test results: STI results (especially HIV) should be given in person
ask again about sex partner(s) and check if sexual partner(s) have
been tested / treated - contact tracing is essential to avoid reinfection
reinforce education and prevention information and check condoms
supplied
encourage patient to present for a check any time they get symptoms or
are at risk of STI e.g. new partner See When to test for STIs
Every patient with an STI diagnosis should have an STI check at 2 to 3 months
after initial treatment
-- about one third are re-infected at 3 months, often because their partner was
not treated
-- patients treated for infectious syphilis e.g. syphilis of less than 2 years duration,
should be tested at 3 - 6 months and at 12 months See Syphilis
-- HIV test should be offered at the time of initial STI diagnosis, however a
repeat test may be needed at 6 weeks - after the window period
See HIV infection
Uncontrolled
Controlled copy
copy
V 1.0
515
Vaginal discharge
Urethral (penile)
discharge / dysuria
Patient has a
symptom of an STI
Genital sores
Pain / swelling
in testes
See Epididymo-orchitis
Signs and / or
symptoms of syphilis
See Syphilis
Chlamydia
Patient has a positive
pathology test
Gonorrhoea
OR
Trichomonas
Syphilis
See Syphilis
HIV
Genital herpes
and / or donovanosis
Genital herpes
and / or donovanosis
Patient is a sexual
contact of someone with
symptoms of an STI
Vaginal discharge
Urethral (penile)
discharge / dysuria
516
Uncontrolled
Controlled copy
copy
V1.0
See Syphilis
Recommend
Treat for chlamydia, gonorrhoea, trichomonas, if a man has a urethral discharge or
dysuria, or a woman presents with vaginal discharge (the cause of vaginal discharge
is difficult to diagnose on clinical examination alone)
If symptomatic or a contact of a patient with a known STI, treat at first presentation
(presumptive treatment - do not wait for pathology results)
Timely (immediate) contact tracing and treatment of sex partners is essential to
avoid re-infection
Ciprofloxacin is not recommended as a first line treatment. Do not offer unless
injection is refused / contraindicated. Ciprofloxacin should not be used in MSM
or gonorrhoea acquired overseas
Background
Chlamydia, gonorrhoea and trichomonas are often asymptomatic or the symptoms
go unrecognised
The most likely cause of a urethral discharge in a man is chlamydia and / or
gonorrhoea
10 - 15% of women with untreated chlamydia or gonorrhoea will develop an upper
genital tract infection (pelvic inflammatory disease) which usually presents with low
abdominal pain
Chlamydia and gonorrhoea can damage the fallopian tubes increasing the risk of
ectopic pregnancy and infertility
Trichomonas is an STI that may persist in women for years (in men probably up to
4 months) [14]
Related topics
Low abdominal pain in female How to do an STI check
- adult
STI specimen collection - blood test, male, female
Epididymo-orchitis
Contact tracing / partner notification
Asymptomatic
-- positive pathology result for chlamydia and / or gonorrhoea and / or trichomonas
-- named contact of someone with chlamydia, gonorrhoea, trichomonas, PID,
epididymo-orchitis
Symptoms
-- men:
a urethral (penile) discharge and / or pain or dysuria
-- women:
creamy yellow or blood stained vaginal discharge or cervix bleeds easily
when swabbed
abnormal bleeding: intermenstrual bleeding (IMB) or post coital (after
sex) bleeding (PCB)
low abdominal pain (PID) which may be mild to severe (acute abdomen)
or pain with penetrative sex
PV bleeding during pregnancy: threatened miscarriage, preterm rupture
of membranes, preterm labour, neonatal infection or postpartum infection
inflammation of the vulva and vaginal walls which may cause soreness
or itching. White or green vaginal discharge which is typically frothy
and has a fishy odour (typical of trichomonas)
Occasionally may present acutely ill with single or multiple painful / inflamed joints
(possible disseminated gonococcal infection)
Uncontrolled
Controlled copy
copy
V 1.0
517
Obtain patient history and offer an examination See How to do an STI check
Perform standard clinical observations
If symptomatic test for: See STI specimen collection
-- chlamydia, gonorrhoea, trichomonas
-- also offer testing for syphilis, HIV, hepatitis B, hepatitis C
-- additionally for women:
urine pregnancy test on all women of childbearing age (12 - 52 years)
urinalysis - if nitrites positive send MSU for MC/S
if the woman complains of low abdominal pain or experiences pain
during the examination or complains of pain during sexual intercourse
assess for pelvic inflammatory disease (PID)
See Low abdominal pain in female - adult
Pap smear if due See Pap smear collection
If patient has been recalled due to positive pathology result or is a named contact
of a patient with a known STI, offer full STI screen See How to do an STI check
4. Management
518
Contact MO on any occasion patient presents acutely ill and with single or multiple
painful / inflamed joints (possible disseminated gonococcal infection). Will require
emergency hospital admission and IV antibiotics
Medication management
-- treat at this presentation (presumptive treatment). Do not wait for pathology
results
symptomatic cases (vaginal discharge / penile discharge or dysuria in
men)
contact(s) of patient with chlamydia, gonorrhoea, trichomonas
people with a positive pathology test for chlamydia, gonorrhoea or
trichomonas
-- check for allergies and treat as per the following table
-- observe the patient taking the medication
Perform timely (immediate) contact tracing and treatment of sex partners which is
essential to avoid reinfection See Contact tracing / partner notification
-- get sexual contact(s) from previous 6 months [14]
-- if trichomonas only on pathology result, treat current partner only
Provide education and prevention and condoms See How to do an STI check
-- advise to abstain from sex until course of treatment is finished and 3 days
after partner has been treated
Uncontrolled
Controlled copy
copy
V1.0
Presents with
Treat for
Vaginal discharge or
penile discharge and / or dysuria
in men
azithromycin
Trichomonas
metronidazole (or tinidazole)
(if pregnant discuss need for
treatment of trichomonas with MO)
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg
Azithromycin
Oral
1g
Stat
[1]
519
Uncontrolled
Controlled copy
copy
V 1.0
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
1g
IM
500 mg
(dilute in 3.5 mL
Vial
deep intragluteal
Stat
1% lignocaine)
(2 mL)
injection
= 4 mL solution
Provide Consumer Medicine Information:
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[1]
Schedule
Ceftriaxone
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
250 mg
500 mg
Ciprofloxacin
Oral
500 mg
Stat
Provide Consumer Medicine Information: take on an empty stomach. Consumption of dairy products, iron
or calcium will reduce absorption of ciprofloxacin
Management of associated emergency: consult MO
[3]
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicine Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
200 mg
Stat
Tablet
Oral
2g
400 mg
Provide Consumer Medicine Information: avoid alcohol while taking and for 24 hours after taking this
medicine. Take with or immediately after food
Management of associated emergency: consult MO
[4]
Schedule
520
Metronidazole
Uncontrolled
Controlled copy
copy
V1.0
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg
Tinidazole
Oral
2g
Stat
Provide Consumer Medicine Information: take with food. Avoid alcohol while taking and for 72 hours
Management of associated emergency: consult MO
[4]
5. Follow up
6. Referral / consultation
Consult MO as above if allergic, pregnant or if symptoms have not resolved
following treatment
Laboratory report from the high vaginal swab notes the presence of clue cells
(asymptomatic infection)
Vaginal discharge that is typically thin, white or grey and has a fishy odour
(similar to trichomonas but not frothy and vaginal walls are not inflamed)
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
521
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
200 mg
Tablet
Oral
400 mg bd
7 days
400 mg
Provide Consumer Medicine Information: avoid alcohol while taking and for 24 hours after taking this
medicine. Take with or immediately after food. Take until course completed
Management of associated emergency: consult MO
[5]
Or clindamycin vaginal cream. Is safe in pregnancy
Schedule
Metronidazole
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Vaginal
1 full applicator
2%
Vaginal
7 nights
cream
nocte
Provide Consumer Medicine Information: store below 25C, cream may damage condoms during treatment
period and for up to 72 hours after course has finished. Complete course
Management of associated emergency: consult MO
[5]
Schedule
5. Follow up
Not required
6. Referral / consultation
Consult MO if recurrent or severe
522
Uncontrolled
Controlled copy
copy
V1.0
4. Management
DTP
IHW / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Sexual and Reproductive Health Program Authorised Registered Nurse may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Pessary
100 mg
1 pessary /
applicator nocte
6 nights
Cream
1%
Provide Consumer Medicine Information: use once daily, preferably in the evening for 6 successive days.
1 applicator should be filled with cream and inserted as deeply as possible into the vagina with the patient
lying on her back. Complete course
Management of associated emergency: consult MO
[6]
Vaginal
Uncontrolled
Controlled copy
copy
V 1.0
523
5.
Follow up
Not required
6. Referral / consultation
Consult MO if symptoms are recurrent or severe
Epididymo-orchitis adult
Recommend
Torsion of the testes is a medical emergency and must be excluded
See Testicular / scrotal pain
Ciprofloxacin is not recommended as a first line treatment and should only be used
if injection is refused. Ciprofloxacin should not be used in MSM or gonorrhoea
acquired overseas
Background
Epididymo-orchitis may occur as a result of infection with STI (gonorrhoea or
chlamydia) or urinary tract infections
If due to STI, treatment of sexual contacts is essential to prevent reinfection
Related topics
Urinary tract infection - adult
Chlamydia / gonorrhoea /
trichomonas
4. Management
524
Bed rest
Perform timely (immediate) contact tracing and treatment of sex partners. This
is essential to avoid reinfection
Provide education and prevention and condoms See How to do an STI check
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg
Azithromycin
Oral
1g
Stat
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
1g
IM
(dilute in 3.5 mL 1%
500 mg
Vial
deep intragluteal
3 days
(2 mL)
lignocaine)
injection
= 4 mL solution
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[2]
Schedule
Ceftriaxone
Uncontrolled
Controlled copy
copy
V 1.0
525
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
250 mg
500 mg
Ciprofloxacin
Oral
500 mg
Stat
Provide Consumer Medicine Information: take on an empty stomach. Consumption of dairy products, iron
and calcium will reduce absorption of ciprofloxacin
Management of associated emergency: consult MO
[3]
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicine Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet /
capsule
50 mg
100 mg
Doxycycline
Oral
100 mg bd
14 days
Provide Consumer Medicine Information: take with food. Do not take at same time as iron, calcium or
antacids. Avoid excess exposure to sunlight - can cause photosensitivity. Take until course completed
Management of associated emergency: consult MO
[2]
526
Uncontrolled
Controlled copy
copy
V1.0
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg
Azithromycin
Oral
1g
Stat
[2]
5. Follow up
Early follow up is important if MO decides to treat as acute epididymo-orchitis and
6. Referral / consultation
Consult MO on all occasions epididymo-orchitis is suspected
Uncontrolled
Controlled copy
copy
V 1.0
527
Recommend
Consult MO urgently if patient is ill with board-like rigidity of abdomen - severe case
Consider ectopic (tubal) pregnancy in all women who present with abdominal pain
and / or vaginal bleeding whether or not the woman suspects she is pregnant
Diagnosis of PID is clinical. Do not wait for pathology results. Response to treatment
confirms the diagnosis
PID must be considered in the presence of low abdominal pain in sexually active
women in whom other causes have been excluded
Ciprofloxacin is not recommended as a first line treatment and should only be used if
injection is refused. Ciprofloxacin should not be used in gonorrhoea acquired overseas
Background
Low abdominal pain due to PID may range from mild (with no other symptoms) to
severe (acute abdomen)
PID in early pregnancy may present as a threatened miscarriage (pain +/- bleeding)
While laboratory tests may help, negative results do not exclude PID
Related topics
Chlamydia / gonorrhoea /
trichomonas
Urinary tract infection in pregnancy
Urinary tract infection - adult
2. Immediate management
3. Clinical assessment
528
Clues to diagnosis
If pregnant, an ultrasound will confirm or exclude a viable
intrauterine pregnancy
PID may be the cause of threatened miscarriage in early
pregnancy
See Urinary tract infection in pregnancy and
See Vaginal bleeding in early pregnancy
PID is likely if:
-- low abdominal pain alone is present
-- the woman is sexually active, of reproductive age and living in
an area where gonorrhoea and chlamydia are common
-- pain responds quickly to appropriate antibiotic treatment
UTI is likely if:
-- urinary frequency / dysuria are present or
-- nitrites are positive
See Urinary tract infection - adult
Appendicitis usually presents with a typical history (pain
moves from umbilicus to RIF, associated low grade fever,
anorexia, nausea)
Pelvic adhesions and endometriosis can only be diagnosed
by laparoscopy
Uterine fibroids and diverticulitis are uncommon in women
aged < 40
See Acute abdominal pain
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
529
Perform timely (immediate) contact tracing and treatment of sex partners which
is essential to avoid reinfection
Provide education and prevention and condoms See How to do an STI check
medicines and the need for early follow up for patient and partner(s)
after partner has been treated
Treat with azithromycin
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg
Azithromycin
Oral
1g
Stat
And ceftriaxone
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
1g
IM
500 mg
(dilute in 3.5 mL
Vial
deep intragluteal
Stat
1% lignocaine)
(2mL)
injection
= 4 mL solution
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[7]
Schedule
530
Ceftriaxone
Uncontrolled
Controlled copy
copy
V1.0
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
250 mg
Stat
Tablet
Oral
500 mg
500 mg
Provide Consumer Medicine Information: take on an empty stomach. Consumption of dairy products, iron
or calcium will reduce absorption of ciprofloxacin
Management of associated emergency: consult MO
[3]
Schedule
Ciprofloxacin
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicine Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
200 mg
Tablet
Oral
400 mg bd
14 days
400 mg
Provide Consumer Medicine Information: avoid alcohol while taking and for 24 hours after taking this
medicine. Take with or immediately after food. Take until course completed
Management of associated emergency: consult MO
[7]
Schedule
Metronidazole
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Tablet /
50 mg
Oral
100 mg bd
14 days
capsule
100 mg
Provide Consumer Medicine Information: take with food. Do not take at same time as iron, calcium or
antacids. Avoid excess exposure to sunlight - can cause photosensitivity. Take until course completed
Management of associated emergency: consult MO
[7]
Schedule
Doxycycline
Uncontrolled
Controlled copy
copy
V 1.0
531
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Tablet
500 mg
Azithromycin
Oral
1g
Stat
5. Follow up
Follow up at 1 - 2 days
6. Referral / consultation
Consult MO on all occasions of acute abdominal pain, abnormal vaginal bleeding
for pelvic ultrasound and laparoscopy to assess for ovarian masses, adhesions
and endometriosis
532
Uncontrolled
Controlled copy
copy
V1.0
Typical sores
Painful?
Enlarged lymph
nodes?
Syphilis
Primary
Painful skin splits or (chancre) one or
Solid lumps, may
cluster of blisters, few sores, 1 - 2 cm
be smooth or warty,
which break down with well defined
asymmetrical,
to form small
edges
no ulceration and
shallow ulcers, with Secondary
no inflammation of
irregular borders
(condylomata lata)
surrounding skin
Surrounding skin
multiple, often
may be inflamed
peri-anal skin,
symmetrical and flat
No
Painful or itchy
Usually painless
Donovanosis
No
No
Heals without
treatment?
No
Treatment
Genital warts
Podophyllotoxin
Exclude syphilis
before treating
See Genital warts
Genital herpes
Yes / No
Yes
within 1 - 2 weeks
but usually recurs
Genital herpes
Valaciclovir
Uncontrolled
Controlled copy
copy
V 1.0
Yes / No
Commences as
one or more sores
or nodules and may
join to form large
destructive ulcers
which are beefy red
and bleed easily
Usually painless
Yes
primary sores within
No, continues to
2 - 3 weeks,
become larger over
secondary sores
time
may come and go
over 12 months
Syphilis
Donovanosis
Always commence treatment for both on
clinical presentation with
Bicillin LA for syphilis and azithromycin
for donovanosis
533
2.
3.
Clinical assessment
4. Management
534
Uncontrolled
Controlled copy
copy
V1.0
Review patient in one week check lesion, all laboratory results and that contacts have been traced and treated
Uncontrolled
Controlled copy
copy
V 1.0
535
Complete the genital ulcer notification report and fax / scan / email immediately
to the Syphilis Register 07 4031 1440 or
North-Qld-Syphilis-Surveillance-Centre@health.qld.gov.au
Consult Syphilis Register or specialist MO regarding the likely diagnosis and
ongoing management
Medication management at time of presentation
-- check allergies and observe the patient taking oral medicine
Treatment
Lesions not typical of herpes and
Treat for both syphilis and
syphilis or donovanosis is likely or
donovanosis
if unsure
Consult MO before starting
treatment if pregnant
Lesions typical of genital herpes
Keep lesions dry with salt baths
and topical Betadine solution
Donovanosis
Treat for donovanosis
Perform timely (immediate) contact tracing and treatment of sex partners which
is essential to avoid reinfection See Contact tracing / partner notification
-- syphilis - trace, treat and investigate sexual contacts (usually up to 12 months)
according to the advice of the Syphilis Register
-- herpes - contact tracing is not necessary, however partner(s) may need to be
counselled regarding the infection
-- donovanosis - contacts should be examined and have a complete STI check
Provide education and prevention and condoms See How to do an STI check
For genital herpes treat with valaciclovir. If pregnant discuss need for treatment
with MO (category B3)
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Adult
500 mg bd
Dose should be
reduced to 500 mg
5 days
Tablet
500 mg
Oral
once daily
if GFR
< 15 mL / min
Provide Consumer Medicine Information: drink plenty of water during treatment. Take until course completed
Management of associated emergency: consult MO
[8]
Schedule
536
Valaciclovir
Uncontrolled
Controlled copy
copy
V1.0
or syphilis: If allergic to penicillin consult the Syphilis Register 1800 032 238
F
or email North-Qld-Syphilis-Surveillance-Centre@health.qld.gov.au
Benzathine penicillin
DTP
(Bicillin LA)
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Adult
Disposable
900 mg
IM
1.8 g (give in 2
Stat
syringe
separate injections)
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[9]
Schedule
Note: Talk to patient about Jarisch-herxheimer reaction which is common and may occur
with treatment of early syphilis. Symptoms may occur 4 to 6 hours after treatment and
include fever, chills, headache, hypotension and flare up of lesions lasting 12-14 hours [12].
Can normally be managed with paracetamol for 24 hours. May cause preterm labour, but
this should not prevent or delay treatment [15] because syphilis can result in miscarriage,
stillbirth and congenital syphilis
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Azithromycin
Stat
If a diagnosis of donovanosis
is made continue azithromycin
treatment weekly for 3 more
doses (total 4 doses) or until
completely healed
Provide Consumer Medicine Information: may be taken with or without food
Management of associated emergency: consult MO
[10]
Tablet
500 mg
Oral
1g
Uncontrolled
Controlled copy
copy
V 1.0
537
5. Follow up
Follow up guidelines for genital ulcer disease (GUD) flowchart
(including donovanosis)
Review patient in one week - check lesion and all laboratory results
Clinically suggestive
of syphilis and / or
syphilis test returns
positive
Seek advice re further
management from
Syphilis Register or local
Sexual Health Unit
Clinically suggestive of
and / or donovanosis and / or and / or
donovanosis
test returns positive
Azithromycin 1 gm once a
week for 3 more weeks (total
4 weeks) or azithromycin
500 mg daily for 7 days only
Review ulcer each week
Examination at 4 weeks
to determine further
management
If no response at 4 weeks
MO review is required
A biopsy to investigate other
causes may be needed
Clinically suggestive
of herpes and / or
HSV test returns
positive
Treat primary episode
and significant
re-current
episodes with antiviral medications
Refer to MO - consider
suppressive treatment
if multiple recurrences
-- patient was compliant with treatment and symptoms and signs have resolved
-- contacts have been tested and treated as appropriate
-- test results have been given
-- if an STI check including an HIV test is offered (if not done at initial visit)
Genital herpes:
-- follow up within 1 week to check symptoms have resolved
-- partners should have an STI check and counselling, but do not need to
be treated
-- refer to MO if symptoms have not resolved within 1 week or the patient has
recurrent episodes. Further medicine may be indicated
Primary, secondary or early latent syphilis (syphilis of less than 2 years duration):
-- follow up at 2 weeks to ensure symptoms have resolved and contacts have
been tested and treated
-- follow up syphilis serology should be taken between 3 and 6 months and
again at 12 months
-- a 2 titre or four fold fall in syphilis serology (e.g. 1 in 64 to 1 in 16) by 6 months
indicates adequate response to treatment
-- if the syphilis serology has not fallen by 2 titres within 6 months call the Public
Health Nurse, Syphilis Register 1800 032 238
-- consult MO if symptoms have not resolved or if patient is pregnant
538
Uncontrolled
Controlled copy
copy
V1.0
Donovanosis:
6. Referral / consultation
Consult MO as above if allergic, if pregnant or if symptoms do not respond to
treatment
Syphilis adult
Reactive syphilis
Recommend
Contact the Public Health Nurse for advice on diagnosis and management. Syphilis
Register 1800 032 238 or email
North-Qld-Syphilis-Surveillance-Centre@health.qld.gov.au
Treatment of syphilis in pregnancy or newborn, contact Syphilis Register for
immediate management
If the time between treatments exceeds 10 days contact the Syphilis Register.
Patient may need to re-commence treatment
Background
Untreated syphilis can be transmitted to sexual partners up to two years after infection
and to babies during pregnancy (by blood), up to nine years after infection in mother
Infection of babies in pregnancy can lead to miscarriage, neonatal death or
congenital syphilis
To interpret syphilis serology the current RPR result and previous RPR / syphilis
serology results and the treatment history is needed
Related topics
No symptoms:
-- no symptoms but with reactive syphilis serology - latent syphilis defined by
2 specific tests being reactive (EIA / TPPA / TPHA / FTA). The nonspecific
test (RPR / VDRL) may be reactive or non-reactive. Latent syphilis is further
defined as early latent (< 2 years) or late latent (> 2 years)
Symptomatic:
-- primary syphilis may present with:
one or a few sores (chancre), which are usually painless, 1 - 2 cm in
diameter and have a well defined edge
lymph nodes in the groin may be enlarged
if untreated, sores will heal by themselves within 3 to 4 weeks
Uncontrolled
Controlled copy
copy
V 1.0
539
540
4. Management
Always contact the Syphilis Register for advice 1800 032 238 or email
North-Qld-Syphilis-Surveillance-Centre@health.qld.gov.au
Medication management
-- if allergic to penicillin consult the Syphilis Register
-- primary and secondary syphilis
if genital sores are present and lesions are not typical of herpes and
syphilis or donovanosis are likely, treat for both syphilis and donovanosis
as it is difficult to distinguish syphilis from early donovanosis on clinical
examination. If donovanosis is suspected do appropriate investigation
prior to 4 week treatment
if treatment is commenced more than 2 weeks after testing, the serology
may have risen. Repeat the syphilis serology on the first day of treatment
(baseline RPR)
-- latent syphilis
latent syphilis (early latent or late latent) if no symptoms but syphilis
serology is reactive and there is no previous history of adequate
treatment (check medical record and the Syphilis Register)
Note: Reactive syphilis serology is defined by 2 specific tests being reactive (EIA / TPPA /
TPHA / FTA), the RPR may be reactive or non reactive
early latent syphilis (less than 2 years duration) treat with LA Bicillin
1.8 g (first line) as a single treatment
late latent syphilis (more than 2 years or unknown duration) treat with LA
Bicillin 1.8 g once weekly for 3 weeks
Perform timely (immediate) contact tracing and treatment of sex partners which is
essential to avoid reinfection See Contact tracing / partner notification
-- contacts of primary, secondary and early latent syphilis (syphilis of less than
2 years duration)
ensure confidentiality. Obtain a list of the names of sexual contacts up
to 12 months (if practical)
contacts should have an STI check, including blood for syphilis serology
treat on the spot with Bicillin LA 1.8 g and azithromycin
-- contacts of late latent syphilis (syphilis of more than 2 years duration)
Uncontrolled
Controlled copy
copy
V 1.0
541
arly latent syphilis (less than 2 years duration) treat with LA Bicillin 1.8 g (first
E
line) as a single treatment
Benzathine penicillin
DTP
(Bicillin LA)
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Adult
Disposable
900 mg
IM
1.8 g (give in 2
Stat
syringe
separate injections)
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[9]
Schedule
Note: Talk to patient about Jarisch-herxheimer reaction which is common and may occur
with treatment of early syphilis. Symptoms may occur 4 to 6 hours after treatment and
include fever, chills, headache, hypotension and flare up of lesions lasting 12 - 14 hours [12]
Can normally be managed with paracetamol for 24 hours. May cause preterm labour, but
this should not prevent or delay treatment [15] because syphilis can result in miscarriage,
stillbirth and congenital syphilis
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Schedule
Azithromycin
Stat
If a diagnosis of donovanosis
is made continue azithromycin
treatment weekly for 3 more
doses (total 4 doses) or until
completely healed
Provide Consumer Medicine Information: may be taken with or without food
Management of associated emergency: consult MO
[10]
Tablet
542
500 mg
Oral
1g
Uncontrolled
Controlled copy
copy
V1.0
Late latent syphilis (more than 2 years or unknown duration) treat with LA Bicillin
1.8 g once weekly for 3 weeks
Benzathine penicillin
DTP
(Bicillin LA)
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Adult
Disposable
1.8 g
900 mg
IM
Once weekly for 3 weeks
syringe
(give in 2
separate injections)
Provide Consumer Medicine Information: complete course
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[9]
Schedule
5. Follow up
Uncontrolled
Controlled copy
copy
V 1.0
543
-- diagnosis and treatment is the same as for non pregnant women, although
more frequent follow up may be needed
-- treatment is adequate if completed at least 30 days prior to delivery and there
is a documented 2 titre or fourfold fall in RPR by the time of delivery
6. Referral / consultation
Always consult an MO
Management of the babies of women needing treatment in pregnancy should be
544
Obtain patient history including whether partner has genital warts or other
symptoms of an STI
Perform standard clinical observations
Perform an examination See How to do an STI check
-- examine the genital area for discharge, nodules, sores and ulcers and the
groin for enlarged nodes
-- exclude normal anatomical variants and other causes of lumps before treating
Test for: See STI specimen collection
-- urine pregnancy test for all women of childbearing age (12 - 52 years)
-- chlamydia, gonorrhoea, trichomonas
-- also offer test for syphilis, HIV, hepatitis C, hepatitis B
-- a Pap smear should be taken, if due, in accordance with the NHMRC guidelines
(more frequent screening is not necessary because of genital warts)
Uncontrolled
Controlled copy
copy
V1.0
4. Management
DTP
IHW / SM R&IP / IPAP / SRH
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Sexual and Reproductive Health
Program Authorised Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
3 days
Followed by 4 days with
no treatment
Applied to each
Cream
0.15%
Topical
wart bd
Repeat the cycle 4 - 6 times
until the warts disappear
4 - 6 week treatment period
Provide Consumer Medicine Information: contraindicated in pregnancy and breastfeeding. During
treatment, women should use birth control. Avoid contact with surrounding skin - can cause burns and
ulcerations. Complete course
Management of associated emergency: consult MO
[11]
Schedule
Podophyllotoxin
5. Follow up
Uncontrolled
Controlled copy
copy
V 1.0
545
6. Referral / consultation
Consult MO or specialist if lesions are atypical or do not respond to treatment
Epididymo-orchitis
Low abdominal pain in female - adult
Genital sores / ulcers
Syphilis
Asymptomatic infection
Seroconversion illness - flu like illness can occur 2 - 6 weeks after infection and
may present with any of the following: fever, headache, rashes, sore throat, mouth
ulcers, muscle aches and pains, enlarged lymph nodes
Any infection which looks unusual, is worse or lasts longer than usual, does not
get better with usual treatment or keeps coming back e.g.:
-- shingles
-- severe or unusual herpes or other skin infections
-- chronic diarrhoea, chronic weight loss
-- generalised enlarged lymph nodes
-- severe recurrent candidiasis in women, oral candidiasis in adults
AIDS defining illness e.g. tuberculosis, opportunistic infections, some malignancies
2. Immediate management
546
Consult MO
Uncontrolled
Controlled copy
copy
V1.0
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
547
Note: very little information is likely to be taken in by the patient after first hearing of their
positive HIV result. Early follow up visits and medical review will be important
Contact the Director of Sexual Health or Infectious Diseases Physician, the local
sexual health team or an MO, to discuss HIV PEP if a patient presents with:
-- needle stick injury from a known HIV positive source or a PNG national patient
who is ill
-- sexual exposure, in particular sexual assault by multiple assailants of unknown
HIV status or in the event of a sexual assault by a PNG national person, or
receptive anal intercourse by MSM without a condom
Very good treatments for HIV are now available that have minimal side effects. A
course of medicine is given in the event of a likely exposure to HIV
Seek expert advice early as PEP is most effective immediately following possible
exposure. See Queensland Health Infection Control Guideline policy for further
details www.health.qld.gov.au/chrisp/default.asp
5. Follow up
As outlined
6. Referral / consultation
HIV positive people should be managed in consultation with a specialist MO
For more information go to: www.health.qld.gov.au/sexhealth/default.asp
548
Uncontrolled
Controlled copy
copy
V1.0
Resources
HIV Transmission and the Law
www.health.qld.gov.au/sexhealth/documents/hiv_law.pdf
Self Collected Specimen Chart www.stipu.nsw.gov.au/
References
1.
Therapeutic Guidelines (2012). "Urethritis and cervicitis." Retrieved August, 2012.
2.
Therapeutic Guidelines (2012). "Epididymo-orchitis." Retrieved August, 2012.
3.
Fagan P. (2012). Public Health Physician - Sexual Health, Cairns Public Health Unit.
4.
Therapeutic Guidelines (2012). "Trichomoniasis (Trichomonas vaginalis)." Retrieved August, 2012.
5.
Therapeutic Guidelines (2012). "Bacterial vaginosis." Retrieved August, 2012.
6.
Therapeutic Guidelines (2012). "Vulvovaginal candidiasis." Retrieved August, 2012.
7.
Therapeutic Guidelines (2012). "Pelvic inflammatory disease." Retrieved August, 2012.
8.
Therapeutic Guidelines (2012). "Genital herpes simplex virus infection ". Retrieved August, 2012.
9.
Therapeutic Guidelines (2012). "Syphilis (Treponema pallidum)." Retrieved August, 2012.
10. Therapeutic Guidelines (2012). "Genital ulcer disease." Retrieved August, 2012.
11. Therapeutic Guidelines (2012). "Human papillomavirus (HPV) infection." Retrieved August, 2012.
12.
Australian Medicine Handbook (2013). "Benzathine penicillin." Retrieved April, 2013.
13.
Royal Australian College of General Practitioners (2012). "Guidelines for preventive activities in
general practice, 8th edn." from www.racgp.org.au/your-practice/guidelines/redbook/
14.
Australian Society for HIV Medicine (2010). "Australasian contact tracing manual ". Retrieved May,
2013, from www.ashm.org.au//images/Publications/Monographs/ctm/ctm_2010.pdf
15.
Queensland Government (2010). Queensland Sexual Health Clinical Management Guidelines.
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
549
550
Uncontrolled
Controlled copy
copy
V1.0
Related topics
Emergency contraception
Trauma and injuries
Immunisation program
Tetanus immunisation
2. Immediate management
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
551
4.
Management
Adult victim / survivor
Consult MO
Provide information on options and encourage the patient to make their own
decision regarding legal action, giving them space and time. They may change
their mind at a later date. Consider the role of telephone counselling (Sexual
Assault Helpline 1800 010 120) to assist the victim in making these decisions
Ensure patient and staff are safe
Be supportive - proceed at their pace. It is important that the patient is able to
retain control of the process and to make the decisions about what is best for
them at this point in time
Post rape / sexual assault prophylaxis
Offer medicine for:
-- chlamydia, gonorrhoea See Chlamydia / gonorrhoea / trichomonas
-- syphilis See Syphilis
-- HIV post exposure prophylaxis (PEP) if indicated, MO will advise
-- hepatitis B - if no demonstrated immunity then give hepatitis B immunoglobulin
within 72 hours and commence vaccination within 7 days post assault
-- tetanus vaccination if indicated
Offer emergency contraception if at risk of pregnancy
552
Uncontrolled
Controlled copy
copy
V1.0
5. Follow up
Ensure the patient, if not evacuated, has a safe place to go after clinical examination
ongoing support if required. It is not uncommon that some people do not wish to
access counselling immediately following sexual assault. The information can be
used in the future
Review next day if not evacuated
See next MO clinic
Review at: 2 weeks post assault - with results of pathology tests taken or if no
tests done, perform STI screening and pregnancy test (if indicated)
-- 1 month post assault - hepatitis B vaccination, pregnancy test (if indicated)
-- 3 months post assault - HbsAg, HIV, syphilis
-- 6 months post assault - hepatitis B vaccination
Ensure staff member receives counselling and de-briefing
6. Referral / consultation
The forensic medical examination is best performed as soon as possible for both
patient comfort and for preservation of evidence
Semen may be found in the high vagina for up to 5 - 7 days but the viability of any
specimen depends on lack of menstruation and not douching. A cervical swab may be
better at a later stage
Forensic examination for injury documentation can take place at any time
A clear explanation of what a forensic medical examination entails is given to the patient
Consent must be obtained prior to beginning a forensic examination. The patient can
consent to all, parts of, or none of the examination offered. Make sure their choice is
documented
Uncontrolled
Controlled copy
copy
V 1.0
553
onsent must be obtained for release of the forensic information and the patient should
C
be informed that the evidence may be used in court
The patient has the choice to have an appropriate support person present during the
forensic examination. Although an appropriate police officer may act as a chaperone
or support person during the examination it is not mandatory for a police officer to be
present during the examination
Procedure
Head to toe external examination carefully documenting and photographing any marks
and injuries and noting patients comments about their origin (when and how the marks
and injuries were caused)
Pay particular attention where the history suggests there may be an injury and note its
presence or its absence and any indicators of age
Take swabs as dictated by the history and your examination findings. Many things can
assist in identifying an assailant or confirming sexual activity including ejaculate, blood,
saliva and lubricant. If unsure ask for assistance from local or Brisbane Forensic MO
through police communications
If the patient is still in clothes worn at time of the assault they are requested to undress
on the drop sheet provided in the sexual assault kit, discuss with police what articles
of clothing they want collected and bag each of these separately in brown paper bags
Provide hospital gown or sheet for patient modesty
If the patient has reported penile penetration of the mouth, oral washings and swabs
should be undertaken ASAP for patient comfort
If the patient has reported possible skin contact with bodily fluids of the alleged offender
(e.g. saliva or ejaculate) then those areas of skin should be appropriately swabbed and
documented
Any blood stains or skin stains should be swabbed
If the patient reported scratching the alleged offender fingernail scrapings may be
indicated
For female
-- genital examination is then conducted. External genitalia is examined for signs of
injuries, swabs are collected from the vulva and low vagina, speculum is introduced
to collect swabs from high vagina and cervix if indicated, vagina and cervix are
examined at this time for signs of injury or abnormality. The use of a speculum may
not be appropriate in all cases. This needs to be considered on an individual basis
For male
-- inspect penis and scrotum for signs of injury. Consider whether collection of
swabs is indicated depending on history given. The use of a proctoscope may be
indicated if rectal swabs are required or if history of severe pain, bleeding or possible
foreign body
Anal examination and collection of two perianal and two rectal swabs as indicated by
history given
Blood can be collected for patients DNA or police may collect buccal swab at later time
Forensic specimens are handed directly to the police as per the sexual assault
investigation kit. If this is not possible refrigerate the samples in a secure place to
ensure the chain of custody for samples is intact
Ensure swabs are appropriately labeled and swabs have been air dried
Ensure bags of patients clothes collected are appropriately labelled, and if wet, advise
police that drying may be required
Blood specimens are not to be enclosed in the brown sexual assault kit, hand these
separately to the police (blood for DNA or toxicology to be sent to John Tonge Centre
by QPS)
References
1.
Queensland Government, Queensland Sexual Health Clinical Management Guidelines 2010,
Queensland Health: Brisbane.
554
Uncontrolled
Controlled copy
copy
V1.0
Section 6
Paediatrics
Paediatric presentation
Section 6
Paediatrics
Contents
History and physical examination - child
Child with fever
Child with cough
Child with stridor
Child with vomiting
Child with abdominal pain
Child with chronic diarrhoea
Meningitis
Respiratory problems
Immune complications
Ear problems
Gastrointestinal problems
Urinary tract problems
Bone and joint problems
Abuse and neglect - child
Uncontrolled
Controlled copy
copy
V1.0
Paediatric presentation
Uncontrolled
Controlled copy
copy
V 1.0
557
Paediatric presentation
Rate pain level in children using face, numbers and behavioural observations.
Physiological changes e.g. altered HR, RR, BP are not good indicators to use in
isolation [2]. Non - verbal children are very vulnerable to having their pain under
estimated [2]
Refer to Childrens Early Warning Tools (ED CEWT) for rural and remote facilities
and for Primary Health Care Centres for pain assessment tools
Presentation
When a child presents for health care the clinician is required to obtain an orderly
collection of information to identify the patients health status. The following is
essential to achieve this:
-- taking a patient history
-- performing standard clinical observations and other vital signs
-- perform physical examination
-- using diagnostic and pathology services and
-- collaboration with other members of the team
Note: not all children are at the same stage of development in areas of physical, cognitive
and psychosocial development
It is a requirement that all clinicians document their findings in a clear and concise
way. This section is set out to assist. It is recommended the page number of HMP
/ CCG is referred to in the documentation
558
Uncontrolled
Controlled copy
copy
V1.0
Paediatric presentation
Types of history
There are four types of history taking [3] See History and physical examination - adult
History taking
The purpose of a full history is to ascertain the cause of the child's illness. A
careful history will make the cause clear in the vast majority of cases
The first priority is to assess whether the child is:
-- seriously ill and needs immediate management or,
-- is a non urgent presentation and there is time for a complete patient history
and health education
Obtaining a full history is done in conjunction with examining the patient
-- in a sick child this entails a full assessment of all systems
-- in a child who has a localised problem it is reasonable to examine the relevant
system only. However, always be guided by the history and be prepared to
examine other systems as necessary. This is particularly important when
examining children who often present with generalised symptoms and signs
-- ask open ended questions
-- believe the carer
Presenting concern
Ask the child or carer what the problem is
Ask about length of illness and exact details of symptoms and signs. For each
symptom the following details are important [4]
Site - where is the pain / symptom? does it go anywhere else?
Onset - when did it start, gradual or sudden onset?
Character e.g. sharp, dull or burning
Radiation - does the pain radiate anywhere else?
Alleviating factors - what makes it better e.g. sitting up, medicines?
Timing - how long did it last, have they had it before?
Exacerbating factors - what makes it worse?
Severity - mild, moderate or severe pain. Pain score 0 - no discomfort to 10 unbearable pain or use facial diagrams
Uncontrolled
Controlled copy
copy
V 1.0
559
Paediatric presentation
Past history
Past medical and
surgical history
Medications
Allergies
Immunisations
Was delivery normal and were there any immediate neonatal problems?
Any problems with growth and development?
Significant illnesses in the past? What and when?
Hospital admissions? Why and when?
Operations or injuries? What and when?
Mother's alcohol history during pregnancy?
Health problems in the family - especially siblings and parents
Who looks after the child, what is the social situation?
Mental health problems in carers / child?
Household smokers?
Recent contacts or trips away
If medicines are given, will they be taken?
Regular medicines (prescribed, herbal, bush medicines, over the counter)
generic name(s), dose, frequency?
Are they taken correctly?
May need to ask about other medicine(s) in the home the child may have taken
See Medication reconciliation and Medication history checklist for more details
Adverse medicine reactions:
-- adverse reactions / allergies to medicines?
-- attach adverse medicine reaction sticker to medication chart if required
Allergens e.g. bee stings, tapes, sticking plaster, nuts:
-- specific reaction e.g. skin reaction, bronchospasm
-- is an EpiPen / medicine used to treat the allergy?
Check if up to date
Documented evidence of immunisation status should be obtained, follow up
with opportunistic immunisation See Immunisation program
Physical examination
560
May be best done with the child on the carers knee. If the child is irritable perform
the examination opportunistically i.e. do what you can when you can. Leave the
most disruptive parts (ears and throat) until last
In general, examination of a child is not a good screening test. Use the
history to guide you to areas where you think you will find an abnormality
In any sick child a thorough and complete examination is required. All clothing
will need to be removed at some stage during the complete examination
Uncontrolled
Controlled copy
copy
V1.0
Paediatric presentation
In a child who is not sick, examine the relevant system first and proceed to further
examination as guided by the history and your findings
Uncontrolled
Controlled copy
copy
V 1.0
561
Paediatric presentation
562
Uncontrolled
Controlled copy
copy
V1.0
Paediatric presentation
Uncontrolled
Controlled copy
copy
V 1.0
563
Paediatric presentation
Point of care testing is available in some facilities, for example iSTAT blood
gases
Pathology request forms:
-- all pathology requests made by SM R&IP must be compliant with the specific
Health Management Protocol
-- if in the clinicians opinion other pathology is required this must be ordered by
an MO
Pathology results / follow up:
-- if an SM R&IP has initiated pathology testing according to the Health
Management Protocol they are responsible for the follow up of pathology
results
-- MO should be consulted if results are abnormal
Refer to the Pathology Queensland Specimen Collection Manual available at:
qheps.health.qld.gov.au/pathology/home.htm
References
1.
Pemsoft (2003-2012). "Normal vital signs." Retrieved November, 2012.
2.
The Royal Children's Hospital Melbourne (2012). "Acute pain management ". Retrieved November, 2012.
3.
Estes M. and Schaefer K.P. (2002). Health assessment and physical examination. Albany, NY Delmar.
4.
Talley N. and OConnor S. (2010). A systematic guide to physical diagnosis: clinical examination.
Australia, Churchill Livingstone: Elsevier.
5.
Murtagh J. and Rosenblatt J. (2011). John Murtagh's general practice McGraw-Hill Australia Pty Ltd
6.
Corrales A.Y. and Starr M. (2010). "Assessment of the unwell child." Australian Family Physician 39(5):
270-275
7.
Douglas G., Nicole F., et al. (2009). Macleods clinical examination Churchill Livingstone: Elsevier.
8. Advanced Paediatric Life Support Group (2011). Advanced Paediatric Life Support The Practical
Approach., Wiley-Blackwell.
564
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
See
Meningitis
Headache,
photophobia
+/Rash
Neck stiffness
or bulging
fontanelle
Rapid onset
high fever
May have
history of URTI
like illness
See
Epiglottitis
Stridor,
drooling,
unable to
eat,
drink or talk,
reluctant to
move neck
Child unwell
Child unwell
See
UTI - child
No other
significant
features
Positive
urinalysis
Dysuria,
frequency,
smelly
urine
Child
unwell
See
Pneumonia child
No other
significant
features
Tachycardia
Rapid
breathing,
chest
recession
Cough
Child unwell
See
Bacterial
skin infections
No other
significant
features
Obvious
abscess or
cellulitis
Basically
well child
No
Yes
See Acute
gastroenteritis
No other
significant
features
Vomiting and
diarrhoea
Basically
well child
See
Acute
otitis media
No other
significant
features
Bulging ear
drum on
examination
URTI type
symptoms may
be present
Basically
well child
Consult MO
See
URTI - child
Basically
well child
Fever is usually an indicator of infection. Two or more infections may co-exist, e.g. URTI plus meningitis
Babies less than 3 months of age contact MO immediately
Consult MO for the child with a fever with no obvious source of infection or a fever that is persistent despite measures taken
Paediatric presentation
565
566
Uncontrolled
Controlled copy
copy
V1.0
Unable to eat,
drink or talk
Mild fever
Cough may be
absent
See
Epiglottitis
No other
significant
features
See
Croup
Reluctant to
move neck
Stridor,
drooling
Mild URTI
symptoms
Mild / moderate
stridor
Rapid onset
high fever
Child unwell
Barking cough
Basically
well child
See
Acute upper
airway
obstruction and
choking
Usually there
is a history of
ingesting or
choking on
something
Airway
compromised
Sudden onset
in previously
well child
See
URTI - child
No other
significant features
Tonsillar
enlargement
Fever, red
inflamed throat
Cervical
lymphadenopathy
No
Yes
See
Pneumonia child
No other
significant
features
Tachycardia
Rapid breathing
with chest
recession
Fever
Child unwell
See
Asthma
No other
significant
features
Wheeze, rapid
breathing
Nocturnal
or exercise
induced
cough
Consult MO
Clinical assessment performed. Babies less than 3 months of age contact MO immediately
See
Pertussis /
(whooping
cough)
No other
significant
features
Apnoea
Paroxysmal
cough
whoop
Paediatric presentation
Slow onset
See
Croup / epiglottitis
Rapid onset
Weak or no cough
Temp >38.5C
Septicaemia
Drooling saliva
Unable to eat or drink
Doesnt talk
Any age
Reluctant to move neck
As the condition
deteriorates the stridor
may decrease
See
Croup / epiglottitis
No
Yes
See
Anaphylaxis and severe
allergic reaction
See
Acute upper airway
obstruction and choking
Consult MO
In the meantime, consider epiglottitis
Obtain full history, including Hib immunisation status. Limit examination. Do not examine mouth or throat
Stridor is a harsh vibrating sound originating from the large upper airways and occurring on inspiration. It occurs due to upper airway
obstruction. Consider the following causes: croup common, inhaled foreign body, epiglottitis rare but important, trauma, angioneurotic
oedema, mass (tumour or abscess). Babies less than 3 months of age contact MO immediately
Paediatric presentation
Paediatric presentation
Uncontrolled
Controlled copy
copy
V 1.0
567
568
Uncontrolled
Controlled copy
copy
V1.0
See
Meningitis
Neck stiffness
+/- Rash
Headaches,
photophobia
+/-
Rapid
breathing
May have
history of
URTI like
illness
See
Pneumonia child
No other
significant
features
Tachycardia
Chest
recession
Cough
Child unwell
Fever
Child unwell
See
Acute
gastroenteritis
No other
significant
features
Fever
Diarrhoea
Basically well
child
See
UTI - child
Fever
No other
significant
features
Positive
urinalysis
Dysuria
frequency
smelly urine
No
See
Pyloric
stenosis
No other
significant
features
Weight loss or
poor gain
Projectile
vomits,
hungry
following
feed
Intussusception
See
No other
significant
features
Red currant
jelly stool
Abdominal
pain
intermittently
Child unwell
See
Diabetes
Ketones on
urinalysis
High
capillary BGL
With or
without signs
of dehydration
Consult MO
3 mths - 3 yrs
Yes
Babies less than 3 months of age contact MO immediately. Vomiting is a common and important symptom, which may indicate serious
illness especially in a very young child. Consider the following causes: infection (pneumonia, UTI, meningitis, otitis media), obstruction
(pyloric stenosis, intussusception, appendicitis, hernia), reflux oesophagitis, raised intracranial pressure (trauma, abscess or tumour),
metabolic (diabetic ketoacidosis, poisoning)
Paediatric presentation
Paediatric presentation
Yes
Yes
Consult MO
Yes
Consider UTI
See Urinary tract infection - child
Yes
Consider pneumonia
See Pneumonia - child
Yes
Consider gastroenteritis
See Child with vomiting / fever /
chronic diarrhoea
Yes
Consider constipation
See Constipation
No
Bile-stained vomiting?
Bloody stool?
Localised tenderness?
Distension?
Guarding?
Rebound tenderness?
Palpable mass?
Inguinal-scrotal pain or swelling?
No
Positive urine dipstick for
leukocytes, nitrates or blood
or bacteria on microscopy
No
Fever +/Tachypnoea
Recession
Cough
Chest pains
No
Diarrhoea +/- vomiting / fever
No
Firm stool palpable in lower abdomen?
No
Consult MO
Uncontrolled
Controlled copy
copy
V 1.0
569
Paediatric presentation
Yes
Consult MO
Yes
Treat if positive
for giardia or
intestinal
worms.
Consult MO if
other +ve result
Yes
See Lactose
intolerance
No
Is test positive?
No
Test for lactose intolerance
See Lactose intolerance
Is test positive?
No
Consider significant features
of asssessment
570
Perianal itch
Sighting of worms
in faeces
Foul smelling,
watery diarrhoea
Flatulence
Nausea
Bloody diarrhoea
Mucous in diarrhoea
Abdominal pain
See
Intestinal worms
See
Giardiasis
Consult MO
Uncontrolled
Controlled copy
copy
V1.0
Meningitis
Meningitis child
Recommend
Consult MO immediately
If a sick looking child has no obvious source of infection which would explain their
symptoms - the diagnosis is meningitis until proven otherwise
-- careful management of fluid and electrolyte balance is important in the treatment
of meningitis [1]. It is important to treat shock. Ongoing management should be
discussed with Paediatrician as soon as possible
Parents or carers may notice early, subtle changes in the childs conscious state.
Their concerns should not be ignored
Perform hearing test 3 months after discharge from hospital
Background
Mortality from bacterial meningitis is up to 15% [4]. Most children will make a full
recovery, if appropriately treated. Deafness is the most common long term complication
Hyponatraemic solutions e.g. 4% glucose with 0.18% sodium chloride or 0.45%
sodium chloride, have no place in the management of meningitis as they may worsen
hyponatraemia and increase the risk of cerebral oedema [1]
Related topics
2. Immediate management
Consult MO
If altered level of consciousness
See DRS ABCD resuscitation / the collapsed patient
If fitting See Fits / convulsions / seizures
Give O2 to maintain O2 saturation > 95%. If > 95% not maintained consult MO
See O2 delivery systems
I nsert IV / IO cannula and take FBC, U/E, blood cultures, PCR for Neisseria
meningitis (meningococcal bacteria)
Uncontrolled
Controlled copy
copy
V 1.0
571
Meningitis
3.
Clinical assessment
4.
Management
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Route of
Form
Strength
Recommended dosage
Duration
administration
50 mg / kg / dose
Stat
Vial
1g
IV / IM
to a max. of 2 g
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[3] [5]
Schedule
5.
Ceftriaxone
Follow up
572
Respiratory problems
6.
Referral / consultation
Consult MO immediately on all occasions if meningitis is suspected
Most patients will require urgent treatment and evacuation / hospitalisation
References
1.
The Royal Children's Hospital Melbourne (2005). "Fluid management in meningitis." Retrieved August, 2012.
2.
The Royal Children's Hospital Melbourne (2009). "Meningitis guideline." Retrieved August, 2012.
3.
Therapeutic Guidelines (2013). "Meningitis: management before hospital." Retrieved September, 2013.
4. Trestioreanu A. Z., Fraser A., et al. (2011). "Antibiotics for preventing meningococcal infections." The
Cochrane Collaboration. Retrieved October, 2012.
5.
Queensland Government (2012). Meningitis management in children. Children's Health Services.
Brisbane, Queensland Health.
Acute asthma
Meningitis - child
Immunisation program
Pneumonia - child
Acute otitis media (AOM) with acute perforation
Acute otitis media (AOM) without perforation
Acute rheumatic fever (ARF)
Acute post streptococcal glomerulonephritis (APSGN)
Uncontrolled
Controlled copy
copy
V 1.0
573
Respiratory problems
4. Management
574
onsult MO if:
C
-- < 3 months of age
-- < 1 year with respiratory rate more than 40 respirations per minute
1 - 2 years more than 35 respirations per minute
2 - 5 years more than 30 respirations per minute
5 - 12 years more than 25 respirations per minute
12 years and older more than 20 respirations per minute
-- respiratory distress or apnoea
-- if child looks sick, not alert or interactive and has temperature over 38C
-- if child still looks sick when temperature reduced
-- if child has any rash
-- if child has a cough productive of mucopurulent sputum, may need further
investigations for possibility of chronic respiratory disease
-- if child has tonsillitis and is sick
If child has cough as the main feature, consider other diagnoses
See Pertussis (whooping cough), Croup / epiglottitis and Acute asthma
If child has an increased respiratory rate or any chest findings consider other
diagnoses See Bronchitis and See Pneumonia - child
If child has evidence of secondary ear infection
See Acute otitis media (AOM) with acute perforation
See Acute otitis media (AOM) without perforation
For the child with URTI, indications for antibiotic treatment are:
-- sore throat and red swollen tonsils, with or without pus, with fever > 38C and
local lymphadenitis
-- sore throat with red swollen tonsils in a child with existing rheumatic heart disease
-- Scarlet fever - has a characteristic and striking red blanching rash and
strawberry tongue due to streptococcal infection. Rash usually starts after
the sore throat and lasts a week
Uncontrolled
Controlled copy
copy
V1.0
Respiratory problems
SeeSimple
Simpleanalgesia
analgesia
See
For the child with indicators present for antibiotic treatment and if not allergic,
treat with oral penicillin
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Tablet
250 mg
Child
Capsule
500 mg
Oral
15 mg / kg / dose bd
10 days
Suspension 150 mg / 5 mL
to a max. of 500 mg bd
Provide Consumer Medicine Information: should be taken on an empty stomach to 1 hour before meals.
Take until course completed
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[1]
Schedule
Phenoxymethylpenicillin
Benzathine penicillin
DTP
(Bicillin LA)
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
3 kg to < 6 kg 225 mg
6 kg to 10 kg 337.5 mg
Disposable
900 mg
IM
10 kg to 15 kg 450 mg
Stat
syringe
15 kg to 20 kg 675 mg
20 kg 900 mg
Use a concentration of 442 mg / mL when measuring part doses. Refer to product information
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needle and deliver injection very slowly (2 minutes)
[1]
Schedule
Uncontrolled
Controlled copy
copy
V 1.0
575
Respiratory problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Tablet for
50 mg
Child
suspension
Oral
4 mg / kg / dose bd
10 days
150 mg
Tablet
to a max. of 150 mg bd
300 mg
Provide Consumer Medicine Information: should be taken on an empty stomach, 15 minutes before food.
Take until course completed
Management of associated emergency: consult MO
[1]
Schedule
Roxithromycin
5. Follow up
R
eview next day, if not improving consult MO
If antibiotics have been given for sore throat:
-- r eview in 2 weeks
-- ask about sore joints, chest pain, breathlessness and check urinalysis
-- consult MO if symptoms persist See Acute rheumatic fever (ARF) or if abnormal
urinalysis See Acute post streptococcal glomerulonephritis (APSGN)
6. Referral / consultation
C
onsult MO as above or if symptoms persist despite symptomatic treatment
If recurrent tonsillitis (> 6 episodes per year) MO may consider prolonged
576
Uncontrolled
Controlled copy
copy
V1.0
Respiratory problems
URTI symptoms
Cough typically paroxysmal i.e. intermittent episodes of prolonged coughing
followed by the characteristic inspiratory whoop as the child catches his / her breath
Vomiting, typically after an episode of coughing
Cyanosis, typically during an episode of coughing
Young babies usually do not have the characteristic whoop but are likely to be very
distressed by coughing and vomiting. They can develop apnoea (stop breathing)
and become cyanosed during a coughing bout
Adults usually have a persistent troublesome cough only, without a whoop. A
cough of several weeks duration, that is worse at night, in an adult, is pertussis
until proven otherwise
Children may present with a prolonged cough - consider investigation
2. Immediate management
3. Clinical assessment
4. Management
5. Follow up
If not evacuated / hospitalised review daily, at least initially
6. Referral / consultation
Consult MO on all occasions whooping cough is suspected
Uncontrolled
Controlled copy
copy
V 1.0
577
Respiratory problems
Croup
Croupy (barking) cough
Temperature < 38.5C (however viral
croup often has a high temperature)
No systemic disturbance
Able to swallow
Will usually drink
Normal or hoarse voice
2. Immediate management
3. Clinical assessment
578
Uncontrolled
Controlled copy
copy
V1.0
Respiratory problems
4. Management
Consult MO
If epiglottitis:
-- have the parents / carer stay with child to comfort
-- handle the child as little as possible
-- MO will organise evacuation by MO skilled with paediatric airway management
and IV insertion for IV ceftriaxone [3]
If croup:
-- symptomatic treatment as per URTI
-- for mild to moderate cases MO may advise:
oral prednisolone 1 mg / kg / dose stat with a second dose for the next
evening or
a single dose of oral dexamethasone 0.15 mg / kg / dose [5]
-- for severe cases MO may advise:
0.6 mg / kg / dose (max. 12 mg) IM / IV dexamethasone
4 mL of adrenaline 1:1,000 via nebuliser [4]
evacuation / hospitalisation
5. Follow up
If child with croup is not evacuated / hospitalised, review next day and consult MO
if not improving
6. Referral / consultation
Consult MO on all presentations of stridor
Bronchiolitis child
Recommend
Consult MO immediately if severe
Background
In bronchiolitis, generally the child is distressed without looking sick or toxic
A viral infection of the chest affecting infants < 12 months of age
Can occur throughout the year in north Queensland (in southern Australia more
common in winter - spring)
More significant in babies < 4 months of age and those with underlying heart or
lung problems
Related topics
Acute asthma
Upper respiratory tract infection - child
Pneumonia - child
2. Immediate management
Consult MO
If severe give O2 to maintain O2 saturation > 95%. If > 95% not maintained consult
MO See O2 delivery systems
Uncontrolled
Controlled copy
copy
V 1.0
579
Respiratory problems
3. Clinical assessment
4. Management
5. Follow up
P
atients who are not evacuated / hospitalised should be reviewed daily
Consult MO if the patient is not improving
6. Referral / consultation
Consult MO on all occasions bronchiolitis is suspected
Pneumonia child
Recommend
I
f baby < 3 months of age contact MO immediately
S
evere dehydration is unusual in pneumonia unless there are abnormal fluid losses
from frequent diarrhoea or vomiting
Background
C
hildren with co-existent illnesses are more at risk. Examples are bronchiolitis and
chronic lung disease e.g. due to prematurity
Related topics
Upper respiratory tract infection - child
Immunisation program
Bronchiolitis
580
Uncontrolled
Controlled copy
copy
V1.0
Respiratory problems
2. Immediate management
I f severe administer O2 to maintain O2 saturation > 95%. If > 95% not maintained
consult MO See O2 delivery systems
C
onsult MO
3. Clinical assessment
4. Management
Child
< 3 months
Contact MO
immediately
Child
3 months - 1 year
Child
1 - 4 years
Child
over 4 years
Resps
40 / min
and / or
Resps
recession
< 40 / min
grunting
apnoea
cyanosis
Resps
40 / min
and / or
Resps
recession
< 40 / min
grunting
apnoea
cyanosis
Resps
30 / min
and / or
Resps
recession
< 30 / min
grunting
apnoea
cyanosis
Resps
25 / min
and / or
Resps
recession
< 25 / min
grunting
apnoea
cyanosis
Moderate
or severe
pneumonia
Uncontrolled
Controlled copy
copy
V 1.0
581
Respiratory problems
Mild pneumonia
MO may advise:
- chest x-ray if available
- oral or IM antibiotics
- antibiotics may not be indicated if typical of viral infection or bronchiolitis
Give O2 to maintain O2 saturation > 95% (if not already in place). If > 95% not
maintained consult MO See O2 delivery systems
MO may advise:
- insert IV cannula - if possible take blood cultures prior to commencing
antibiotics
MO will advise quantities and rate
- to commence IV antibiotics
Evacuation / hospitalisation
Give analgesia
SeeSimple
Simpleanalgesia
analgesia
See
5.
Follow up
6.
Patients with mild pneumonia who are not evacuated / hospitalised should be
reviewed daily
Consult MO if the patient is not improving
See next MO clinic
Referral / consultation
References
1.
Therapeutic Guidelines (2012). "Pharyngitis and / or tonsillitis." Retrieved August, 2012.
2.
Therapeutic Guidelines (2012). "Pertussis." Retrieved August, 2012.
3.
Therapeutic Guidelines (2012). "Acute epiglottitis (supraglottitis) ". Retrieved August, 2012.
4.
The Royal Children's Hospital Melbourne (2011). "Croup (Laryngotracheobronchitis)." Retrieved August,
2012.
5.
AMH Children's dosing companion (2013). "Dexamethasone." Retrieved July, 2013.
582
Uncontrolled
Controlled copy
copy
V1.0
Immune complications
Related topics
2. Immediate management
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
583
1 year
2 years
4 years
6 years
8 years
10 years
12 years
14 years
16 years
> 17 years
Immune complications
BP upper level
of normal
103
56
106
61
111
69
114
74
116
78
119
80
123
81
128
82
134
84
136
87
1 year
2 years
4 years
6 years
8 years
10 years
12 years
14 years
16 years
> 17 years
systolic
diastolic
systolic
104
105
108
111
115
119
123
126
128
129
diastolic
58
63
70
74
76
78
80
82
84
84
Anti-DNase B titre
366
499
473
390
265
4. Management
584
Immune complications
Benzathine penicillin
DTP
(Bicillin LA)
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
3 kg to 6 kg 225 mg
6 kg to 10 kg 337.5 mg
Disposable
900 mg
IM
10 kg to 15 kg 450 mg
Stat
syringe
15 kg to 20 kg 675 mg
20 kg 900 mg
Use a concentration of 442 mg / mL when measuring part doses. Refer to product information
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[3]
Schedule
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Tablet for
50 mg
Child
suspension
Oral
4 mg / kg / dose bd
10 days
150 mg
Tablet
to a max. of 150 mg bd
300 mg
Provide Consumer Medicine Information: should be taken on an empty stomach, 15 minutes before food.
Take until course completed
Management of associated emergency: consult MO
[3]
Schedule
Roxithromycin
Uncontrolled
Controlled copy
copy
V 1.0
585
Immune complications
5. Follow up
M
ost children will require evacuation / hospitalisation
If not evacuated / hospitalised the child requires close follow up with daily review
2 weeks
4 weeks
2 months
6 months
1 year
2 years
microalbuminuria is. If urinalysis shows protein on follow up, collect urine for
urine protein / creatinine ratio. If persistent proteinuria refer to Paediatrician
Blood should be tested to check the immune system complement factor (C3) level
has returned to normal after three months
6. Referral / consultation
C
onsult MO on all occasions of suspected APSGN
Most will need paediatric referral and follow up
References
1.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children
and Adolescents (2005). "The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood
Pressure in Children and Adolescents." Retrieved August, 2012, from
www.nhlbi.nih.gov/health/prof/heart/hbp/hbp_ped.htm
2.
Steer A C., Vidmar S., et al. (2009). "Normal ranges of streptococcal antibody titres are similar whether
streptococci are endemic to the setting or not." Clinical and Vaccine Immunology 16(2): 172-175.
3.
Therapeutic Guidelines (2012). "Impetigo." Retrieved July, 2012.
4.
Wong W. (2009). "Glomerulonephritis." Starship. Retrieved August, 2012, from
www.adhb.govt.nz/starshipclinicalguidelines/Glomerulonephritis.htm
586
Uncontrolled
Controlled copy
copy
V1.0
Immune complications
Uncontrolled
Controlled copy
copy
V 1.0
587
Immune complications
2.
3.
Clinical assessment
See 2012 Updated Australian guidelines for the diagnosis of ARF available on
page 9 of the Australian guideline for prevention, diagnosis and management of acute
rheumatic fever and rheumatic heart disease (2nd edition) Quick reference guides.
[2]
4.
Management
the diagnosis
Record ECG (if not already done)
Do baseline echocardiogram (within 3 months of presentation)
Administer benzathine penicillin on MO instruction. If realiably documented
allergy to penicillin consult MO
SeeSimple
Simpleanalgesia
analgesia
back cover
See
588
Uncontrolled
Controlled copy
copy
V1.0
Immune complications
Benzathine penicillin
(Bicillin LA)
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Disposable
syringe
900 mg
Child < 20 kg
450 mg
IM
As ordered by
MO / NP
Notifiable
-- ARF is a notifiable condition in Queensland. Unlike most other notifiable
diseases, ARF is not based solely upon a laboratory diagnosis and therefore
notification has to be done by a clinician
-- the ARF notification form is available from the Communicable Diseases
website www.health.qld.gov.au/cdcg/documents/nr-arf.pdf
-- fax / scan / email ARF notification form to the nearest Public Health Unit (PHU)
who are responsible for entering the case data onto the Notifiable Conditions
System (NoCS) and for contacting the RHD Register and Control Program
-- the RHD Register and Control Program can be contacted at
Arf&RhdRegister@health.qld.gov.au or 1300 135 854
5. Follow up
recall system
For ongoing assistance with secondary prophylaxis contact the RHD Register
and Control Program at Arf&RhdRegister@health.qld.gov.au or
1300 135 854
Recommended duration of secondary prophylaxis
Resources available
include - Strong Heart Strong Body book, DVD and injection reminder cards (from
Queensland RHD Register and Control Program)
Uncontrolled
Controlled copy
copy
V 1.0
589
Immune complications
Give influenza and pneumococcal vaccines according to the current edition of the
6. Referral / consultation
References
1.
RHDAustralia (ARF/RHD writing group) and National Heart Foundation of Australia and the
Cardiac Society of Australia and New Zealand (2012). "Australian guideline for prevention,
diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)."
from www.rhdaustralia.org.au/sites/default/files/guideline_0.pdf
2.
RHDAustralia (ARF/RHD writing group) and National Heart Foundation of Australia and the Cardiac
Society of Australia and New Zealand (2012). "Australian guideline for prevention, diagnosis and
management of acute rheumatic fever and rheumatic heart disease. Quick reference guides (2nd
edition)." from www.rhdaustralia.org.au/sites/default/files/quick_reference_guides_0.pdf
590
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
Ear symptoms
-- pain, fever, discharge, itchy?
-- a young child may not localise pain, but parent may notice that they are
unsettled or pulling on their ears
-- when did it start, severity?
Treatment and / or medicine given - what, how much, when, how often, effect?
Risk factors e.g. history of URTI? (when), exposure to passive smoking / smoker,
swimming (especially in dirty dam or creek), dusty environment
First episode?
Previous episodes - acute otitis media with or without perforation, chronic ear discharge,
operations? when? treatment?
Hearing loss / any hearing tests? problems with speech and language, learning?
Under care of Ear Nose and Throat (ENT) Specialist / Audiologist?
Examination
Outer ear
Inspect - any inflammation?
Palpate
-- ear - warm to touch? pain on moving pinna? tender?
-- mastoid bone - swollen? hot? tender?
-- occiput, around ears, both sides or neck for lymph glands
Ear canal
Inspect for any obvious discharge, redness / swelling
If pain levels allow look inside with otoscope - inspect canal for - swelling, redness,
fungus, debris, lumps or bony growths, foreign body, extruding grommets, wax, lesions
Tympanic membrane (TM) (eardrum)
Normal TM is shiny, translucent, pearl / grey colour, cone of light visible - right ear at 5
oclock, left ear at 7 oclock
Sections of handle of malleus visible through translucent drum - right ear 1 oclock, left
ear 11 o'clock
Left
Right
Uncontrolled
Controlled copy
copy
V 1.0
591
Ear problems
Inspect TM (eardrum)
-- intact? normal colour, red, dull, bulging, retracted?
-- any air / fluid or bubbles behind the eardrum?
-- perforations or discharge? - clean the ear using tissue spears until all pus has
been removed and the drum can been seen - document the size and position
of perforation on a diagram in the case notes.
-- if an unsafe perforation (in the attic region) of the eardrum is found
consult MO as urgent referral to ENT Specialist is required
Attic perforation
- unsafe perforation
Safe perforation
Related systems
Nose and throat
Examine the nose and throat - is there any discharge from nose? describe
Chest
Auscultate the chest for air entry and any added sounds (crackles or wheezes)
Note other injuries if present e.g. cause of traumatic rupture of the eardrum
Hearing screening and assessment commences from birth across the life span.
Refer to current edition of Chronic Disease Guidelines available at www.health.qld.gov.au/cdg
for procedures in performing:
Otoscopy
Audiometry to assess hearing level
Tympanometry to test middle ear function
If a patient is under the care of an Ear Nose and Throat Specialist or Audiologist ensure
they are up to date with appointments / care
592
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
Uncontrolled
Controlled copy
copy
V 1.0
593
Ear problems
Note:
These guidelines reflect specific recommendations for high risk populations (Aboriginal
and Torres Strait Islander populations)
In some rural and remote Aboriginal communities complications of ear disease are much
more common. They include hearing loss, tympanic membrane perforations, chronic
suppurative otitis media (CSOM), otitis media with effusion (OME) and mastoiditis. This
is the reason that higher dose and longer duration antibiotics are recommended in these
children, while in low risk populations (non Aboriginal and Torres Strait Islander populations)
the advantage of antibiotics is small unless systemic features are present [1] [2]
Dosing in this area is complex, for more detail see Australian Government and Menzies
School of Health Research (2011). Recommendations for Clinical Care Guidelines on
the Management of OTITIS MEDIA in Aboriginal and Torres Strait Islander populations
available at:
www.health.gov.au/internet/main/publishing.nsf/Content/health-oatsih-pubs-omp.htm
Dry perforation
Otitis externa
594
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
Recommend
Consult MO immediately if child is < 3 months of age, is sick or hot or meets any of
the other criteria outlined at beginning of paediatric section
Health clinics have targeted hearing health programs to focus on 0 - 5 year old
children where intervention may prevent ear damage and hearing loss
Personal hygiene in children - washing hands and face is important
Background
High risk populations (Aboriginal and Torres Strait Islander populations). In
some rural and remote Aboriginal communitites complications of otitis media are
much more common. They include hearing loss, tympanic membrane perforations,
CSOM, OME and mastoiditis. This is the reason that antibiotics are recommended
in these children, while in low risk populations (non Aboriginal and Torres Strait
Islander populations) the advantage of antibiotics is small unless systemic features
are present [1] [2]
Related topics
1.
2.
3.
4.
Bronchiolitis - child
Assessment of the ear
Irritability
Fever
Ear ache
Fluid behind the eardrum found on routine exam
Management
Consult MO if child:
- < 3 months of age
- temperature over 38C or below 36C
- has any rash, increased respiratory rate or respiratory distress or meets any
of the other criteria as outlined at beginning of paediatric section - this child
needs to be managed as a septic infant
Uncontrolled
Controlled copy
copy
V 1.0
595
Ear problems
Give antibiotics
-- to all children < 2 years of age from Aboriginal and Torres Strait Islander
populations with bilateral disease and those with a history of AOM with ear
discharge [1]
-- to non Aboriginal and Torres Strait Islander children less than 6 months or
with systemic features - vomiting and fever [2]
Talk to the family about the need to complete the full course of antibiotics and to
return at 4 - 7 days for the ear to be checked
Give or help to give the first dose in the clinic and ensure the family know the right
dose to give. If family do not have a fridge at home they may have to return to the
health service for medicine each day
Give amoxycillin if not allergic to penicillin
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12 years
250 mg
Capsule
500 mg tds
500 mg
Schedule
Amoxycillin
Oral
7 days
[1] [2]
If parent or Health Care Worker think it will be difficult for patient to comply with oral
antibiotics or if the child / adult has significant diarrhoea or vomiting, treat with IM
procaine penicillin with the option to return to oral antibiotic once vomiting settles
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult
1.5 g daily
Disposable
5 days
1.5 g
IM
Child
syringe
50 mg / kg / dose daily
to a max. of 1.5 g daily
Provide Consumer Medicine Information: complete course
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
-- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
-- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needleand deliver injection very slowly (2 minutes)
[3] [4]
Schedule
596
Procaine penicillin
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Child
25 mg / mL
Suspension
Oral
10 mg / kg / dose tds up to
5 days
50 mg / mL
a max. of 250 mg tds
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: consult MO
[2]
Schedule
Cefaclor
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Schedule
Tablet
250 mg
Cefuroxime
Oral
Adult
500 mg bd
5 days
Provide Consumer Medicine Information: best taken with food. Swallow whole (do not cut, crush or chew).
Take until course completed
Management of associated emergency: consult MO
[2]
5. Follow up
R
eview the patient in 4 - 7 days or earlier if indicated
If bulge persists after seven days increase dose of amoxycillin to 90mg / kg / day
on MO order [1]
If there are concerns about any of these refer for formal hearing assessment if not
done recently
To prevent recurrent otitis media and transmission of bacteria to other children
encourage personal hygiene in children - washing hands and face
Breathe, Blow, Cough (BBC) program is targeted at school aged children.
Information available at:
www.healthinfonet.ecu.edu.au/key-resources/promotion-resources?lid=16498
Review at 3 months to identify those with chronic disease [1]
6. Referral / consultation
C
onsult MO as above
If otitis media is recurrent the MO may consider antibiotics for prophylaxis [1]
ENT Specialist for those with frequent painful AOM
Uncontrolled
Controlled copy
copy
V 1.0
597
Ear problems
598
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
4.
Management
drops
If the discharge has been present for 14 days the condition is chronic suppurative
otitis media (CSOM) See Chronic suppurative otitis media (CSOM)
SeeSimple
Simpleanalgesia
analgesia
See
If has perforation within the last 6 weeks and not allergic to penicillin give amoxycillin
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
250 mg
Capsule
Adult and child 12 years
500 mg
500 mg tds
Schedule
Suspension
125 mg / 5 mL
250 mg / 5 mL
Amoxycillin
Oral
14 days
procaine penicillin with the option to return to oral antibiotic once vomiting settles
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended
Form
Strength
Duration
administration
dosage
Adult
1.5 g daily
Disposable
1.5 g
IM
Child
5 days
syringe
50 mg / kg / dose daily
to a max. of 1.5 g daily
Provide Consumer Medicine Information: complete course
Management of associated emergency: See Anaphylaxis and severe allergic reaction
Administration tips - as per patient preference:
- apply EMLA cream to the injection site 30 - 60 minutes prior to injection and allow medicine to warm
up to room temperature or
- allow medicine to warm up to room temperature, apply pressure with thumb (to the exact injection site)
30 seconds prior to the injection, use 21 G needle and deliver injection very slowly (2 minutes)
[3] [4]
Schedule
Procaine penicillin
Uncontrolled
Controlled copy
copy
V 1.0
599
Ear problems
If child allergic to penicillin and has perforation within the last 6 weeks - give cefaclor
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Child
25 mg / mL
Suspension
Oral
10 mg / kg /dose bd up to a
14 days
50 mg / mL
maximum of 250 mg bd
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: consult MO
[2]
Schedule
Cefaclor
If adult allergic to penicillin and has perforation within the last 6 weeks - give
cefuroxime
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Schedule
Tablet
250 mg
Cefuroxime
Oral
Adult
500 mg bd
14 days
Provide Consumer Medicine Information: best taken with food. Swallow whole (do not cut, crush or chew).
Take until course completed
Management of associated emergency: consult MO
[2]
Schedule
If discharge present for longer than 14 days and meets PBS restrictions MO
may add ciprofloxacin ear drops
4
Ciprofloxacin hydrochloride
ear drops
DTP
IHW / IPAP
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
5. Follow up
6. Referral / consultation
Consult MO as above
Refer for audiology if concerns about hearing, speech, language development,
If hearing is impaired in school children make sure the school is informed, with
parental consent, as teacher can use measures to assist child e.g. sound fields
and student placement
Where prolonged medical therapy fails i.e. > 6 weeks, MO may refer to ENT
Specialist
Any patient with an attic perforation (unsafe perforation) refer to ENT Specialist
Uncontrolled
Controlled copy
copy
V 1.0
601
Ear problems
Related topics
Acute otitis media (AOM) without perforation
Immunisation program
Usually is asymptomatic
Parents may be concerned about the childs hearing
Diagnosis may also be suspected at routine ear examination, in a child being
followed up after AOM, or in a child referred for medical assessment because of
hearing impairment on testing
Child may have:
-- past history of recurrent otitis media
-- concerns about speech or language development
Reported decrease in hearing
Reported poor hearing leading to learning difficulties
4. Management
602
Antibiotics are not routinely recommended for OME. However, long term
antibiotics (e.g. amoxycillin 25 - 50 mg / kg 1 - 2 times daily for 3 - 6 months) are
an option for infants who are at high risk of developing CSOM [1]
Arrange for audiology if there are concerns about hearing, speech, learning
difficulties or OME is persistent for > 3 months
Refer to ENT Specialist:
-- if hearing test shows moderate impairment in both ears for more than 3 months
-- if there is speech delay and effusion persists more than 3 months or
-- if there is more severe hearing impairment or concerns about the appearance
of the drum
Encourage personal hygiene in children - washing hands and face and keeping
face clear of nasal discharge
Breathe, Blow, Cough (BBC) program is for school aged children. Information
available at:
www.healthinfonet.ecu.edu.au/key-resources/promotion-resources?lid=16498
Check immunisation status particularly pneumococcal vaccination and perform
catch up immunisation if required
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
5. Follow up
3
monthly
If OME persists for > 3 months arrange - audiometry and tympanometry
See the current edition of the Chronic Disease Guidelines available at:
www.health.qld.gov.au/cdg
6. Referral / consultation
N
ext MO visit
Refer to ENT Specialist if:
Recommend
Consult MO immediately if unsafe perforation of the eardrum found (in the attic
region) See Assessment of the ear
Clean pus adequately from ear and then instill antibiotic ear drops [1]
Document the duration of ear discharge and size and position of perforation [1]
Treat discharging ears actively
Ciprofloxacin ear drops are not recommended generally as first line treatment except
in high risk populations [1] [2]
Background
CSOM is diagnosed in people who have discharging ears for more than 2 weeks [1]
Related topics
Cholesteatoma
Cleaning technique for ears with
chronic discharge
Assessment of the ear
Dry perforation
Uncontrolled
Controlled copy
copy
V 1.0
603
Ear problems
3. Clinical assessment
Obtain a complete patient history. Always ask about speech and language
See Assessment of the ear
Document length of time discharge has been present
Perform standard clinical observations
Perform physical examination See Assessment of the ear
-- clean the ear until all pus has been removed and the drum and perforation
can be seen
-- document the size and position of perforation on a diagram in the case notes
4. Management
Schedule
Ciprofloxacin hydrochloride
ear drops
DTP
IHW / IPAP
604
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
or
5. Follow up
Children < 5 years of age, review and treat daily for 7 days. If not drying in older
children consider daily treatment in the clinic. Suction under direct vision is very
useful to clear the ear if clinics have the equipment and staff have experience
and training
If not improving consult MO. See next MO clinic
Teach patient / carer cleaning technique and instillation of drops. Encourage
parents to return to a clinic early if discharge becomes worse or an ear that is dry
starts discharging again
Review weekly thereafter until ear is dry
If the ear is still discharging, consult MO
When the ear dries review at 3 months
To prevent recurrent otitis media encourage personal hygiene in children - washing
hands and face
6. Referral / consultation
F
or hearing assessment - audiometry and tympanometry when ear dry
With education staff, Speech Pathologist if indicated
Consult MO when patient presents with perforation in the upper drum (attic).
Uncontrolled
Controlled copy
copy
V 1.0
605
Ear problems
This can be done safely by a child on their own or by the parent. It should be done
whenever the ear discharges. The tissue paper actively absorbs the moisture
In the management of chronic suppurative otitis media, the tissue spear method
should be used in conjunction with regular eye dropper irrigation by the Health
Care Worker
Technique
1. Make a spear by twisting corner of tissue paper
2. Insert into ear gently, twisting slowly
3. Leave in place for 30 seconds then remove and repeat until tissue tip is dry
4. Perform at least twice per day until the ear is dry
Dropper method
The ear canal can be cleaned by irrigating with clean water using an eye dropper
or a 10 mL syringe or squirty bottle
An eye dropper uses a small volume of wash solution at low pressure and is
therefore relatively safe in unskilled hands
Eye droppers are cheap and easy to obtain and to clean for use at home
Equipment
A clean eye dropper and bulb. This can be washed with soap and water or an
antiseptic
A clean container of clean water (sterile or cool boiled) (some rainwater tanks
may be contaminated)
Clean container for the dirty water from the ear
Technique
1. The patient should be sitting or lying down with the affected ear upwards
2. Using a clean dropper filled with clean water, squirt water into the discharging
ear. Only the tip of the dropper needs to be in the canal. Without withdrawing
the dropper and just by releasing the bulb, suck the water and pus back into the
dropper
3. Discard the contents of the dropper into the container for dirty water. Do not squirt
the water in and out of the ear. When all the pus has been washed out of the ear,
the water sucked back into the dropper is clear
4. Repeat the above steps until there is clean return from the ear
5. Dry the ear canal using tissue spears See Tissue spear method - dry mopping
Suction
Suction under direct vision is the most effective technique but this requires special
equipment and training. Significant damage can occur if untrained staff perform
suctioning [9]
606
he patient should be sitting or lying down with the affected ear upwards
T
Clean and dry the ear canal as per dropper method and tissue spears
Instil the ear drops
Apply tragal pressure (pressing several times on the flap of skin in front of ear canal)
after the drops have been instilled to assist the drops through the perforation [1]
Keep the patient in position for several minutes
Use of cotton wool as a plug is not advised as it just soaks up the medicine. Let
excess run out
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
4. Management
5. Follow up
As per MO instructions
Advise no swimming. If this is not possible in a hot tropical climate, ear plugs with
a swimming cap for swimming are recommended for children with grommets.
Effective ear plugs can be custom built or made from silicon putty, cotton wool
with Vaseline or Blu-Tack
6. Referral / consultation
As above
Obtain a complete patient history. Always ask about speech and language
See Assessment of the ear
- document length of time perforation has been present
Perform standard clinical observations
Perform physical examination
-- note site of perforation in particular if perforation found in attic region (unsafe
perforation) of the eardrum
-- document the size and position of perforation on a diagram in the case notes
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
607
Ear problems
Encourage patient to keep ears dry, especially when bathing, by keeping head
out of water or by using water proof ear plugs
Ensure ongoing audiological and educational support
5. Follow up
Tell patients with dry perforations to attend the clinic for oral and topical antibiotics
6. Referral / consultation
Audiologist for hearing test when dry perforation persists for 3 months or more
Speech Therapist for all patients with language or behavioural problems for
speech therapy
If hearing is impaired in school children make sure the school is informed, with
parental consent, as the teacher can use measures to assist child e.g. sound
fields and student placement
ENT Specialist
-- all children > 6 years with a dry perforation persisting for > 6 months
-- those with significant conductive hearing loss (> 20 dB) or recurrent infections
-- perforation in attic region (unsafe perforation)
-- surgical treatment (myringoplasty) if eligible
Acute otitis media (AOM) with acute perforation Assessment of the ear
2. Immediate management
608
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
3. Clinical assessment
4. Management
5. Follow up
If confirmed, surgical treatment is required
6. Referral / consultation
Refer to ENT Specialist . Paediatrician may assist in getting early ENT appointment
2. Immediate management
Consult MO immediately
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
609
Ear problems
4.
Management
5.
Follow up
6.
Referral / consultation
Recommend
established otitis externa aural toilet may be indicated to remove debris. Consult MO
Related topics
Ear wick techique for otitis externa
Assessment of the ear
1.
Infection of the skin of the ear canal which may be acute or chronic
Varying degrees of canal redness and peeling, debris collects in the canal, ear
pain (sometimes severe) or itch
Tender, swollen outer ear and ear canal which is very painful if outer ear
manipulated, discharge not always present
Ear blockage, deafness or fullness, a foreign body may be present
2.
3.
Clinical assessment
4.
Management
610
Gentle cleaning with dry mopping to keep the ear canal dry, then instillation of drops
or in severe cases, a wick soaked with Sofradex ear drops or cortocosteroid
plus antibiotic ointment to remove pus and debris. The ear should be kept dry for
at least two weeks after treatment [7]. Advise not to swim until healed
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
Schedule
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Ear drops
Topical to ear
3 drops tds
7 days
Soaked gauze
or
ear wick
See above
or
Uncontrolled
Controlled copy
copy
V 1.0
611
Ear problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
The wick is left in the
Topical Ear drops
As above
Soaked gauze
canal for 2 days then
ear wick
review
Provide Consumer Medicine Information:
Management of associated emergency: consult MO
Administration tip - ear wick
-- remove the wick using forceps. Inspect and clean the ear. Reinsert new ear wick if required
[7]
Schedule
or
Triamcinolone compound
DTP
(Kenacomb)
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Recommended dosage
Duration
Form
Strength
administration
Triamcinolone 0.1%
The wick is left in the
Neomycin 0.25%
Topical Ointment Gramicidin 0.025%
Soaked gauze
canal for 2 days then
ear wick
Nystatin 100,000
review
units / g
Provide Consumer Medicine Information:
Management of associated emergency: consult MO
Administration tip - ear wick
-- remove the wick using forceps. Inspect and clean the ear. Reinsert new ear wick if required
[4]
Schedule
5. Follow up
R
eview in 2 days and in 1 week
Advise not to swim and keep ears dry until healed
Next MO visit if ear canal not back to normal at 1 week or if recurrent
6. Referral / consultation
O
titis externa can become chronic or recurrent, especially in hot humid climates
General prevention involves keeping the ear canal dry and protected by a lining
of wax. Using drying ear drops e.g. Aquaear / Vosol, after swimming and
showering will help prevent recurrence. Do not use if grommets or perforation
Advise patient to keep foreign objects such as cotton buds out of their ears. If
necessary remove built-up wax with e.g. Waxsol
Patients with recurrent infections often have a chronic fungal infection present.
This infection may be seen with fungal hyphae looking like wet blotting paper or
dry like cotton wool or the infection may be suspected even if the canal looks
clean and normal but is itchy
Suction, ear toilet, followed by Sofradex ear drops / ear wick or flumethasone
0.02% + clioquinol 1% ear drops / wick (Locacorten Vioform) or Kenacomb
ointment ear wick to prevent further acute bacterial infection
612
Uncontrolled
Controlled copy
copy
V1.0
Ear problems
Trauma to teeth
Head injuries
Assessment of the eye
Fractured mandible / jaw
Glasgow coma scale / AVPU
2. Immediate management
3. Clinical assessment
4. Management
onsult MO who will advise antibiotic ear drops if water penetrated the perforation
C
e.g. fall into water. The ear should be kept dry until healed. Antibiotic ear drops
are not necessary if hole was caused by dry trauma (blow to head)
5. Follow up
R
eview in 2 days and then weekly
If perforation not healed in 2 weeks, consult MO
6. Referral / consultation
Consult MO on presentation and if perforation not healed in 2 weeks
Uncontrolled
Controlled copy
copy
V 1.0
613
Ear problems
4. Management
onsult MO unless small object and seen to be near external ear opening and
C
easily removable using e.g. nasal packing forceps
Larger foreign bodies and those further down the canal require special equipment
and training for removal and may even require a general anaesthetic (send to
hospital with ENT facilities)
Live insects in the ear canal should be immobilised by first instilling 2% lignocaine
2 - 3 drops [9] or cooking oil introduced by the blunt end of a syringe or via a
cut-off butterfly needle (or other plastic tubing is also effective). Then syringe
with warm water
After removal of foreign body or insect, instil Sofradex ear drops to prevent
infection secondary to the trauma caused to the skin of the ear canal
See above
Topical to ear
3 drops tds
7 days
5. Follow up
I f foreign body or insect easily removed, review in 2 days
Review See Otitis externa if secondary infection occurs after removal
6. Referral / consultation
References
1. Australian Government and Menzies School of Health Research (2011). Recommendations for Clinical
Care Guidelines on the Management of OTITIS MEDIA in Aboriginal and Torres Strait Islander Populations
updated 2010. Canberra. [cited June 2012]
www.health.gov.au/internet/main/publishing.nsf/Content/health-oatsih-pubs-omp.htm
2. Therapeutic Guidelines (2012). "Otitis media." Retrieved November, 2012.
3. Australian Medicine Handbook (2012). "Procaine Penicillin ". Retrieved June, 2012.
4. Dr A White (2012). Paediatrician
5. Australian Medicine Handbook (2012). "Ciprofloxacin (ear)." Retrieved June, 2012.
6. Isaacson G., Diagnosis of pediatric cholesteatoma. Pediatrics 2007. (3): p. 603-608.
7. Therapeutic Guidelines (2012). "Otitis externa." Retrieved June, 2012.
8. Murtagh J. and Rosenblatt J. (2011). John Murtagh's general practice McGraw-Hill Australia Pty Ltd.
9. Tintanelli E.J. (2011). Tintanelli's Emergency Medicine: A comprehensive study guide, seventh edition,
McGraw Hill Medical
614
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
Intraosseous infusion
Vomiting
Diarrhoea
Cramping abdominal pain
Irritability in the young child
Fever
Dehydration
Lethargy, floppy, unresponsive
2. Immediate management
Uncontrolled
Controlled copy
copy
V 1.0
615
Gastrointestinal problems
3. Clinical assessment
Some signs
Moderate 5 - 10%
Definite signs
Severe > 10%
Eyes
normal
sunken
moist
dry
very dry
Condition
alert
restless, irritable,
lethargic
extreme lethargy
ragdoll appearance
drinks normally,
may be thirsty
drinks poorly or
not able to drink
Respiratory rate
normal
increased
fast
Pulse
normal
fast
Capillary return
normal ( 2 seconds)
Management
Consult MO
Require urgent
rehydration usually
nasogastric / IV
Consult MO
Requires resuscitation
Thirst
616
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
4. Management
onsult MO immediately - for those children with risk factors or moderate / severe
C
dehydration and children < 3 months
Children and babies with watery diarrhoea lasting 2 - 3 days should have bloods
taken for electrolytes. Take bloods earlier if indicated
Do not use:
--
anti-diarrhoeal agents
-- metoclopramide or prochlorperazine in children. MO may order ondansetron
if vomiting is preventing oral intake [2]. Ondansetron not recommended for
children < 6 months of age or < 8 kg [1]
-- antibiotics (rarely indicated)
Dilution
Example
1 part in 20 parts
1 part in 5 parts
20 mL (1 tablespoon) plus 80 mL
water
Uncontrolled
Controlled copy
copy
V 1.0
617
Gastrointestinal problems
Diagnosis of
Gastroenteritis
in doubt?
Yes
No
Significant
co-morbidities or
risk factors such
as age
< 3 months,
febrile
Yes
No
Vomiting
prominent?
Yes
MO may consider
ondansetron wafer
Trial of oral fluids
10 - 20 mL / kg for 1
hour unless severe
dehydration
No
Assess
dehydration
Mild
Moderate
Severe
Consult MO
Requires urgent
rehydration
nasogastric / IV.
MO may organise
evacuation /
hospitalisation
Consult MO urgently
who will organise
evacuation /
hospitalisation
IV / IO insertion
Commence bolus of
20 mL / kg
sodium chloride 0.9%
618
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
Uncontrolled
Controlled copy
copy
V 1.0
619
Gastrointestinal problems
5. Follow up
Evacuation / hospitalisation of children with moderate (if indicated) or severe
dehydration
Children with mild dehydration i.e. < 5% and no clinical signs, review in 24 hours
620
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
Uncontrolled
Controlled copy
copy
V 1.0
621
Gastrointestinal problems
6. Referral / consultation
Consult MO immediately as above
Children with chronic diarrhoea See Child with chronic diarrhoea flowchart
Children with weight loss or poor weight gain who are not acutely unwell - refer to
Nappy rash
Child with chronic diarrhoea flowchart
4. Management
622
Gastrointestinal problems
eintroduce normal formula after 2 - 4 weeks starting with 1/3 normal to 2/3
R
lactose free and increasing the proportion of normal formula over 3 - 4 days
If symptoms recur, revert to lactose free formula and try again in 2 - 4 weeks
5. Follow up
6. Referral / consultation
C
onsult MO on all occasions lactose intolerance suspected
Dietitian if available
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
623
Gastrointestinal problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Tablet
500 mg
Tinidazole
Oral
Stat
Provide Consumer Medicine Information: take with food. Avoid alcohol while taking and for 72 hours
Management of associated emergency: consult MO
[4]
or
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
200 mg
Adult
Tablet
400 mg
2 g daily
Schedule
Metronidazole
Oral
3 days
Child
30 mg / kg / dose daily
to a max. of 2 g daily
Provide Consumer Medicine Information: avoid alcohol while and for 24 hours after taking this medicine.
Take with food or immediately after food. Take until course completed
Management of associated emergency: consult MO
[4]
Suspension 200 mg / 5 mL
5. Follow up
R
eview next day
Consult MO if diarrhoea not settling
Provide education and advice concerning handwashing before handling food,
eating and after toilet and avoid food preparation and public swimming pools until
diarrhoea has settled
6. Referral / consultation
Consult MO as above
624
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
2.
Perianal / perineal itch - pinworm (thread worm), small threadlike worm may be
seen (doesnt cause diarrhoea or failure to thrive)
Anaemia - hookworm
Acute diarrhoea - strongyloides
Failure to thrive - strongyloides can contribute
3. Clinical assessment
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
625
Gastrointestinal problems
Mebendazole
Albendazole
Praziquantel
Ivermectin
(not recommended in children 5
years of age or less)
Schedule
Worm
Threadworm (pinworm)
Hookworm
Roundworm
Threadworm (pinworm)
Hookworm
Roundworm
Whipworm
Threadworm (pinworm)
Hookworm
Roundworm
Strongyloidiasis
Whipworm
Cutaneous larva migrans
Beef tapeworm and pork tapeworm
Dwarf tapeworm
Strongyloidiasis
Filariasis
Onchocerciasis
Crusted (Norwegian) scabies
Head lice
Cutaneous larva migrans
Pyrantel
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
125 mg
Stat
Tablet
10 mg / kg / dose
250 mg
Oral
Repeat after 7 days if
to a max. of 1 g
Suspension
50 mg / mL
heavy infestation
Provide Consumer Medicine Information: can be used in children < 6 months of age and pregnant women.
Take until course completed
Management of associated emergency: consult MO
[5]
626
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
DTP
IHW / SM R&IP / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse may proceed
Route of
Form
Strength
Recommended dosage
Duration
administration
Threadworm (pinworm),
hookworm, roundworm
Adult and child 10 kg
Stat
400 mg
Child < 10 kg
Chewable
200 mg
200 mg
Oral
tablet
400 mg
Strongyloidiasis,
3 days
whipworm
Adult and child 10 kg
Then for
400 mg daily
Strongyloidiasis repeat
Child < 10 kg
after 7 - 14 days
200 mg daily
Provide Consumer Medicine Information: women should use effective contraception during and for one
month after treatment. To increase absorption for systemic indications e.g. strongyloides, take medicine
with fatty meal. For other indications take on an empty stomach. Take until course completed
Management of associated emergency: consult MO
[5]
Schedule
Albendazole
Mebendazole
or
Schedule
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Threadworm (pinworm)
Adult and child 10 kg
Tablet
100 mg
100 mg
Stat
Child < 10 kg
50 mg
Oral
Whipworm, hookworm,
roundworm
3 days
Adult and child 10 kg
Suspension 100 mg / 5 mL
100 mg bd
Child < 10 kg
50 mg bd
Provide Consumer Medicine Information: take until course completed
Management of associated emergency: consult MO
[5]
5. Follow up
6. Referral / consultation
Consult MO as above
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
627
Gastrointestinal problems
Constipation child
Recommend
Maintenance programs consisting of medicine, toileting program, dietary advice and
follow up to prevent recurrence
Background
Constipation is the difficult passage of infrequent dry, hard stools that often cause
pain and discomfort. The most common cause is functional - no underlying cause [6]
Constipation starts a vicious cycle - passing hard stool is painful, so the child avoids
straining at stool, the constipation gets worse and so on. Part of the battle is forming
a habit for the child to go to the toilet each day
Straining is normal in babies
628
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
onsider possible organic problem (and refer for further work up) if:
C
-- child has constipation from birth
-- child has vomiting and abdominal distension
-- there is any bile vomiting
-- the child is not growing well
-- there is more than just a streak of blood on the stool
-- constipation does not improve with simple measures
4. Management
Dietary interventions:
-- encourage a healthy diet with fruit and vegetables and wholegrain cereals
-- encourage drinking plenty of water
-- pears (fresh or pureed) or prunes will stimulate the gut gently and soften stools
-- excessive dietary intake can cause constipation in children
Encourage physical activity
Toileting programs:
-- take advantage of the gastrocolic reflex. Most people, especially children
have the urge to pass a motion after eating a meal, especially breakfast
-- advise that the child should sit on the toilet after each meal and attempt to
pass a motion without straining
-- positively reinforce good behaviour. A reward for sitting on the toilet and
passing a motion is often beneficial
D
isimpaction:
-- oral laxatives
liquid paraffin, chocolate flavoured liquid paraffin e.g. Parachoc . Avoid
in infants under 12 months of age
lactulose, senna, Movicol Half
-- enemas (only if oral laxative has failed)
micro-enemas such as Microlax
Most constipation in children will resolve with these measures. If it persists, refer
to the next Child Health Nurse or MO clinic or Continence Advisor
5. Follow up
Children with constipation should be reviewed regularly to assess progress.
Once the problem settles remember to continue with dietary improvement and
increased water intake to prevent recurrence
Advise parent / carer to use appropriate gentle fibre or laxative (prune / pear juice
/ psyllium) for at least 3 months to regulate peristalsis
6. Referral / consultation
Uncontrolled
Controlled copy
copy
V 1.0
629
Gastrointestinal problems
2. Immediate management
3. Clinical assessment
4. Management
5. Follow up
All babies with suspected pyloric stenosis must be managed in hospital. Diagnosis
6. Referral / consultation
Consult MO on all occasions of suspected pyloric stenosis. These infants may
630
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
Intussusception child
Background
Suspect in a young child who looks unwell and has intermittent severe abdominal pain
In 15% of cases the classic triad of abdominal pain, palpable sausage shaped
abdominal masses and red currant jelly stool is present. The small bowel telescopes
into itself (as if it were swallowing itself)
Most common cause of obstruction in children 6 - 36 months of age (60%
< 12 months of age)
Intermittent severe abdominal pain (may settle and appear well between bouts of
pain 10 - 20 minutes apart)
Intermittent inconsolable crying
Poor feeding
Vomiting
Blood per rectum (classically red currant jelly but is often a late sign)
Child may look pale and unwell
2. Immediate management
Consult MO
3. Clinical assessment
4. Management
5. Follow up
Monitor child on return to community
6. Referral / consultation
Consult MO on all occasions of suspected intussusception
Uncontrolled
Controlled copy
copy
V 1.0
631
Gastrointestinal problems
Related topics
Anaemia - child
Giardia
Intestinal worms
Lactose intolerance
Urinary tract infection - child
Any condition
A child whose weight has crossed down 2 or more major centile lines on standard
growth charts (and who is not overweight or obese) [7]
632
Gastrointestinal problems
-- urinalysis
-- check haemoglobin on haemoglobinometer (HemoCue)
-- collect stool specimen for lactose intolerance testing
Perform a complete physical examination:
-- head to toe assessment of current state of health, looking for evidence of
undetected illness
-- do naked weigh, check length and head circumference - plot growth chart
4. Management
Uncontrolled
Controlled copy
copy
V 1.0
633
Gastrointestinal problems
Food prescription
Drinks
Nutritional supplement - usually Pediasure at least one 237 mL can or one cup
250 mL of supplement every day or 5 scoops of powder in 200 mL water
Water, breast milk, infant formula, cows milk if over 12 months
Food
Meals - breakfast, lunch, dinner, snacks containing fruit, vegetables
5. Follow up
Place child on individualised care plan, setting out actions, targets and who is
6. Referral / consultation
C
onsult MO. Child may need hospitalisation
Child development unit for developmental screening of gross and fine motor,
and bubs
www.health.qld.gov.au/cdg
634
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
Anaemia child
Recommend
Aim to achieve haemoglobin level above 110 g / L [8]
Suite of Growing Strong resources, especially iron rich food available at:
www.health.qld.gov.au/ph/documents/hpu/growing_strong.asp
Regular calibration of haemoglobinometer (HemoCue)
Background
Nutrient requirements, especially iron, are very high in young children between the
ages of 6 months and 24 months
Consider causes other than dietary e.g hereditary causes
Anaemia is common in Aboriginal and Torres Strait Islander children particularly in
the 6 to 30 months age group
Childhood anaemia is more likely if mother had low iron status or was anaemic in
pregnancy and / or if baby was premature or low birth weight
Anaemia is largely due to dietary deficiency in iron and / or folate and the inhibitory
effects of infestations and infections
There are higher rates of iron deficiency and anaemia in infants and toddlers where
high cow's milk intake is encouraged or allowed
Failure to thrive may or may not co-exist
Overweight and obesity may or may not co-exist
Iron deficiency of any degree affects child development
Related topics
Giardia
Intestinal worms
Uncontrolled
Controlled copy
copy
V 1.0
635
Gastrointestinal problems
-- n
utrition intake, breast or formula fed or both - when did formula start? what
type of milk is child drinking? cow's milk?
-- solids, type - when were solids introduced?
-- eating pattern
-- urine output / number of stools per day
Perform standard clinical observations +
-- urinalysis
-- weigh - use naked weight in children aged less than 2 years and record
against most recent recorded weight
-- check length and do head circumference and plot against growth chart
-- check haemoglobin on haemoglobinometer (HemoCue) (if not already done)
Perform a complete physical examination:
-- from head to toe, assessing current state of health and looking for evidence
of undetected illness
4. Management
636
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
Ferrous sulfate
DTP
(Ferro-Liquid / Ferro-Gradumet)
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Child under 6 months
1 mL daily (in collaboration
with MO on individual
30 mg
patient basis)
(equiv. to 6 mg of
Child 5 - 9 kg 5 mL
elemental iron)
Liquid
Oral
per mL
Child 10 - 14 kg 10 mL
Schedule
Child 15 - 19 kg 15 mL
1 month
daily or
then review
daily dose given twice
by MO
weekly supervised
Child
Ferrous
Max. of 6 mg / kg / day of
sulfate 325 mg
elemental iron
(equivalent to
18 kg 1 tablet
Oral
Tablet
36 kg 2 tablets
105 mg of
daily or
elemental iron)
daily dose given twice
per tablet
weekly supervised
Provide Consumer Medicine Information: overdose of iron can be fatal. Keep iron mixtures and tablets out
of reach of children. Warn patient / carer about dark, tarry stools and constipation. Give with orange juice
or provide Pentavite. Take until course completed
Note: Therapeutic Guidelines state continue for 3 months after Hb returned to normal to replenish stores
Management of associated emergency: consult MO
[9]
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Recommended dosage
Duration
Form
Strength
administration
Schedule
Tablet
(dispersible)
500
microgram
Folic acid
Oral
Child < 10 kg
500 microgram
Child 10 kg - 20 kg
1 mg
(tablet dispersed in water)
daily or
daily dose given twice
weekly supervised
1 month
then review
by MO
Provide Consumer Medicine Information: tablet disperses in water - becomes cloudy but is tasteless
Management of associated emergency: consult MO
[12]
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
637
Gastrointestinal problems
ive nutrition advice. Use Growing Strong resources - breastfeeding, iron rich
G
foods, healthy food and drinks and many more available at:
www.health.qld.gov.au/ph/documents/hpu/growing_strong.asp
Recommend breastfeed exclusively for first 6 months
Appropriate iron rich first foods at around 6 months
-- foods rich in iron and / or folate:
red meat, beef / lamb liver or kidneys, bush meat
chicken, fish, egg yolks
iron fortified baby cereal
green vegetables
fruit and vegetables (to help iron absorption)
breast milk or infant formula (NOT normal cow or goat milk unless over
1 year of age)
no turtle or dugong liver or kidneys or intestines - as concern about
cadmium content
no cow's milk - liquid or powdered before 1 year old
no tea or coffee
no soft drink, juice or cordial
5. Follow up
Place child on individualised care plan, setting out actions, targets and who is
6. Referral / consultation
638
Uncontrolled
Controlled copy
copy
V1.0
Gastrointestinal problems
Uncontrolled
Controlled copy
copy
V 1.0
639
Gastrointestinal problems
Iron injection
Warning: iron can stain patient's skin. Injections should only be given by staff
trained and experienced in IM administration of iron using the Z track injection
technique as described.
The ventrogluteal site (not the buttock) is recommended for injection. The Hochstetter method (using
a Z track injection technique) must be used to prevent the injected solution from running back into the
subcutaneous tissues and discolouring the skin. Iron injections should never be injected into the arm or
other exposed areas.
Z track procedure
Pull the skin over the site of the injection about 2 cm
Insert the needle at a right angle to the skin (90)
After the injection the needle is slowly withdrawn and pressure from a finger applied beside the puncture
site. This pressure is maintained for about one minute
The patient should move about after the injection [10]
Up to 3 ml of fluid may be given in this site [13]
Z track injection method
Skin
90
Subcutaneous tissue
Muscle
Medicine
During injection
After injection
[14]
References
1.
Royal Children's Hospital Melbourne (2009). "Gastroenteritis." Retrieved August, 2012, from
www.rch.org.au/clinicalguide/cpg.cfm?doc_id=12364
2.
Therapeutic Guidelines (2012). "Infectious diarrhoea: other supportive therapies." Retrieved August, 2012.
3.
The Children's Hospital at Westmead and Sydney Children's Hospital Randwick & Kaleidoscope* Hunter
Children's Health Network (2010). "Fact Sheet Gastroenteritis." Retrieved August, 2012.
4.
Therapeutic Guidelines (2012). "Giardia intestinalis (giardiasis)." Retrieved August, 2012.
5.
Therapeutic Guidelines (2012). "Anthelmintic drugs." Retrieved August, 2012.
6.
IMPACT Paediatric Bowel Care Pathway (2006). A Guide to the Management of Constipation and Faecal
Impaction in Children Australia.
7.
Robert W Block. and Nancy F Krebs. (2005). "Failure to Thrive as a Manifestation of Child Neglect." American
Academy of Pediatrics Committee on Child Abuse and Neglect and the Committee on Nutrition 116.
8.
The World Health Organization (2001). "Iron deficiency anaemia, assessment, prevention and control.
A guide for program managers." Retrieved August, 2012.
9.
Therapeutic Guidelines (2012). "Iron deficiency." Retrieved August, 2012.
10. MIMS (2012). "Ferrum H Injection." Retrieved August, 2012, from www.mimsonline.com.au
11. Therapeutic Guidelines (2012). "Community worm programs." Retrieved October, 2012.
12. Shann F. Royal Children's Hospital Melbourne (2010). Drug Doses, Collective Pty Limited.
13. Cocoman A. and Murray J. (2012). "Clinical Practice - IM injections: How's your technique." Retrieved
November, 2012.
14. Nursingcrib (2012). "Z Track Method." Retrieved November, 2012.
15. Greenway K. (2004). "Using the ventrogluteal site for intramuscular injection " Nursing Standard 18(25):
39-42
16. Australian Government (2012). "The Australian Immunisation Handbook 10th edition (in press)."
Retrieved November, 2012.
17. PEMSoft (2013). "Ventrogluteal site." Retrieved March, 2013.
640
Uncontrolled
Controlled copy
copy
V1.0
btain a complete patient history See History and physical examination - child
O
-- when did symptoms start? What has the progression been?
-- ask about fever, cough, fast breathing, diarrhoea, vomiting?
-- how is the childs appetite, feeding, sleeping, waking?
Perform standard clinical observations +
-- assess growth and plot against chart for age and sex
P
erform physical examination:
-- head to toe examination looking for signs of infection - ears, throat, skin,
chest abdomen
-- palpate for loin tenderness which may be present in pyelonephritis
-- UTI should be considered in all babies and children with fever, vomiting or
unwell, but it is often not possible to differentiate from other infections including
meningitis, pneumonia or even viral infections. In older children there will
usually be urinary symptoms
C
ollection of urine sample
-- children who are unwell and most children under 6 months of age will usually
need management in hospital. If possible collect clean catch urine and blood
culture before starting antibiotics (but giving antibiotics is more important if
not possible)
Midstream sample - children old enough to pass urine on demand
-- method - clean genital area and collect a midstream sample
Uncontrolled
Controlled copy
copy
V 1.0
641
4. Management
5.
Follow up
I f not evacuated review daily for next 2 days - if not improving, consult MO
Check results of urine MC/S (24 - 48 hours) and discuss with MO - advice on
6. Referral / consultation
Consult MO on all occasions of suspected UTI in children
Renal ultrasound - atypical UTI, boys less than 3 months, children less than 6
References
1.
The Royal Children's Hospital Melbourne (2011). "Urinary Tract Infection Guideline." Retrieved August,
2012, from www.rch.org.au/clinicalguide/cpg.cfm?doc_id=5241
2.
Therapeutic Guidelines (2012). "Urinary tract infections: children." Retrieved August, 2012.
3.
NHS National Institute for Health and Clinical Excellence (2012). "Urinary tract infection children."
Retrieved August, 2012, from www.nhs.uk/Conditions/Urinary-tract-infection-children/Pages/Symptoms.aspx
642
Uncontrolled
Controlled copy
copy
V1.0
Septic arthritis
Pain, limp, refusal to weight bear
Refusal to move joint or pain on
moving joint
Pain and tenderness localised to joint
May be swelling and redness over joint
Fever
2. Immediate management
Consult MO
3. Clinical assessment
Uncontrolled
Controlled copy
copy
V 1.0
643
4.
Management
5.
Follow up
6.
Referral / consultation
References
1.
644
The Royal Children's Hospital Melbourne (2008). "Osteomyelitis and Septic Arthritis." Retrieved August, 2012.
Uncontrolled
Controlled copy
copy
V1.0
Uncontrolled
Controlled copy
copy
V 1.0
645
2. Immediate management
I f you suspect abuse always obtain advice. Consider discussing the case with
your line manager, Paediatrician, Child Protection Liaison Officer (CPLO) or Child
Protection Advisor (CPA)
Physical abuse
Assessment
-- history of injury: whenever a child presents with an injury, take and record a
detailed history about how the injury occured. What happened? What went
wrong? When? Who was there?
-- past history: previous injury, medical problems, who is the child's carer
and guardian?
-- examine the child. Record the injury and also any other injuries. Check the
whole body. Use child abuse diagram to record injury or bruises. Think of
non accidental injury if:
the injury is in a pattern shape you recognise such as a hand, belt
or buckle
the child or someone else tells you that it was caused by a parent / carer
a non mobile baby who has bruises, head injury, neurological symptoms
a baby less than 2 years of age with any fracture
there is delay in seeking medical attention
bruises or fractures where the explanation does not make sense
or changes
Management
-- treat the physical injury
-- document the history and the injury. Child abuse diagrams to assist with recording
abuse are available at www.rch.org.au/clinicalguide/cpg.cfm?doc_id=5170
-- if any disclosures are made document using exact words and phrases
-- discuss with senior colleague, Nurse Manager, senior Health Worker, Director
of Nursing, Child Protection Advisor, Child Protection Liaison Officer
-- discuss with MO. May need to transfer to hospital for further investigation
-- ensure child is safe
-- if suspicion of non accidental injury is formed notify Child Safety Services,
Department of Communities, Child Safety and Disability Services
See How to make a report to Child Safety Services
646
Uncontrolled
Controlled copy
copy
V1.0
Sexual abuse
Assessment
-- if the history suggests recent sexual abuse (because of the story or
genital injury)
document history provided
don't try to question the child or young patient yourself. But if they make
disclosures write it down word for word
don't examine the child's genitals, unless needed because of serious
injuries / bleeding
don't wash the child or change their clothes (may be forensic evidence)
-- if episode(s) of abuse are not recent
general examination not genital examination
-- sexual activity in adolescents
consider age of child, intellectual and emotional development
for adolescents, consider age of young patient, age of sexual partner
and differences in ages
under 14 years of age, report all sexual activity, all matters that
require a pregnancy or PCR test or provision of contraception
over 14 years of age, report sexual activity that has been assessed
as non-consensual, not fully comprehended by the young patient,
suggestive of an inappropriate power differential, constituting an
age gap (5 years or more), involving coercion, exposure to or use
of pornographic material, involving other family member
Management
-- Child Sexual Assault (CSA) examinations should only be performed at the
request of Queensland Police Service (QPS) and / or Child Safety Services
after there has been some further corroboration of possible sexual abuse. CSA
examination needs to be performed by an MO with appropriate paediatric skills
including child protection and / or sexual medical examination training or skills
-- do not request STI tests in an asymptomatic child as the initial response to a
suspicion of sexual abuse
-- if episode(s) are recent
involve senior colleague, Nurse Manager, senior Health Worker, Director
of Nursing, Child Protection Advisor, Child Protection Liaison Officer, MO
discuss with MO and with Child Protection Advisor. If recent assault
will need to transfer to regional centre for urgent forensic examination.
Child Safety Services and / or Child Protection and Investigation Unit
would also be involved in this process
notify the Child Safety Services
See How to make a report to Child Safety Services
-- if episode(s) of abuse are not recent
consider the safety of the young patient
there is often no physical or medical evidence of sexual abuse
support child / young patient and their protective parent / carer
notify Child Safety Services
See How to make a report to Child Safety Services
Neglect
Assessment
-- check the following issues which might suggest / impact on carer neglecting child:
child is unkempt, unwashed, hungry
forms inappropriate relationships e.g. clingy with clinical staff
concern raised about financial resources available to care for child
knowledge of parental / carer mental illness and when unwell are not
able to care for the child
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
647
Neglect
Assessment continued
-- take history about child's care and carers
-- ask about difficulties such as substance use and family violence
-- arrange for MO review to consider medical problems e.g. for failure
to thrive
-- record concerns, support offered and action taken
Management
-- ensure the carers understand the needs of the child
-- work with family to develop a plan to meet the child's needs
-- involve appropriate health team members, Child Health Nurse, MO,
Health Worker
-- if medical issues refer to Paediatrician
-- notify Child Safety Services if no progress in child's condition despite providing
or attempting to provide support
See How to make a report to Child Safety Services
Emotional abuse [3]
Assessment
-- ask carer / young person about behaviours which may indicate emotional
abuse
disruptiveness, aggressiveness, bullying, threatening, scaring, exposure
to domestic violence, ridiculing or other non-physical forms of hostile
behaviour or rejecting treatment
Management
-- ensure the carers understand the impact of behaviours and action on
child's needs
-- determine the severity of the problem
-- child may require assessment of resultant symptoms including withdrawal,
excessive anger or aggression, eating disorders, failure to thrive, developmental
delay and emotional disturbances (depression, anxiety, fearfulness,
running away)
-- consider referral to Paediatrician and / or Child and Youth Mental
Health Services
-- consider referral to support, counselling agencies (if available)
-- if symptoms are significant and are / could be the result of parental actions
or behaviours, a mandatory report of child abuse and neglect is required and
advice of harm provided to Child Safety Services
See How to make a report to Child Safety Services
648
Uncontrolled
Controlled copy
copy
V1.0
When a staff member formulates a reasonable suspicion of child abuse and neglect, this staff
member shall immediately verbally report their concerns directly to an authorised officer of the
Department of Communities Child Safety Services: Regional Intake Service
Additionally, all verbal reports shall be followed up with a written report to Department of
Communities Child Safety Services: Regional Intake Service within seven days on the Queensland
Health report of a reasonable suspicion of child abuse and neglect (SW010) form available from
http://qheps.health.qld.gov.au/csu/reportingforms.htm
Fax a copy of the SW010 Report Form to the Regional Intake Service that received your verbal report
File the original copy of the SW010 Report Form in the correspondence section of the patient's
clinical record
Forward the yellow carbonated copy of the SW010 Report Form to your Local Hospital
Health Services Child Protection Unit. Contact details are available on the QHEPS site
http://qheps.health.qld.gov.au/csu/districtcpacplo.htm
A staff member who has made a report of reasonable suspicion of child abuse and
neglect shall comply with requests by Department of Communities Child Safety Services
for further relevant information if needed to properly assess the harm or likely harm
A doctor or nurse who does not comply with the reporting requirements of s191 and s192 of the
Public Health Act 2005 commits an offence and may be subject to penalty (s193 Public Health
Act 2005)
Phone number
1300 678 801
1300 683 259
1300 683 596
1300 704 514
1300 705 201
1300 705 339
1300 683 042
Fax number
3884 8801
4616 1796
4039 8320
4799 7273
5420 9049
3259 8771
4938 4697
Uncontrolled
Controlled copy
copy
V 1.0
649
6.
Referral / consultation
Consult MO. Child may need evacuation
Seek advice from the Local Hospital Health Services Child Protection Officer and
/ or Child Protection Liaison Officer who are available to offer support, clinical
advice and reporting information
For more detail See Protecting Children and Young People Policy, Implementation Standards,
Protocol and Procedures available at: www.health.qld.gov.au/qhpolicy/html/index-p.asp
Resources
Child Abuse Diagrams to assist with recording abuse
www.rch.org.au/clinicalguide/cpg.cfm?doc_id=5170
http://qheps.health.qld.gov.au/csu/reportingforms.htm
References
1.
Queensland Government (2012). "Protecting Children and Young People." Retrieved June, 2012, from
www.health.qld.gov.au/qhpolicy/html/index-p.asp
2.
Queensland Government (2010). "Factsheets." Retrieved June 2012, from
http://qheps.health.qld.gov.au/csu/Factsheets.htm
3.
Queensland Government (2009). "Emotional abuse - clinical risk factors and indicators." Retrieved June,
2012, from http://qheps.health.qld.gov.au/csu/Factsheets.htm
650
Uncontrolled
Controlled copy
copy
V1.0
Section 7
Immunisation
Immunisation
Section 7
Immunisation
Contents
Immunisation program
Sexual health immunisation program
Tetanus immunisation
652
Uncontrolled
Controlled copy
copy
V1.0
Immunisation
Acute Hepatitis A
Acute Hepatitis B
Uncontrolled
Controlled copy
copy
V 1.0
653
Immunisation
4. Management
654
Uncontrolled
Controlled copy
copy
V1.0
Immunisation
Schedule
Vaccines
DTP
IHW / SM R&IP / IPN / Mid
Diphtheria - tetanus - acellular pertussis hepatitis B - inactivated poliovirus Haemophillis influenzae type B
(DTPa-hepB-IPV-Hib)
Hepatitis A
Hepatitis B #
Rotavirus
Varicella (VV)
Hepatitis B Immunoglobulin #
(Midwives only)
For babies of HBsAG positive mothers only
[1]
Legend
1
Uncontrolled
Controlled copy
copy
V 1.0
655
Immunisation
5. Follow up
6. Referral / consultation
Consult MO / Public Health Physician as above
Acute Hepatitis A
Acute Hepatitis B
HIV infection
656
Immunisation
4. Management
Schedule
Vaccines
DTP
IHW / SM R&IP / SRH / IPN
Situations
Hepatitis A
Hepatitis B
As per the Australian Immunisation Handbook / current NIPs
Human papillomavirus (HPV)
Measles, mumps, rubella (MMR)
Provide Consumer Medicine Information
Management of associated emergency: See Anaphylaxis and severe allergic reaction
[1]
Legend
1
5. Follow up
6. Referral / consultation
Consult with MO or Public Health Physician as above
Uncontrolled
Controlled copy
copy
V 1.0
657
Immunisation
Burns
Spider bites (general)
Tick bites
Funnel-web (big black) spider bite
All wounds other than clean minor cuts are considered tetanus prone
In particular assess [1]
-- compound fractures
-- bite wounds
-- deep penetrating wounds, wounds containing foreign bodes (especially wood
splinters)
-- wounds complicated by pyogenic infections
-- wounds with extensive tissue damage e.g. contusions or burns
-- superficial wounds contaminated with soil, dust or horse manure (especially
if topical disinfection is delayed more than 4 hours)
-- re-implantation of an avulsed tooth
Does the patient inject drugs? in particular practise skin 'popping' (injecting under
the skin)
See Immunisation program
4. Management
658
Immunisation
wounds
< 3 doses or uncertain
All other wounds
YES
Tetanus
Immunoglobulin
(TIG)*
NO
NO
NO
NO
NO
NO
NO
YES
* Recommended dose for TIG is 250 International units, given by IM injection, as soon as practicable after the
injury. If more than 24 hours has elapsed, 500 International units should be given. Because of its viscosity,
TIG should be given to adults using a 21 G needle. For children, it can be given slowly using a 23 G needle
All wounds, other than clean minor wounds, should be considered tetanus prone
Patients with a humoral immune deficiency (including HIV-infected patients who have immunodeficiency)
should be given TIG if they have received a tetanus prone injury, regardless of the time since their last dose
of tetanus-containing vaccine
Patients who have no documented history of a primary vaccination course (3 doses) with a tetanus toxiodcontaining vaccine should receive all missing doses and must receive TIG. See Australian Immunisation
Handbook for catch-up
DTP
IHW / SM R&IP / IPAP / IPN
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic must consult MO / NP
Scheduled Medicines Rural & Isolated Practice Registered Nurse and Immunisation Program Authorised
Registered Nurse may proceed
Dose, route and timing interval of administration of vaccines to be
given in accordance with the Australian Immunisation Handbook /
current NIPs
Condition
To determine eligibility for funded vaccines refer to the current
NIPs Queensland
Route of
Vaccine
Recommended age
administration
Diphtheria, tetanus
IM
Paediatric formulation < 10 years
acellular pertussis (DTPa)
Schedule
Vaccines
Diphtheria, tetanus
acellular pertussis (dTpa)
IM
IM
Adult formulation
Uncontrolled
Controlled copy
copy
V 1.0
[1]
659
Immunisation
Form
Strength
Route of
administration
Recommended dosage
Duration
250
International
units
IM
Stat
5. Follow up
Review wound See Acute wounds
If TIG or vaccine given notify primary health care provider
If catch-up schedule required arrange / confirm next visit to complete
immunisation course
Promptly report any significant adverse event following immunisation (AEFI)
directly to Queensland Health by completing an AEFI form available at
www.health.qld.gov.au/immunisation/documents/adverse_event_immun.pdf
and fax to number on form. Queensland Health will forward on to the TGA.
There is no need to complete a TGA form.
If practising outside Queensland report directly to the TGA Australian Adverse
Reaction Reporting System available at www.tga.gov.au/hp/problem.htm
6. Referral / consultation
Consult MO / Public Health Unit as above
References
1.
Australian Government (2013). "The Australian Immunisation Handbook 10th edition." Retrieved April, 2013.
660
Uncontrolled
Controlled copy
copy
V1.0
Appendices
Appendices
Contents
1. Medication reconciliation
2. Medication history checklist
3. Management of patient death
4. Glasgow coma scale / AVPU
662
Uncontrolled
Controlled copy
copy
V1.0
Appendix 1
Medication reconciliation
Medication reconciliation
Medication reconciliation: 4 simple steps to improve patient safety
Matching up medicines that the patient should be prescribed with those that are actually
prescribed is a process called medication reconciliation. This can help ensure continuity of
care and prevent harm by reducing the opportunity for medication errors [1].
This table has been adapted from the MATCH UP medicines: A guide to medication reconciliation brochure
produced by the ACSQHC [1]
Uncontrolled
Controlled copy
copy
V 1.0
663
Appendix 2
References
1. Australian Commission on Safety and Quality in Healthcare (2013). "MATCH Up medicines: A guide to
Medication Reconciliation ". Retrieved September, 2013, from http://www.safetyandquality.gov.au/ourwork/medication-safety/medication-reconciliation/match-up-medicines/
664
Uncontrolled
Controlled copy
copy
V1.0
Appendix 3
2.
A decision must be made if the death is a reportable death in accordance with the
Coroners Act 2003. Criteria for a reportable death may be found at:
www.courts.qld.gov.au/courts/coroners-court/forms
Where the death is considered a reportable death or if unsure and there is a need to
seek Coroners advice, complete a Form 1a: Medical Practitioner Report of Death to
the Coroner and fax / scan / email to the Coroner found at:
www.courts.qld.gov.au/courts/coroners-court/forms
3.
Where the death is not a reportable death a Form 9 Death Certificate can be completed
by an MO only
4.
An MO is not to complete a Form 9 Death Certificate for a reportable death, this must
be completed by the Coroner
5.
Where the death is a perinatal death (baby at least 20 weeks gestation or 400 grams
weight and died within 28 days after birth) a Perinatal Supplement to Cause of Death
Certificate must also be completed. This is a Form 9a
6.
7.
Where a deceased person requires transport, funeral directors may require an Authority
to Transport - check Hospital and Health Service forms
8.
9. All inpatient deaths in Queensland Health facilities and non inpatient deaths where the
patient was treated by a Queensland Health facility within the last 30 days are subject
to a local death review process. Contact the Hospital and Health Service Director of
Medical Services for more information and applicable forms.
Uncontrolled
Controlled copy
copy
V 1.0
665
Appendix 3
Deceased person
Not reportable
Perinatal death
Form 9 and Form 9a
Resources
Queensland
Coronial management resources
http://qheps.health.qld.gov.au/psq/coronial/resources.htm
New South Wales
www.health.nsw.gov.au/aboutus/legal/death.asp
PD2012_036 Death - Extinction of Life and the Certification of Death - Assessment
www.health.nsw.gov.au/policies/PD/2012/PD2012_036.html
Victoria
Coroner court
www.coronerscourt.vic.gov.au
Coroner clinical liaison service
www.health.vic.gov.au/cls/index.htm
666
Uncontrolled
Controlled copy
copy
V1.0
Appendix 4
(GCS)
Child
2 - 5 years
Eyes open
Best verbal
response
5. Fully orientated
4. Confused, disorientated:
not sure of their name or
where they are or what
happened
3. Inappropriate
meaningless words
2. Incomprehensible noises
- grunts, moans
1. No sounds
Best motor
response
6.
5.
4.
3.
2.
1.
Obeys commands
Localises to pain
Withdraws to pain
Flexor response to pain (bends arm or leg)
Extensor response to pain (straightens arm or leg)
No response
Infant
0 - 23 months
Scale
Alert
Responds to Verbal statement
Responds to Painful stimuli
No response (Unresponsive)
References
1.
UpToDate (2013). "Glasgow coma scale." Retrieved March, 2013.
2.
Children's Coma Scale (Modified Glasgow coma scale Adelaide Coma Scale Paediatric Coma Scale).
Retrieved March, 2013
Primary Clinical Care Manual 2013
Uncontrolled
Controlled copy
copy
V 1.0
667
Index
Index
A
ABCD tool
100
Abscess
- dental
276
- skin
321
- tonsils
adult
258
child
573
Abdominal injuries - adult / child
122
Abdominal pain - adult / child
178
Abdominal pain female
- pelvic inflammatory disease (PID)
528
Abuse and neglect - child
645
Acute coronary syndrome (ACS)
79
Acute gastroenteritis and dehydration - child 615
Acute hypertensive crisis
93
Acute otitis media with acute perforation
598
Acute otitis media without perforation
595
Acute post streptococcal glomerulonephritis
(APSGN)
583
Acute pulmonary oedema
87
587
Acute rheumatic fever (ARF)
- prophylaxis for acute rheumatic fever
358
Acute upper airway obstruction and choking
55
Acute wounds
139
Adult Deterioration Detection System
(ADDS)
10, 11
Advanced life support flowchart
- adult
39
- child / infant
40
Advice to patients who have received
an injury to the head
117
Aerosol sniffing
222
Airway obstruction
55
Alcohol
- intoxication
408
- misuse
403
- related epigastric pain
182
- withdrawal
411
Alcoholic beverages - standard drinks
406
Alginate dressings
346
Allergic conjunctivitis
304
Allergic reaction
255
- mild / moderate
- severe
58
Altered level of consciousness
- adult / child / infant
49
Amputation
144
Anaphylaxis
58
- flowchart
60
Anaphylaxis and severe allergic reaction
58
Anaemia - child
635
Analgesia
- simple
back
cover
front
fold
out
Angina
79
Ankle sprains
135
Animal bites
152
Antenatal care
425
Antepartum haemorrhage
449
Antivenom
- box jellyfish
240
668
- snake polyvalent
Anxiety disorders
Arterial occlusion, acute
Assesment of
- adult
- child
- lower limb ulcers
- mental health
- the ear
- the eye
- skin, hair and nails
- suicide risk
- hydration in child
Asthma
- acute - adult / child
- chronic - adult / child
229
396
95
9,11
9, 557
345
369
591
286
314
374
616
70
360
B
Back slab
- splinting for limb injuries
Bacterial
- conjunctivitis
- sinusitis
- skin infections
- vaginosis
Bacteriuria in pregnancy
Barmah Forest Virus
Basic life support flowchart
- adult / child / infant
Bends, the
Bite
- animal
- bat
- human
- snake
- sea snake
- spider
- funnel web (big black) spider
- redback spider
- centipede
- tick
Birth and labour
Bleeding in pregnacy
- after 20 weeks gestation
- before 20 weeks gestation
Blood pressure in pregnancy
Bluebottle sting
Blue-ringed octopus
Blunt eye injury
Boils
Bone infection
Bowel obstruction
Box jellyfish
- sting
- antivenom
Breast abscess
Breathlessness
Broken rib
Broken teeth
Bronchiolitis
Bronchitis
- adult
Bullrout sting
Uncontrolled
Controlled copy
copy
V1.0
129
301
261
315
521
451
355
34
168
152
155
152
226
226
230
231
233
235
236
463
449
445
441
243
245
295
320
643
188
238
240
486
76
111
269
579
258
246
Index
Burns
- assessment
- dressings
- major
- minor
- referral criteria
- rule of nines
- total body surface area
158
163
159
163
157
158
158
C
Candidiasis (thrush)
- oral
283
- vaginal
523
Cannabis
221
Carbon monoxide - poisoning
208
Carbuncles
320
Cardiac
- arrest
35
- arrhythmias
91
Cardiorespiratory arrest - child / adult
35
Care of the newborn
470
Catfish sting
246
Caustic substances
209
Cellulitis
- orbital
300
- skin
322
Centipede bites
235
Cervical spine fractures
120
Charcoal, activated
199
Chemical burns
- eyes
293
- skin
165
Chest
- injuries
110
- pain
79
Children's Early Warning Tools (CEWT) 10, 557
Child with
- abdominal pain
569
- chronic diarrhoea
570
- cough
566
- fever
565
- stridor
567
- vomiting
568
Chironex fleckeri sting
238
Chlamydia
- chlamydia / gonorrhoea / trichomonas
517
Chlamydial conjunctivitis
304
Choking flowchart 55
Cholesteatoma 608
Chronic
- asthma
360
- COPD
361
- diabetes
365
- heart disease
364
- hypertension
362
- hypertension in pregnancy
445
- kidney disease
363
- suppurative otitis media
603
- wounds
343
Ciguatera poisoning
251
Cleaning ears with chronic discharge
606
Clinical Care Guidelines (CCG)
3
Clinically infected wounds
348
Primary Clinical Care Manual 2013
Cold, common
258
- adult
- child
573
Collapsed patient
33
Combined hormonal contraception
492
Communicable diseases
- Barmah Forest Virus
355
- dengue
356
- hepatitis A
351
- hepatitis B
352
- hepatitis C
354
- Ross River Fever
355
Compartment syndrome
136
Compound fractures
130
Condoms
505
- education
515
Cone shell envenomation
245
Conjunctivitis
- allergic
304
- bacterial
301
- chlamydial
304
- gonococcal
304
- viral
302
Consciousness
- altered level of consciousness
49
- unconsciousness
49
- glasgow coma scale / AVPU
667
Constipation - child
628
Consulting the Medical Officer (MO) 17, 20, 564
Contact tracing / partner notification
514
Contraception
490
- barrier methods
505
- combined hormonal
492
- condoms
505
- diaphragm
505
- emergency
503
- IUCD
506
- long-acting hormonal
500
- missed pill flowchart
496
- natural
507
- progestogen only pill
498
- sterilisation
507
- sub-dermal progestogen implant
503
Convulsions
62
Cord prolapse, umbilical
461
Corneal
- abrasion
290
- ulceration
306
Coroner
665
Criteria for Early Notification for Interfacility
Transfer
106
Croup
578
Cultural considerations
- mental health
371
- alcohol misuse
404
Cyanide poisoning
209
Cystitis
- in pregnancy
451
D
Death - patient
Decision making for escalation and
CT scanning
Uncontrolled
Controlled copy
copy
V 1.0
665
118
669
Index
Decompression illness (DCI)
- the bends
168
Dehydration - child
615
Delirium
386
Dementia
388
Dengue fever
356
Dental
- abscess
276
- gingivitis
281
- gum disease
281
- haemorrhage
279
- toothache
273
- trauma
269
Dental pain presentation flowchart
274
Depression
- adult / child
392
- perinatal
392, 426, 489
Diabetes
- adult / child
365
- infection in foot
340
- osteomyelitis in foot
342
- diabetes in pregnancy
433
- gestational
435
- type 1 / type 2
436
Diabetic ketoacidosis
66
Diagnostic and pathology services
- adult
16
- child
564
Diarrhoea - child
570, 615
Differential diagnosis for unconsciousness 51
Digital nerve block
146
Dislocations
134
Domestic violence
428
Donovanosis 533
Dressings
- alginate
346
- acute wounds / minor burns
163
- cadexomer iodine
347
- film
346
- foam
347
- hydrocolloid
346
- hydrofibres
346
- hydrogel
346
- hypertonic saline
347
- medical honey
347
- silicone
347
- silver impregnated dressings
347
Drowning
75
DRS ABCD resuscitation
33
Drug induced psychosis
390
Drug Therapy Protocol (DTP)
2
Dry socket (alveolar osteitis)
280
Dysuria
- adult
311
- child
641
- in pregnancy
451
608
- cholesteatoma
- chronic suppurative otitis media
603
- cleaning ears with chronic discharge
606
- discharge in the presence of grommets 607
- discharging and non-discharging
598, 601
- dry perforation
607
- ear wick technique
611
- foreign body / insect
613
- glue ear
601
- infections
593
- otitis externa
610
- otitis media with effusion
601
- traumatic rupture of eardrum
613
Eating disorders
399
Eclampsia
442
Ectopic pregnancy
446
Electric shock
92
Electrocution
92
Emergency contraception
503
Envenomation
- box jellyfish
238
- marine
238
- scorpion and centipede
235
- spider
230
- snake and sea snake
226
Environmental emergencies
- decompression illness
168
- heat exhaustion / heat stroke
172
- hypothermia
170
Epididymo-orchitis
524
Epigastric pain, alcohol related
182
Epiglottitis
578
Epilepsy
- febrile convulsions
62
- fits / convulsions / seizures
62
Episcleritis
307
Episiotomy and repair of perineum
480
Epistaxis
175
Epithelialising superficial wounds flowchart 348
Erysipelas, cellulitis
322
Essential guidelines for assessment
of lower limb ulcers
345
Eye
- blunt injury
295
- chemical burn
293
- conjunctivitis
301
- examination
286
- flash burn
292
- foreign body
290
- iritis, acute
308
- padding
287
- penetrating injury
297
- red painful
289
- sudden loss of vision
299
- ulceration
306
Evacuation by air
21
Eyelid eversion, procedure for
288
E
F
Ear
- acute mastoiditis
- acute otitis media with perforation
- acute otitis media without perforation
- assessment of the ear - adult / child
670
609
598
595
591
Uncontrolled
Controlled copy
copy
V1.0
632
62
565
155
Index
Fish hook - removal of
Fish stings
Fits
- alcohol withdrawal
- convulsions / seizures
- decompression illness
- diabetic ketoacidosis
- during pregnancy
- headache, acute / chronic
- hypoglycaemia
- meningitis - child
- mental health behavioural emergencies
- petrol / glue / aerosol sniffing
- poisoning / overdose
- unconscious / altered level of consciousness
Flail chest
Flash burn to eye
Foam dressings
Focussed Assessment with
Sonography for Trauma (FAST)
Folliculitis
Foreign body
- eye
- ear
Forensic medical examination
Fractures
- compound
- jaw
- mandible
- pelvis
- simple
Fungal skin infections
- tinea / ringworm
- candidiasis
- tinea versicolor / pityriasis versicolor
Fungating wounds
Funnel-web (big black) spider
Furunculosis
147
246
411
62
168
66
442
267
68
571
379
222
196
49
110
292
347
103
320
290
613
553
130
132
132
131
125
326
328
330
350
231
320
G
Gastroenteritis and dehydration - child
615
Gastrointestinal bleeding
185
Genital sores / ulcers
533
Genital ulcer disease (GUD)
- management guidelines flowchart
535
Genital warts
544
- human papilloma virus (HPV)
544
Gestational diabetes mellitus
435
Giardiasis
623
Gingivitis
281
Glaucoma, acute
309
Glasgow coma scale (GCS)
667
Glucose
- hypoglycaemia
68
- in pregnancy
429, 430, 431
Glue ear
601
Glue sniffing
222
Glyceryl trinitate (GTN)
- acute pulmonary oedema
89
- chest pain
84
Gonorrhoea
- chlamydia / gonorrhoea / trichomonas
517
Granulating wounds
349
Primary Clinical Care Manual 2013
Group A streptococcal
- acute post streptococcal glomerulonephritis
- acute rheumatic fever
- respiratory
adult
child
- skin adult / child
Group B Streptococcus prophylaxis
Gum disease
583
587
258
573
315
453
281
H
Haemorrhage
- antepartum
449
175
- nose
- postpartum
475
- tooth
279
139
- wounds, acute
Haemothorax
110
Hair jellyfish
244
Haloperidol overdose
205
Headache
- acute
267
- chronic
267
- subarachnoid haemorrhage (SAH)
98
Head injuries
114
- decision making tool for CT scan
118
- patient advice
117
Head lice
- nits
336
Head to toe assessment
104
Health check - women
421
Health (Drugs and Poisons) Regulation 1996
1
3
Health Management Protocol (HMP)
Heart
- disease, chronic
364
87
- failure
Hepatitis, acute
-A
351
-B
352
-C
354
Heat
- exhaustion
172
- stroke
172
Heroin overdose
215
Herpes 533
High risk pregnancy management
427
History and physical examination
- adult
11
- child
557
History taking
- adult
12
- child
559
- mental health
369
- sexual health
510
Human papilloma virus (HPV)
544
Honey - medical
347
How to collect a wound swab / culture
348
How to do an STI check
510
How to make a report to Child Safety Services 649
How to prepare suitable fluid
for rehydration - child
617
Uncontrolled
Controlled copy
copy
V 1.0
671
Index
Human immunodeficiency virus (HIV)
- test results
Human (tooth-knuckle) injury
Hydration - child
Hyperglycaemia
- diabetic ketoacidosis
Hypertension
- chronic
- crisis
- in pregnancy
Hyperthermia
Hypnotics
Hypoglycaemia - adult / child
Hypotension
- shock
Hypothermia
Hypoxia
- O2 delivery systems
546
547
152
615
66
362
93
440
172
224
68
52
170
41
- toenail
155
- trauma and injuries
102
Insomnia
401
Intraosseous
- infusion
46
- insertion
47
625
Intestinal worms
Intrauterine contraceptive device (IUCD) 506
Intussusception
631
Iritis - acute
308
Irukandji syndrome
241
Iron
- injection
639
J
Jellyfish stings
Jimble sting
Joint infections - child
238
244
643
I
Identification Situation Observation Background
Responsibility (ISOBAR)
20
Immunisation program
653
- sexual health immunisation - adult
656
- tetanus immunisation
658
Impetigo
315
Ineffective cough
57
Infections
- acute post streptococcal glomerulonephritis 583
- acute rheumatic fever
587
- bone and joint - child
643
- ear
593
- eye
301
- group B streptococcus
453
- marine
149
- mastitis
486
- menigitis
571
- mouth
274
- respiratory
adult
258
child
573
- sexually transmitted
509
- skin
315
- to foot in patient with diabetes
340
- urine
adult
311
child
641
pregnancy
451
Influenza
adult
258
child
573
immunisation
653
Inflamed gums
281
Injections
- iron
639
Injuries
- burns
156
- eardrum
613
- eye
295, 297
- fingernail
155
- sea urchin
250
- stingray
248
- teeth
269
672
K
Ketoacidosis
Kidney disease - chronic
66
363
L
Labour and birth
- 1st stage
463
- transition
467
- 2nd stage
467
- birth
468
- care of the newborn
470
Lactose intolerance
622
Laryngeal mask airway (LMA) - insertion of 44
Left ventricular failure
87
Leprosy
331
Log roll
121
Long-acting hormonal contraception (DPMA) 500
Loss of vision - sudden
299
Low blood glucose
68
Low abdominal pain in female
- pelvic inflammatory disease (PID)
528
M
Magnesium sulfate in pregnancy
Major burns
Malodourous wounds
Mania
Marine envenomation
Marine lacerations
Mastitis
Mastoiditis
Mauve stinger
Medication reconciliation
Medication history checklist
Meningitis
Mental Health Act (2000)
Mental health
- behavioural emergencies
- presentations, history and assessment
Uncontrolled
Controlled copy
copy
V1.0
444
159
350
395
238
149
486
609
244
663
664
571
382
379
369
Index
- risk screening tool
- suicide risk assessment
Mental state examination (MSE)
Mild and moderate allergic reaction
Minor burns
Miscarriage
Missed pill - flowchart
Monoarthritis
Mood disorders
- anxiety
- depression
- mania
- perinatal depression
Mouth ulcers
Mulga stick injury - see acute wound
Myocardial infarction
372
374
372
255
163
447
496
643
396
392
395
392
275
140
79
603
594
220
207
200
201
203
205
205
222
213
215
215
206
215
41
Nail
- fingernail
155
- toenail
155
Naloxone
- adult
216
- newborn
484
Nappy rash
338
Natural methods, contraception
507
Neck injuries
120
Needle thoracentesis
112
Neglect, abuse and - child
645
Neonatal
- respiratory distress syndrome
460
- resuscitation
482
Neurological examination
- Glasgow coma scale (GCS) / AVPU
667
Neuropathic ulcer
345
Newborn baby care
470
Newborn life support flowchart
485
Nifedipine in pregnancy
443, 459
Nitrous oxide
466
Nits
336
Non accidential injury - child
645
Non shockable rhythm
36
Nose bleed
175
Non-steroidal anti-inflammatory drugs (NSAID) 214
Nutrition during / after gastroenteritis
621
- chronic suppurative
- recurrent, acute
Overdose
- amphetamines
- aspirin
- anticholinergic agents
- anticonvulsants
- antidepressants
- antihistamines
- antipsychotics
- gamma-hydroxybutrate (GHB)
- lithium
- methadone
- morphine
- olanzapine
oxycodone
Oxygen (O2) delivery systems
432
112
215
283
300
216
342, 643
417
610
595
598
601
Pain
- chest
- dental
- eye
- headache
- in labour
- in trauma and injuries
- management, interfacility transfer
Pap smear collection
Parasites
- crusted scabies
- norwegian scabies
- scabies
Paracetamol - poisoning
Patient death - management of
Patient presentation and assessment
Patient transport
Pelvic inflammatory disease (PID)
Penetrating eye injury
Penile discharge
- chlamydia / gonorrhoea / trichomonas
Perinatal depression
Periorbital cellulitis
Periodontal disease
- gum disease / gingivitis
- periodontitis
Pertussis (whooping cough)
Petrol / glue / aerosol sniffing
Pharyngitis
- adult
- child
Physical examination
- adult
- child
Physical restraints, mental health
Pityriasis versicolor
Placenta
- delivery
Plaster back slab
- splinting for limb injuries
Pneumonia
- adult
- child
Uncontrolled
Controlled copy
copy
V 1.0
79
273
286
267
465
107
25
422
333
333
333
218
665
9
21
528
297
517
392
300
281
281
576
222
258
573
11
557
385
330
471
129
262
580
673
Index
Pneumothorax
- open
112
- simple
112
- tension
112
Poison Information Centre (PIC)
196
Poisoning
- anticholinergic
200
- anticonvulsants
201
- antidepressants
203
- antihistamines
205
- antipsychotics
205
- aspirin
207
- carbon monoxide / cyanide
208
- hydrocarbons
211
- iron
212
- organophosphates
216
- opioids
215
- paracetamol
218
- recreational drugs
220
- risk assessment
197
Poisoning and drug emergencies
196
Poisoning / overdose general approach
196
Police
- mental health
375, 385
- sexual assault
550
- child sexual assault
647
Polyarthralgia
643
Polyarthritis
587
Post extraction haemorrhage
279
Postnatal check up
488
Polyvalent snake antivenom
229
Postpartum haemorrhage (PPH)
- primary
475
- secondary
479
Pre-eclampsia
442
Pregnancy
425
- antenatal care
- antepartum haemorrhage
449
- blood pressure flowchart
441
- cord presentation
461
- diabetes, gestational, type 1 and 2
433
- eclampsia
442
- ectopic
446
- fitting
442
- group B Streptococcus
453
- haemorrhage
postpartum (PPH)
475
antepartum (APH)
449
- hypertension disorders
439
- incidential bleeding
447
- mastitis
486
- miscarriage
447
- obstetric risk score
432
- postnatal check up
488
- pre-eclampsia
442
- preterm labour, suppression of
457
- preterm prelabour rupture of membranes 455
- protocol for commencing insulin
437
- Rh D immunoglobulin
472
- umbilical cord presentation / prolapse
461
- urinary tract infection, in
451
- vaginal bleeding, in early pregnancy
445
426
Pregnancy Health Record
Pressure immobilisation bandaging
227
Preterm prelabour rupture of membranes 455
674
460
102
475
498
437
390
390
87
37
311
641
451
630
Q
Queensland Emergency Medical System
(QEMS)
18
Quinsy
260, 575
R
Rape and sexual assault
550
Recognition and management of the
deteriorating patient
10
Rectal bleeding
186
Redback spider bite
233
Removal of
- tick
236
- tight ring
148
- small embedded fishhook
147
Renal colic
189
Repair of perineum
480
Respiratory tract infection
- adult
258
- child
573
Resuscitation 33
Retention of urine
192
Rheumatic fever
- acute
587
- prophylaxis
358
Rh D immunoglobulin
472
Rickettsia
236
Ringworm
326
Risk screening tool
- obstetric
432
- suicide
374
Ross River Fever
356
Routine antenatal tests
428
Royal Flying Doctor Service (RFDS)
18
Rule of nine, burns
158
Rupture of membranes, preterm
455
S
Salbutamol
Scabies
Schizophrenia
Scleritis
Scope of practice when administering
and supplying medicines
Uncontrolled
Controlled copy
copy
V1.0
73
333
390
307
1
Index
Scratches
155
- bat, flying fox
Scrub typhus
236
Sea snakebite
226
Sea urchin sting
250
Secondary postpartum haemorrhage
479
Secondary prophylaxis
- for acute rheumatic fever
358
Secondary survey
103
Sedation score
26, 383
Seizures, fits / convulsions
62
Self harm
376
Septic arthritis
- child
643
Sexual assault - adult / child
550
Sexual health immunisation program
656
Sexually transmitted infections (STIs)
- chlamydia
517
- contact tracing
514
- donovanosis
535
- education, prevention, condoms
515
- epididymo-orchitis - adult
524
- herpes
533
- HIV infection
546
- how to do an STI check
510
- genital sores / ulcers
533
- genital warts
544
- gonorrhoea
517
- pelvic inflammatory disease (PID)
low abdominal pain in female
528
- STI specimen collection - female
513
- STI specimen collection - male
512
- STI HMP selection flowchart
516
539
- syphilis
- trichomonas
517
- when to test for STIs
510
Shock
52
Shockable rhythm
35
76
Shortness of breath
Simple fracture
125
Simple pneumothorax
112
Sinusitis
261
Skin glue
145
Skin infections
- assessment
314
- bacterial
315
- fungal
326
- parasites
333
Skin parasites
333
- head lice
336
- nits
336
- scabies
333
Sleep problems - insomnia
401
Sloughy or necrotic wounds
349
Smoking, tobacco
414
Snakebite
226
Snake venom detection kits (SVDK)
228
Sniffing - aerosol / glue / petrol
222
Soft tissue injury
135
Sore throat
- adult
258
- child
573
Specific poisons
200
Primary Clinical Care Manual 2013
Spider bites
- general
- funnel-web (big black)
- redback
Spinal injuries
Splint - limb
Sprains
Standard clinical observations
- adult
- child
Standard drinks - chart
Standard vaccination procedures
Sterilisation - contraception
Stingray injuries
Stings
- bullrout
- cat fish
- fish
- jellyfish
bluebottle
box
hair
irukandji
jimble
mauve
other
- stingray
- scorpion
- sea urchin
- sponges
- stonefish
Stridor - child
Stroke
Subarachnoid haemorrhage
Sub-dermal progestogen implant
Submersion
Substance misuse
- alcohol
- other drugs
- tobacco
Subungual (fingernail / toenail) haematoma
Sudden loss of vision
Suicide
- behaviour or risk
- risk assessment guide
Superficial wounds
- epithelialising
Suppurative otitis media
Suturing
Swimmer's ear
Sydenhams chorea
Syphilis
230
230
231
233
120
129
135
11
560
406
653
507
248
246
246
246
243
238
244
241
244
244
244
248
235
250
250
246
567
99
98
503
75
403
417
414
155
299
376
374
348
603
143
610
587
539
T
Teeth
- broken
- displaced
- trauma
Temperature
- control in very premature newborn
Tension pneumothorax
Terminology
Testicular / scrotal pain
Tetanus immunisation
Uncontrolled
Controlled copy
copy
V 1.0
269
269
269
483
105
xxiv
193
658
675
Index
Thrush
- oral
- skin
- vaginal
Tick
- paralysis
- removal
- typhus
Tinea
Tobacco smoking
Tonsillitis
- adult
- child
Tooth
- abscess
- ache
- avulsed
- broken
- displaced
- trauma
Total Body Surface Area (TBSA)
- assessment
Tooth-knuckle injury
Toxinology (bites and stings)
Trachoma
Transient ischaemic attack (TIA)
Transition - in labour
Trauma and injuries
Traumatic rupture of the eardrum
Trauma to teeth
Trichomonas
- chlamydia / gonorrhoea / trichomonas
Tropical ear
Tubal / ectopic pregnancy
Tuberculosis
Type 1 diabetes in pregnancy
Type 2 diabetes in pregnancy
283
328
523
236
267
236
326
414
258
573
276
273
269
269
269
269
158
152
226
305
99
467
102
613
269
517
610
445
265
433
433
U
Ulcer
- arterial
345
- genital
533
- lower limb
345
- mouth
275
- neuropathic
345
- venous
345
Umbilical cord presentation / prolapse
461
Unconscious / altered level of consciousness 49
Unstable angina
79
Upper airway obstruction
55
Upper gastrointestinal bleeding
185
Upper respiratory tract infection (URTI)
- adult
258
- child
573
Urethral discharge / dysuria
- chlamydia / gonorrhoea / trichomonas
517
Urinary tract infection (UTI)
- adult
311
- child
641
- in pregnancy
451
- cystitis in pregnancy
451
676
V
Vaccination procedures
Vaginal discharge
- see chlamydia / gonorrhoea / trichomonas
Vaginal bleeding
Vaginitis
- see chlamydia / gonorrhoea / trichomonas
Vaginosis - bacterial
Venous ulcer
Viral conjunctivitis
Vision loss
Vitamin K
Vomiting
- child with
- dehydration
- flowchart
- gastroenteritis
- lactose intolerance
- pyloric stenosis
Vomiting and diarrhoea - child
653
517
445
517
521
345
302
299
472
568
615
568
615
622
630
615
W
Warts
- genital
Whooping cough
Withdrawal, alcohol
Women
- health check
Worms - intestinal - adult / child
Wounds
- acute
- chronic
- dressings
- epithelialising superficial
- fungating
- granulating
- how to collect a wound swab / culture
- infected
- malodorous
- management - in burns
- necrotic
- sloughy
- superficial
544
576
411
421
625
139
343
346
348
350
349
348
348
350
163
349
349
348
Uncontrolled
Controlled copy
copy
V1.0
Simple analgesia
Simple analgesia
Schedule
Paracetamol
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Adult and child 12 years
1 - 2 tabs every 4 - 6 hours
Stat
to max. 8 tabs / day (4 g daily)
Tablet
500 mg
Oral
Further doses on
Child 7 - 12 years
MO / NP orders
- 1 tab every 4 - 6 hours
to a max. 4 times / day
120 mg / 5 mL
(24 mg / mL)
Suspension
or
100 mg / mL
drops
Child
15 mg / kg / dose to a max of 1 g
every 4 - 6 hours if necessary
to a max. of 4 times per day
Oral
Stat
Further doses on
MO / NP orders
125 mg
250 mg
500 mg
Rectal
Children 7 - 12 years
250 - 500 mg
Stat
Warning: the paracetamol content of all medicines the patient may have taken at home
must be considered [1]
Simple analgesia
Paracetamol 500 mg /
DTP
Codeine phosphate 15 mg
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Form
Strength
Recommended dosage
Duration
administration
Schedule
Tablet
3*
500 mg / 15 mg
Oral
Stat
Adult and child 12 years
1 - 2 tablets every 4 - 6 hours
Further doses on MO /
up to a max. of
NP orders
8 tablets / day
Provide Consumer Medicine Information: May be taken with or without food. Avoid repeated doses if at all
possible, particularly if breastfeeding and infant is less than 1 month old [4]. Reduce the dose in people who
have significant liver disease, are malnourished, or small size or in frail older patients under 45 kg
Management of associated emergency: consult MO See Poisoning / overdose - opioids
[3]
*Note
Codeine phosphate 15 mg contains less than 12 mg of anhydrous codeine. The Standard
for the Uniform Scheduling of Medicines and Poisons (Australian Government) No 2 2011
states preparations containing 12 mg or less of anhydrous codeine are Schedule 3
DTP
IHW / IPAP
Authorised Indigenous Health Worker and Isolated Practice Area Paramedic may proceed
RN and SM R&IP See Scope of practice when administering and supplying medicines
Route of
Recommended dosage
Duration
Form
Strength
administration
Stat
Adult
Tablet
200 mg
Oral
400 mg
Further doses on MO /
NP orders
Precautions: do not use in patients: with asthma, renal disease, heart disease, GI bleeding conditions,
significant liver disease, coagulation disorder; who are dehydrated, pregnant, lactating; who are taking
ACE-inhibitors, angiotensin receptor blockers (ARB), diuretics, warfarin or lithium
Provide Consumer Medicine Information
Management of associated emergency: consult MO
[1]
Schedule
Ibuprofen
References
1.
Therapeutic Guidelines (2012). "Stepwise approach to acute pain management." Retrieved December,
2012.
2. Therapeutic Guidelines (2012). "Pharmacological management of pain in children: paracetamol."
Retrieved December, 2012
3.
Australian Medicine Handbook (2012). "Codeine." Retrieved January 2013.
4.
Therapeutic Guidelines (2013). "Drugs and their categories in pregnancy and breastfeeding."
Retrieved March, 2013
2